Extracellular DNA in head and neck biofilms by Shields, Robert Colquhoun.
  EXTRACELLULAR DNA IN 
HEAD AND NECK BIOFILMS  
 
 
 
 
 
 
Robert Colquhoun Shields 
 
A thesis submitted for the degree of Doctor of Philosophy 
 
School of Dental Sciences 
Institute for Cellular and Molecular Biosciences 
 
296 Pages / 93,264 Words 
 
May 2014
i 
 
Acknowledgements 
 
I would like to begin by thanking Prof. Grant Burgess for providing me with the 
opportunity to start an MPhil. We always had the intention of me expanding onto a PhD 
and Grant helped facilitate that. Ever since I saw Grant give a lecture, when I was 
studying for a marine biology degree, I have admired his intelligence and eccentricity. 
In that lecture he stood on top of a table to prove a point about biofilms, exciting and 
inspiring. Obviously, I cannot go too much further without expressing my utmost thanks 
to Dr. Nick Jakubovics. Again, Nick helped me move from an MPhil to a PhD but 
above all he has been a true friend. Nick’s office is always open to me, and within it I 
absorb ideas that I wish I’d thought of. He is an exceptional scientist, and I’ve learnt so 
much from him. Actually, the idea of researching elsewhere has made me wonder what 
I’ll do without that office inspiration. However, I know that Nick will always help me in 
whichever way he can. I would also like to extend my thanks to my other supervisors, 
Dr. Michael Hall and Mr. Mohamed Reda ElBadawey. In particular, Mohamed was 
always pleasant to be around and made my trips to the Freeman Hospital enjoyable. I 
cannot forget to thank Mr. John Evans and Prof. Peter Olive too, both important people 
who nurtured my scientific character. 
Of course, when you work in a research laboratory for three years you meet many 
people who provide moments of friendship and advice. I started in Nick’s laboratory 
group as the only PhD student but it has quickly grown. I would like to thank everyone I 
met in the Level 7 Oral Biology Laboratory but in particular I have to thank Dr. Helen 
Bosomworth and Jill Robinson (soon to be Dr.) for their support. Laboratory time 
passed much quicker when having a laugh. Helen finished a year before me, so I gained 
a lot of research knowledge from her. Myself and Jill have been to a few scientific 
meetings, from Warwick, to Ghent and they were always enjoyable in her company, 
even if she does not like flying! Thank you to Lesley Old for always keeping me tidy, 
and teaching me how to do many things, like pouring agar plates! Other  people to thank 
include, Rachel, Katrin, Sufian, Suhair, Richard, Syatirah, Nine, Tim, Philippa, Sophie, 
Ted, Adam, David, Andrew, Hilary, Lucy, Helen, and Norehan. Also thank you to Max 
for his great humour, Ralf for his advice, Pam for her chats, Karen for her moans, Mark 
for much more than IT, and Ruth for letting me borrow her socks! 
I’d like to thank the Society for General Microbiology for providing the funding for 
my research visit to the University of Michigan. Thanks also to my supervisors Dr. Nick 
Jakubovics and Dr. Alexander Rickard for facilitating the collaboration. I had a fantastic 
ii 
 
stay in Ann Arbor and thanks are due to the laboratory members there, particularly 
Derek Samarian but also Andrew, Mark, Amala, Ethan, Katie, Kate, Ting, Jean, Erika, 
Hanna, and Ella. I can’t also forget to mention the lads that I cycled with out there from 
the Ann Arbor Velo Club and the University of Michigan Cycling Team. Tim, Danny, 
Patrick, John, Kurt and Matt all made my research visit that bit easier. 
I would struggle without the support of my friends and family. I’ve met many friends 
whilst in Newcastle but those that stand out to me are Steven and Lynne, David, Nick, 
Joe, Daniel and Aidan. Friends hopefully for many years to come, and some bicycle 
rides yet to share. Ultimately, I wouldn’t be the person I am without the love of my 
parents and my kid sister, Gemma. My Mum and Dad have always tried to help me 
wherever possible. They’ve worked incredibly hard, and moved great distances to make 
sure myself and Gem can succeed in life. Wherever I am in the World I know that 
they’d help me out at the drop of a hat, or welcome me into their home with open arms. 
An important part of their parenting philosophy is to try and help Gem and I achieve 
more than they have. Another key person in my life is my wonderful friend Lorna. 
We’ve shared four years together and she is always the first person to tell me how smart 
I am, or how hard I work. I don’t recognise those traits in myself but I’m always glad 
for her support. It was a joy to marry you and now let’s spend a life together!  
 
 
 
iii 
 
Abstract 
 
Extracellular DNA (eDNA) is a ubiquitous component of the extracellular matrix of 
microbial biofilms. It has a number of functions that include a role as an adhesin during 
biofilm attachment, and facilitating matrix stability in mature biofilms. Increasingly, 
deoxyribonuclease (DNase) enzymes have been shown to reduce the colonisation of 
many microbial biofilms, both bacterial and fungal. Biofilms are estimated to be 
responsible for around 60% of bacterial infections, including many chronic diseases. 
The aim of this work was to determine the role of eDNA in chronic mixed-species 
biofilm infections, and to explore the potential of DNase enzymes for biofilm control. 
This included three major areas of research, focusing on chronic rhinosinusitis, 
tracheoesophageal speech valves (TESVs), and dental plaque. An important aspect was 
to test the efficacy of a novel bacterial nuclease, NucB, isolated from a seaweed-
associated strain of Bacillus licheniformis, against microbial biofilms. 
The colonisation of speech valves by micro-organisms was studied using scanning 
electron microscopy (SEM). In keeping with previous observations, these biofilms were 
co-aggregations of fungal and bacterial species. Using confocal laser scanning 
microscopy, eDNA was observed in the biofilm matrix. Extracellular DNA was 
extracted and quantified from TESV biofilms. All six biofilms studied had detectable 
nucleic acids, as measured by NanoDrop spectrophotometry. The eDNA was apparently 
heavily degraded, and produced smears by agarose gel electrophoresis. Nevertheless, 
eDNA appeared to be providing biofilm stability since micro-organisms were liberated 
from the surface of the valves following treatment with NucB in over 60% of the 
TESVs tested.  
To assess the role of eDNA in biofilms associated with chronic rhinosinusitis, 
‘obstructive mucin’ and sinus mucosa biopsy samples collected during functional 
endoscopic sinus surgery at the Freeman Hospital, Newcastle, were analysed for the 
presence of biofilms and biofilm-forming micro-organisms. An average of 3.75 
bacterial species per patient were cultured from obstructive mucin. The most commonly 
isolated micro-organisms were Staphylococcus aureus, coagulase-negative 
staphylococci and α-haemolytic streptococci. Micro-organisms were not detected by 
transmission electron microscopy of the obstructive mucin and this material appeared to 
originate through a host inflammatory response. However, bacteria were visualised on 
the surface of sinus mucosa using a peptide nucleic acid fluorescence in situ 
hybridization (PNA-FISH) universal bacteria probe. Twenty-four bacterial isolates were 
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assessed for their ability to form biofilms in a microtitre plate model. All micro-
organisms tested formed biofilms, and 14 of 22 were susceptible to NucB. In total, 15 of 
24 microbial species produced eDNA that was detectable by agarose gel 
electrophoresis. By SEM, cellular colonisation was lower in treated samples and, in the 
case of Streptococcus constellatus FH20 stringy, matrix-like material was not present 
after DNase treatment.  
The role of eDNA in matrix stability and initial biofilm attachment was also studied 
in oral bacteria. Streptococcus gordonii DL1, Streptococcus mutans GS-5, 
Fusobacterium nucleatum 25586 and Actinomyces oris MG1 were examined using 
DNase treatment, CLSM, and eDNA extraction. Of these species, all except S. gordonii 
appeared to rely on high molecular weight (HMW) eDNA for biofilm attachment and 
biofilm stability. Although S. gordonii did not produce detectable HMW eDNA, nucleic 
acids were detectable by NanoDrop spectrophotometry. Furthermore, this species 
produces an extracellular nuclease which may degrade the HMW eDNA in the 
conditions used to culture biofilms. Interestingly, four S. mutans strains differed in their 
sensitivity to DNase treatment. Oral biofilms were also modelled in a BioFlux 
microfluidics device using flowing human saliva. Mixed-species biofilms and single 
species biofilms of S. mutans UA159 and S. gordonii DL1 were cultured using this 
technique, to determine whether this model would allow more realistic experiments for 
DNase testing.  
Finally, the extracellular nuclease, SsnA, of S. gordonii DL1 was characterised. A 
nuclease-deficient mutant did not produce extracellular nuclease activity on DNase Test 
agar or during a Forster Resonance Energy Transfer (FRET) assay. Nuclease activity 
was cell-wall-associated as predicted from the predicted amino acid sequence of SsnA. 
Allelic exchange mutagenesis determined that ssnA expression was regulated by CcpA 
in response to repressing sugars. However, in planktonic culture non-repressing carbon 
sources also inhibited enzyme activity during a FRET assay. Further experiments using 
acidic buffers replicated the inhibition of SsnA without the presence of sugars. SsnA 
was purified as a GST-tagged fusion protein in an Escherichia coli protein expression 
system, and had anti-biofilm activity against S. mutans GS-5. However, this species is 
strongly acidogenic and therefore it is hypothesised that although SsnA may be a 
competition biofilm factor, acid production by S. mutans may reduce its efficacy in 
vivo.  
In conclusion, this thesis has provided strong evidence for the role of eDNA in 
facilitating biofilm formation and mature biofilm stability of clinically relevant 
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biofilms. Nucleic acids were present in biofilms associated with a chronic infection, 
medical implant biofouling and dental plaque. A variety of DNase enzymes (NucB, 
DNase I, and SsnA) were capable of reducing biofilm colonisation. Given the adhesive 
function of eDNA in biofilm matrices it is proposed that DNase enzymes may be 
beneficial for controlling healthcare-related biofilms. 
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Chapter 1: Introduction 
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Chapter 1: Introduction  
 
Bacteria are often thought of as planktonic life forms, devoid of senses and very much 
alone in life. This concept exists because microbiology was born via the study of micro-
organisms in test tube pure culture. However, it has become increasingly apparent that 
our perception of micro-organisms, and this life-cycle, is not applicable to most of the 
environments that they reside in. For the most part, micro-organisms must survive in 
challenging circumstances and therefore live as co-aggregations. Antonie van 
Leewenhoek in the 17
th
 century was the first to observe collections of micro-organisms 
that he termed ‘scruf’ on the surface of his teeth. This term was lost, and in 1978 
Costerton et al., (1978) coined the term ‘biofilm’ for a collection of sessile micro-
organisms that are enclosed in an extracellular matrix. However, it is important to note 
intermediate researchers like Arthur Henrici who also discovered that most aquatic 
bacteria live on surfaces rather than as planktonic organisms (Henrici, 1933). 
Microbiologists now believe that the biofilm is the most common way that micro-
organisms exist. This life-system is vastly different to planktonic micro-organisms, as it 
facilitates a community that has different niches, and provides a robust barrier to 
external insults via the extracellular matrix.  
These highly specialised and complex biological systems have been identified in 3.2-
billion-year-old rocks in Pilbara Craton, Australia (Rasmussen, 2000). Ancient biofilms 
have also been preserved in sediments that were likely in a marine hydrothermal 
environment in modern day South Africa, 3.3-3.5 billon-years-ago (Westall et al., 
2001). Interpreting microbial signatures in these ancient rocks is not easy but by 
studying them it may be possible to apply the same techniques in the search for extra-
terrestrial life on Mars (Westall et al., 2003). Earth in the Paleoarchaean eon of 3.2-3.5 
billion-years-ago would bear little resemblance to modern Earth. During this period 
micro-organisms would have produced energy by anoxygenic photosynthesis due to a 
lack of atmospheric oxygen and organic matter (Nisbet and Fowler, 2011). It is 
interesting that at this stage, biofilms were capable of surviving on planet Earth. 
Clearly, this early appearance in nature exhibits how integral biofilm production is to 
prokaryotic organisms. Furthermore, it suggests that the robustness of biofilms, to 
external insults and poor ecological conditions, increases microbial survival and allows 
them to reside in all manner of environments. Given the environmental constraints of 
Archaen Earth (high ultraviolet (UV) exposure and temperature extremes) it might have 
been beneficial to evolve synergistic social interactions. In addition, the extracellular 
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matrix would have provided a desirable barrier to poor external conditions. Therefore, 
biofilms apparently increased the fitness of singular micro-organisms that were 
surviving 3.5 billion-years-ago.  
Prokaryotic biofilm formation continues to be incredibly versatile on modern Earth, 
allowing micro-organisms to adapt to a wide range of environments (Costerton et al., 
1987). An example of extreme biofilm formation exists amongst the archaeal Sulfolobus 
spp., that grow in geothermically active areas at temperatures of 70-85°C and pH of 2-3 
(Koerdt et al., 2010). Microbial biofilms are also capable of surviving and growing near 
deep-sea sulphide vents, in temperatures as low as 2°C or as warm as 100°C+ (Schrenk 
et al., 2003). Three and a half billion years of evolutionary adaptation has led to 
microbial biofilms that are incredibly tenacious. It appears that the biofilm mode of life 
is the most successful biological system on Earth. Knowledge of primitive Earth, and 
microbial biofilm survival in extreme environments can give the basic understanding of 
this system, primarily the reasons for its evolution and the incredibly tenacity of 
biofilms. 
 
1.1 Biofilm formation and life-cycle 
 
There are a sequence of changes as a singular micro-organism becomes attached to a 
surface, and begins forming a biofilm. This process is complex, and shares complexity 
with the life cycles of multicellular organisms. Myxococcus xanthus swarms are an 
example of multicellular behaviour exhibited by a collection of prokaryotes, and 
biofilms have been likened to this biological system  (Monds and O'Toole, 2009). 
Biofilm formation has been most thoroughly researched in model organisms such as 
Gram-positive Bacillus subtilis (Vlamakis et al., 2013) and Gram-negative 
Pseudomonas aeruginosa (Sauer et al., 2002). Essentially there are five stages to 
biofilm formation and maturation (Figure 1.1): (i) initial reversible attachment, (ii) 
irreversible attachment, (iii) biofilm maturation with an extracellular matrix, (iv) 
continued maturation with distinct cell phenotypes, and (v) biofilm dispersal.  
Initial adhesion is the first major step in biofilm formation and relies firstly on 
physio-chemical forces. Lifshitz-Van der Waals forces are the most significant 
(generally) attractive forces, occurring due to an interaction between oscillating dipoles 
on surface molecules. This attractive force is negatively impacted by electrostatic forces 
on the bacterial cell surface and substratum, which cause repulsion. Ultimately, when 
bacterial cells are close enough to a surface (<5 nm) the attractive force is stronger than 
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Figure 1.1 The life-cycle of a mono-species biofilm. Biofilm formation occurs over 
several stages, and is usually initiated by environmental cues. 1) The initial attachment 
of a micro-organism can be active if the species is motile and/or produces adhesions that 
are actively regulated, or passive if the species lacks motility. 2) Microbes are at first 
reversibly adhered to a surface, usually facilitated by a conditioning film that promotes 
adhesion through Lifshitz-Van der Waals and electrostatic forces. 3) Cells differentiate 
into a non-motile phenotype and become irreversibly attached by adhesion/receptor 
interactions to a surface, before producing an extracellular matrix (4). 5) As the biofilm 
ages micro-organisms take on functionally distinct roles (as outlined by red coloured 
cells), although the cells are genetically identical. The last step in biofilm maturation is 
the shedding of free-floating cells from the biofilm (6). This process can be actively 
promoted by matrix-degrading enzymes, or caused by environmental forces.  
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the repulsive force and adhesion is initiated. Although greatly simplified, this forms the 
basis of the Derjaguin, Landau, Verwey, and Overbeek (DLVO) theory of bacterial 
adhesion (Hermansson, 1999). However, this theory does not fully describe the 
complexity of microbial attachment to a surface, where other forces such as gravity, 
sheer stresses, Brownian motion, acid-base interactions, and hydrophobic interactions 
also facilitate or reduce adhesion. Molecules on the surface of micro-organisms, and 
those on the attachment surface impact the adhesion process by altering the balance of 
physio-chemical forces. Bacterial adhesion is complex and for the purpose of this thesis, 
the macromolecule eDNA, and the effect it has on bacterial attachment is the major 
point of consideration (discussed in section 1.4.1). Once strongly adhered to a surface, 
by intermolecular forces, bacteria can become irreversibly bound by the interaction 
between specific receptor and adhesin proteins.  Micro-organism attachment is often 
facilitated by a conditioning film of molecules that builds up on clean surfaces once 
they are exposed to a liquid or gas. Initial attachment is thought to be initiated once 
microbes sense environmental conditions that would favour biofilm formation. For 
instance, environmental conditions such as temperature, glucose, and pH alter total 
biofilm extent in clinical isolates of Burkholderia pseudomallei (Ramli et al., 2012). It 
is likely that the optimal conditions for biofilm formation are species, and even strain, 
specific. With motile species, like P. aeruginosa, it is logical that biofilm formation 
may be an active process. Biofilm maturation to microcolonies in P. aeruginosa PA14 
on polyvinylchloride (PVC) plastic requires flagella and type IV pili mediated motility 
(O'Toole and Kolter, 1998). However, this model of P. aeruginosa biofilm formation is 
challenged by the results of Heydorn et al., (2002) where P. aeruginosa PA01 motility-
deficient mutants formed more microcolonies than wild-type. Therefore, it appears that 
biofilm formation is strain as well as species dependant.  
After irreversible attachment, micro-organisms begin to synthesise and excrete an 
extracellular matrix which ultimately surrounds the cells. As with many aspects of 
biofilm formation, matrix production could be either an active or a passive process. Cell 
to cell signalling appears to play a role in P. aeruginosa matrix production (Davies, 
1998), although the key regulators are still unknown (Branda et al., 2005). In Vibrio 
cholerae it appears that quorum sensing again has a role in matrix production. For this 
species, increased cell density leads to HapR-mediated down-regulation of matrix 
production (Zhu and Mekalanos, 2003). Therefore, in this micro-organism low cell 
density leads to extracellular matrix synthesis. Individual components of the biofilm 
matrix can be released in a variety of mechanisms. For instance, extracellular DNA, can 
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be produced via excretion mediated by DNA-containing membrane-bound vesicles 
(Renelli et al., 2004), or lytic release (Paganelli et al., 2013). Therefore, not only is the 
regulation of matrix production incredibly complex, but also the excretion or synthesis 
of individual components.  
Another important aspect of biofilm development is the detachment of cells in 
mature biofilms. This phase of the biofilm life-cycle allows cells to colonise new 
environments and escape competitors or harsh environmental conditions. Furthermore, 
it has a major role in disease transmission. Biofilm detachment can be either an active or 
passive process. Additionally, there are three major modes as outlined by Kaplan et al., 
(2010): erosion, seeding and sloughing. Erosion is a process of constant cell release 
during biofilm formation, whereas seeding and sloughing release large clumps of cells 
in mature biofilms. Sloughing occurs from the exterior of the biofilm, and seeding from 
internal cavities. Of particular interest is the production of extracellular enzymes by 
biofilm-forming micro-organisms that target the biofilm matrix, thereby releasing cells. 
These enzymes are interesting because they could be used to disperse deleterious 
biofilms. Examples of naturally produced biofilm detaching enzymes are dispersin B 
(Kaplan et al., 2003), NucB (Nijland et al., 2010) and alginate lyase (Boyd and 
Chakrabarty, 1994).  
The oral biofilm (dental plaque) (discussed again in section 1.8.2), and its formation, 
provides an incredibly useful model for studying the biofilm life-cycle. There are well-
known steps in dental plaque formation, which begins with molecules adhering to the 
oral surface. These molecules build up and are collectively known as the acquired 
salivary pellicle (Lendenmann et al., 2000). The acquired salivary pellicle is a collection 
of glycoproteins, from human saliva, that bond to tooth enamel forming a film coating. 
Following this process, micro-organisms adhere to the pellicle, often passively, via 
weak physio-chemical forces that reside on the microbial and pellicle surfaces. Weak 
attachment is later replaced by irreversible attachment via adhesin-receptor binding with 
strong attachment forces (Whittaker et al., 1996). Thereafter, secondary and late 
colonisers adhere to cell-surface receptors of already attached micro-organisms 
(Kolenbrander et al., 2006). This process of microbial succession is incredibly complex 
with multiple interactions, antagonistic and synergistic, occurring between a diverse 
range of oral bacteria. There are still many interactions to be studied, and many proteins 
that may have important roles in shaping dental plaque microbial composition. Firstly, 
understanding these interactions could reveal novel proteins for controlling dental 
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plaque. Furthermore, as the oral biofilm provides a detailed model of biofilm formation 
as a whole, by studying it our knowledge of other biofilm systems will increase.  
 
1.2 Biofilm resistance and chronic diseases 
 
Biofilms are suggested to be less susceptible to phagocytes, viral attack, UV radiation, 
shear stresses, dehydration, biocides, and antibiotics than planktonic micro-organisms
 
(Wolcott and Ehrlich, 2008). For instance, the biofilm matrix may block UV light in P. 
aeruginosa RM4440, as shown using a model that replicates an alginate matrix typical 
of Pseudomonas spp. biofilms (Elasri and Miller, 1999). Resistance, to antibiotics or 
biocides is due to many factors: 1) restricted penetration of antimicrobials, 2) slow 
growth of bacteria, 3) resistant phenotypes (persisters), and 4) altered chemical micro-
environments (Lewis, 2001; Stewart and Costerton, 2001; Hall-Stoodley et al., 2004). 
Micro-organisms living within a biofilm can exhibit extremely complex and co-
ordinated behaviour. Cell signalling and quorum sensing allows the microbes to sense 
and respond to the local environment, thereby increasing survival chances (Hall-
Stoodley and Stoodley, 2009). High levels of resistance are therefore related to the 
matrix “wall”, bacterial behaviour, and the heterogeneous communities within the 
biofilm. Complexity means the biofilm is extraordinarily resistant to deleterious agents 
and conditions. 
Bacterial biofilms often form on living tissues or on the inert surfaces of indwelling 
medical devices (reviewed by Costerton et al., 1999). Of the bacterial infections treated 
by physicians, some 60% are thought to be biofilm related (Costerton et al., 1999). A 
common example of this would be dental plaque, a biofilm that is kept in check by the 
mechanical action of a toothbrush. Dentistry and improved oral hygiene is an example 
where modern medicine has been able to effectively treat a biofilm disease. However, 
for the most part, where conventional medicine treats planktonic bacteria satisfactorily, 
traditional therapy can have little effect on biofilms. For example, biofilms are 
substantially less susceptible to antibiotics than free-floating bacteria (Gilbert et al., 
1997). Therefore, it is not surprising that chronic diseases arise from biofilm infections. 
Some examples of biofilm issues in the head and neck region are shown in Figure 1.2.  
Biofilm infections and their link to a disease pathogenesis can be hard to establish. 
For example the sinuses can be colonized by microbial biofilms in healthy patients, as 
well as those suffering from chronic rhinosinusitis (CRS) (Bezerra et al., 2011). 
Furthermore, diagnosis of a biofilm infection is often related to the sampling technique  
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Figure 1.2 Clinical complications caused by microbial biofilms in the head and 
neck region of humans. Anti-clockwise from 1) contact lens associated keratitis, 2) 
dental plaque, 3) tracheoesophageal speech valve biofouling, 4) ventilator-associated 
biofouling, 5) chronic otis media, 6) chronic rhinosinusitis, and 7) bone adhered hearing 
aid biofouling.  
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used. For instance, biofilm sampling through culture-dependent analysis can lead to 
culture-negative results (Hall-Stoodley et al., 2006), which is likely due to the 
inadequacies of culture media in sustaining biofilm micro-organisms. The diagnosis 
criteria for biofilm infections has been added to and modified over the last 10 years to 
include several features. Parsek and Singh (2003) suggest that the infection must be 
surface-associated, exhibit cell aggregates living within a matrix, be localised to one 
region of the host, and be recalcitrant to antimicrobial treatment. Additionally, given the 
reduced ability of culture media to support biofilm micro-organism, biofilm diagnosis 
must include multiple diagnostic techniques (Fux et al., 2003). For example, in chronic 
otitis media detection of microbial DNA by PCR and fluorescence in situ hybridization 
microscopy gave higher microbial detection rates (80-90%) than culture-dependent 
analysis (Hall-Stoodley et al., 2006). In keeping with their extensive research, Hall-
Stoodley and Stoodley (2009) suggest diagnosis criteria should also include evidence of 
reduced host immune system efficacy in contact with microbial aggregates and take into 
account a negative culture result with obvious infection symptoms. Diagnosis should 
include the biofilm matrix, although it is briefly highlighted in the ‘Parsek-Singh 
criteria’ mentioned above. Components of the matrix vary widely but it may be that 
common components, such as extracellular DNA (eDNA), could provide a reliable 
marker for biofilm colonisation. Furthermore, the extracellular matrix is an important 
component in biofilm formation and resistance. The biofilm matrix is discussed in 
greater detail in the next section. 
 
1.3 The biofilm matrix  
 
Biofilm micro-organisms account for approximately one tenth of the total dry mass of a 
biofilm (Flemming and Wingender, 2010), although this is likely to vary greatly 
depending on the species present. Ninety percent of a biofilm is the extracellular matrix 
of macromolecules and water that are predominately produced by the micro-organisms 
themselves. The extracellular matrix has also been called the glycocalyx, a slime, and 
extracellular polymeric substances (EPS). In the past the extracellular matrix was 
thought to consist mostly of polysaccharides, and the term EPS, meaning 
exopolysaccharides, often relates to this older concept. The role of polysaccharides in 
the P. aeruginosa biofilm matrix, principally alginate, Psl and Pel, has been heavily 
researched (Ryder et al., 2007). However, although the extracellular matrix is a plastic 
trait, and will change depending on many factors, it appears that many other substances 
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contribute to the extracellular matrix. This slime is composed of polysaccharides, lipids, 
proteins, nucleic acids, water, and other small compounds (Flemming and Wingender, 
2010). Furthermore, in P. aeruginosa PA01 polysaccharides are only a minor 
component of the biofilm matrix in relation to proteins and DNA (Matsukawa and 
Greenberg, 2004).  
There is substantial difficulty in obtaining reliable biochemical profiles of biofilm 
matrix samples. It can be hard to separate the extracellular matrix from cells, and there 
can be substantial differences in yields of the different components depending on the 
technique used. Ultimately, it is currently prohibitive to study all the elements of a 
single species biofilm matrix, and researchers tend to focus on one component. Through 
this approach we now understand the matrix components to have at least fourteen 
functions, as outlined by Flemming and Wingender (2010). These functions include 
providing a protective barrier, acting as a nutrient reservoir, retaining water, and 
exchanging genetic information. In particular, many of the components, proteins, 
nucleic acids, and polysaccharides, can be involved in biofilm adhesion and retaining 
cohesion in mature biofilms. Of these macromolecules, DNA appears to be the most 
universal component of biofilm matrices that facilitates biofilm stability and initial 
attachment. 
 
1.4 Extracellular DNA and its proposed functions 
 
Extracellular DNA ‘slime’ was observed in micro-organisms in the mid-1950s (Catlin, 
1956; Catlin and Cunningham, 1958). Four micro-organisms were found to produce 
eDNA that was compositionally similar to intracellular DNA. Furthermore, eDNA 
accumulation in the biofilm matrix of Staphylococcus aureus was increased in a broth 
of pH 6 with low calcium content (Catlin and Cunningham, 1958). This was because the 
extracellular DNase that controls S. aureus biofilm formation was inhibited in these 
conditions. More recently, DNA was found to be important in cell flocculation for a 
marine bacterium from the genus Rhodovulum (Watanabe et al., 1998). However, after a 
publication by Whitchurch et al., (2002) showed that DNA in the biofilm matrix of P. 
aeruginosa was important during biofilm formation, attention became focussed on 
eDNA in biofilms with a structural function. Subsequently, there has been extensive 
research into the role of eDNA in microbial biofilms. The exact role of eDNA remains 
uncertain but it seems probable it has a number of functions including a means of 
exchanging genetic information (Molin and Tolker-Nielsen, 2003), a nutrient source
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Figure 1.3 Microbial uses of extracellular DNA. The extracellular matrices of many 
biofilm-forming micro-organisms contain nucleic acids. Furthermore, the environment 
can also harbour DNA that persists long enough to be actively used by micro-organisms 
in a number of ways including, horizontal gene transfer, nutrient uptake, binding of 
antimicrobials, induction of antibiotic resistance genes, biofilm adhesion and maintain 
matrix stability in mature biofilms. 
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(Finkel and Kolter, 2001), a scaffold for matrix stability (Dominiak et al., 2011), use as 
an adhesin (Vilain et al., 2009) and antimicrobial protection (Jones et al., 2013) (Figure 
1.3). Despite the uncertainty, eDNA, which was once viewed as simply a by-product of 
cell lysis, now appears integral to the extracellular matrix and biofilm organisation in 
many micro-organisms. 
The amount of eDNA present within the biofilm matrix differs greatly between 
microbial species. In comparison to the protein and polysaccharide components of P. 
aeruginosa biofilm matrices eDNA is 5 and 18-fold more abundant respectively in a 
static microtiter biofilm model (Matsukawa and Greenberg, 2004). Extracellular DNA 
is 17% of the total DNA extracted from P. aeruginosa biofilms (Steinberger and 
Holden, 2005). In this study four micro-organisms were examined and there was 
substantial variation in the total amount of eDNA extracted, with Pseudomonas putida 
producing eDNA so that it was a third of the total DNA extracted. The amount of eDNA 
also differed between the four biofilms tested by Tang et al., (2013), with  Reinheimera 
sp. Strain F8 producing the most at 33 µg/mL, a modest 15 µg/mL produced by 
Pseudomonas sp. FW,  and only minor amounts in Microbacterium sp. FW3 (1.5 
µg/mL), and Serratia sp. FW2 (0.07 µg/mL). In activated sludge eDNA is found in 
surprisingly high concentrations (300 mg/mL) within some microcolonies (Dominiak et 
al., 2011). Total eDNA extracted differs greatly between the method employed. Wu and 
Xi (2009) evaluated seven eDNA extraction methods, finding that chemical and 
enzymatic treatments yielded the highest amounts of DNA from biofilm matrices. 
Furthermore, they found that Acinetobacter sp. strain AC811 produced 15 µg/mL 
eDNA, Escherichia coli 9 µg/mL, P. aeruginosa 7 µg/mL and S. aureus 12 µg/mL. It is 
difficult to compare eDNA concentrations between studies due to differences in biofilm 
growth, biomass quantification and DNA quantification.  
It is possible that micro-organisms release eDNA, or use environmental DNA as a 
template for gene uptake. The release of eDNA is discussed in detail in section 1.4.3. 
Natural DNA release and DNA uptake (competence) has been demonstrated for bacteria 
such as Streptococcus pneumoniae (Steinmoen et al., 2002) and Neisseria gonorrhoeae 
(Hamilton et al., 2005). For S. pneumoniae cell lysis, of a subpopulation of cells, 
appears to be induced by competence stimulating peptides (CSPs) and this leads to 
DNA release (Moscoso and Claverys, 2004). Mutants lacking the CSP sensor gene, 
comD, did not produce exogenous DNA. Furthermore, cell lysis is suggested to play a 
role as mutants lacking the major autolytic amidase, LytA, or an autolytic lysozyme, 
LytC, released less DNA (Steinmoen et al., 2002; Moscoso and Claverys, 2004). 
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Streptococci have evolved to naturally exchange genetic information, and eDNA is 
integral to this process. For instance, Streptococcus mutans may obtain transforming 
DNA from neighbouring species, such as  Streptococcus gordonii, via bacteriocin 
production (Kreth et al., 2005). In this example, the bacteriocin, mutacin IV, probably 
led to cell lysis of S. gordonii and uptake of a pVA838 shuttle vector by S. mutans. 
However, CSP-induced DNA release has also been suggested to promote biofilm 
stability in S. mutans and S. pneumoniae (Moscoso and Claverys, 2004; Petersen et al., 
2005; Perry et al., 2009). DNA release and uptake may have important consequences 
for bacteria. For example, antibiotic resistance genes have been found within river 
sediment eDNA in Northern China, and bacteria can naturally uptake these genes (Mao 
et al., 2013). Extracellular DNA uptake by S. mutans may also allow adaptation to the 
oral cavity by creating phenotypic changes that assist persistence (Narisawa et al., 
2011). Within biofilms the release and uptake of DNA may share similarities to 
eukaryotic sexual reproduction, as it could allow the dissemination of genes that lead to 
greater survival, as hypothesised by Spoering and Gilmore (2006).  
Besides providing a means of transferring antibiotic resistance genes (Mao et al., 
2013), eDNA can also reduce the activity of antimicrobials directly. Extracellular DNA 
produced by Haemophilus influenzae is capable of binding the human β-defensin-3 
(hBD-3) antimicrobial peptide and reducing its efficacy against biofilms (Jones et al., 
2013). The activity of hBD-3 could be restored by incubating biofilms in the presence 
of DNase I. Exogenous DNA can have a negative effect on bacterial survival by causing 
cell lysis due to removal of metal cations from the cell surface (Mulcahy et al., 2008). 
However, it does appear that the anionic ability of DNA can also protect bacteria from 
antimicrobial killing. Recently, Chiang et al., (2013) discovered that exogenous DNA 
that is artificially added to P. aeruginosa biofilms decreases the efficacy of 
aminoglycosides. This reduction in antibiotic efficacy has been linked to cation 
chelation, principally Mg
2+
 (Mulcahy et al., 2008). In P. aeruginosa a lack of available 
Mg
2+
 induces the PhoPQ and AmrAB regulators that activate the antimicrobial peptide 
resistance operon in this species. The role of metal cations, eDNA, and antimicrobial 
resistance in P. aeruginosa has been reviewed extensively by Lewenza et al., (2013).  
 
1.4.1 Extracellular DNA increases biofilm stability and attachment 
 
Extracellular DNA appears to play a key role in facilitating the initial attachment of 
some micro-organisms to surfaces. The presence of eDNA does not affect Lifshitz-Van 
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der Waals forces (Das et al., 2010). However, eDNA on the cell surface increases 
bacterial cell surface hydrophobicity, and enhances acid-base interactions (Das et al., 
2010; Das et al., 2011). DNA is essentially hydrophilic as the sugar-phosphate 
backbone is polar, and the hydrophobic nucleobases are shielded inside the 
macromolecule. The bacterial cell wall contains both polar and non-polar molecules, 
and the interaction of DNA with the cell wall leads to increased hydrophobicity possibly 
by it interacting with polar sites like peptidoglycans, leaving hydrophobic sites free. 
Hydrophobic bacteria aggregate to one-another and to hydrophobic surfaces, although 
eDNA has also been shown to increase binding to hydrophilic surfaces such as glass 
(Das et al., 2010). Acid-base interactions are repulsive in the absence of eDNA in 
Streptococcus mutans LT11, P. aeruginosa PA01, and Staphylococcus epidermidis 
1457 (Das et al., 2011). Electron transfers between eDNA, bacterial cells, and substrata 
appeared to facilitate bond formation for these micro-organisms. However, there was a 
point at which bacteria absorbed too much eDNA and it became deleterious for cell 
attachment (Das et al., 2011). It is important to note, that bacteria that do not produce 
eDNA will still adhere to surfaces because of the effect of Lifshitz-Van der Waals 
forces and other interactions (see section 1.1). The metal chelating properties of DNA 
(Mulcahy et al., 2008) may also impact on biofilm formation. Recently, the binding of 
Ca
2+
 to eDNA was shown to increase cationic binding between bacterial cells via eDNA 
(Das et al., 2014). Extracellular DNA can intercalate with pyocyanin, a metabolite 
produced by P. aeruginosa, in a process that increases cell-cell aggregation (Das et al., 
2013). A pyocyanin-deficient mutant, ΔphzA-G, was unable to bind eDNA which led to 
decreased hydrophobicity. This example suggests that eDNA interacts with other 
molecules in order to exert a positive effect on cell adhesion.  
There are many examples of eDNA promoting the initial attachment of biofilm-
forming micro-organisms. Bacillus cereus ATCC 14579 cells become covered in eDNA 
during the exponential growth phase, and this facilitates biofilm formation (Vilain et al., 
2009). Cell lysis and eDNA release is an important step in S. aureus biofilm formation 
(Mann et al., 2009). Harmsen et al., (2010) showed that eDNA was important in the 
initial biofilm formation of 41 Listeria monocytogenes isolates by treating biofilms with 
DNase I. Furthermore, genomic DNA could restore biofilm adhesion in eDNA-free 
cultures but only in the presence of the peptidoglycan building block 
N-acetylglucosamine. This again indicates that eDNA often interacts with other 
molecules when facilitating cell-cell or cell-surface interactions. Exogenous addition of 
DNA cannot fully restore biofilm formation after DNase I treatment in many microbial 
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species, which is again indicative of other molecules probably contributing to eDNA-
associated biofilm formation (Harmsen et al., 2010; Lappann et al., 2010; Das et al., 
2011). However, exogenous DNA (320 ng/mL) added to mature C. albicans biofilms 
increased biomass by up to 60% (Martins et al., 2010). Addition of chromosomal 
meningococcal DNA to Neisseria meningitidis biofilms restored attachment in DNase I 
treated cultures but not to the levels seen in untreated biofilms (Lappann et al., 2010). 
Exogenous DNA seeding (pneumococcal and salmon sperm DNA) also had a positive 
effect on S. pneumoniae biofilm extent in mutants lacking phage and bacterial lysins 
(Carrolo et al., 2010). Clearly, eDNA facilitates biofilm attachment in many microbial 
species but this process is complex and likely requires other molecules to function 
correctly.  
Extracellular DNA has also been shown to contribute to mature biofilm stability, 
although it is often suggested that this is a lesser role for eDNA than in initial 
attachment. For example, DNase treatment of Rhodococcus ruber C208 biofilms 
reduced biofilm formation by up to 25% but had no effect on mature biofilms (Gilan 
and Sivan, 2013). In this species RNase treatment had a more substantial effect than 
DNase treatment. Biofilm stability is most heavily influenced by eDNA in early 
biofilms, and eDNA contributes less to stability as biofilms mature. P. aeruginosa 
biofilms are only susceptible to DNase treatment up to 60 hours after inoculation 
(Whitchurch et al., 2002). Again, Vibrio cholerae biofilm colonisation was reduced at 
24 hours but not 72 hours by DNase treatment (Seper et al., 2011). Many studies 
incubate biofilms for between 20-48 hours before extracting eDNA or testing dispersal 
with DNase enzymes. It is unknown if this truly represents mature biofilm formation. 
However, there are many examples of eDNA promoting stability in these early biofilms 
(Fredheim et al., 2009; Tetz et al., 2009; Harmsen et al., 2010; Nijland et al., 2010; 
Steichen et al., 2011; Muscariello et al., 2013). Pulmozyme
®
, a human DNase enzyme, 
reduced pneumococcal biofilm extent in 6-day-old biofilms in a dose-dependent manner 
(Hall-Stoodley et al., 2008). This suggests that eDNA contributes to biofilm stability in 
some mature biofilms but it is unknown if eDNA exerts much of an influence in 
biofilms that have been forming over longer periods (weeks or months). It may be that 
other molecules become more influential during biofilm maturation as eDNA degrades 
either through environmental or microbial processes.  
The amount of eDNA produced by different strains of the same species or by 
different species varies extensively and the concentration does not always correlate with 
DNase sensitivity (Shields et al., 2013). Harmsen et al., (2010) showed that high 
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molecular weight (HMW) DNA exerted more of an influence on biofilm formation than 
low molecular weight (LMW) DNA. A nuclease-deficient mutant of S. aureus produced 
more HMW DNA compared to wild type, and biofilm formation was enhanced in the 
mutant (Kiedrowski et al., 2011). Interestingly, LMW (500 bp or less) DNA inhibited 
Caulobacter crescentus biofilm formation (Berne et al., 2010). In this species biofilm 
formation was not inhibited by HMW genomic DNA (gDNA). Extracellular DNA 
extracted from biofilm matrices often migrates at a similar rate to intracellular DNA 
(apparent size ~30 kbp) on agarose gels (Kiedrowski et al., 2011; Shields et al., 2013). 
However, two Streptococcus anginosus strains isolated from chronically infected 
sinuses did not produce HMW eDNA but were susceptible to DNase treatment, 
indicating that LMW, or degraded DNA can influence biofilm stability (Shields et al., 
2013).  
It appears that eDNA facilitates initial cell attachment to surfaces and can promote 
cell aggregation in early biofilms. The eDNA macromolecule is perhaps the only 
conserved component of biofilm matrices, as its primary structure is relatively 
unchanged between microbial species. There are areas of research that merit further 
investigation, including the contribution of eDNA to mature biofilm stability, and the 
interaction of other molecules with eDNA during cell-cell or cell-surface binding.  
 
1.4.2 Origins of microbial eDNA 
 
Clearly, eDNA appears to be an integral component of the extracellular matrix in many 
microbial biofilms. The release of eDNA and the source (e.g. plasmid DNA, cellular 
DNA, etc) has been well studied in recent years. Extracellular DNA in P. aeruginosa 
biofilms had an identical sequence to gDNA (Steinberger and Holden, 2005; Allesen-
Holm et al., 2006). More recently, six genes of L. monocytogenes spread evenly across 
the genome were amplified from eDNA, again suggesting eDNA was essentially 
equivalent to gDNA prior to release into the extracellular milieu (Harmsen et al., 2010). 
Extracellular DNA was also found to be identical to gDNA in the fungal species 
Aspergillus fumigatus by random amplification of polymorphic DNA (RAPD) PCR 
(Rajendran et al., 2013). Again, Staphylococcus epidermidis extracellular and 
intracellular DNA appeared to be homologous when studied (Qin et al., 2007). 
However, when eDNA produced in a multi-species biofilm of P. aeruginosa, 
Pseudomonas putida, Rhodococcus erythropolis, and Variovorax paradoxuswas was 
analysed it appeared distinct from cellular or total DNA (Steinberger and Holden, 
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2005). Furthermore, there were sequence differences in eDNA and gDNA produced by 
an aquatic bacterium (strain F8) (Böckelmann et al., 2006). The above studies indicate 
that the structure and origin of eDNA in the biofilm matrix of micro-organisms differs 
between different biofilms. Further research is required as the sequence of eDNA may 
be an important feature for its particular function in a microbial biofilm, and this may be 
one reason for the observed differences in the contribution of eDNA to biofilm stability 
between microbial species.  
 
1.4.3 Extracellular DNA release mechanisms 
 
The release of eDNA is variable but it appears that most species produce it during cell 
lysis. Cell lysis can be triggered by quorum sensing (QS) molecules, autolysins, 
metabolites or bacteriocins. In Gram-positive micro-organisms autolysins appear to play 
a major role in facilitating eDNA release. This hypothesis has been postulated because 
some biofilm-forming micro-organisms produce less eDNA when genes linked to cell 
lysis are disrupted. For example, eDNA production in S. epidermidis is reliant on the 
autolysin, AtlE (Qin et al., 2007). A mutant lacking the atlE gene released only 10% of 
the eDNA that was produced by the isogenic wild type. In S. aureus cell lysis initiated 
by the cidA murein hydrolase regulator is linked to eDNA production (Rice et al., 2007; 
Mann et al., 2009). Furthermore, the recently identified major autolysin of 
Enterococcus faecium, AtlAEfm, leads to eDNA release through cell lysis and this in turn 
causes increased biofilm formation (Paganelli et al., 2013). Inactivation of the major 
autolysin of S. gordonii, atlS, resulted in decreased eDNA production (Liu and Burne, 
2011). Poor biofilm formation of the atlS-deficient mutant was partially restored by 
exogenous addition of eDNA. Extracellular DNA production in S. gordonii is also 
dependant on hydrogen peroxide (H2O2) release (Itzek et al., 2011). It has been 
hypothesised that high levels of H2O2 (1-2 mM) causes DNA damage that leads to 
eDNA release (22-35 ng/mL), possibly by cell lysis. It is thought that eDNA release 
through cell lysis only kills a subpopulation of cells as cultures continue to grow as 
measured by A600. Interestingly, concentrations of H2O2 greater than 5 mM lead to 
eDNA production arrest through total killing of S. gordonii cells. 
In other Streptococcus species eDNA release can be promoted by CSPs, which are 
characteristic of QS molecules (Steinmoen et al., 2002; Moscoso and Claverys, 2004; 
Petersen et al., 2004; Perry et al., 2009). Streptococcus pneumoniae eDNA release is 
promoted by CSPs that trigger the major autolysin, LytA, and the autolytic lysozyme, 
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LytC (Moscoso and Claverys, 2004). However, a non-autolytic pathway involving 
lysogenic phages has also been shown to facilitate eDNA release that improves biofilm 
formation in S. pneumoniae R36A and R36AP (Carrolo et al., 2010). Quorum sensing 
also facilitates eDNA production in P. aeruginosa (Allesen-Holm et al., 2006). Cell 
lysis of subpopulations of cells is triggered by the QS molecules acylated homoserine 
lactones and Pseudomonas quinolone signal (PQS) (Allesen-Holm et al., 2006). 
Mutants deficient in these QS molecules produced biofilms that contained less eDNA, 
as visualised with confocal laser scanning microscopy (CLSM) and the DNA stain 
DDAO. Hydrogen peroxide liberation generated through phenazine production is also 
linked to cell lysis and eDNA release in P. aeruginosa (Das and Manefield, 2013). 
Phenazines are controlled by PQS molecules, and therefore it appears that QS is again 
causing eDNA release in this mechanism. Interestingly, it has been suggested that a 
basal level of eDNA production is controlled by a mechanism independent of QS in P. 
aeruginosa (Allesen-Holm et al., 2006).  
Non-lytic mechanisms of eDNA release have also been demonstrated. For example, 
P. aeruginosa produces membrane bound vesicles that contain DNA (Renelli et al., 
2004). Earlier observations of eDNA release in S. gordonii suggested that conditions of 
high H2O2 (1 mM and 10 mM) were causing eDNA excretion without the presence of 
any obvious cell lysis, as visualized by FISH ribosomal microscopy, and an apparent 
lack of autolysis when placed in an autolysis buffer, as measured by A600 (Kreth et al., 
2009). It is unknown if this mechanism acts independently of the AtlS-dependant 
pathway suggested by Liu and Burne (2011). Early biofilms of Enterococcus faecalis 
produce two distinct types of eDNA that both originate without any obvious cell lysis, 
as determined by biochemical assays (Barnes et al., 2012). In this recent paper, eDNA 
was visualised using scanning electron microscopy (SEM) and anti-dsDNA conjugated 
to immunogold particles. This technique led to fascinating images that show eDNA 
localised near the septum of E. faecalis cells, which is suggestive of excretion, rather 
than cell lysis. Furthermore, the eDNA appeared to be intertwined with another 
unidentified matrix component. As E. faecalis biofilms mature eDNA release becomes 
controlled by a fratricidal mechanism that involves cell lysis (Thomas et al., 2009). A 
subpopulation of cells deficient in QS are lysed by gelatinase (GelE) produced by the 
majority of cells. Due to QS-deficiency the subpopulation does not produce a gelatinase 
immunity protein, SprE. The target of GelE was shown to be the major autolysin, AtlA, 
as knockout mutants produced over 10-fold less eDNA than the wild-type. Both AtlA 
and GelE mutants formed less extensive biofilms than wild type. Clearly, in E. faecalis 
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eDNA release mechanisms change during the biofilm life cycle from lysis-independent 
to lysis-dependant methods. Interestingly, the absence of AtlA (Atn) in E. faecalis does 
not stop the release of eDNA but slows it, again suggestive of multiple release pathways 
(Guiton et al., 2009). In early biofilms, with low cell density, it may be beneficial to 
produce eDNA via a non-lytic mechanism.  
Extracellular DNA may also be produced via environmental factors, such as 
microbial competition. Streptococcus mutans bacteriocin-mediated cell lysis of S. 
gordonii leads to the release of eDNA (Kreth et al., 2005). Although this DNA was 
hypothesised to be used during horizontal gene transfer it is also possible that S. mutans 
acquires it for biofilm formation. Biofilm stability in S. mutans can be reliant on eDNA 
(Perry et al., 2009). In mixed species biofilms DNA release may result from autolysin 
production from one species that subsequently lyses other species. This would be a 
synergistic interaction if eDNA then contributed to biofilm stability. Harsh 
environmental conditions, acidic pH or high temperatures, could also lead to cell lysis 
and DNA release. Again, increased levels of DNA in biofilm matrices could have 
beneficial consequences for micro-organisms surviving in extreme conditions.  
 
1.4.4 Inflammatory effects of extracellular DNA 
 
Extracellular DNA produced by P. aeruginosa has been implicated in the 
inflammatory response of the host immune system in cystic fibrosis (Lipford et al., 
1998). These findings suggest that eDNA is not immunologically inert. This immune 
response is triggered by non-methylated CpG (cytosine-guanine) dinucleotide motifs in 
bacterial DNA binding to Toll-like receptors (Hemmi et al., 2000). Non-methylated 
CpG motifs exist in a much lower frequency in mammalian DNA, and thus the host 
immune system is alerted to foreign bacterial DNA. However, host derived eDNA can 
elicit an auto-immune response in the chronic disease systemic lupus erythematosus (Su 
and Pisetsky, 2009). Bacterial CpG DNA activates macrophages, lymphocytes, NK 
cells and dendritic cells to produce cytokines, initiating immune responses (Krieg et al., 
1995; Krieg, 2002). Respiratory epithelial cells are also stimulated by CpG motifs (Platz 
et al., 2004). Biofilm infections are often epithelial associated attachments so this 
immune reaction might be triggered. It may partly explain why some chronic biofilm 
infections, like CRS, are associated with inflammation. This is a potentially damaging 
consequence of producing eDNA for biofilms, as it will lead to increased bacterial cell 
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death. However, the combined beneficial aspects of eDNA production (discussed 
above) must out-weigh this deleterious effect for this trait to have evolved.  
Recently, DNase I was found to reduce the proinflammatory effect of P. aeruginosa 
biofilms through degradation of matrix eDNA (Fuxman Bass et al., 2010). Furthermore, 
eDNA-deficient P. aeruginosa strains stimulated a lower release of cytokines by 
neutrophils. Dornase alfa, a human DNase I, has an anti-inflammatory effect in severe 
cases of cystic fibrosis (Konstan and Ratjen, 2012) which may be partly due to 
degrading bacterial eDNA. However, treatment with DNase enzymes is not without 
caution as it may reduce the efficacy of host immune system extracellular traps that 
employ eDNA to adhere micro-organisms. In plants, exogenous DNase I reduces the 
innate immunity of root-tip defences in a system that shares homology to mammalian 
cells (Hawes et al., 2011).  
 
1.5 Microbial extracellular DNases and eDNA turnover 
 
As eDNA is abundant in the local environment, micro-organisms have evolved to 
produce extracellular deoxyribonuclease enzymes. DNase enzymes catalyse the 
hydrolysis of the phosphodiester bond that links the phosphate of one nucleotide with 
the sugar 3’ carbon of the next nucleotide in the chain. The cleavage of nucleotides can 
either occur within the DNA strand (endonuclease) or at the ends of single stranded 
DNA (exonuclease).  
In mammals, DNase I is an endonuclease that is universally produced by pancreatic 
cells. It has been heavily studied, and it understood to be involved in several processes, 
including, digesting DNA for nutrition (Lu et al., 2003), eDNA waste management 
(Samejima and Earnshaw, 2005), and clearing DNA during apoptosis (Oliveri et al., 
2001). The activity of DNase I is dependent on the presence of both Ca
2+
 and Mg
2+
. In 
particular, Ca
2+
 binds tightly to DNase I and stabilises its active conformation. Without 
Ca
2+
, DNase I activity is negligible (Price, 1975). DNase I activity is highest at 
physiological pH (7.3-7.4), and is inhibited by sodium dodecyl sulphate (SDS), ethylene 
glycol tetraacetic acid (EGTA) (Price, 1975), actin (Lazarides and Lindberg, 1974), and 
many other substances. Importantly, the activity, function, and structure of microbial 
DNase enzymes is incredibly varied. As a result, it is not possible to infer a great deal 
from DNase enzymes, unless a novel one shares close homology to already 
characterised nuclease enzymes. However, DNase I because it has been extensively 
studied does provide a basis of DNase enzyme knowledge. 
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Many species of micro-organisms produce DNase enzymes that are released from the 
cell, or are bound to the cell-wall-surface. As extracellular DNase production is genus 
or species specific, it has long been used as a way to diagnostically determine a cultured 
isolate. For instance, DNase testing (e.g. DNase test agar) is often used to distinguish S. 
aureus from coagulase-negative staphylococci. Furthermore, in the 1950s Weckman 
and Catlin (1957) suggested that DNase tests could be a useful characteristic to study 
bacterial taxonomy. These authors also found that the supernatant fluid of S. aureus 
cultures contained highest DNase activity, suggesting that they were studying non-cell-
wall-bound nuclease enzymes. This interesting finding occurred because the DNase test, 
which determined the viscosity of DNA after incubation with culture fluids, allowed the 
use of broth cultures, supernatants, and cell pellets. There are many different tests for 
DNase activity, with the common procedure being the growth of micro-organisms on 
DNase test agar. This test is quick, but cannot provide detailed information such as 
enzyme location in relation to the cell. The FRET nuclease activity assay developed by 
Kiedrowski et al., (2011) to study S. aureus Nuc1 is another approach to studying 
extracellular DNases. This assay uses a short qPCR probe with a fluorophore attached 
to the 5’ end, and a fluorescence quencher on the 3’ end. Once the probe is cleaved by a 
DNase enzyme, quenching of fluorescence ceases and light emission can be quantified 
with a microplate reader. Other DNase tests include in gel zymography, and agarose gel 
electrophoresis after DNA digestion (Shak et al., 1990). 
Extracellular DNase enzymes are produced by a diverse range of micro-organisms. 
Fungi, such as Cryptococcus neoformans, can produce extracellular nucleases, although 
this trait is genus specific (Cazin et al., 1969). A wide-range of periodontal bacteria 
have been tested, and 27 out of 34 produced DNase activity (Palmer et al., 2012). 
Clinical isolates of anaerobic micro-organisms, including Fusobacterium spp., very 
commonly produce extracellular DNase enzymes (Porschen and Sonntag, 1974). Again, 
extracellular nuclease activity was often genus specific amongst anaerobic micro-
organisms. Many species of streptococci also possess extracellular DNases, including S. 
pneumoniae (Hasegawa et al., 2010), Streptococcus pyogenes (Zhu et al., 2013), and 
Streptococcus suis (Fontaine et al., 2004). Extracellular DNase production also appears 
to be a key characteristic of S. aureus (Tang et al., 2011) and P. aeruginosa (Mulcahy et 
al., 2010). Ultimately, it appears as though this trait of micro-organisms is very 
common. 
Extracellular DNA is a ubiquitous macromolecule, and its ubiquity is the likely 
reason for the sheer diversity of micro-organisms that produce one, or more DNase 
Chapter 1: Introduction 
21 
 
Table 1.1 Extracellular bacterial nucleases and their proposed functions. 
Micro-organism Protein Size (aaa) Conserved Domains Proposed Function References 
Streptococcus gordonii SsnA 779 MnuA domain, OBF (1) Unknown This thesis 
Streptococcus suis SsnA 1041 EEP domain, OBF (3) Virulence (Fontaine et al., 2004) 
Streptococcus pyogenes Spd1 252 
Non-specific nuclease 
domain 
Virulence (Korczynska et al., 2012) 
  SpnA 910 EEP domain, OBF (3) Virulence 
(Hasegawa et al., 2010; 
Chang et al., 2011) 
  Sda1 390 
Non-specific nuclease 
domain 
NET evasion (Buchanan et al., 2006) 
Streptococcus 
pneumoniae 
EndA 248 
Non-specific nuclease 
domain 
NET evasion 
(Midon et al., 2011; Zhu et 
al., 2013) 
Streptococcus 
agalactiae 
NucA 261 
Non-specific nuclease 
domain 
NET evasion (Derré-Bobillot et al., 2013) 
Staphylococcus aureus Nuc1 215 SNc domain 
NET Evasion and biofilm 
formation 
(Berends et al., 2010; 
Kiedrowski et al., 2011; 
Beenken et al., 2012) 
 Nuc2 177 SNc domain 
Biofilm formation and 
virulence 
(Beenken et al., 2012; 
Kiedrowski et al., 2014) 
Bacillus licheniformis NucB 142 NucA/NucB domain Biofilm formation (Nijland et al., 2010) 
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Vibrio cholerae Dns 231 EndA domain 
NET evasion, transformation 
and biofilm formation 
(Blokesch and Schoolnik, 
2008; Seper et al., 2011; 
Seper et al., 2013) 
  Xds 869 EEP domain, OBF (1) 
NET evasion and biofilm 
formation 
(Seper et al., 2011; Seper et 
al., 2013) 
Shewanella oneidensis ExeM 871 EEP domain, OBF (1) Biofilm formation (Heun et al., 2012) 
  ExeS 948 MnuA domain, OBF (1) Biofilm formation (Heun et al., 2012) 
  EndA 258 EndA domain eDNA digestion (Heun et al., 2012) 
Pseudomonas 
aeruginosa 
EddB 779 MnuA domain, OBF (1) eDNA digestion (Mulcahy et al., 2010) 
Neisseria gonorrhoeae Nuc 233 SNc domain Biofilm formation (Steichen et al., 2011) 
Mycoplasma genitalium MG186 250 SNc domain eDNA digestion (Li et al., 2010) 
a
Amino acid residues 
MnuA, membrane-associated nuclease of Mycoplasma pulmonis homologue; OBF, oligonucleotide/oligosaccharide fold homologue; EEP, 
exonuclease-endonuclease-phosphatase catalytic domain homologue; NucA/NucB, deoxyribonuclease NucA/NucB homologue; EndA, endonuclease I 
homologue; SNc, staphylococcal nuclease homologue;  
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enzymes. There are many proposed functions for these enzymes, and it is possible that 
each DNase could have a number of roles. A selection of microbial DNases with their 
proposed functions is listed in Table 1.1. Many of the extracellular nucleases that are 
produced by pathogenic bacteria have been linked to virulence. A key factor that 
increases the virulence of DNase producing micro-organisms is the ability to degrade 
neutrophil extracellular traps (NETs). These networks of DNA and some globular 
protein domains are produced by neutrophils, and entrap bacteria (Brinkmann et al., 
2004). It is therefore highly desirable for a pathogenic micro-organism to be able 
destroy NETs, thereby reducing their antimicrobial potential. This trait has been studied 
in a number of micro-organisms. When nuc-deficient strains of S. aureus USA 300 
LAC were cultured in the presence of NETs they were significantly more likely to be 
entrapped by the DNA matrix than wild-type S. aureus (Berends et al., 2010). 
Streptococcus agalactiae NucA can degrade NETs, but substitution of histidine
148
 by 
alanine impaired this function as it abolishes enzyme activity by altering the enzyme 
active site (Derré-Bobillot et al., 2013). Cell death caused by the host immune system 
during disease also releases large amounts of DNA into the extracellular milieu. 
Extracellular DNA can be found in the lungs of cystic fibrosis patients (Shak et al., 
1990). It is unknown if DNase production helps disseminate micro-organisms through 
viscous mucus that contains DNA but biofilm dispersal has been suggested as a 
mechanism to promote pathogen transmission (Hall-Stoodley and Stoodley, 2005). 
Interestingly, Shewanella oneidensis produces three extracellular nucleases, ExeM, 
ExeS, and EndA, with each having a distinct function. Deletion of EndA removed the 
ability of S. oneidensis to use eDNA as a source of phosphorus (Heun et al., 2012). 
ExeS and ExeM are involved in biofilm formation, as deletion of either gene affects 
biofilm formation (Gödeke et al., 2011). When stained with DDAO, eDNA can be 
visualized surrounding dense aggregations of cells in the exeM-deficient S. oneidensis 
biofilm. Other species of bacteria that can produce two or more DNase enzymes that are 
proposed to have differing roles include S. pyogenes (Sumby et al., 2005; Buchanan et 
al., 2006; Hasegawa et al., 2010; Chang et al., 2011; Korczynska et al., 2012), and 
Vibrio cholerae (Seper et al., 2011; Seper et al., 2013). In V. cholerae the extracellular 
nuclease, Dns, is involved with transformation (Blokesch and Schoolnik, 2008). As cell 
densities and the quorum-sensing regulator HapR increase Dns is repressed, leading to 
higher transformation frequencies.  However, the other V. cholerae extracellular DNase, 
Xds has been linked to biofilm modulation through the degradation of DNA (Seper et 
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al., 2011). More recently, the same authors have proposed that Xds and Dns are 
involved in facilitating NET escape (Seper et al., 2013). 
Extracellular DNA may be an important bacterial nutrient in nutrient poor 
environments. Although DNA is an unstable molecule (Lindahl, 1993), it can persist for 
long periods of time. Recently, mitochondrial DNA was sequenced from a femur 
belonging to a Denisovan hominin that lived 400,000 years ago (Meyer et al., 2013). 
Therefore, eDNA is a nutrient source that bacteria can rely on, and DNase production 
can allow utilization of this substrate. Deoxyribonucleic acid consumption by bacteria 
was first observed in E. coli (Finkel and Kolter, 2001) and has since been shown in 
Shewanella spp. (Pinchuk et al., 2008; Heun et al., 2012) and Helicobacter pylori 
(Liechti and Goldberg, 2013). The Archaean species, Haloferax volcanii, may use 
intracellular DNA as a phosphorus storage polymer, and it is hypothesised by Zerulla et 
al., (2014) that DNA may have evolved for this function. It is unknown whether micro-
organisms ingest biofilm matrix eDNA during periods of starvation. 
If extracellular DNases are required for nutrient metabolism then they may be 
influenced by transcriptional regulators, in relation to available carbon sources. The 
major regulator of carbon source utilisation in streptococci, such as S. gordonii, is the 
carbon catabolite regulator, carbon catabolite protein A (CcpA) (Dong et al., 2004). 
This protein down-regulates genes encoding systems for utilization of less favourable 
carbon sources when more energetically favourable sources are available. There is 
evidence that CcpA also has a role in regulation of extracellular DNases. For instance, 
the gene of the cell-bound DNase of S. suis, SsnA, contains a catabolite responsive 
element (CRE) that is bound by CcpA, repressing ssnA during the stationary phase of 
cell growth (Willenborg et al., 2014). In S. pyogenes MGAS5005, the extracellular 
DNase, Spd, is regulated by CcpA (Shelburne et al., 2008). Gene transcription of a 
ccpA-deficient strain of S. pyogenes was compared with strain MGAS5005 by 
quantitative real time PCR. In times of nutrient limitation spd transcription was higher 
in the wild-type strain than the ccpA mutant, indicating that in this model CcpA is an 
activator of Spd in glucose-limited media, such as saliva. CcpA appears to regulate 
extracellular DNases in different environmental conditions, which may influence a 
number of DNase functions, including: (i) transformation, (ii) nutrient scavenging, (iii) 
virulence (e.g. NET degradation), (iv) host biofilm control, (v) competitor biofilm 
dispersal, and (vi) protection against the deleterious effects of eDNA. It is not yet 
known whether CcpA regulates extracellular DNases in oral streptococci. 
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The role of extracellular DNases during transformation and nutrient acquisition may 
be linked, and it has been suggested that competence evolved to meet the nutritional 
demands of bacteria. Extracellular dsDNA binds to cell-wall proteins, such as ComB in 
B. subtilis (DNA uptake reviewed in detail by Dubnau, 1999). Internalization of DNA 
relies on it being modified from dsDNA to ssDNA through the activity of a specific 
nuclease, such as EndA in S. pneumoniae (Lacks and Neuberger, 1975). DNA 
transporter proteins in the cell-wall facilitate ssDNA uptake, with the energy required 
coming from ATP. This process is therefore reliant on specific, cell-bound nucleases, 
such as EndA to convert dsDNA to ssDNA. It is possible that the strand released by 
nuclease activity could remain in the periplasm in Gram-negative bacteria, to be utilized 
as a nutrient source. However, it is likely that half the DNA is lost to the surrounding 
medium and it therefore represents a wasteful pathway for obtaining nutrition from 
DNA and more likely has the singular function of gene uptake. Non-specific nucleases, 
including NucB in B. subtilis, which are released into the extracellular milieu may be 
more plausible candidates for DNase enzymes involved in DNA metabolism. In this 
manner, non-specific nucleases may degrade dsDNA into a size that is able to permeate 
the cell wall, or allow further enzyme activity, such as extracellular phosphatases that 
can remove phosphorus groups from DNA. This is a phenomenon that occurs in 
Shewanella spp. (Pinchuk et al., 2008). The role of extracellular DNases in DNA uptake 
is likely to change depending on environmental pressures. Recently, S. pneumoniae 
EndA was shown to be secreted, and have anti-NET activity via a pathway that is 
independent of competence development (Zhu et al., 2013). Extracellular DNA uptake 
is complex, and it would be interesting to study the impact that strain, species and 
environmental variability has on the DNA uptake machinery used.  
Given the clear role of eDNA in promoting biofilm adhesion and maintaining mature 
biofilm stability there have been a number of studies examining the role of extracellular 
DNases in releasing cells from biofilms. As already discussed S. oneidensis produces 
three extracellular nucleases that alter biofilm formation (Gödeke et al., 2011). 
Furthermore, biofilm extent is increased in S. aureus when nuc1 and nuc2 extracellular 
nuclease genes are deleted (Kiedrowski et al., 2011; Beenken et al., 2012).  However, 
these in vitro experiments were not reproduced in a murine catheter model, where 
biofilm formation was decreased in nuc1 and nuc2 mutants compared to wild-type S. 
aureus (Beenken et al., 2012). In addition, it has been proposed that extracellular 
nuclease release may be responsible for biofilm dissemination in Bacillus licheniformis 
(Nijland et al., 2010). Recently, a nucB-deficient mutant of B. licheniformis was found 
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to produce a thicker biofilm during sporulation (Edward Mason, unpublished data). It 
was Akrigg and Mandelstam (1978) who first demonstrated that B. subtilis produces a 
DNase, NucB, during sporulation. It is thought that B. subtilis NucB degrades DNA 
released by mother cell lysis, at the latter stages of sporulation (Hosoya et al., 2007), 
and this may share homology with B. licheniformis NucB. Although the effects of 
extracellular DNases against the host micro-organism have been studied it is so far 
unknown if these enzymes are used to compete against other micro-organisms in mixed-
species biofilms. Many micro-organisms rely on eDNA for promoting biofilm 
formation, and it therefore seems plausible that bacteria such as S. aureus could reduce 
the colonisation of eDNA-producing bacteria. 
Extracellular DNases may also protect against the deleterious effects of eDNA on 
microbes. For instance, eDNA can bind and sequester divalent metal cations, like Mg
2+
 
and Ca
2+
. Removal of these cations from the bacterial cell surface, by eDNA, can lead 
to cell lysis (Mulcahy et al., 2010). Furthermore, bacterial DNA can alert the host 
immune system to the presence of foreign micro-organisms (Hemmi et al., 2000). 
Therefore, invading bacteria could mask themselves by degrading their own eDNA. 
Lastly, eDNA inhibits biofilm development in Salmonella enterica (Wang et al., 2013). 
Biofilm formation was restored when abiotic surfaces were treated with DNase I. 
In conclusion, persistence of DNA in the environment has led to many possible 
functions for extracellular DNase enzymes. The most important roles of these enzymes 
are likely facilitating NET degradation, consumption of DNA as a nutrient source, and 
regulating biofilm formation. A neglected aspect of research is biofilm competition. For 
instance, many periodontal bacteria produce DNase enzymes (Palmer et al., 2012), and 
this could re-shape the mixed-species biofilms that form in the oral cavity.  
 
1.6 Biofilm removal with DNase enzymes 
 
Given the importance of eDNA in allowing adhesion of many microbes to surfaces, and 
providing matrix support in mature biofilms, it is a logical approach to try and eradicate 
biofilms with DNase enzymes. Biofilm-forming micro-organisms produce many anti-
biofilm molecules, like DNases, that can inhibit or disperse other microbial species 
(reviewed by Rendueles and Ghigo, 2012). These enzymes are perfectly adapted for the 
degradation of extracellular matrix components, including eDNA. Therefore, it may be 
possible to develop novel biofilm detachment antimicrobials by studying biofilm 
competition and enzyme release. 
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An example of a naturally produced matrix degrading enzyme is dispersin B, which 
is produced by Aggregatibacter actinomycetemcomitans (Kaplan et al., 2003). This 
enzyme degrades poly-N-acetylglucosamine (PNAG), a polysaccharide component of 
some biofilm matrices, such as A. actinomycetemcomitans, and S. epidermidis (Kaplan 
et al., 2003; Kaplan et al., 2004). Escherichia coli is able to reduce the initial 
attachment of micro-organisms though the release of group II capsule polysaccharides 
(Valle et al., 2006). Many more naturally produced anti-biofilm proteins exist but 
DNase enzymes show particular promise. One advantage of DNase removal of micro-
organisms is that it can act both during initial formation, and once biofilms are mature, 
due to the importance of eDNA throughout the biofilm life-cycle. Furthermore, the 
structure of DNA is ubiquitously conserved throughout nature, and therefore DNase 
enzymes do not suffer from specificity issues. Molecules like dispersin B only degrade 
the biofilm matrices of organisms that contain PNAG. If eDNA exists in a biofilm 
matrix, a DNase enzyme will disperse it, as long as the eDNA is not protected by 
another mechanism. 
Some biofilm-forming micro-organisms release extracellular nucleases that can 
inhibit or disperse other microbial species. For instance, a nuclease produced by S. 
aureus, Nuc1, reduces biofilms formed by Haemophilus parasuis, Actinobacillus 
pleuropneumoniae, and P. aeruginosa (Tang et al., 2011). Recently, a marine strain of 
B. licheniformis isolated from the surface of seaweed was found to produce a microbial 
extracellular nuclease (Nijland et al., 2010). This nuclease, NucB, is suggested to have 
evolved for the purpose of host biofilm dispersal but also disperses biofilms of E. coli, 
Micrococcus luteus and B. subtilis. Both Nuc1 and NucB may play important roles in 
mixed-species biofilm competition. 
Several DNase enzymes have been used to study the role of eDNA in biofilm 
formation. At least 43 microbial species have been cultured as biofilms and subjected to 
DNase treatment, either during adhesion or after maturation (Table 1.2). Ultimately, 
90% of these species were shown to be sensitive to DNase treatment (publication bias is 
an important factor), underlining the significant proportion of biofilm-forming micro-
organisms that produce eDNA for biofilm stabilisation and attachment. Therefore, 
research has in some cases looked at the potential to apply DNase enzymes to treating 
biofilm healthcare issues. Interestingly, Pulmozyme
®
, a human recombinant DNase 
(rhDNase), has been used in the treatment of cystic fibrosis (CF) since the mid-1990s. 
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Table 1.2 Examples of microbial biofilms that have been treated with exogenous DNases. 
Species Observations DNase Enzyme References 
Gram-positive bacteria 
   
Aggregatibacter 
actinomycetemcomitans 
Biofilms grown on glass coverslips were 
dispersed by DNase treatment 
DNase I (Inoue et al., 2003) 
Bacillus cereus Biofilm formation requires eDNA DNase (Vilain et al., 2009) 
Bacillus licheniformis Dispersal of 26-h-old biofilms NucB, DNase I (Nijland et al., 2010) 
Bacillus subtilis Mature biofilm dispersal NucB (Nijland et al., 2010) 
Enterococcus faecalis Reduced accumulation of 26-h-old biofilms DNase I (Thomas et al., 2008) 
Lactobacillus plantarum 24-h-old biofilm reduced by 50% when treated DNase I (Muscariello et al., 2013) 
Listeria monocytogenes 
Attachment of biofilm cells reduced, mature 
biofilm dispersed 
DNase I (Harmsen et al., 2010) 
Micrococcus luteus Mature biofilm dispersal NucB (Nijland et al., 2010) 
Rhodococcus ruber Inhibition of up to 25%, no dispersal DNase I (Gilan and Sivan, 2013) 
Staphylococcus aureus 
Decreased biofilm formation, and mature biofilm 
dispersal 
NucB, DNase I, 
DNase1L2, 
Varidase, 
rhDNase I 
(Nemoto et al., 2000; Eckhart et 
al., 2007; Rice et al., 2007; Tetz et 
al., 2009; Tetz and Tetz, 2010; 
Tang et al., 2011; Kaplan et al., 
2012; Shields et al., 2013; 
Swartjes et al., 2013) 
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Staphylococcus epidermidis Biofilm formation inhibited at 10 mg/mL rhDNase I 
(Kaplan et al., 2012; Shields et al., 
2013) 
Staphylococcus 
haemolyticus 
All of the 53 biofilm-producing isolates were 
detached when treated 
DNase I (Fredheim et al., 2009) 
Streptococcus anginosus Static biofilms dispersed after 18 h incubation NucB (Shields et al., 2013) 
Streptococcus constellatus Biofilm extent reduced when treated NucB (Shields et al., 2013) 
Streptococcus intermedius 
Biofilm formation reduced by 52% in presence 
of DNase 
DNase I (Petersen et al., 2004) 
Streptococcus mutans 
16-h-old biofilm biomass was reduced by 20-
30% 
DNase I (Perry et al., 2009) 
Streptococcus pneumoniae 6-h-old, 18-h-old, 6-day-old biofilms dispersed 
NucB, DNase I, 
Pulmozyme
®
 
(Moscoso et al., 2006; Hall-
Stoodley et al., 2008; Shields et 
al., 2013) 
Streptococcus pyogenes Dispersal of 24-h-old biofilms DNase I (Tetz et al., 2009) 
Streptococcus salivarius 18-h-old biofilms dispersed NucB (Shields et al., 2013) 
Gram-negative bacteria 
   
Actinetobacter baumanii 
DNase treatment resulted in decrease biofilm 
biomass 
bpDNase I (Tetz et al., 2009) 
Actinobacillus 
pleuropneumoniae 
Up to 50% dispersal of static biofilms cultured 
for 36 h 
NUC1, DNase I, 
MNase 
(Tang et al., 2011) 
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Bdellovibrio bacteriovorus Biofilm detached when treated, also inhibited DNase I (Medina and Kadouri, 2009) 
Bordetella bronchiseptica 
Static, flowing and mouse respiratory tract 
biofilms reduced when treated 
DNase I (Conover et al., 2011) 
Bordetella pertussis 
Static, flowing and mouse respiratory tract 
biofilms reduced when treated 
DNase I (Conover et al., 2011) 
Burkholderia cenocepacia Treatment led to increased biofilm thickness Pulmozyme
®
 (Novotny et al., 2013) 
Campylobacter jejuni Decrease in 2-day-old biofilms DNase I (Svensson et al., 2009) 
Comamonas denitrificans Inhibited initial biofilm attachment DNase I (Andersson et al., 2009) 
Escherichia coli  
24-h-old biofilm dispersal by up to 70%, 
decreased tolerance to antibiotics 
NucB, bpDNase 
I 
(Tetz et al., 2009; Nijland et al., 
2010) 
Fusobacterium nucleatum Biofilms were not disersed in the model used DNase I (Ali Mohammed et al., 2013) 
Haemophilus influenzae Biofilm biomass reduced in 24 and 6 h biofilms bpDNase I 
(Izano et al., 2009; Tetz et al., 
2009) 
Haemophilus parasuis 
Up to 40% dispersal of static biofilms cultured 
for 36 h 
NUC1, DNase I, 
MNase 
(Tang et al., 2011) 
Klebsiella pneumoniae Treatment reduced biofilm biomass at 24 h DNase I (Tetz et al., 2009) 
Myxococcus xanthus 
Efficacy of DNase treatment was increased when 
combined with SDS, or sonication 
DNase I (Hu et al., 2012) 
Neisseria gonorrhoeae Mature biofilm dispersal Nuc (Steichen et al., 2011) 
Neisseria meningitidis Biofilm formation was inhibited in 31 out of 50 DNase I (Lappann et al., 2010) 
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meninogococcal strains tested 
Porphyromonas gingivalis  Biofilms were not disersed in the model used DNase I (Ali Mohammed et al., 2013) 
Pseudomonas aeruginosa Biofilms younger than 60 h are reduced 
Varidase, DNase 
I, DNase1L2, 
lsDNase, Nuc1 
(Whitchurch et al., 2002; Nemoto 
et al., 2003; Eckhart et al., 2007; 
Parks et al., 2009; Tang et al., 
2011; Brown et al., 2012; Swartjes 
et al., 2013) 
Rhodovulum sp.
a
 Flocculated cells dispersed by DNase treatment bpDNase I (Watanabe et al., 1998) 
Salmonella enterica 
Initial biofilm formation (6 h to 48 h) increased 
in presence of DNase 
DNase I (Wang et al., 2013) 
Shewenlla oneidensis 
Biofilms cultured in static and flowing models 
were disrupted by treatment 
DNase I (Gödeke et al., 2011) 
Vibrio cholerae 
Treatment reduced colonisation at 24 h, but not 
72 h 
DNase I (Seper et al., 2011) 
Gram-variable bacteria 
   
Gardnerella vaginalis 
Biofilm formation was inhibited by 80%, and 
mature biofilms dispersed by 50% 
bpDNase I (Hymes et al., 2013) 
Fungi 
   
Aspergillus fumigatus 24-h-old biofilms were destabilized when treated bpDNase I (Rajendran et al., 2013) 
Candida albicans Biofilm formation reduced bpDNase I (Martins et al., 2010; Pammi et al., 
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2013) 
Mixed-species biofilms 
   
C. albicans and S. 
epidermidis 
Dual-species biofilms were more susceptible to 
DNase treatment than mono-species 
DNase I (Pammi et al., 2013) 
TESV Biofilms 
Biofouling micro-organisms were liberated from 
the surface of valves 
NucB (Shakir et al., 2012) 
Biofilms in activated sludge 
DNase treatment resulted in dissolution of 
microbial flocs 
DNase I (Dominiak et al., 2011) 
a
Flocculated cells were treated, not cultured as a biofilm. 
bpDNase I, bovine pancreatic DNase I; rhDNase I, recombinant human DNase I; DNase I, exact origins unknown; DNase1L2, DNase 1-like 2 
produced by epidermal keratinocytes; Varidase, streptokinase and streptodornase (streptococcal DNase) solution; MNase, micrococcal nuclease; NucB, 
extracellular nuclease of B. licheniformis; Nuc, extracellular nuclease of N. gonorrhoeae; NUC1, staphylococcal nuclease; lsDNase, Lucilia sericata 
nuclease; Pulmozyme
®
, proprietary name for dornase alfa, a human recombinant DNase I used in cystic fibrosis treatment. 
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Cystic fibrosis is characterized by airways obstruction caused by thick mucus 
secretions. These secretions contain DNA, which contributes to the viscosity of the 
mucus. As a result, inhalation of Pulmozyme
®
 by CF sufferers can lead to increased 
lung function and reduced antibiotic demand (Frederiksen et al., 2006). However, recent 
research suggests that Burkholderia cenocepacia biofilms mature to be thicker in the 
presence of Pulmozyme
®
 (Novotny et al., 2013). It is unknown what implications this 
has for Pulmozyme
®
 treatment as the majority of DNA in CF lung mucus is human in 
origin (Lethem et al., 1990). Therefore, the fact that Pulmozyme
® 
is a human DNase 
may mean it is better suited to the degradation of human DNA. Recombinant human 
DNase I has shown efficacy against some biofilm-forming microbes (Hall-Stoodley et 
al., 2008; Kaplan et al., 2012). 
Another example of DNase treatment that pre-dates the Whitchurch et al., (2002) 
paper is the use of Varidase
®
 to treat chronic wound infections. The efficacy of 
Varidase
®
 is based on the combination of a DNase (streptodornase) and a plasminogen 
activator (streptokinase). Due to the presence of a DNase enzyme, Varidase
®
 has been 
shown to reduce biofilm colonisation of S. aureus and P. aeruginosa in vitro (Nemoto 
et al., 2000; Nemoto et al., 2003). Varidase
®
 has shown efficacy in wound healing 
(Poulsen et al., 1983) but its quality and composition (streptodornase and streptokinase 
are a small proportion of total protein content) has been questioned. It is no longer 
widely available, and it appears to have limited efficacy in wound treatment (Steed, 
2004). The use of a Blow fly, Lucilia sericata, nuclease is another example of DNase 
treatment potential in wound healing (Brown et al., 2012). Blow fly larvae are used in 
wound debridement, and therefore it is a logical approach to test the extracellular 
enzymes it produces against microbial biofilms. Established biofilms of a P. aeruginosa 
wound isolate were dispersed by L. sericata DNase (Brown et al., 2012). Further 
validation, for instance in an in vivo model, is required before it is used a treatment aid.  
A potentially important characteristic of DNase enzymes is their ability to act 
synergistically with antibiotics. Within a biofilm, microbial cells are significantly more 
resistant to antimicrobial agents (Stewart and Costerton, 2001). Therefore, the release of 
cells by a DNase could increase the efficacy of antibiotics. Furthermore, eDNA binds 
positively charged antimicrobials such as aminoglycosides, which reduces their 
diffusion through the extracellular matrix (Chiang et al., 2013). DNase enzymes have 
been shown to increase antimicrobial efficacy in a number of biofilm systems, including 
bacteria and fungi (Tetz et al., 2009; Kaplan et al., 2012; Martins et al., 2012; Ratner 
and Hymes, 2013).  
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There are a number of studies that have shown DNase activity against microbial 
biofilms. Of the forty-three species studied to date only Fusobacterium nucleatum, 
Porphyromonas gingivalis, Burkholderia cenocepacia, and Salmonella enterica have 
exhibited no change in extent or thicker biofilm biomass when treated with DNase (Ali 
Mohammed et al., 2013; Novotny et al., 2013; Wang et al., 2013). It is unknown how 
publication bias, towards positive results, has influenced the number of DNase-resistant 
microbial biofilms reported. Increasingly, research is also studying the role of eDNA in 
in vivo biofilms and mixed-species models, as there has been a tendency to study in 
mono-species models where biofilms form on abiotic surfaces. Recently, DNase I was 
shown to have increased efficacy against Candida albicans and S. epidermidis biofilms 
when grown as a dual species biofilm in a mouse subcutaneous catheter mouse model 
(Pammi et al., 2013). Furthermore, DNase treatment has disseminated biofilms in 
activated sludge (Dominiak et al., 2011). In another in vivo model, of the mouse 
respiratory tract, Bordetella spp. nasal biofilms have been shown to be sensitive to 
DNase treatment (Conover et al., 2011). These promising studies show the potential of 
nuclease enzymes in complex biofilms, and hopefully will be expanded in the next 5 
years. 
Although many DNase enzymes exist and have been shown to have efficacy against 
microbial biofilms, NucB from B. licheniformis EI-34-6 (Nijland et al., 2010) has a 
number of potential benefits compared with mammalian enzymes. Human recombinant 
DNases require glycosylation to be active, thermally stable, and have resistance to 
proteolysis, therefore meaning that they cannot be produced in bacterial protein 
expression systems (Fujihara et al., 2008). In contrast, NucB can be produced in large 
quantities, using a method that has been optimized (Rajarajan et al., 2013). Producing 
pure DNase enzymes is important, as shown with Varidase
®
, where a lack of purity led 
to treatment concerns. NucB has been produced to a point where it is 95% pure (Prof. 
Alastair Hawkins, unpublished data). Importantly, optimal conditions (pH 8, 5 mM 
Mn
2+
 cations, 37°C) for NucB enzyme activity have been quantified, which will 
improve efficacy against microbial biofilms. Differential scanning calorimetry analysis 
has shown that NucB is thermally stable to a temperature of approximately 57°C (Prof. 
Alastair Hawkins, unpublished data). Interestingly, NucB is capable of re-folding once 
cooled from 80°C to 25°C. Nuclease activity, using a salmon sperm DNA substrate, was 
ca. 40% once cooled, compared to the original non-heated NucB. Although activity was 
lower once heated, in contrast, DNase I does not appear capable of any re-folding once 
heated to its melting point of 67.4°C in pure water (Chan et al., 1996). Recently, NucB 
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was included in a micronucleus toxicity assay (Cyprotex, UK) in CHO-K1 (Chinese 
hamster ovary) cells and found to not be deleterious to cell viability at a concentration 
used for biofilm dispersal (5 µg/mL) (Unpublished work). Lastly, NucB has likely 
evolved for the purpose of biofilm dispersal, and this may explain the greater efficacy it 
has against B. licheniformis biofilms than DNase I (Nijland et al., 2010). Dispersal of 
microbial biofilms with NucB was also incredibly rapid, taking only 2 minutes. As 
antimicrobial resistance is a growing concern, new anti-biofilm agents like NucB are 
becoming increasingly important. With research, NucB could become important in 
tackling medically relevant biofilm issues.  
 
1.7 Medical device associated biofilm infections 
 
Artificial devices used to improve human quality of life were the first to be recognised 
as being colonised by microbial biofilms (Hall-Stoodley et al., 2004). Biofilm growth 
on an artificial device is widely referred to as biofouling. Many medical devices are 
known to be colonised by microbial biofilms, and these include hip replacements, 
prosthetic joints, catheters, heart valves, and pacemakers (reviewed by Donlan, 2001). 
Any device that is in contact with the human body has the potential to become 
colonised. However, medical devices are an indispensable element of modern 
healthcare, particularly through managing critically ill patients. For instance, the central 
venous catheter (CVC) is used for a combined 15 million days per year in the USA 
alone (von Eiff et al., 2005). Obviously, the microbial biofilms that form on these 
devices have the potential to create disease. They also deteriorate devices quicker than 
would occur if they were biofilm-free. Micro-organisms become irreversibly bound to 
medical devices ensuring that replacement, with subsequent costs and increased staff 
workload, is the only option to stop infection. Therefore, microbial biofouling on 
artificial medical devices is a major issue in healthcare today. 
Many of the infections are nosocomial in origin but can originate from the skin of 
patients, poor cleaning of devices and other environmental sources (Donlan, 2001). Due 
to the prevalence of these biofilms they have been termed as chronic polymer-associated 
infections. Commonly these infections are caused by staphylococci (principally S. 
aureus and S. epidermidis), P. aeruginosa, E. coli, C. albicans and Klebsiella 
pneumoniae. However, many more micro-organisms have been isolated from medical 
devices. To date, despite numerous efforts to reduce biofilm colonisation of artificial 
Chapter 1: Introduction 
36 
 
medical devices (reviewed by Francolini and Donelli, 2010) there still remains a great 
deal of progress to be made.  
It is currently unknown whether eDNA contributes to medical-device-associated 
biofilm stability or attachment. Furthermore, DNase treatment, although a potentially 
important therapeutic step in treating these infections, has to our knowledge never been 
tested against medical device biofilms. Nuclease treatment could be of benefit because 
it could either inhibit biofilm formation, or be applied as a cleaning solution for biofilm 
dispersal. 
 
1.7.1 Tracheoesophageal speech valve biofouling 
 
Since the introduction of the silicone rubber tracheoesophageal speech valve (TESV) 
(Figure 1.4), developed by Blom and Singer (Singer and Blom; Singer et al., 1981) in 
the 1970s, voice rehabilitation in patients who have had a total laryngectomy has been 
revolutionised. Several different prostheses exist but all are made from silicone rubber 
and work in a similar way; allowing air into the oesophagus for phonation whilst 
preventing food from entering the respiratory tract via the neopharynx.  The TESV is 
placed in a tracheoesophageal fistula that is created during surgery. However, because 
these devices are placed in a non-sterile environment they quickly-become colonized by 
micro-organisms. Candida albicans, a common opportunistic pathogen, is often 
involved with TESV biofouling (Bauters et al., 2002). Microbial colonization results in 
the need to remove TESVs from patients every 3-6  months (Hancock et al., 2013; 
Kress et al., 2013). Silicone deterioration due to microbial biofilms leads to TESV 
leakage (Balm et al., 2011), tracheal irritation (Acton et al., 2008), and increased 
difficulty in producing speech (Elving et al., 2003). Two distinct versions of the TESV 
exist. The non-indwelling voice prosthesis can be removed by the patient, whereas the 
indwelling type has to be removed by a speech therapist or clinician. Indwelling TESVs 
have a longer lifespan and have become the favoured method, particularly the system 
manufactured by Provox, in European countries (Balm et al., 2011). Although the 
indwelling system requires a hospital visit the replacement of the TESV is a quick, 
minor procedure that can be completed in an outpatient setting. Non-indwelling devices 
are easier to use, and can be regularly patient-maintained, but are more likely to become 
colonized by micro-organisms through handling. At the Freeman Hospital, Newcastle, 
TESVs are purchased from Blom-Singer, and both indwelling and non-indwelling 
devices are used by patients.  
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Figure 1.4 A heavily fouled tracheoesophageal speech valve. The TESV was viewed 
from the posterior (A) and lateral sides (B). Black arrows indicate a dense biofilm that 
has formed on the silicone surface. 
  
Chapter 1: Introduction 
38 
 
Patients who have previously undergone radiotherapy experience a shorter lifespan 
of valves of up to one month less on average (Eerenstein et al., 1999).  Irradiated users 
produce less saliva and carry more Candida spp. in the oropharynx, which may explain 
quicker device replacement (Martin et al., 1981). The production of less saliva may aid 
bio-deterioration as it has been demonstrated that saliva reduces the bond of microbes to 
silicone surfaces
 
(Busscher et al., 1997). Many patients who require voice prostheses 
will have received radiotherapy for the cancer of the larynx or hypopharynx that 
required a total laryngectomy. There are many complications to consider with TESV 
patient use.  
It is unlikely that a single bacterial or fungal species would reside on a TESV. 
However, C. albicans is often considered the key colonizer of voice prostheses 
(Eerenstein et al., 1999). Other Candida spp., like Candida glabrata, are also isolated 
from TESVs (Bauters et al., 2002). It is also clear that commensal bacteria, which 
reside on the skin, or the oral cavity, are often present on speech valves. These micro-
organisms include staphylococci, oral streptococci, and lactobacilli (Buijssen et al., 
2012). For example, Lactobacillus spp., were found on 97% of explanted TESVs by 
Buijssen et al., (2007). Bacteria have increased importance as they are known to 
increase the adherence of C. albicans to surfaces (Holmes et al., 1995; Holmes et al., 
1996). Interestingly, the adhesion of C. albicans, Candida krusei and Candida tropicalis 
to silicone rubber was less when bacteria were present (Millsap et al., 2001). However, 
FISH analysis of TESV biofilm architecture has shown interactions between 
streptococci, lactobacilli and fungi (Buijssen et al., 2012). Micrococcus luteus and 
Klebsiella oxytoca speech valve isolates attached to C. albicans cells in vivo (Kania et 
al., 2010). It is unknown if the species composition of TESV biofilms differs between 
indwelling and non-indwelling devices. 
Currently there are no methods for cleaning indwelling TESVs, and non-indwelling 
devices, although cleanable, still require replacement every 3-5 months (Van Den 
Hoogen et al., 1996). Many previous attempts have been made to control the 
development of biofilms on voice prostheses: use of antibiotics and antifungal agents, 
adjusting the surface properties of the silicone rubber, probiotic nutrition, synthetic 
saliva, and biosurfactants (reviewed by Rodrigues et al., 2007).  Although TESVs are 
often colonised by fungi, and the use of antifungals like amphotericin B increases 
speech valve lifespan (Mahieu et al., 1986), they are not routinely used because of 
microbial resistance worries. Consumption of buttermilk appears to reduce biofilm 
formation on TESVs (Busscher et al., 1998). However, its use is limited as it requires 2 
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litres of buttermilk to be ingested daily. Biosurfactants isolated from Lactococcus lactis 
and Streptococcus thermophilus have been shown to decrease adherence of micro-
organisms to silicone rubber in an artificial throat model (Rodrigues et al., 2004). 
Biosurfactants are used by bacteria, like Streptococcus mitis, to compete with other 
biofilm producers, to stop them adhering nearby (van Hoogmoed et al., 2000). Further 
novel techniques for inhibiting or dispersing TESV biofilms are desirable. 
The colonization of TESVs by microbial biofilms provides an interesting model for 
biofilm research. Patients regularly replace the devices so they are relatively easy to 
obtain. Furthermore, they are colonized by important opportunistic pathogens and 
commensal micro-organisms. For the study of eDNA, TESV biofouling could prove 
particularly useful. The contribution of eDNA to mixed-species biofilms has been 
under-researched to date. A number of species associated with TESV biofouling have 
been shown to produce eDNA. For instance, extracellular DNA is present in C. albicans 
SC5134 biofilm matrixes and treatment with bovine DNase I decreases biofilm biomass 
(Martins et al., 2010). Further research by Martins et al., (Martins et al., 2012) showed 
increased efficacy of the antifungals, amphotericin B, and caspofungin, against C. 
albicans when biofilms were treated with DNase I. Other biofilm-forming species 
associated with TESV biofouling that are susceptible to DNase treatment include, 
Staphylococcus spp., streptococci, and lactobacilli (Qin et al., 2007; Perry et al., 2009; 
Kaplan et al., 2012; Muscariello et al., 2013). These are promising results although it is 
unknown how significantly eDNA contributes to a TESV biofilm. Multi-species 
biofilms in activated sludge have been dispersed with DNase treatment (Dominiak et 
al., 2011), as have dual-species biofilms of C. albicans and S. epidermidis (Pammi et 
al., 2013) but DNase treatment of TESVs could provide additional proof for the 
importance of eDNA in polymicrobial biofilms. 
Biofilm formation is detrimental to TESVs and this has an impact on patients and 
healthcare services. Therefore, if proven to have efficacy, DNase treatment of TESVs 
could improve their use. Nuclease enzymes could be applied in two ways; either directly 
coating the voice prosthesis, or adding to a cleaning fluid. Many patients use voice 
prostheses that can be independently cleaned but whilst a cleaning product may be 
successful patients may not always comply with a cleaning routine. Furthermore, 
patients are unable to clean indwelling voice prostheses. A coating that included a 
nuclease, such as NucB, could prove a more powerful method of reducing TESV 
biofilm colonisation. Recently, Swartjes et al., (2013) showed that coating 
polymethylmethacrylate with DNase I can reduce adhesion of S. aureus and P. 
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aeruginosa by over 90%. However, enzyme activity began to reduce after 8 hours, and 
therefore further research is required to improve DNase coating efficacy over longer 
periods. 
 
1.8 Chronic biofilm infections on living tissues 
 
The list of infections known to be caused by persistent microbial biofilms is vast: otitis 
media, CRS, periodontitis, native valve endocarditis, cystic fibrosis, pneumonia, 
bacterial prostatitis, muscoskeletal infections, biliary tract infections and many more 
(reviewed by Costerton et al., 1999).  Biofilms are up to 1,000-fold more resistant to 
antibiotics than planktonic infections (Gilbert et al., 1997). Furthermore, when 
planktonic bacteria disseminate from the biofilm, for instance from dialysis catheters, 
the infection can spread around the body, causing bacteremia and other secondary 
problems (Allon, 2004). The human immune system will very rarely resolve biofilm 
infections, even in healthy individuals (Stewart and Costerton, 2001). With no universal 
cure these diseases are a 21st century medical challenge.  
It is unknown what contribution eDNA makes to biofilm stability in clinically 
relevant biofilms. Given that eDNA is a ubiquitous biofilm attachment and stability 
macromolecule, it may be that DNase enzyme treatment could have a positive influence 
on many biofilm infections. An infectious disease with an established biofilm link is 
discussed next. 
 
1.8.1 Chronic rhinosinusitis 
 
Of the many human infections associated with biofilms, CRS is one of the most 
common, resulting in 18 to 22 million visits to general practitioners in the USA per year 
(Benninger et al., 2003). Furthermore, CRS affects approximately 10% of the adult 
European population (Hastan et al., 2011). Rhinosinusitis is an inflammation of the 
mucous membrane that lines the paranasal sinuses. The disease is divided into several 
categories, largely based on the length of time a patient has experienced symptoms of 
rhinosinusitis. Acute and recurrent acute rhinosinusitis last up to four weeks, and may 
consist of many episodes (between disease-free states) in the latter case. The transition 
to CRS is known as subacute rhinosinusitis and is defined as rhinosinusitis that has 
lasted four to twelve weeks. Rhinosinusitis is deemed ‘chronic’ if it has lasted twelve 
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Figure 1.5 Functional endoscopic sinus surgery. Chronic rhinosinusitis mucus is 
aspirated during FESS (A) and placed in a test tube filled with reduced transport fluid 
(B).The aspirate is a tenacious, thick, bloody mucus, although the appearance varies 
widely between patients.  
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consecutive weeks or longer. The symptoms patients experience are similar, and as a 
result the disease can be hard to classify, which is why classification is defined 
chronologically. In addition, the location of the infection can be based in one or more of 
the paranasal sinuses. There are several paranasal sinuses, including, maxillary, frontal, 
ethmoidal, and sphenoidal sinuses.  
Treatment of the infection begins with medical therapy and only in severe cases is 
surgical therapy recommended (Ragab et al., 2004). Wood and Douglas (2010) 
advocate 3 week medical treatment with a corticosteroid (prednisone) and an antibiotic 
(e.g. doxycycline). After this period, patients use a sinus douche to administer saline, 
and also use a corticosteroid spray. Ultimately, if symptoms still persist after this 
regime, surgery is instructed. Although antibiotics are favoured by clinicians there is 
little evidence for their efficacy (Lim et al., 2010). Macrolides, such as roxithromycin, 
may be beneficial because of their anti-inflammatory effect (Wallwork et al., 2006). 
Furthermore, the use of the antifungal amphotericin B improved symptoms in 75% of 
patients tested (Ponikau et al., 2002). Nasal lavage with amphotericin B has been shown 
to have no treatment efficacy (Ebbens et al., 2006). Chronic rhinosinusitis is 
challenging to treat because it caused by a number of factors (discussed in the next 
paragraph). Surgical therapy, primarily the non-invasive procedure, functional 
endoscopic sinus surgery (FESS) (Figure 1.5A), is carried out in hard to treat cases, to 
open up the airways and relieve some symptoms. However, the efficacy of this 
treatment is unproven (Khalil and Nunez, 2006). An example of the material removed 
during FESS is shown in Figure 1.5B. 
In all cases CRS is an inflammatory disease. However, the cause of the inflammation 
can be due to many factors, and it is likely that CRS is an overarching name for a 
number of different diseases with similar symptoms. For instance, the development of 
CRS has been linked to smoking (Hastan et al., 2011), allergies (Perez-Novo et al., 
2005), viruses (Benninger et al., 2003), fungi (Lanza et al., 2006), bacteria (Benninger 
et al., 2003), staphylococcal super antigens (Seiberling et al., 2005), and underlying 
systemic diseases (Benninger et al., 2003). Increasingly over the last decade bacterial 
and fungal biofilms have been recognised as a major cause of CRS, with increasing 
evidence from several authors (see Table 1.3). It is important to note that microbial 
biofilms are not the sole cause of CRS, but it appears they are a significant factor in the 
pathogenesis of CRS. Furthermore, the presence of biofilms is independent of other 
clinical factors like allergies (Zhang et al., 2011).  
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Table 1.3 Bacterial biofilms on clinical mucosal specimens removed from sufferers and non-sufferers of chronic rhinosinusitis. 
Reference Imaging Method CRS Mucosa Control Mucosa 
(Bezerra et al., 2011) SEM 24/33 (73%) 13/27 (48%) 
(Healy et al., 2008) FISH-epifluorescent microscopy 9/11 (82%) 2/3 (67%) 
(Hochstim et al., 2010) Hematoxylin-eosin staining 15/24 (63%) 1/10 (10%) 
(Foreman et al., 2009) FISH-CLSM 36/50 (72%) 0/10 (0%) 
(Psaltis et al., 2007)  CLSM 17/38 (45%) 0/9 (0%) 
(Ramadan et al., 2005) SEM 5/5 (100%) ND
a
 
(Sanclement et al., 2005) SEM  24/30 (80%) 0/4 (0%) 
(Sanderson et al., 2006) FISH-epifluorescent microscopy 14/18 (78%) 2/5(40%) 
a
ND, not determined. 
SEM, scanning electron microscopy; FISH, fluorescence in situ hybridization; CLSM, confocal laser scanning microscopy. 
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Evidence of microbial biofilms on the surface of sinus mucosa is produced through 
microscopic analysis of mucosal biopsies. A range of techniques have been used to 
visualise micro-organisms in chronically infected sinuses, including, FISH-CLSM 
(Foreman et al., 2009), hematoxylin-eosin staining (Hochstim et al., 2010), and SEM 
(Sanclement et al., 2005). They are present on the sinus mucosa of CRS patients in 45-
100% of cases (Table 1.3) (Foreman et al., 2012). The most convincing visual studies of 
biofilms on CRS patient mucosa is via the use of FISH stains, as these are selective for 
prokaryotic or eukaryotic organisms. Bacteria appear as punctate dots against large 
eukaryotic cells (Shields et al., 2013). Further evidence for the biofilm pathogenesis of 
CRS was revealed through testing isolated micro-organisms for their ability to form 
biofilms in vitro. Prince et al., (2008) cultured sinonasal aspirates in a Calgary Biofilm 
Detection Assay (CBDA) and 45 out of 157 were positive for biofilm formation. Again, 
biofilm formation was linked to surgical interventions. The CBDA has also been used 
more recently, with biofilm formation shown in 21% of patient samples (Zhang et al., 
2011). Lastly, the simple microplate crystal violet assay has also been used to show 
biofilm formation in bacteria isolated from the paranasal sinuses of CRS patients 
(Bendouah et al., 2006). It is important to consider that the threshold set for biofilm 
formation will have a strong influence on the amount of biofilm-forming micro-
organisms reported and there is no gold standard approach for this. 
Although micro-organisms are implicated in the pathogenesis of CRS, the bacterial 
flora of healthy and diseased paranasal sinuses are largely similar (Araujo et al., 2007). 
There is a high prevalence of coagulase-negative staphylococci, Streptococcus spp., and 
S. aureus in both groups. More recently, culture-independent techniques have been used 
to study the microflora of CRS (Stressmann et al., 2011; Feazel et al., 2012; Boase et 
al., 2013). Although molecular methods have greater detection sensitivity, culture-
dependent and culture-independent techniques appear to demonstrate similar micro-
organisms in CRS disease (Feazel et al., 2012). It is unclear if specific pathogens are 
involved in disease manifestation. Pathogenic species like S. aureus, M. catarrhalis, P. 
aeruginosa, and S. pneumoniae can be more prevalent in CRS patient sinuses (Boase et 
al., 2013). However, it seems increasingly likely that a biofilm phenotype contributes to 
the symptoms of CRS, and it is unknown how biofilm formation begins. Although it is 
important to note that biofilms are found on the surface of healthy sinus mucosa (Table 
1.3).  
There are still a number of aspects of CRS microbiology that are unclear, including 
the prevalence of anaerobic micro-organisms (Ramadan et al., 2002) and the role of 
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fungi in facilitating disease (Ebbens et al., 2009). Fungi are either cultured in high 
incidence (Ponikau et al., 1999), or detected in few cases (Araujo et al., 2007). The 
fungal pathogenesis of CRS is distinct to biofilm-associated CRS, and probably affects 
a minor proportion of sufferers of the disease. Similarly, anaerobic micro-organism 
carriage is either found to be in a high number of cases (Brook, 1989) or very low 
(Doyle and Woodham, 1991). Culture technique will likely bias results because 
laboratories close to sample collection will facilitate greater survival of anaerobes. The 
oxygen content of sinuses can drop when blocked with extensive amounts of mucin 
(Carenfelt and Lundberg, 1977). Therefore, in extreme cases, anaerobic micro-
organisms may be more common. 
As previously discussed, biofilm-forming micro-organisms exhibit greater levels of 
antibiotic resistance, which may explain the lack of efficacy in treating CRS with 
antibiotics in some cases (Lim et al., 2010; Fokkens et al., 2012). Interestingly, biofilms 
are often observed in patients who have previously undergone FESS, which is 
suggestive of the difficulty in eliminating biofilm infections (Bendouah et al., 2006; 
Zhang et al., 2011) Novel ideas for eradicating microbial biofilms are required to 
improve the management of CRS. Extracellular DNA is a common characteristic of the 
biofilm matrices of micro-organisms. Therefore, targeting the eDNA molecule and 
reducing biofilm stability may increase treatment efficacy. Bacteria that are CRS-
associated and have been dispersed or inhibited with DNase I include S. pneumoniae 
(Hall-Stoodley et al., 2008), Neisseria spp. (Lappann et al., 2010), P. aeruginosa 
(Whitchurch et al., 2002), S. aureus (Kaplan et al., 2012), and E. coli (Tetz and Tetz, 
2010). In addition, Bordetella spp. have been dispersed from the upper respiratory tract 
of mice (Conover et al., 2011), highlighting the efficacy of delivering a DNase solution 
to a nasal biofilm. However, it is unknown how recently isolated bacteria from a clinical 
condition will respond to DNase treatment. It is also unknown if eDNA is important in 
CRS-associated biofilm-forming micro-organisms. At this early stage it would be useful 
to culture isolates in uncomplicated models to test their sensitivity to DNase enzymes.  
No optimal therapy for CRS has yet been discovered. Medical therapy with 
antibiotics has limited efficacy (Lim et al., 2010), as does FESS (Khalil and Nunez, 
2006). Nasal irrigation with saline solutions does have some benefits, although it is less 
effective than topical steroids (Harvey et al., 2007).  Adding a chemical to a solution 
that can be delivered to the sinus that subsequently dissolves the biofilm is a concept 
that could improve treatment. One previous attempt of this using sterile water, citric 
acid and caprylyl sulfobetaine (zwitterionic surfactant) applied at pressure to biofilm 
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forming isolates from CRS was successful at causing biofilm reduction (Desrosiers et 
al., 2007). There was a 99.9% reduction of P. aeruginosa biofilm mass. Given this 
research was an in vitro study this cannot yet be applied in a clinical environment but it 
does suggest that this concept may work in vivo. Addition of the novel bacterial 
nuclease, NucB, to a saline solution could work in much the same way. Administered 
prior to surgery to soften or even dissolve the biofilm it could allow for less intrusive 
surgery. Remaining planktonic bacteria may be more susceptible to conventional 
antibiotics. However, before this application the efficacy of nuclease treatment needs to 
be researched in clinical isolates from CRS patient sinuses. An improvement in clinical 
practice would undoubtedly save health services considerable amounts of time and 
money. Furthermore, it would improve the quality of life for up to 10% of the adult 
European population. 
 
1.8.2 Human oral health and biofilms 
 
The biofilms that develop on teeth and on oral mucosal surfaces are complex 
communities. For example, culture-independent methods have shown that 700 microbial 
species can colonise the human mouth (Aas et al., 2005). As outlined in section 1.1, the 
formation of the oral biofilm occurs through a sequence of events. Ultimately, the 
process has enough homology with other biofilm systems that the oral biofilm, or dental 
plaque, provides a model for the overall understanding of biofilms. Importantly, 
although the mouth contains many beneficial micro-organisms, there are circumstances 
whereby pathogenic microbes can thrive. A key component of a disease-causing oral 
biofilm is the biofilm matrix. Therefore, by understanding the role of eDNA in 
facilitating biofilm attachment or biofilm stability it may be easier to target disease-
causing biofilms.  
Some oral bacteria have been shown to have greater importance in the development 
of dental plaque, both in healthy and diseased mouths. For instance, streptococci, 
including S. gordonii, are well characterised as initial colonizers of the tooth surface. 
Streptococcus spp. constitute 60-80% of the oral biofilm microflora in the early stages 
(4-8 hours) of biofilm formation, as analysed by 16S rRNA PCR amplification (Diaz et 
al., 2006). The reason for their abundance at this early time point is the wide plethora of 
surface adhesins that streptococci use to attach to surfaces (reviewed by Nobbs et al., 
2009). Actinomyces spp. are also common in early dental plaque formation, and have 
been shown to interact with streptococci in a way that leads to increased biofilm 
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formation (Palmer et al., 2001). Recently, Actinomyces naeslundii 2 was renamed to 
Actinomyces oris (Henssge et al., 2009). Actinomyces oris is important because 
Fusobacterium nucleatum binds to this species. During in vitro flow cell experiments 
using saliva, F. nucleatum only grew if A. oris was also present (Periasamy et al., 
2009). Therefore, A. oris and Strepotococcus spp. are responsible for providing a basis 
for the co-aggregation of many oral bacteria, as F. nucleatum can bind to early and late 
colonizers (Kolenbrander et al., 2006). Due to this ability, F. nucleatum is known as a 
bridging micro-organism in the succession of oral biofilm formation. Another important 
aspect of F. nucleatum colonisation is its putative role as a pathogenic species in 
periodontitis. Fusobacterium nucleatum is a poor inducer of immune response (Signat 
et al., 2011) but is a dominant organism in the periodontium   (Bolstad et al., 1996). It 
seems likely that whilst F. nucleatum is a commensal micro-organism its ability to bind 
pathogenic species like Porphyromonas gingivalis or Prevotella intermedia could 
facilitate the onset of a disease-causing biofilm. Streptococci and F. nucleatum also 
bind to each other in co-aggregations. These dynamics were analysed by Al-Ahmad et 
al., (2007) by employing specific FISH probes and CLSM. A key Streptococcus spp. is 
S. mutans, a micro-organism strongly linked to the causation of dental caries (van 
Houte, 1994). Clearly, oral bacteria are able to form many interactions that can have 
positive or deleterious impacts on human health. Often oral disease is related to 
environmental conditions. With dental caries, increased dietary sugar leads to an acidic 
pH that selects for acidogenic micro-organisms, such as S. mutans. These changes also 
modify the extracellular matrix, which impacts on species composition and 
cariogenicity (Paes Leme et al., 2006). Although it is impossible to define a healthy 
microflora it is important to consider the roles of commensal species, such as S. 
gordonii, in facilitating a disease-causing biofilm. 
Oral micro-organisms have been shown to produce eDNA, including S. gordonii, S. 
sanguinis (Kreth et al., 2009), S .mutans (Perry et al., 2009), F. nucleatum and 
Porphyromonas gingivalis (Ali Mohammed et al., 2013). Although eDNA did not 
contribute to biofilm stability in F. nucleatum and Porphyromonas gingivalis (Ali 
Mohammed et al., 2013), it promoted stability in S. mutans (Perry et al., 2009). These 
are the limited examples of experiments being designed to test the contribution of 
eDNA to oral bacteria biofilm matrices. Candida albicans, is often associated with oral 
health issues, such as denture stomatitis (Kulak-Ozkan et al., 2002), and has been 
shown to require eDNA for biofilm stability (Martins et al., 2010). Further research is 
required to determine the significance of eDNA in oral biofilms, starting with simple 
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single-species models and ultimately moving towards mixed-species microcosms grown 
from human saliva. Modelling natural biofilms such as dental plaque presents a 
significant challenge for oral microbiologists. Currently many research laboratories 
employ a static model system in microtiter wells which is useful for studying early 
biofilm formation. However, continuous-flow systems that circulate fresh nutrients 
allow for the development of mature biofilms in an environment that is more akin to the 
natural habitat of the mouth (e.g. hydrodynamic influences). Recently, a high-
throughput model system, the BioFlux (Fluxion), has been shown to replicate the 
species composition of the oral biofilm whilst culturing in flowing human saliva (Nance 
et al., 2013). This system would represent a unique opportunity to test DNase enzymes 
against oral biofilms in a laboratory environment. 
Another interesting facet of eDNA production in the oral biofilm is microbial 
competition. For instance, S. mutans acquires transforming DNA from S. gordonii by 
causing cell lysis with a bacteriocin (Kreth et al., 2005). However, many oral bacteria 
also produce extracellular DNase enzymes, including S. gordonii (Palmer et al., 2012). 
Therefore, micro-organisms like S. mutans that rely on DNA either for matrix stability 
or horizontal gene transfer could be negatively impacted by DNase-producing bacteria. 
This is a concept that has not been reported to date but may be an important factor in 
oral biofilm microbial competition.  
Excellent oral hygiene is an effective way of maintaining a healthy mouth and 
removing oral disease causing bacteria (van der Weijden and Hioe, 2005; van der 
Weijden and Slot, 2011). However, the NHS spends £1.23 billion per year treating 
dental diseases (Audit Commission for Local Authorities and the National Health 
Service in England and Wales, 2002), many of which are caused by oral bacteria. As 
has been shown, there is considerable evidence for DNase enzymes having an effect on 
forming or pre-formed biofilms. Therefore, there is much needed research to determine 
the in vitro effect of deoxyribonuclease enzymes, like NucB or DNase I, versus oral 
biofilms, to resolve their potential value in oral hygiene products. Obviously, studies on 
natural dental plaque formed in situ, and ultimately in vivo studies in humans, will be 
required to establish the potential of NucB or other DNases for the control of oral 
biofilms. 
 
1.9 Aims and objectives 
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Before 2010 there had been minimal research into the role of eDNA in biofilm-forming 
micro-organisms recently isolated from clinical diseases. Furthermore, the potential for 
DNase enzymes to treat clinical issues caused by biofilms was as yet untested. 
Therefore, the primary aim of this thesis was to assess the efficacy of NucB in two ENT 
biofilm-associated problems. Subsequently, research was focused on oral biofilms, 
eDNA and microbial nucleases. The objectives were as follows: 
 
1. To characterise the role of eDNA in TESV biofilms 
- Biofilms were visualised in detail using CLSM and SEM. Next, eDNA was 
extracted and quantified from TESV biofilms. Lastly, TESVs were treated 
with NucB to study the biofilm dispersal potential of the enzyme. 
2. To study the efficacy of NucB against biofilm-forming CRS isolates 
- Micro-organisms were isolated from material aspirated during FESS. These 
isolates were then assessed for biofilm formation, and subsequently treated 
with NucB. Microscopic analysis of sinus mucosa and sinus mucin was also 
undertaken. Furthermore, eDNA was extracted and quantified from isolate 
biofilms. 
3. To measure eDNA and DNase efficacy in selected oral bacterial biofilms 
- Four oral bacteria, S. gordonii, A. oris, S. mutans and Fusobacterium 
nucleatum were cultured as biofilms and treated with DNase I. Extracellular 
DNA in the biofilm matrix was also quantified. The efficacy of NucB and 
DNase I was compared versus S. mutans GS-5. Lastly, oral biofilms were 
modelled in a microfluidics device during a research visit to the University 
of Michigan, MI, USA.  
4. To characterise the extracellular DNase produced by S. gordonii 
- The gene encoding extracellular nuclease production was identified by 
bioinformatics research. Given the reliance of S. mutans GS-5 on eDNA, the 
interaction between S. gordonii nuclease activity and this species was 
studied. The nuclease, SsnA, was cloned into an E. coli protein expression 
system and purified. DNase activity of SsnA was then assessed using in gel 
zymography and biofilm assays. The regulation of ssnA by carbon sources, 
and inhibition of SsnA by acid was also studied.  
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Chapter 2: Materials and Methods 
 
2.1 Reagents and equipment 
 
2.1.1 Reagents 
 
Reagents are listed in the text, with manufacturers, and if required are abbreviated after 
first mention.  
 
2.1.2 Equipment 
 
Table 2.1 Equipment used in this study 
Application Device Manufacturer 
Gradient PCR T100 
PTC-200 
Bio-Rad 
MJ Research 
PCR GeneAmp PCR 
System 9700 
Applied Biosystems 
Centrifugation J2-21 
SK10 
Beckman 
Sigma Centrifuges 
Bench-top Centrifugation MiniSpin Eppendorf 
Orbital Shaker  Jencons 
Static Incubator 30/37°C Laboratory Thermal 
Equipment 
Anaerobic Incubator Bug Box Plus Ruskin 
Microfluidics Biofilm Culture Bioflux™ Fluxion 
Sample Disruption TissueLyser LT Qiagen 
Microplate Reader Synergy HT Biotek  
Determination of Nucleic Acid 
Absorption 
ND-1000 NanoDrop 
Determination of Optical Densities UV2 Unicam 
Confocal Laser Scanning 
Microscopy 
TCS SP2 Leica 
Transmission Electron Microscopy CM100 Philips 
Scanning Electron Microscopy Stereoscan 240 Cambridge 
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DNA Electrophoresis Gel Tank 
Power Pac 300 
Apollo Instrumentation 
Bio-Rad 
Agarose Gel Imaging G:Box Syngene 
Protein Electrophoresis Gel Tank 
Power Pack 
ATTO 
Consort 
 
2.2 Ethical approval 
 
Ethical approval (no. 10/H0904/44) was gained for the chronic rhinosinusitis (CRS) 
study by the National Research Ethics Service Committee (North East – Sunderland). 
Each patient had to give their consent before enrolment to the study. 
For the tracheoesophageal speech valve (TESV) project no ethical approval was 
required as the study was anonymous and did not use human tissue samples. 
 
2.3 Sample collection 
 
2.3.1 Tracheoesophageal speech valves 
 
Tracheoesophageal speech valves were obtained from patients at the Freeman Hospital, 
Newcastle-upon-Tyne. Patients regularly change their voice prostheses due to leakage 
of the valve. After removal at the hospital’s Speech and Language Therapy Department 
the valves were placed in phosphate buffered saline (KH2PO4 20mM, Na2HPO4 20mM, 
NaCl 0.15 mM, pH 7.1) (PBS) and transferred to the Centre for Oral Health Research, 
Newcastle University. Tracheoesophageal speech valves were stored at 4°C for up to 
three days before analysis. 
 
2.3.2 Chronic rhinosinusitis obstructive mucin and sinus mucosa 
 
A total of 20 patients undergoing functional endoscopic sinus surgery (FESS) for the 
treatment of CRS at the Freeman Hospital, were recruited to this study. All patients met 
the CRS diagnosis criteria published by the Chronic Rhinosinusitis Task Force 
(Benninger et al., 2003). Patients were recruited to the study only if obstructive mucin 
was observed during the surgical procedure. During FESS, ‘obstructive mucin’ that was 
dislodged surgically was collected with mucous traps (Sigma Aldrich) and immediately 
placed into sterile reduced transport fluid (RTF) (Syed and Loesche, 1972). Specimens 
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were transferred to the Centre for Oral Health Research and stored at 4°C. All samples 
were processed within 24 h. Mucosal biopsy specimens were fixed in 10% formalin 
directly after surgery, and stored at 4°C for up to one month. 
 
2.3.3 Saliva 
 
Whole stimulated saliva was collected from six healthy individuals who were asked not 
to eat 2 h prior to collection. Saliva was collected on ice, aliquoted and kept at -20°C 
until use as the inoculum in mixed species biofilm experiments 
 
2.4 Microbiological methods 
 
2.4.1 Bacterial strains and culture techniques 
 
2.4.1.1 Culture of tracheoesophageal speech valve isolates 
 
Micro-organisms liberated from the surface of used TESVs (see 2.10.1) were cultured 
on Sabouraud Dextrose Agar (Oxoid) and Nutrient Agar (Oxoid). Plates were incubated 
aerobically at 37°C and checked for growth every 24 h for at least 7 days. Sabouraud 
Dextrose Agar was used as a medium on which to grow fungi, including Candida spp., 
that often foul TESVs. Nutrient Agar was used as a non-selective medium for the 
culture of both bacteria and fungi. 
 
2.4.1.2 Isolation and culture of chronic rhinosinusitis micro-organisms 
 
A variety of growth media were employed for the isolation and routine culture of CRS 
isolates. Blood agar contained 37 g/L Brain Heart Infusion (Oxoid), 5 g/L Yeast Extract 
(Merck), and 15 g/L Agar (Merck). After sterilization, 5% (v/v) Defibrinated Horse 
Blood (TCS Biosciences) was added. Chocolate agar was prepared using the same 
recipe except that, after the addition of horse blood, the medium was heated to 70°C for 
10 min. Fastidious Anaerobe Agar (FAA) was purchased from LabM and Sabouraud 
Dextrose Agar was from Oxoid. 
For isolation of micro-organisms, a portion of sinus aspirate from each patient was 
homogenized in sterile phosphate buffered saline (PBS) and inoculated onto blood agar, 
chocolate agar, FAA and two plates of Sabouraud Dextrose Agar. Blood and chocolate 
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agar plates were incubated in 5% CO2 at 37°C. Pre-reduced FAA plates were incubated 
at 37°C anaerobically (Ruskinn, Bugbox Plus) in a gas mix consisting of 10% CO2, 
10% H2 and 80% N2. The Sabouraud Dextrose Agar plates were incubated aerobically, 
one at 37°C and another at 30°C. Plates were examined every 24-48 h for at least seven 
days. Individual colonies were picked and sub-cultured three times to obtain pure 
isolates. Strains were stored at -80°C in BHY medium (brain heart infusion 37 g/L and 
yeast extract 5 g/L) diluted to 50% strength by the addition of glycerol (Sigma Aldrich). 
 
2.4.1.3 Routine culture of oral bacteria 
 
Streptococcus gordonii DL1, Actinomyces oris MG1 and Streptococcus mutans GS-5 
were routinely cultured in THYE medium containing 30 g/L Bacto
TM
 Todd Hewitt 
Broth (Becton Dickinson and Co.) and 5 g/L yeast extract at 37°C anaerobically (10% 
CO2, 10% H2 and 80% N2). Fusobacterium nucleatum subsp. nucleatum ATCC 25586 
was grown in BHIG comprising 37 g/L brain heart infusion, 5 g/L yeast extract, and 2.5 
g/L L-glutamic acid (Sigma Aldrich) anaerobically at 37°C.  
 
2.4.1.4 Culture of Escherichia coli 
 
Strains of Escherichia coli (see table 2.2) were used for cloning and overexpression of 
proteins. The strains were grown in Luria Bertani (LB) Broth (Melford Laboratories 
Ltd.) at 35°C, whilst shaking at 200 RPM in aerobic conditions. Escherichia coli were 
also grown aerobically on LB agar (LB broth plus 15 g/L agar) at 37°C. When required, 
the appropriate antibiotics were added (all Sigma Aldrich); ampicillin (50 μg/mL), 
kanamycin (50 μg/mL), erythromycin (400 µg/mL) and chloramphenicol (33 µg/mL).  
 
2.4.1.5 Biofilm formation in microtiter plates 
 
For biofilm assays, microbial stock cultures (5 µL) were added to triplicate wells of 
sterile polystyrene microtiter-well plates containing growth media (200 µL). Plates were 
wrapped in parafilm and incubated without shaking aerobically or anaerobically at 37°C 
for various time periods. Following overnight growth (20 h), non-adherent planktonic 
cells were removed and transferred to a clean 96-well plate (Greiner Bio-One) and the 
OD600 was read in a microplate reader (BioTek Synergy HT) to quantify growth in the 
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planktonic phase. Biofilm extent was quantified using the crystal violet assay (see 
section 2.10.2). 
 
2.4.2 Strains used in this study 
 
Table 2.2 Strains used in this study 
Strain Description Source or Reference 
E. coli strains   
TOP10 F– mcrA Δ(mrr-hsdRMS-
mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 araD139 
Δ(ara leu) 
7697 galU galK rpsL 
(StrR) endA1 nupG 
Invitrogen 
GEXssnA amp
r
, cam
r
, expresses SsnA-
GST 
This thesis (NSJ)
a
 
DH5α F– Φ80lacZΔM15 
Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 
(rK–, mK+) phoA supE44 
λ– thi-1 gyrA96 relA1 
Invitrogen 
BL21(DE3)pLysS F- ompT hsdSB (rB-mB-) gal 
dcm (DE3) pLysS (cam
r
, 
amp
r
) 
G. Scholefield, 
CBCB, UK 
B. subtilis strains   
ATCC6633 Produces subtilin ATCC 
NZ8900 pNZ8901 (Nijland et al., 2010) 
S. gordonii strains   
DL1 Wild type Newcastle Dental 
Hospital Isolate 
ccpA::ermAM ∆ccpA, ermr This thesis 
malR::ermAM ∆malR, ermr This thesis 
ssnA::ermAM ∆ssnA, ermr This thesis (NSJ)a 
ssnA::aphA3 ∆ssnA, kanr This thesis (NSJ)a 
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Other oral bacteria   
A. oris MG1 Wild type J. Cisar, NIDCR, 
USA 
F. nucleatum 22586 Wild type ATCC 
S. mutans GS-5 Wild type Newcastle Dental 
Hospital Isolate 
S. mutans NG8 Wild type L. C. Dutton, Bristol 
University, UK 
S. mutans UA140 Wild type Unknown 
S. mutans UA159 Wild type ATCC 
CRS Isolates   
C. propinquum FH1 Isolated from patient 8 This thesis 
C. pseudodiphtheriticum FH2 Isolated from patient 6 This thesis 
M. catarrhalis FH3 Isolated from patient 3 This thesis 
M. catarrhalis FH4 Isolated from patient 6 This thesis 
S. aureus FH5 Isolated from patient 3 This thesis 
S. aureus FH6 Isolated from patient 5 This thesis 
S. aureus FH7 Isolated from patient 7 This thesis 
S. epidermidis FH8 Isolated from patient 1 This thesis 
S. epidermidis FH10 Isolated from patient 4 This thesis 
S. epidermidis FH11 Isolated from patient 5 This thesis 
S. lugdunensis FH12 Isolated from patient 6 This thesis 
S. lugdunensis FH13 Isolated from patient 8 This thesis 
S. lugdunensis FH14 Isolated from patient 15 This thesis 
S. warneri FH15 Isolated from patient 7 This thesis 
S. warneri FH17 Isolated from patient 14 This thesis 
S. anginosus FH18 Isolated from patient 3 This thesis 
S. anginosus FH19 Isolated from patient 17 This thesis 
S. constellatus FH20 Isolated from patient 4 This thesis 
S. constellatus FH21 Isolated from patient 7 This thesis 
S. intermedius FH22 Isolated from patient 4 This thesis 
S. pneumoniae FH26 Isolated from patient 10 This thesis 
S. salivarius FH27 Isolated from patient 1 This thesis 
S. salivarius FH28 Isolated from patient 4 This thesis 
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S. salivarius FH29 Isolated from patient 17 This thesis 
a
Unpublished strain constructed by Nick Jakubovics as part of this project. 
 
2.4.3 Identification of micro-organisms 
 
2.4.3.1 Routine microbiological identification 
 
Whilst culturing micro-organisms, they were often checked for the presence of 
contaminant microbes using standard microbiological techniques. These included the 
Gram stain, the catalase test, and checking cell morphology using light microscopy. The 
appearance of colonies on agar was also used as a general guide for culture of the 
correct microbe. 
 
2.4.3.2 Microbiology of chronic rhinosinusitis  
 
All isolates were initially characterized by Gram staining, inspection of colony 
morphology, testing for catalase production, haemolysis, DNase production and ability 
to grow aerobically or anaerobically. The majority of clinical isolates were further 
identified to species level using a Matrix Assisted Laser Desorption/Ionization Time-of-
Flight (MALDI-TOF) Mass Spectrometer (Bruker, Microflex). Isolates were streaked 
onto blood agar, incubated under 5% CO2 or in the absence of oxygen, at 37°C for 24 h 
and transferred to the Pathology Department, Freeman Hospital, Newcastle upon Tyne, 
for identification. 
In cases where MALDI-TOF analysis yielded ambiguous results, for example the 
majority of α-haemolytic streptococci, bacterial identification was confirmed by 
analysis of the 16S rRNA gene. The gene was amplified using the oligonucleotide 
primers 0063F and 1387R (Marchesi et al., 1998) in a ReddyMix
™
 reaction. PCR 
reactions were run using a GeneAmp PCR System 9700 (Applied Biosystems). PCR 
products were checked on a 1% agarose gel, and fragments of the expected size were 
sequenced by MWG Eurofins. Forward and reverse sequences were aligned and 
sequence matched using the Ribosomal Database Project website 
(http://rdp.cme.msu.edu/).  
 
2.4.4 Growth of bacterial populations 
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Bacterial growth was calculated by measuring the turbidity of a bacterial population, 
growing in culture medium. Using a spectrophotometer the absorbance at 600 nm of 1 
mL of suspension was determined, using unconditioned medium to measure background 
absorbance.  
This method of optical density measuring was used to calculate the growth rate of 
organisms. Isolates were cultured overnight, subcultured the following day into pre-
warmed media, and grown for a period of 6-8 h, with optical density measurements 
taken every hour. To determine the doubling time the number of generations (g) was 
calculated using the following equation: 
 
g = (Log10Nt - Log10N0)/Log10
2
 
 
Nt = A600 at time exiting the exponential growth phase 
N0 = A600 at time beginning the exponential growth phase 
 
After g was calculated, the value was divided by the number of min the exponential 
growth phase lasted, thereby giving a doubling time. 
 
2.4.5 DNase agar test for extracellular nuclease activity 
 
DNase agar is a nutrient rich medium that contains DNA. If an organism produces an 
extracellular enzyme that hydrolyses DNA it is possible to observe this activity by 
staining the agar. All chronic rhinosinusitis isolates, oral bacteria and mutants of S. 
gordonii DL1 were tested for nuclease activity in this way. A single thick streak of each 
bacterium was plated onto DNase Test Agar (Oxoid). Plates were incubated aerobically 
or anaerobically at 37°C for between 24-96 h. Once colonies had grown, plates were 
flooded with 4 mL of 0.1% (w/v) toluidine blue (Sigma Aldrich) or 4 mL of 1N HCl, to 
highlight nuclease production. HCl precipitates the DNA, creating an opaque medium 
except for areas of nuclease activity, whereas toluidine blue appears blue in the presence 
of intact DNA and pink when complexed with nucleotides.  
 
2.5 Molecular biology methods 
 
2.5.1 Polymerase chain reaction 
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DNA was typically amplified in 50 µL reactions, using ReddyMix™ (ABgene) or 
Expand High Fidelity PCR System (Roche). ReddyMix
™
 was used to amplify short 
fragments of DNA, or when diagnostically checking the size of amplified DNA. For 
reactions that required more efficient PCR, with fewer base errors, the Expand High 
Fidelity PCR System was used as it contains the Tgo DNA polymerase (from 
Thermococcus gorgonarius) with proofreading activity. The general protocols for both 
kits are shown in Table 2.3 and 2.4, although annealing temperatures were optimised 
depending on the primers used. 
 
Table 2.3 ReddyMix
™
 reaction mix and thermal cycling 
50 µL Reaction Mix Thermal Cycler Protocol 
Template – 1 µL 
Primers (10 μM) – 5 µL 
each 
ReddyMix™ – 25 µL 
dH2O – 14 µL 
Initial 
Denaturation 
94°C / 2 min 1x 
Denaturation 
Annealing 
Elongation 
94°C / 10 s 
55°C / 30 s 
68°C / 1 min
a
 
 
35 cycles 
Final Elongation 68°C / 7 min 1x 
a
1 minute per 1000 base pairs. 
 
Table 2.4 Expand high fidelity PCR system reaction mix and thermal cycling 
50 µL Reaction Mix Thermal Cycler Protocol 
Template – 1 µL 
Primers (10 μM) – 5 µL 
each 
Nucleotide Mix – 1 µL 
Reaction Buffer
a
 – 10 µL 
Taq Enzyme – 0.5 μL 
dH2O – 27.5 μL 
Initial 
Denaturation 
94°C / 2 min 1x 
Denaturation 
Annealing 
Elongation 
94°C / 15 s 
56°C / 30 s 
72°C / 2 min 
 
10 cycles 
Denaturation 
Annealing 
Elongation 
94
°
C / 15 s 
56°C / 30 s 
72°C / 2 min +5 s
b
 
 
20 cycles 
Final Elongation 72°C / 7 min 1x 
a
When required, MgCl2 concentration altered to 2.5 or 3.5 mM by adding MgCl2 from a 
25 mM stock solution and lowering dH2O. 
b
increased by 5 s each cycle. 
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2.5.2 Agarose gel electrophoresis 
 
DNA was separated and visualised on 1 % agarose gels. Molecular Biology Grade 
Agarose (Melford) was placed in 1x TAE buffer (40 mM Tris, 20 mM glacial acetic 
acid (Fisher Scientific), 1 mM ethylenediaminetetraacetic acid (EDTA) (Sigma 
Aldrich), pH 8.0) and dissolved by boiling. After the solution had cooled for 20 min, 
ethidium bromide (2 μg/mL) was added. The agarose solution was then poured into gel 
trays, with gel combs, and allowed to solidify. Set gels were placed into a gel tank and 
immersed in 1x TAE buffer. Samples containing DNA were mixed with 5x DNA 
loading dye (1:5) (Bioline) if needed. For estimation of DNA molecular weight, 
samples were compared against 5 μL of either HyperLadder™ 1 kbp (Bioline) or 
HyperLadder™ 100 bp. Gels were run at 120 V for up to 1 hour. DNA bands were 
visualised with an ultraviolet source (G:Box, Syngene).  
 
2.5.3 Purification of PCR products from PCR reactions or agarose gels 
 
PCR reactions that yielded single bands on agarose gels were purified from the PCR 
reaction mix using the StrataPrep PCR purification kit (Agilent Technologies), 
according to the manufacturer’s protocol. This method of DNA purification uses a DNA 
binding solution, and a fiber matrix that binds DNA before it is eluted with elution 
buffer (10 mM Tris pH 8.5). 
When one or more band was visible on an agarose gel, the band of interest was 
removed from the gel before further downstream applications. Gels were placed on a 
UV-table and appropriate bands were excised using a scalpel blade and then purified 
from the agarose gel using the QIAquick gel extraction kit (Qiagen). Agarose gel slices 
were weighed, and dissolved by heating at 50°C in a high-salt buffer. Nucleic acids 
were then absorbed onto a silica-membrane, impurities removed by washing, and eluted 
with elution buffer. 
 
2.5.4 Colony PCR 
 
Recombinant Escherichia coli colonies were screened by PCR for correct DNA inserts. 
Single colonies were picked from agar plates with a pipette tip and placed into a PCR 
reaction mix. DNA was released from within cells by heating at 95°C for 10 min, before 
standard thermal cycling was started. 
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When releasing DNA from Streptococcus gordonii colonies GeneReleaser
®
 
(Cambio) was used to facilitate DNA release from this Gram positive organism. 
GeneReleaser
®
 uses a polmer matrix, and a range of incubation temperatures to release 
DNA and segregate PCR inhibitors released during cell lysis. To 1 μL of cells, 20 μL of 
GeneReleaser
®
 was added before following the manufacturer’s thermal cycler protocol. 
The PCR reaction mix was combined with the lysis solution and DNA amplified on a 
thermal cycler. 
 
2.5.5 Nanodrop spectrophotometry 
 
The NanoDrop ND-1000 (NanoDrop) spectrophotometer was used for determining the 
concentration of DNA in samples. Before measuring samples, elution buffer was placed 
on the NanoDrop stage to obtain a blank value of light absorbance. DNA samples were 
then loaded in 2 μL volumes onto the NanoDrop stage. This method estimates nucleic 
acid content based on an equation which subtracts readings that are likely to be protein. 
The ratio of 260 to 280 nm absorbance was used as an estimate of DNA puritiy (a ratio 
of 1.8-2.0 was considered acceptable).  
 
2.5.6 DNA extraction from whole cells 
 
Bacteria were cultured in BHY broth, and harvested by centrifugation at 4,000 g. Cells 
were resuspended in 150 µl spheroplasting buffer (26% (w/v) raffinose (Sigma 
Aldrich), 10 mM MgCl2 (BDH), 20 mM Tris-HCl, pH 6.8) supplemented with 37.5 µg 
lysozyme (Sigma Aldrich) and 50 U mutanolysin (Sigma Aldrich), and incubated at 
37°C for 30 min. Following incubation, DNA was extracted using the MasterPure™ 
Gram Positive DNA Purification Kit (Epicentre® Biotechnologies) in accordance with 
the manufacturer’s instructions. Included during the extraction process was a bead 
beating (TissueLyser LT) step of 50 Hz, for 5 min, using 25 mg of acid washed glass 
beads (0.1 mm). After extraction, DNA was suspended in 25 µl elution buffer (10 mM 
Tris pH 8.5). 
 
2.5.7 Measuring DNA concentration with PicoGreen 
 
When required, plasmid and extracellular DNA concentrations were measured using the 
Quant-iT
™
 PicoGreen
®
 dsDNA kit (Invitrogen). Measurements were made by following 
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the manufacturer’s protocol. Briefly, DNA samples were diluted (1:20) in TE buffer (10 
mM Tris-HCl, 1 mM EDTA, pH 7.5). A standard curve was made by diluting a Lambda 
DNA standard (2 μg/mL) in TE buffer in a range from 1000 ng/mL to 0 ng/mL. The 
PicoGreen
®
 dye was diluted 200 times in TE buffer, and an equal volume was added to  
DNA samples or dsDNA standards. Samples were transferred to a 96-well microplate in 
200 μL volumes. Fluorescence was measured using a Synergy HT microplate reader 
(excitation: 485 nm, emission: 528 nm). Unknown DNA concentrations were calculated 
from the DNA standard curve. 
 
2.5.8 PCR primer design 
 
Primers were designed from DNA sequences using Primer3Plus (Untergasser et al., 
2007) taking care to design them with optimal length (18-22 bp), guanine:cytosine 
content (40-60 %), and melting temperature (between 50-60
°
C). Primers were also 
designed in a way that minimised primer pairing and secondary structures. 
Oligonucleotide primers were ordered and synthesised by Eurogentec. 
 
2.5.9 Restriction digest 
 
DNA and plasmids were digested by specific enzymes during DNA cloning and for 
diagnostically checking plasmids for correct insertion of genes of interest. Appropriate 
restriction enzymes were selected using the NEBcutter V2.0 (Vincze et al., 2003) or by 
manually scrutinising sequences. Typically digest reactions were made with the 
appropriate reaction buffer, and 1 U of enzyme for every 1 μg of DNA included. For 
diagnostic tests 500 ng of DNA was digested, while 1-2 μg of DNA was digested for 
cloning. Reaction mixes were incubated for 1 h at 37°C, and then heat inactivated (e.g. 
80°C for 20 min) if appropriate. Digests were then checked on agarose gels, along with 
uncut DNA or plasmid. 
 
Table 2.5 Restriction enzymes used during this study 
Restriction Enzyme Recognition Site
a
 NEBuffer
b
 
AscI 5’ GG▼CGCGCC 3’ 
3’ CCGCGC▲GG 5’ 
4 (100 %) 
EcoRI 5’ G▼AATTC 3’ EcoRI (100 %) 
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3’ CTTAA▲G 5’ 
HindIII 5’ A▼AGCTT 3’ 
3’ TTCGA▲A 5’ 
4 (50 %) 
XhoI 5’ C▼TCGAG 3’ 
3’ GAGCT▲C 5’ 
4 (100 %), BSA 
XbaI 5’ T▼CTAGA 3’ 
3’ AGATC▲T 5’ 
4 (100 %), BSA 
a
Triangles indicate sites of digestion 
b
Buffer used, according to the New England BioLabs nomenclature. Percentage in 
brackets indicates the activity of each restriction enzyme in the buffer used. Lastly, 
bovine serum albumin (BSA) was included if required.  
 
2.5.10 Escherichia coli cloning 
 
Genes of interest were cloned into the pCR
®
2.1 vector, supplied by Invitrogen, using 
the TA Cloning
®
 Kit (Invitrogen) and following the manufacturer’s guidelines. Briefly, 
PCR products were amplified with Taq polymerase, which adds a single 
3’deoxyadenosine (A) overhang to the end of PCR products. Products were inserted into 
the pCR
®
2.1 vector by incubating for 20 h at 14°C in the presence of Topoisomerase I, 
following manufacturers guidelines. Competent E. coli TOP10 cells were transformed 
according to the manufacturer’s handbook. Transformations always included pUC19 as 
a positive control. The pCR
®
2.1 vector contains the lacZα gene, which allows for blue-
white colony screening for PCR inserts. E. coli TOP10 has a mutant lacZ gene 
(lacZΔM15), and when expressed with lacZα produces β-galactosidase. This enzyme 
cleaves 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) (Melford) that is 
spread onto agar plates (40 μL of a 40 mg/mL stock solution) resulting in blue colonies. 
Successful ligation creates E. coli cells lacking in β-galactosidase, by disrupting the 
lacZα gene, thus resulting in white colonies. After transformation, white colonies were 
selected and analysed by colony PCR and gene sequencing.  
 
2.5.11 DNA sequencing 
 
Samples of DNA were sent to MWG Eurofins for DNA sequencing. Sample template 
concentration was measured using a NanoDrop spectrophotometer (ND-1000) and the 
concentration was adjusted to the amount required (plasmid DNA, 50-100 ng/µL; PCR 
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products, 10 ng/µL). Templates (15 µL) were sent with sequencing primers at a 
concentration of 10 pmol/µL in a total volume of 15 µL.  
 
2.5.12 Primers and plasmids  
 
Table 2.6 Primers used during this study 
Primer 5’-3’ Sequence Source or 
Reference 
Sequencing   
M13 Forward (-20) GTAAAACGACGGCCAG Invitrogen 
M13 Reverse CAGGAAACAGCTATGAC Invitrogen 
0063F CAGGCCTAACACATGCAAGTC (Marchesi et al., 
1998) 
1387R GGGCGGWGTGTACAAGGC (Marchesi et al., 
1998) 
gbpC5’ GAGAAAGCACTTTGGTTTCAA (Sato et al., 2002) 
gbpEx3’ ATTGCCATGTAAGTCAACAGATGAG (Sato et al., 2002) 
gbpC3’ GTCCCAACCTCTTTTTATAGA (Sato et al., 2002) 
PA5’ GCGCAACAGCTACATACACT (Sato et al., 2002) 
PAS3’ CCGCACGGATTTTACCA (Sato et al., 2002) 
PAL3’ ATAATTCGTTGAACCGGCA (Sato et al., 2002) 
ermseqF TGAAACACGCCAAAGTAAACAA This thesis (NSJ) 
ermseqR TTTGGTTGAGTACTTTTTCACTCGT This thesis (NSJ) 
Mutagenesis   
ccpAF1 AACCCCTTTGACTGGTAGGG This thesis 
ccpAR1 CCATAGAAACCCCTGCTTCA This thesis 
ccpAF2 GCAGGGGTTTCTATGGGGCGCGCCG
GACTAGCTGATTGCG 
This thesis 
ccpAR2 GTCTCTTGGCGGCATGTAAG This thesis 
ermAMF1 TGCAGGCGCGCCGAATTATTTCCTC
CCGTTAA 
This thesis 
ermAMR1 TGCAGGCGCGCCGGAGTGATTACAT
GAACAAA 
This thesis 
malRF1 AATTGGCTGCCATTCGTTAC This thesis 
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malRR1 GTTCATGTAATCACTCCTTACAGTTG
AGGGCGAAACC 
This thesis 
malRF2 ACGGGAGGAAATAATTCTGGCATCT
GGTGTTTGTGAT 
This thesis 
malRR2 ACCATCAGAGGCTGTCGGTA This thesis 
ermAMF2 GAATTATTTCCTCCCGTTAA This thesis (NSJ) 
ermAMR2 GGAGTGATTACATGAACAAA This thesis (NSJ) 
SsnA Purification   
ssnA_Pf7 GACTGGATCCGAAGAGACGGAAAA
TTCTTC 
This thesis (NSJ) 
ssnA_Pr7 CGATGAATTCACTCTTTTTGTTTTCA
CCTGA 
This thesis (NSJ) 
 
Table 2.7 Plasmids used during this study 
Plasmid
a
 Description Size (bp) Source or 
Reference 
pUC 19 amp
r
 promoter, amp
r
, lacZα, 
pUC ori 
2686 Invitrogen 
pCR
®
2.1 lacZα, f1 ori, kanr, ampr, ori 3930 Invitrogen 
pCR
®
2.1-ccpA ccpA flanking regions insert 5010 This thesis 
pCR
®
2.1-ccpA::ermAM ccpA flanking regions insert, 
ermAM insert 
5762 This thesis 
pVA838 erm
r
, cam
r
 9065 (Macrina et al., 
1982) 
pGEX-KT pMB1 ori, lacIq, lacZ, tac 
promoter, GST, glycine kinker, 
thrombin cleavage site, 
BamHI/MCS/EcoRI, amp
r
 
4978 (Hakes and 
Dixon, 1992) 
pGEXssnA SsnA-GST 7128 This thesis 
(NSJ) 
a
see Appendix D for vector maps. 
 
2.6 Microscopy 
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2.6.1 Confocal laser scanning microscopy 
 
2.6.1.1 LIVE/DEAD analysis of microbial biofilms 
 
The biofilm architecture of oral bacteria and CRS isolates, with a particular focus on 
extracellular DNA was visualized by confocal laser scanning microscopy (CLSM) using 
biofilms cultured on glass surfaces. Sterile 13 mm diameter glass coverslips were placed 
in wells of a six-well tissue culture plate containing 3 mL growth medium. Wells were 
inoculated with 50 µL of stock bacterial cultures and incubated statically in air at 37°C 
for 18-72 h. Coverslips were removed, rinsed three times with PBS, and inverted onto a 
rubber O-ring (10 mm diameter) that had been placed on a microscope slide and filled 
with LIVE/DEAD
®
 BacLight
TM
 stain (Molecular Probes). LIVE/DEAD BacLight
TM
 
contains two fluorescent stains, SYTO
®
 9 and propidium iodide (PI), that allow for the 
monitoring of bacterial cell viability (Boulos et al., 1999). Both of these fluorescent 
dyes bind to nucleic acids but SYTO® 9 has specificity for chromosomal DNA, 
whereas PI will stain both intracellular and extracellular DNA. Furthermore, PI 
displaces SYTO
®
 9 if it enters a compromised cell membrane. These characteristics 
allow the kit to be useful for visualising eDNA, as well as monitoring cell viability. 
Biofilms were examined using a Leica TCS SP2 confocal microscope with an 
argon/neon laser for visualisation of SYTO
®
 9 (excitation 485 nm, emission 519 nm), 
and PI (excitation 536 nm, emission 617 nm).  
 
2.6.1.2 Extracellular DNA staining of voice prosthesis biofilms 
 
Voice prosthesis biofilms were visualised using a CLSM dual stain technique developed 
previously (Kania et al., 2010) with the addition of 4',6-diamidino-2-phenylindole 
(DAPI) (Invitrogen). Used TESVs were washed three times with PBS to remove 
planktonic cells. Samples were then immersed in 2 mL of PBS to which 10 µL of PI (1 
mg/mL) (Sigma Aldrich) were added; this was incubated in darkness, at room 
temperature, for 5 min on a moving plate after which excess stain was rinsed off. The 
valve was then incubated with 50 µg/mL Concanavalin A Alexa Fluor® 488 
(Invitrogen) for 5 min at room temperature. Finally, the biofilm was stained with 2 
µg/mL DAPI at room temperature, in darkness, for 15 min. Excess stain was removed 
and valves were mounted on vacuum grease in 6 well tissue culture microtiter plates 
(Greiner Bio-One). PBS was added to wells until samples were fully immersed in 
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liquid. Biofilms were examined using a Leica TCS SP2 with a diode/argon/helium-neon 
laser for visualisation of ConA (excitation 485 nm, emission 519 nm), PI (excitation 
536 nm, emission 617 nm) and DAPI (excitation 358 nm, emission 461 nm). 
 
2.6.1.3 Visualization of bacteria on the surface of sinus mucosa 
 
Fluorescence in situ hybridisation (FISH) was performed using a peptide nucleic acid 
(PNA) probe corresponding to the well-characterised EUB338 probe (Amann et al., 
1990). The probe was synthesized as a fluorescein amidite (FAM) conjugate by 
Panagene. Mucosal biopsy specimens were fixed in 10% formalin directly after surgery, 
and stored at 4°C for up to one month. For PNA-FISH analysis, specimens were 
transferred to 50% (v/v) ethanol and incubated for 16 h at -20°C. Biopsy material was 
transferred to 1 mL permeabilization buffer (10 mg/mL lysozyme in PBS) and 
incubated at 37°C for 30 min. Samples were immersed in 1 mL pre-warmed wash buffer 
(10 mM Tris-HCl pH 9.0, 1 mM EDTA) for 30 min at 55°C. Pre-warmed hybridization 
buffer (25 mM Tris-HCl pH 9.0, 100 mM NaCl, 0.5% SDS, 30% formamide) 
containing 150 pmol/mL of the PNA probe was added to samples and incubated in 
darkness for 90 min at 55°C. Unbound PNA probe was removed by incubating in pre-
warmed wash buffer for 30 min at 55°C. Eukaryotic cells were counterstained by 
immersing the specimens in 1 mL PBS with DAPI in darkness at 20°C for 15 min. 
Samples were glue-mounted onto a plastic surface and immersed in 2 mL PBS. 
Visualisation of surface bacteria and eukaryotic cells was performed using a Leica TCS 
SP2 microscope with an argon/neon laser for imaging of FAM conjugates (excitation 
495 nm, emission 520 nm), and DAPI (excitation 358 nm, emission 461 nm). 
 
2.6.1.4 Microfluidic oral biofilm modelling 
 
Biofilms were grown in a BioFlux (Fluxion) microfluidics device using a similar 
protocol used by Nance et al., (2013). Biofilms were cultured from pooled human 
saliva, S. mutans UA159, and S. gordonii DL1. During single-species experiments S. 
mutans was grown in presence of 2% sucrose plus cell free saliva (CFS), and S. 
gordonii with 1% THYE plus CFS. Saliva biofilms were cultured in CFS only. After 
micro-organisms were cultured for 20 h they were stained with LIVE/DEAD
®
 
BacLight
TM
 and visualised using a Leica SPE CLSM. Afterwards images were rendered 
using Imaris (BitPlane) imaging software so that a 3D representation of biofilm 
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architecture was made. Image analysis was performed on a dedicated image processing 
computer in the Bio-imaging Unit at Newcastle University.  
 
2.6.2 Scanning electron microscopy 
 
Scanning electron microscopy was used to study biofilm formation on TESVs and 
single-species biofilms of chronic rhinosinusitis isolates grown on coverslips. Both 
types of samples were fixed in 2% (v/v) glutaraldehyde at 4°C for 16 h. Specimens were 
then rinsed twice in PBS and dehydrated through a series of ethanol washes as follows: 
25% ethanol 30 min, 50% ethanol 30 min, 75% ethanol 30 min, and two washes for 1 h 
in 100% ethanol. Samples were dried in a critical point dryer (Bal-tec), mounted on 
aluminium stubs and sputter coated with gold at Electron Microscopy Research 
Services, Newcastle University. Biofilms were visualised using a scanning electron 
microscope (Cambridge Stereoscan 240). 
 
2.6.3 Transmission electron microscopy of chronic rhinosinusitis obstructive 
mucin 
 
Samples of obstructive material removed from patients during functional endoscopic 
sinus surgery were cut into ~1 mm
3
 pieces and placed into 2% glutaraldehyde, at 4°C, 
immediately after surgery. These samples were dehydrated through a series of ethanol 
washes, embedded and sectioned at Electron Microscopy Research Services, Newcastle 
University. Sections were analysed in a transmission electron microscope (Philips, 
CM100). 
 
2.7 Quantification of extracellular DNA within biofilm matrices 
 
To quantify eDNA in monospecies biofilms, bacteria (Table 2.8) were cultured in 6-
well microtiter plates. To each well, 3 mL of medium was added and plates were 
incubated at 37°C for 72 h. Spent medium was replaced with fresh medium every 24 h. 
Following incubation, the supernatant was removed and two wells were used to 
determine the extent of the biofilms by staining with crystal violet. Briefly, 1 mL of 
0.5% crystal violet was added and incubated at 20°C for 15 min, wells were washed 
three times with PBS, and residual stain was dissolved in 1 mL of 7% (v/v) glacial 
acetic acid. The A570 was read in a BioTek Synergy HT microplate reader. The 
Chapter 2: Materials and Methods 
68 
 
remaining four wells were used to quantify eDNA, using a modification of the method 
of Kreth et al., (2009). Wells were immersed in 1.5 mL of PBS and biofilms were 
gently harvested using a cell scraper. The biofilms from the four wells were combined, 
vortexed for 20 sec, and incubated at 37
°
C for 1 h with 5 µg mL
-1
 Proteinase K (Sigma 
Aldrich). Cells were separated from the supernatant, containing eDNA, by 
centrifugation at 16,000 g for 2 min. Extracellular DNA in the supernatant was 
extracted with phenol:chloroform:isoamyl alcohol (25:24:1) (Fisher Scientific). 
Samples were centrifuged at 16,000 g for 5 min, and the aqueous phase was collected. 
DNA was precipitated by isopropanol, pelleted by centrifugation at 16,000 g for 10 min, 
air dried, and re-suspended in 50 µL of 10 mM Tris pH 8.5. Intracellular DNA was 
purified using the MasterPure
™
 DNA Purification Kit. The concentration of DNA was 
determined using a NanoDrop-1000 spectrophotometer, or via PicoGreen
®
 dsDNA 
quantification. DNA was also visualized by agarose gel electrophoresis. Each extraction 
was performed three times independently. 
 
Table 2.8 Strains tested for eDNA production with culture techniques 
Strain Media Growth Conditions
a
 
S. gordonii DL1 THYE Candle jar 
A. oris MG1 THYE Candle jar 
F. nucleatum 22586 BHIG Anaerobic 
S. mutans GS-5 THYE Candle jar 
C. propinquum FH1 BHY Aerobic 
C. pseudodiphtheriticum FH2 BHY Aerobic 
M. catarrhalis FH3 BHY Aerobic 
M. catarrhalis FH4 BHY Aerobic 
S. aureus FH5 BHY Aerobic 
S. aureus FH6 BHY Aerobic 
S. aureus FH7 BHY Aerobic 
S. epidermidis FH8 BHY Aerobic 
S. epidermidis FH10 BHY Aerobic 
S. epidermidis FH11 BHY Aerobic 
S. lugdunensis FH12 BHY Aerobic 
S. lugdunensis FH13 BHY Aerobic 
S. lugdunensis FH14 BHY Aerobic 
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S. warneri FH15 BHY Aerobic 
S. warneri FH17 BHY Aerobic 
S. anginosus FH18 BHY Aerobic 
S. anginosus FH19 BHY Aerobic 
S. constellatus FH20 BHY Aerobic 
S. constellatus FH21 BHY Aerobic 
S. intermedius FH22 BHY Aerobic 
S. pneumoniae FH26 BHY Aerobic 
S. salivarius FH27 BHY Aerobic 
S. salivarius FH28 BHY Aerobic 
S. salivarius FH29 BHY Aerobic 
a
All strains were incubated statically at 37°C. 
 
2.8 Biochemical techniques 
 
2.8.1 Protein gel electrophoresis 
 
Separation of proteins was achieved using 12 % SDS polyacrylamide gels (SDS-
PAGE). First, a 12 % acrylamide resolving gel was prepared by mixing 8 mL 30 % 
acrylamide (29:1 acrylamide:bisacrylamide) (Sigma Aldrich), 5 mL 1.5 M Tri-HCl pH 
8.8, 200 μL 10 % SDS (w/v) (Sigma Aldrich), 6.6 mL distilled water, 200 μL 10 % 
freshly prepared ammonium presulfate (APS) (w/v) (Sigma Aldrich) and 20 μL of the 
polymerisation agent tetramethylethylenediamine (TEMED) (Sigma Aldrich). This 
solution was gently mixed and poured between two sealed glass plates, until 2-3 cm 
from the top of the plates. Distilled water was overlaid to remove any bubbles, and the 
resolving gel was allowed to set, after which excess water was removed. The stacking 
gel was prepared by mixing together the reagents listed in Table 2.9, poured on top of 
the resolving gel and allowed to set once a comb of appropriate sized wells had been 
placed between the two glass plates. The glass plates were placed in a gel tank (ATTO) 
and submerged in 1x running buffer (0.2 M glycine (Melford), 0.025 M Tris, 0.1 % 
SDS, pH 8.3) before protein samples were added.  
During gel preparation proteins were diluted 1:1 in a denaturing buffer, Laemmli 2x 
concentrate (Sigma Aldrich), and heated at 100°C for 10 min. Once gels had set, and 
proteins were denatured, the gel comb was removed and protein samples were added to 
wells. A protein standard ladder for determining the mass of proteins was always 
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included. Gels were run at 180 V for 1-2 h before being transferred to Coomassie 
Brilliant Blue R-250 staining solution (70 mL/L acetic acid, 400 mL/L methanol, 530 
mL/L dH20 and 2.5 g/L Coomassie Brilliant Blue R-250 (BioRad)) for 2-3 h. Protein 
bands were visualized by de-staining the gel for 2-3 h in a solution containing 100 mL/L 
glacial acetic acid, 500 mL/L methanol (Fisher Scientific) and 400 mL/L dH2O. 
 
Table 2.9 Composition of SDS-PAGE gels 
Resolving Gel Stacking Gel 
H2O 6.6mL H2O 7.25 mL 
30% Acrylamide Mix 8.0 mL 30% Acrylamide Mix 1.25 mL 
1.5M Tris (pH 8.8) 5.0 mL 1M Tris (pH 6.8) 1.39 mL 
10% SDS 200 µL 10% SDS 100 µL 
10% APS 200 µL 10% APS 100 µL 
TEMED 20 µL TEMED 20 µL 
 
2.8.2 Determination of protein concentration 
 
Protein concentrations were determined either via the Bradford assay, or by 
densitometry. The Bradford assay uses a dye, Coomassie Brilliant Blue G-250 (Bio-
Rad), which binds to basic and aromatic amino acid residues, causing a change in the 
absorption maximum of the dye from 465 to 595 nm (Bradford, 1976). A protein 
standard curve was generated using concentrations of bovine serum albumin (BSA) 
(Thermo Scientific) ranging from 0.05 mg/mL to 0.5 mg/mL. Ten μL of each standard 
were added in triplicate to wells of a sterile polystyrene 96-well plate. Protein samples 
were diluted and added to the plate in 10 μL volumes. Next, 200 μL of the Bradford 
reagent (Bio-Rad), diluted 1:5 with dH2O, were added to all samples and standards. 
After 20 min, to allow the colour change to develop, the absorbance of each well was 
measured at 560 nm using a Synergy HT (BioTek) plate reader. Protein concentrations 
were calculated from the standard curve generated. 
Interference with the Bradford dye caused by detergents or highly concentrated 
buffers can lead to an overestimation of protein concentration. Therefore, in certain 
circumstances, protein concentration was estimated using BSA standards on SDS-
PAGE gels. Gels with BSA standards ranging from 62.5 μg/mL to 1000 μg/mL and 
sample proteins were stained with Coomassie Brilliant Blue, and then scanned using a 
G:Box (Syngene) gel viewer. GeneTools (Syngene) software was used to calculate 
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protein concentration from the BSA standard curve, whilst also subtracting any 
background interference. 
 
2.8.3 Purification of B. licheniformis NucB 
 
NucB was produced by a collaborator (Nithya Rajarajan) using a previously described 
method (Nijland et al., 2010). Bacterial strain Bacillus subtilis NZ8900 containing 
plasmid pNZ8901 was inoculated into 5 mL sterile Luria Bertani broth containing 
5 mg l
-1
 chloramphenicol and cultured aerobically at 37°C for 18 h. The culture was 
adjusted to an optical density (OD600) of 1.0,  and 100 µL were transferred to 10 mL of 
sterile LB containing chloramphenicol and incubated aerobically at 37°C for 3 h until 
OD600 ~ 1.0 was reached. At this point, 5% v/v cell free supernatant of an overnight B. 
subtilis ATCC6633 culture was added to provide the subtilin required to induce NucB 
production, and this was incubated for a further 2.5 h. Cells were removed by 
centrifugation at 6000 g for 20 min and the supernatant was sterilized by passing 
through a 0.2 µm syringe filter (Pall Corporation). NucB was purified from the 
supernatant using trichloroacetic acid (TCA) precipitation followed by Superose™ 12 
gel filtration. Proteins in the active fractions were further concentrated by TCA 
precipitation again and analysed by SDS-PAGE. The concentration of protein was 
estimated by densitometry analysis, in comparison with standards of known 
concentration (BSA). NucB was stored at 4°C for up to 3 months. 
 
2.8.4 Production of S. gordonii DL1 SsnA 
 
2.8.4.1 Construction of SsnA-GST vector 
 
Previously, a system was designed to express SsnA from pGEX-KT, a vector that 
includes an N-terminal GST tag for affinity chromatography purification. The ssnA 
gene, minus the C-terminal LPxTG cell anchor motif and N-terminal secretion signal 
domain, was amplified using primers ssnA_Pf7 and ssnA_Pr7, creating a product of 
~2150 bp. This product was cloned into pGEX-KT and transformed into E. coli DH5α. 
The vector was transferred to E. coli BL21(DE3)pLysS. 
 
2.8.4.2 Overexpression of S. gordonii DL1 SsnA 
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Escherichia coli BL21(DE3)pLysSpGEXssnA was cultured overnight at 30°C in an 
orbital shaker (150 RPM) in 5 mL of YT-G (8 g/L tryptone, 5 g/L yeast extract, 2.5 g/L 
NaCl and 10 g/L glucose) containing ampicillin (100 μg/mL) and chloramphenicol (33 
μg/mL).The next day, 2.5 mL of cells were subcultured to YT-G containing ampicillin 
and chloramphenicol and incubated at 30°C with 200 RPM shaking, until an OD of 0.6-
1.0 was reached. At this point, 1 mL of the culture was taken and incubated as an 
uninduced control. To induce SsnA expression in the remaining culture isopropyl β-D-
1-thiogalactopyranoside (IPTG) (Sigma Aldrich) was added to a final concentration of 1 
mM, and cells were incubated at 30°C with 200 RPM shaking for a further 4 h. Every 
hour, a 1 mL sample was removed for analysis of protein expression. After 4 h, cells 
were harvested by centrifugation at 4,000 g for 20 min.  
 
2.8.4.3 Lysis of E. coli pGEX-ssnA 
 
Cleared lysates were generated from E. coli cell pellets that had been frozen overnight 
at -20°C. Each 50 mL cell pellet was thawed on ice for 15 min and resuspended in 5 mL 
of lysis buffer that contained PBS, protease inhibitors (Roche), Benzonase (3 U per mL 
of culture) (Novagen), 1 mM dithiothreitol (DTT) (Sigma Aldrich), 1 mM EDTA, 1 % 
Triton
®
 X-100 (Sigma Aldrich), and 1 mg/mL lysozyme . The pellet plus lysis buffer 
was incubated on an end-over-end shaker at room temperature (20-25°C) for 30 min. 
After this period, 1% Triton
®
 X-100 was added, and the lysate was centrifuged at 
15,000 g for 30 min at 4°C. The supernatant was poured into a container and stored at 
4°C. 
 
2.8.4.4 Purification of GST-Tagged SsnA 
 
E. coli cell lysates were separated by affinity chromatography using a glutathione 
(GSH) resin to capture the GST-tagged SsnA protein. Briefly, 1 mL of 50 % glutathione 
superflow (Qiagen) was poured into an empty polypropylene column (Qiagen). The 
settled resin was the equilibrated with 5 mL of PBS-EW, a buffer that contained PBS, 1 
mM DTT, and 1 mM EDTA. Cleared lysates were run through the resin (collecting the 
flow-through) and then the column was washed twice with 2.5 mL of PBS-EW. After 
washing, 500 µL of elution buffer (50 mM Tris pH 8, 0.1 M NaCl, 50 mM L- reduced 
glutathione (GSH) (Sigma Aldrich), 0.1 % Triton
®
 X-100 and 1 mM DTT) were 
incubated with the resin containing SsnA-GST for 15 min at room temperature (20-
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25°C) and the elute collected thereafter. The elution step was repeated twice, until all 
SsnA-GST had been collected. Fractions were stored at -20°C, and analysed by SDS-
PAGE. 
 
2.8.4.5 Thrombin cleavage of SsnA-GST 
 
For some experiments the N-terminal 26 kDa GST protein tag was cleaved with 
thrombin (Sigma). Thrombin cleaves between arginine and glycine at a specific 
cleavage site (Leu-Val-Pro-Arg-Gly-Ser). Sequence analysis using NEBcutter V2.0 
(Vincze et al., 2003) confirmed there were no other thrombin cleavage sites within the 
recombinant protein. Thrombin cleavage was optimised using various units of enzyme, 
times of incubation and temperatures of reaction. Thereafter reactions were performed 
at room temperature, for 24 h, with 1 U of thrombin for every 0.025 mg of SsnA.  
 
2.8.4.6 Buffer exchange of SsnA-GST 
 
After affinity chromatography, SsnA was exchanged from elution buffer to a storage 
buffer (10 mM Tris-HCl pH7.5, 10 mM CaCl2 (Sigma Aldrich), 10 mM MgCl2 and 50% 
glycerol) using Slide-A-Lyzer
®
 dialysis cassettes (Thermo Scientific). After dialysis, 
following the manufacturer’s protocol, the SsnA sample was aliquoted (100 µL) and 
stored at -80°C.  
For thrombin cleavage experiments SsnA was exchanged from elution buffer to TNC 
buffer (20 mM Tris-HCl (pH 7.5), 50 mM NaCl, and 1 mM CaCl2) for optimal cleavage 
of the GST-tag.  
 
2.8.4.7 Peptide mass fingerprinting 
 
To confirm the protein identity of the SsnA-GST preparation, samples were sent to the 
Newcastle University Protein and Proteome Analysis (NUPPA) centre for peptide mass 
fingerprinting (PMF). Six SsnA-GST samples (3 µg per well) were run on a SDS-PAGE 
gel. During this process, new buffers were made, gloves were worn, and new containers 
were used, to keep protein contamination to a minimum. After gel electrophoresis, the 
gel was transported to the NUPPA facility. At the NUPPA facility, the SsnA-GST band 
was removed from the gel, digested with trypsin, and the resulting peptide masses 
detected using a matrix-assisted laser desorption/ionization time of flight/time of flight 
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(MALDI TOF/TOF) mass spectrophotometer. Peptide masses of the ‘unknown’ protein 
were then compared against the known protein sequences of S. gordonii DL1, and 
statistically analysed to find the closest protein match.  
 
2.8.5 Gel zymography for determining nuclease activity 
 
Zymography is an electrophoretic technique that detects the degradation of a substrate 
by an enzyme, in this case the degradation of double stranded DNA in the presence of 
nuclease enzymes. Sample enzymes were prepared in Lammelli’s buffer without 
boiling, as this may have interfered with the refolding of the enzyme after 
electrophoresis. SDS-PAGE gels were prepared with 100 μg/mL Salmon Sperm DNA 
(Sigma Aldrich) included in the resolving gel. Following electrophoresis, the gel was 
incubated in an enzyme reactivation buffer (40 mM Tris-HCl, 5 mM CaCl2, 5 mM 
MgCl2 and 3% delipidated milk powder (Premier International Foods)) for 20 h at 37°C. 
The gel was stained with ethidium bromide (0.5 μg/mL) for 30 min and washed 3 times 
in distilled water for 15 min each time. Areas of enzyme digestion appeared as dark 
spaces, where staining had not occurred, when viewed using a ultraviolet light source 
(G:BOX). 
 
2.8.6 Förster resonance energy transfer analysis of nuclease activity 
 
DNase activity was measured quantitatively using a fluorescence-based assay. Assays 
for nuclease activity often measure the release of oligonucleotides following DNA 
digestion, by calculating the change in optical density at 260 nm. Förster Resonance 
Energy Transfer (FRET) is distance-dependant energy transfer between two 
chromophores, from a donor chromophore to an acceptor chromophore. In this state, no 
photon is emitted. By using a qPCR PrimeTime™ probe (Integrated DNA 
Technologies), in a method previously developed (Kiedrowski et al., 2011), it is 
possible to measure nuclease activity when the enzyme cleaves the phosphodiester bond 
between two nucleotides. Cleavage causes the donor and acceptor chromophores to no 
longer be in close proximity, allowing emission of fluorescence.  
The FRET substrate was a short sequence (5’ CCCCGGATCCACCCC 3’) of single-
stranded oligonucleotide, modified at the 5’ end with a Hex fluorophore and at the 3’ 
end with a Black Hole Quencher 2. FRET substrate was diluted to 2 μM in a buffer 
consisting of 20 mM Tris-HCl (pH 8) and 10 mM CaCl2. Fluorescence was measured 
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by mixing 25 μL of diluted FRET substrate with 25 μL of a nuclease source in a well of 
a 384-well microtiter plate (Greiner Bio-One), and measuring the rate of fluorescence 
change (excitation 530 nm / emission 590 nm) at 30°C over 40 min using the Synergy 
HT (BioTek) microplate reader. Background nuclease activity was determined by 
mixing FRET substrate with the buffer of the nuclease source. 
 
2.8.7 Nuclease activity of planktonic cultures 
 
The FRET assay was also developed so that it could be used to determine the nuclease 
activity of bacterial cultures. Bacteria were cultured overnight at 37°C, the following 
day the optical density of cultures (OD600) was read, and cultures were diluted to OD600 
= 1. Cultures were then separated into a pellet and supernatant by centrifuging at 3,000 
g for 10 min. The pellet was washed twice with PBS, to remove loosely bound 
exonucleases, and re-suspended in PBS to an OD600 of 1. The FRET assay (see above) 
was then performed using 25 µL of sample cells or supernatant.  
S. gordonii DL1 cells were also re-suspended in acidic buffers, to investigate the 
effect of pH on SsnA. Overnight cells were prepared as before and re-suspended in a pH 
4.5 buffer (77.1 g/L ammonium acetate, 70 mL/L glacial acetic acid), or a pH 5.5 buffer 
[96.3 mL of solution I (13.61 g/L KH2PO4 (BDH)) and 3.6 mL of solution II (35.81 g/L 
Na2HPO4)] and PBS (pH 7.1). FRET readings were taken at 0 h, 1 h and 2 h. Cells were 
incubated at room temperature (20-25°C). Whilst taking FRET measurements, cells 
were always washed in PBS and then re-suspended in PBS (as acid may affect the 
FRET assay). After 2 h, cells previously incubated in acidic buffers were transferred to 
PBS pH 7.1, so that any change in nuclease activity could be measured over the next 
two h. Cells were split in two, with one half being placed in PBS plus chloramphenicol 
(12.5 µg/mL). Chloramphenicol inhibits de novo synthesis of proteins (Gale and Folkes, 
1953), and so any nuclease activity return would be due to re-folding of the enzyme.  
 
2.9 Regulation of SsnA 
 
2.9.1 CcpA and MalR promoter binding sites 
 
Regulatory sequence motifs contained within the ssnA promoter region were identified 
using RegPrecise (http://regprecise.lbl.gov/RegPrecise/) (Novichkov et al., 2010), a 
database of transcription factors. Contained within the ssnA promoter were consensus 
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binding sites for the transcription factors catabolite control protein A (CcpA) and the 
maltose repressor, MalR. To determine the role of these transcription factors in ssnA 
regulation they were chosen as targets for gene knockouts in S. gordonii DL1. 
 
2.9.2 Mutagenesis of S. gordonii DL1 
 
2.9.2.1 Genetic manipulation 
 
The CcpA and MalR genes were replaced with the ermAM erythromycin resistance 
determinant by allelic exchange mutagenesis in S. gordonii DL1. Primer sequences are 
given in Table 2.6.  
For ccpA mutagenesis the gene was replaced with ermAM via cloning in a pCR
®
2.1 
vector. Primers ccpAF1 and ccpAR1 were used to amplify a 507-bp fragment consisting 
of a 61-bp 5’ region of ccpA and 446-bp upstream. A 573-bp fragment compromising a 
234-bp 3’ region of ccpA and a 339-bp downstream region, was amplified using primers 
ccpAF2 (containing an AscI (New England Biolabs) restriction site) and ccpAR2. 
Following this, a long PCR, using primers ccpAF1 and ccpAR2, was employed to 
amplify and combine both short fragments together into a 1080-bp product. This 
product included the up and downstream regions of the ccpA gene and a central AscI 
restriction site. AscI was chosen since pCR
®
2.1 and the ccpA flanking regions did not 
contain this restriction site. Next, the 1080-bp fragment was ligated into pCR
®
2.1, and 
transformed into E. coli TOP10, creating pCR
®
2.1-ccpA. A 752-bp region containing 
the ermAM erythromycin determinant was amplified from the streptococcal vector 
pVA838 (Macrina et al., 1982) using primers ermAMF1 and ermAMR1, that both 
contained AscI restriction sites. The ermAM product and the pCR
®
2.1-ccpA vector were 
digested with AscI. Digested ermAM was then ligated into pCR
®
2.1-ccpA, and 
transformed into E. coli TOP10, creating pCR
®
2.1-ccpA::ermAM. The 1832-bp 
ccpA:ermAM insert was removed from the vector using the restriction enzyme EcoRI 
(New England Biolabs), run on an agarose gel, and then the correct fragment was 
purified from the gel before being used to transform S. gordonii DL1. 
Mutagenesis of the malR gene was performed without a cloning vector. Using the 
primers malRF1 and malRR1 a 471-bp region including 58-bp of 5’ malR sequence was 
amplified. A 421-bp downstream region was PCR amplified with malRF2 and malRR2, 
which contained 227-bp of 3’ malR sequence. The malRR1 and malRF2 primers 
contained 17-bp complementary sequences for ermAMF2 and ermAMR2 primers. After 
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amplifying the erythromycin resistance determinant, ermAM, from pVA838 a PCR 
reaction was set-up that included the up and downstream malR products and ermAM in 
equal ratios. A long PCR was performed, with malRF1 and malRR2. The resulting 
1644-bp product, containing the ermAM erythromycin resistance determinant, was then 
transformed into S. gordonii DL1.  
 
2.9.2.2 Transformation of S. gordonii DL1 
 
Prior to transformation, 10 mL of BHY broth were inoculated with S. gordonii DL1 and 
incubated at 37°C overnight. Whilst incubating, 2x 5 mL of BHY, plus 50 µL fetal calf 
serum (FCS) (Sigma Aldrich) (heat inactivated at 60
o
C for 30 min), and 12.5 µL 40% 
glucose (BDH) were pre-warmed at 37°C. The next day, 50 µL of the S. gordonii DL1 
overnight was subcultured into 5 mL of pre-warmed BHY/FCS/Glucose and incubated 
at 37°C, in a candle jar, until an OD600 of 0.3 was reached. Fifty µL were further 
subcultured into 5 mL fresh, pre-warmed BHY/FCS/Glucose and incubated for 60 min 
at 37°C in a candle jar. Aliquots (800 µL) of the culture were dispensed into 1.5 mL 
eppendorfs (Starlab), and DNA (up to 10 µg) was added and incubated at 37°C for a 
further 4 h. One hundred µL portions (neat or diluted) were plated onto selective agar 
and incubated for 48 h at 37°C. Transformation was confirmed by the presence of 
colonies on selective agars, colony PCR and DNA sequencing. 
 
2.10 Dispersal of biofilm micro-organisms with DNase enzymes 
 
2.10.1 Dispersal of tracheoesophageal speech valve biofilm micro-organisms 
with NucB 
 
The efficacy of NucB at removing micro-organisms from tracheoesophageal speech 
valves (TESVs) was determined by treating halves of TESVs with NucB or PBS. First, 
TESVs were removed from the PBS they were stored in, placed on a sterile petri dish, 
and sliced in half along their longitudinal axes using a sterile scalpel blade. Each half 
was placed in separate wells of a sterile polystyrene 12-well microtiter plate (Greiner 
Bio-One), containing 3 mL sterile PBS, and washed 3 times with 3 mL sterile PBS. 
After washing, one half was submerged in 500 μL NucB (3 μg/mL) and 2.5 mL PBS, 
and the other half was placed in a well containing 3 mL PBS. Valve halves were 
incubated for 1 hour at 37°C. 
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After the incubation period, triplicate samples of the supernatant (50 µL), undiluted 
or diluted 10-fold in sterile PBS were spread evenly onto Sabouraud dextrose or nutrient 
agar using a sterile spreading loop. Plates were incubated aerobically at 37°C for 20 h. 
Colonies ≥ 2 mm in diameter were counted and these counts were used to determine the 
colony forming units (CFUs) released. Plates were only counted if they contained 10 to 
400 colonies. Occasionally, cultured organisms captured were selected for isolation and 
identification using microscopy and Gram staining.  
 
 
 
Figure 2.1 TESVs were cut along their longitudinal axes before being treated with 
NucB. The dotted line indicates the area where a scalpel blade was used to cut the 
TESV. Scale bar is 10 mm.  
 
2.10.2 Crystal violet biofilm assay 
 
For quantifying biofilm extent, both for determining growth of bacteria and treatment 
efficacy of nuclease enzymes, the crystal violet (CV) assay was used. Biofilm extent 
was quantified by staining with 100 µL 0.5 % (w/v) CV (per well). After incubating for 
15 min at room temperature (20-25°C), wells were rinsed 3 times with PBS. Remaining 
CV was dissolved in 100 µL 7 % acetic acid (v/v) and the A570 was read using a 
microplate reader (Synergy HT). The absorbance value of a negative control (stained 
and washed un-inoculated wells) was subtracted from sample absorbance values. Each 
assay was repeated three times independently. 
 
2.10.3 Measuring the efficacy of DNase enzymes against biofilms formed on 
microtiter well surfaces 
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To assess the efficacy of nuclease enzymes (bpDNase I, NucB, SsnA) at retarding or 
dispersing microbial biofilms, biofilms were cultured in microtiter plates, treated with 
enzyme (5 µg/mL) and biofilm extent was quantified with the crystal violet assay. 
When testing for biofilm inhibition, enzyme was included (with media and inoculae) 
during biofilm formation. For dispersal, enzyme was added after biofilm formation for 1 
hour at 37°C. Biofilm extent was then measured with the CV assay. This was compared 
with control biofilms that had not been treated with nuclease enzymes.  
 
2.11 Statistical analysis 
 
Experiments were repeated in triplicates as standard. Graphs and tables were made 
using Microsoft Excel, and throughout results are given as the mean ± standard error. 
Statistical comparisons were made using IBM SPSS Statistics 19. Mean values of two 
groups were compared for significant difference using the two-sample t-test, after a test 
for normality had proved the distribution of sample values was normal. A p-value less 
that 0.05 was deemed an acceptable level of statistical significance. 
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Chapter 3: Tracheoesophageal Speech Valve Biofouling 
 
3.1 Outline 
 
The colonisation of medical implants by microbial biofilms is a major concern for 
healthcare services because it limits the lifespan of the devices and can cause infections 
such as sepsis (von Eiff et al., 2005). Tracheoesophageal speech valves (TESV) are 
given to patients who have had a total laryngectomy as a way of rehabilitating speech. 
The TESV is the most commonly used method of alaryngeal speech owing to a number 
of advantages, primarily, natural sounding speech, and quick rehabilitation. In a recent 
study, Singer et al., (2013) measured speech intelligibility in over 200 patients using 
TESVs, esophageal speech, or electrolaryngeal devices, finding that TESVs gave the 
quickest rehabilitation of speech. Thousands of patients in the US use TESVs (Ramage 
et al., 2006). However, the major disadvantage is the need to regularly replace valves, at 
a cost, when they become damaged over their lifespan by microbial biofilms. This 
study, the first of its kind, investigated the role of eDNA in providing stability in the 
polymicrobial biofilms that form on the surfaces of TESVs.  
 
The average lifespan of TESVs is between 108 to 207 days (Hancock et al., 2013; Kress 
et al., 2013). Device design, patient characteristics and treatment program all change the 
lifespan of TESVs. The most common reason for replacement is leakage through the 
device, caused by Candida spp. biofouling (Balm et al., 2011). Replacement is typically 
a quick procedure, requiring only a visit to an out-patient clinic. However, replacement 
every 3 to 6 months leads to substantial costs for healthcare services or patients. The 
Freeman Hospital, Newcastle (NHS) spent £44,000 in 2010 on TESVs, not including 
staff costs (Shakir et al., 2012). Recently, it was estimated that the yearly cost for TESV 
use per patient is £530-£670, in the Newcastle area (Owen and Paleri, 2013). It is clear, 
that a reduction in microbial colonisation is needed to increase the lifespan of these 
devices for improved patient satisfaction and to minimise healthcare expenditure. 
 
The ability to clean biofouling from TESVs depends on the device type, as there are a 
number on the market, both indwelling and non-indwelling (Provox and Blom-Singer 
produce the widest used TESVs). Several attempts have been made to increase the 
lifespan of TESVs (reviewed by Rodrigues et al., 2007). These include: (i) probiotic 
diet, (ii) use of bio-surfactants, (iii) modification of the silicone surface, and (iv) 
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treatment with antifungal agents. However, biofilm colonisation could be controlled 
with DNases if TESV biofilms rely on eDNA for matrix support. This is a potentially 
novel technique for the cleaning of TESVs. 
 
The biofilm that forms on the TESV surface is an aggregation of many fungal and 
bacterial species. Candida albicans is considered a key coloniser but other Candida 
spp., such as Candida glabrata, are often present (Bauters et al., 2002).  However, the 
location of the voice prosthesis, in the neck, connected to skin and close to the oral 
cavity leads to commensal bacteria colonising the TESV device. It is clear that 
staphylococci, oral streptococci and lactobacilli are often present in TESV biofilms 
(Buijssen et al., 2012). Recently, lactobacilli were isolated from 33 of 34 explanted 
TESVs, and were shown to grow intertwined with Candida spp. (Buijssen et al., 2007). 
Candida albicans binds to many bacterial species, including oral streptococci (Holmes 
et al., 1996), and this has been shown to allow the colonisation of surfaces by Candida 
(Holmes et al., 1995). FISH analysis of TESV biofilms has highlighted the important 
interaction of bacteria with fungi (Buijssen et al., 2012). Therefore, whilst Candida 
albicans is often considered the key organism in TESV biofouling, bacteria cannot be 
overlooked in the colonisation process.  
 
Exogenous DNA has been measured in C. albicans biofilms, and DNase treatment 
reduces mature biofilm extent of mono-species biofilms formed by strain SC5314 by up 
to 40% (Martins et al., 2010). Lactobacillus plantarum LM3 biofilms were reduced by 
51% when incubated with DNase I after growth for 24 h (Muscariello et al., 2013). 
Futhermore, Streptococcus mutans UA159, an oral streptococcus, has 20% less biofilm 
extent when treated with DNase I than a control (Perry et al., 2009). Lastly, 
Staphylococcus spp. are susceptible to DNase treatment (Qin et al., 2007; Kaplan et al., 
2012; Shields et al., 2013). Although these species are all relevant to the types of 
organisms that are known to colonise TESVs the biofilms were all grown in vitro as 
single species, and it remains to be seen how eDNA may contribute to a polymicrobial 
biofilm on a TESV. Recently, eDNA, and subsequent DNase degradation has been 
shown in multi-species activated sludge biofilms (Dominiak et al., 2011). 
 
The objectives of this study were to determine the eDNA content of TESV biofilms, 
both by microscopy and extraction, and then to treat TESV biofilms with NucB, a novel 
bacterial DNase. The primary aim was to establish if NucB has potential for dispersing 
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microbes from the surface of TESVs, thereby prolonging their lifespan. To our 
knowledge this is the first study to look at the contribution of eDNA to TESV biofilm 
stability, and one of few to determine eDNAs role in complex, clinical, polymicrobial 
biofilms.  
 
3.2 Extracellular DNA in the extracellular matrix of TESV biofilms 
 
The contribution of eDNA to the matrix stability and initial attachment of biofilm cells 
is well understood in single-species biofilms. However, it remains less well researched 
in mature polymicrobial biofilms. TESVs provide a good model for studying the 
reliance on eDNA of biofilm-forming micro-organisms in mature biofilms. Therefore, 
this study began by extracting eDNA from the biofilm matrix of used TESVs, and then 
visualizing the biofilms in more detail with SEM and CLSM.  
 
3.2.1 Extraction of eDNA from the extracellular matrix 
 
Six explanted TESV devices were collected and examined for the presence of eDNA. 
Biofilms were removed by careful scraping into an eppendorf, and eDNA was then 
extracted from the separated EPS fraction (see Materials and Methods 2.7). Finally, 
eDNA was measured using PicoGreen
®
 dye, and visualized on a 1 % agarose gel 
(Figure 3.1). PicoGreen
®
 spectrophotometry was chosen because this method of dsDNA 
quantification is more selective for dsDNA than determination of absorbance at 260 nm, 
where contaminants, nucleotides, RNA and single-stranded nucleic acids can interfere 
with measurements. The PicoGreen
® 
dye emits fluorescence when bound to dsDNA and 
exhibits very little fluorescence when unbound. The total eDNA recovered from TESV 
biofilms varied between a minimum of 82 ng/mL (sample 6) and a maximum of 1200 
ng/mL (sample 1) (Figure 3.1A). Importantly, all samples had detectable nucleic acids 
when analysed with the PicoGreen® stain. The large amount extracted from sample 1 
was due to the large biomass of biofilms on this device. Therefore, eDNA concentration 
was obtained by calculating the amount of eDNA per µg of biomass. This measure 
showed sample 5 to have the highest concentration of eDNA, again, sample 6 had the 
lowest (Figure 3.1A). By running eDNA onto an agarose gel, the total abundance was 
visualised. Smears of nucleic acid were seen in samples 1, 4 and 5 (Figure 3.1B). These 
samples also had the highest total eDNA present, as measured by the PicoGreen
®
 dye. 
There was no high molecular weight band of eDNA present, as seen in mono-species
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Figure 3.1 Extracellular DNA quantification from the biofilm matrices of six TESV biofilms. (A) Biofilms were removed by scraping, and the 
biomass weighed. Subsequently, eDNA was extracted from the EPS and measured using PicoGreen® dye so that the total eDNA present (total volume 
9 mL) could be calculated (white bars), and the amount of eDNA per µg of biomass (grey bars). (B) Extracted eDNA was also visualised on a 1 % 
agarose gel, where M is the molecular weight marker, and 1-6 is the TESV biofilm samples.  
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chronic rhinosinusitis isolate biofilms (Chapter 4). Extracellular DNA migrated to a 
weight of between 200 bp to 10 kbp. This smear is indicative of DNA that has 
degraded, as might be expected from biofilms that were up to 3 months old. Samples 1, 
4 and 5 contained lower molecular weight smears and bands, which may be RNA. This 
would not have been measured by PicoGreen
®
 as this dye is selective for dsDNA. It 
may be possible to identify this material by treating “eDNA” extractions with DNase 
(see Chapter 5 Figure 5.1A) and RNase. For samples 4 and 5, there are distinct bands 
occurring at approximately 400 bp, 200 bp and a lower molecular weight. These bands 
resolve at similar weights in both samples. 
 
3.2.2. Visualization of TESV biofilms and eDNA 
 
Initially, one TESV was examined for the presence of microbial biofilms by scanning 
electron microscopy (SEM) (Figure 3.2) (see Materials and Methods 2.6.2). At lower 
magnifications, biofilms could clearly be seen on the flat outer surface of the TESV 
(Figure 3.2A). The silicone surface of the TESV was rough. It is unknown if this was 
due to deterioration as unused TESVs were not visualised. At higher magnification 
biofilms consisted of a dense network of Candida species, with both budding and 
filamentous cell types present (Figure 3.2B). Although biofilms were colonising the 
silicone surface, large areas were cell-free or contained only small aggregations of 
microbes (Figure 3.2C). Within the biofilms there was a network of bacterial cells, cocci 
and bacilli, with fungal cells also present (Figure 3.2D). Here, the biofilm was clearly 
polymicrobial and cells of different species are closely aggregated in a complex 
network-like structure. Extracellular matrix surrounded bacterial and fungal cells, 
although it should be noted that the sample had been dehydrated (critical for SEM) and 
therefore had lost its 3D architecture (Figure 3.2B and D). 
To further investigate biofilm formation, and attempt to visualise eDNA in the EPS, 
TESVs were stained with PI and DAPI (DNA stains) to visualise micro-organisms and 
eDNA, and ConA-FITC (binding to α-D-mannosyl and α-D-glucosyl) to identify fungal 
cell walls (Figure 3.3) (see Materials and Methods 2.6.1.2). At lower magnification the 
size and thickness of the TESV biofilms was apparent (Figure 3.3A). There was little 
discernible structure, and the biofilm appeared to be an intertwined network of yeast 
hyphae and yeast cells. At higher magnifications, yeast cells were visualised at the 
single cell level (Figure 3.3C and D). These cells were either alive (blue) or dead (red 
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Figure 3.2 Scanning electron micrographs of a mature TESV biofilm. A TESV was 
fixed in glutaraldehyde, processed for SEM, and then viewed. (A) Colonies were visible 
to the naked eye and when viewed at high magnifications were clearly dominated by 
fungal hyphae. (B) Fungal colonization with both yeast cells (a) and fungal hyphae (b), 
a morphology indicative of Candida spp., known as pseudohyphae. (C) Large areas of 
the TESV contained very few cells (c) but a rough silicone surface. (D) In this 
micrograph there is a collection of cocci (e), bacilli (f), and fungal hyphae surrounded 
by an extracellular matrix (d). 
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Figure 3.3 Biofilms on TESVs visualised with CLSM and triple-staining with 
fluorescent dyes. (A) Biofouling covered large areas and these biofilms were thick, 
with a network of fungal cells. (B) These biofilms contained areas of eDNA, apparent 
because of co-localisation of DAPI and PI (a) or very diffuse DAPI staining (b) in the 
extracellular matrix. (C) By increasing the magnification of an area (white box) fungal 
cells could be visualised at the single-cell level, where cells walls (c) were clearly 
stained by ConA-FITC. (D) Yeast hyphae (d) were also visible when stained with 
ConA-FITC. Red colour, PI; blue colour, DAPI; green colour, ConA-FITC. 
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and blue). Propidium iodide (red) only crosses the membrane of compromised cells, 
whereas DAPI (blue) can enter either live or dead cells. The nucleic acid stains PI and 
DAPI have been validated for bacterial micro-organisms. However, PI also enters 
damaged Candida albicans cell membranes (Jin et al., 2005), and DAPI enters both 
prokaryotic and eukaryotic organisms. Therefore this staining approach was acceptable 
in these mixed-species biofilms. Extracellular DNA was visible as the co-localisation of 
red and blue dyes (Figure 3.3B). There were also large areas of diffuse blue staining. In 
these examples, the staining was not cellular, and appeared to be outside cells, which is 
indicative of eDNA. However, it is unknown why some eDNA would only stain with 
DAPI, and some with both DAPI and PI, this requires further investigation. Unlike with 
SEM, bacteria were hard to visualise using this technique. With CLSM only the outer 
layer of the biofilm was accurately imaged. It appeared that bacteria were more often 
found within the biofilm, and that fungal species tended to dominate the outer layers of 
the biofilm. This was evident with both CLSM and SEM.  
 
3.3 Dispersal of TESV microbes with NucB 
 
As shown by microscopy, the TESVs were heavily colonised by microbial biofilms. 
These biofilms also appear to contain eDNA. To determine whether eDNA contributes 
to biofilm stability, 20 TESVs were treated with NucB (3 µg/mL), a novel bacterial 
nuclease, to examine the efficacy of this enzyme at removing microbes from the silicone 
surface (see Materials and Methods 2.10.1). TESVs were cut in half and treated with 
either PBS (control) or with NucB (treatment) for 1 hour at 37°C. The solution that 
TESV valve halves were placed in was then diluted and plated onto growth media. Of 
the 20 TESVs treated, 3 were excluded from statistical analysis because one produced 
no growth, and when two were treated microbial colonies were too abundant to be 
accurately counted.  
The rationale for the experimental design was that more micro-organisms may be 
liberated from the TESV half placed in a NucB solution, and that this could be counted 
on growth media. Nutrient agar was chosen as a non-selective agar, and Sabouraud agar 
was chosen to select for fungi (primarily Candida spp.), which are common on TESVs. 
Figure 3.4 highlights this method, and shows that when NucB was used (Figure 3.4A), 
more microbes grew on a nutrient agar plate, than when treated with PBS alone (Figure 
3.4B). This suggests that increased numbers of microbes are liberated from TESV 
biofilms when NucB is present. Once the colony forming units (CFUs) were calculated 
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Figure 3.4 Liberation of micro-organisms from the surface of TESVs using a novel 
bacterial nuclease, NucB. TESV halves were placed into either a PBS control solution 
or a solution containing the NucB enzyme. Valves were incubated for 1 hour at 37°C, 
and then the solution was spread onto agar plates. This technique allowed the 
enumeration of the total number of microbes dispersed from TESVs and an example of 
this, on nutrient agar, shows that more micro-organisms were removed using a NucB 
solution (A), than the PBS control solution (B). A total of 17 TESVs were included in 
the analysis of colony forming units (CFUs) in treatment solutions after incubation, the 
ratio of CFUs between treatments on the two agars was calculated (C).  
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Table 3.1 Colony forming unit counts of micro-organisms released from TESVs 
biofilms, when using NucB or PBS, on nutrient agar. 
TESV No.
a
 NucB CFU PBS CFU p-value
b
 
1 10,230 2,760 .0001 
2 55,740 78,120 .0001 
3 2,520 600 .0001 
4 21,960 21,840 .941 
5 2,910 90 .0001 
6 21,000 12,360 .0001 
7 1,890 300 .0001 
8 1,710 1,110 .145 
10 27,960 24,300 .0387 
11 10,080 3,930 .0001 
12 6,420 1,470 .0001 
14 9,690 8,850 .426 
15 5,922 582 .0001 
16 28,020 20,760 .0001 
17 3,820 2,640 .058 
19 2,400 200 .0001 
20 15,400 15,040 .79 
a
TESV 9, 13, and 18 were excluded from analysis.  
b
p-values were calculated from a two-sample t-test comparing the means from 3 
replicate counts. Bold p-values indicate NucB significantly releasing more micro-
organisms, whereas an italic p-value shows a greater, significant release when using 
PBS. 
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Table 3.2 Colony forming unit counts of micro-organisms released from TESVs 
biofilms, when using NucB or PBS, on Sabouraud agar.  
TESV No.
a
 NucB CFU PBS CFU p-value
b
 
1 4,410 12,120 .0001 
2 61,440 93,120 .0001 
3 2,370 540 .0005 
4 39,120 31,800 .0038 
5 7,470 600 .0001 
6 12,360 8,880 .0021 
7 1,380 150 .0001 
8 2,520 1,710 .108 
10 14,880 5,910 .0001 
11 5,790 3,510 .0023 
12 2,670 90 .0001 
14 7,530 4,050 .0001 
15 6,900 480 .0001 
16 30,480 21,600 .0001 
17 5,838 4,122 .0264 
19 2,360 140 .0001 
20 15,720 8,960 .0001 
a
TESV 9, 13, and 18 were excluded from analysis.  
b
p-values were calculated from a two-sample t-test comparing the means from 3 
replicate counts. Bold p-values indicate NucB significantly releasing more micro-
organisms, whereas an italic p-value shows a greater, significant release when using 
PBS. 
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from both treatment solutions it was possible to conclude which treatment liberated 
more micro-organisms. When micro-organisms were captured on nutrient agar, more 
were cultured from TESV halves treated with NucB in 11 out of 17 samples (65%) 
(Table 3.1). Furthermore, the use of Sabouraud agar showed that Candida spp. were 
released in greater numbers when treated with NucB in 14 out of 17 samples (82%) 
(Table 3.2). The ratio of CFUs between PBS and NucB treatments showed that 5.7-fold 
(S.E. 
+/-
 2.0) more microbes were released onto Sabouraud agar when NucB was used. 
There was 5.0-fold (S.E. 
+/-
 1.9) more micro-organisms liberated onto nutrient agar 
when NucB was present in treatment solutions.  
Micro-organisms that were captured on growth media were identified in order to 
determine if the microflora of these TESVs was similar to those previously studied. 
Many different species of micro-organisms were recovered from TESVs when placed in 
PBS or NucB solutions. This was evident by the variety of colony morphologies on 
nutrient and Sabouraud agar. Individual colonies were selected and re-plated three times 
to select for contaminant-free micro-organisms. More detailed analysis with Gram 
staining and light microscopy showed that Gram negative bacilli, yeast and Gram 
positive cocci were highly prevalent. Furthermore, microbial strains from two TESVs 
were identified by MALDI-TOF (at the Freeman Hospital, Newcastle). This method 
identified Candida albicans (both TESVs), Corynebacterium striatum, Staphylococcus 
epidermidis, Staphylococcus aureus, Enterococcus faecalis, and Pseudomonas 
aeruginosa.  
 
3.4 Discussion 
 
This preliminary study aimed to determine the contribution of eDNA to the biofilm 
matrix stability of micro-organisms growing on TESVs. Biofouling has a significant 
impact on the lifespan of TESV devices and currently there is no optimal regime for 
increasing this lifespan. Furthermore, there has been little research into the abundance 
of eDNA in complex, mature, polymicrobial biofilms. Therefore, this project provided 
two novel aims.  
Significant biofouling was observed in most of the TESV samples, and this was 
visible to the naked eye. The dominant micro-organisms on the TESV visualised by 
SEM, Candida spp., cocci and bacilli, fitted with the brief microbial identification of 
microbes from two TESVs. This analysis showed colonisation by C. albicans, 
staphylococci, C. striatum, E. faecalis and P. aeruginosa. These species all follow 
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previous research that has shown Candida spp. to be the dominant microflora, along 
with commensal bacterial species (Bauters et al., 2002; Buijssen et al., 2012). However, 
no lactobacilli were identified which have been found on 97% of TESVs previously 
(Buijssen et al., 2007) but this was likely due to limited sampling, and/or the agar media 
utilised. Scanning electron microscopy and CLSM revealed that Candida spp. are the 
dominant micro-organisms on the outer layer of the TESV biofilm. During SEM 
visualisation bacteria were observed deeper into the biofilm. Candida albicans attaches 
to oral streptococci via specific cell surface proteins (Holmes et al., 1996). These 
interactions may lead to biofilm enhancement, and therefore increased levels of anti-
microbial resistance (Morales and Hogan, 2010). Fungal-bacterial interactions may be 
important during the colonisation of TESVs.  
Nucleic acids, presiding in the biofilm matrix, were visualised during agarose gel 
electrophoresis as smears of DNA for 3 samples. These smears appear to show that the 
eDNA in TESV biofilms is degraded, and is different to the high molecular weight 
DNA found in single-species model biofilms, which has a migration similar to 
chromosomal DNA (see Chapter 4 and 5). DNA is an unstable molecule (Lindahl, 
1993), and it is likely that the longevity of TESV biofilms (ca. 2-3 months) leads to a 
loss of DNA integrity and hydrolysis. It is feasible that microbial-produced DNase 
enzymes contribute to DNA degradation. How this impacts biofilm matrix stability over 
time is unknown. Previous research on the abundance of eDNA in mature, 
polymicrobial biofilms is limited but it has been measured in activated sludge biofilms 
(Dominiak et al., 2011). Extracellular DNA may originate through cell lysis (Mann et 
al., 2009), active release through quorum sensing (Spoering and Gilmore, 2006), or via 
excretion from membrane-bound vesicles (Renelli et al., 2004). With such a mature 
biofilm (ca. 2-3 months) cell death and lysis is likely to be the most obvious explanation 
for the release of eDNA in this system. During CLSM there were live and dead 
microbial cells in TESV biofilms, although they were not quantified. There was also 
LMW material extracted from TESV biofilm matrices, that may be DNA, RNA or some 
other material. Sharp bands migrating to roughly 200 and 400 bp were visualised in two 
samples. It is interesting to note that eukaryotic chromatin DNA, with histones, migrates 
to approximately these molecular weights. This may indicate that human DNA is a 
component of TESV biofilm matrices. However, further research is required, with 
DNase, and RNase treatment of samples, to begin to understand this LMW material. 
Further analysis, with DNA sequencing, could reveal the origin of the eDNA. This 
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material is important, as it appears to be a significant proportion of the eDNA extracted 
from some TESV biofilm matrices. 
Although eDNA is abundant in C. albicans SC5314 single-species biofilms cultured 
in RPMI medium (Martins et al., 2010) it is unknown how competitive interactions 
between species may influence eDNA concentrations in multi-species biofilms. 
Therefore, extrapolating from single-species eDNA data could under-or-overestimate 
eDNA levels in polymicrobial biofilms. Ultimately, this study is the first to directly 
measure eDNA in a clinically relevant, mature, mixed-species biofilm.  
Extracellular DNA was visualised in the biofilm matrix using a triple-stain technique 
developed for CLSM. This approach was similar to that used by Kania et al., (2010) but 
added DAPI to the previously used PI and ConA-FITC stains. Mannose containing 
macromolecules were stained by the lectin ConA, a technique previously used to stain 
the matrix of Staphylococcus aureus biofilms (Akiyama et al., 2002). However, fungal 
cell wall polysaccharides also contain mannose residues (Bowman and Free, 2006) and 
ConA-FITC provided clear images of fungi within TESV biofilms. DAPI was used to 
differentiate between living and dead cells, as live cells form a barrier to PI but not 
DAPI. However, DAPI (DNA stain) also allowed the visualisation of nucleic acids in 
the extracellular matrix, either as a diffuse staining or its co-localisation with PI. 
Although eDNA staining and CLSM is not without difficulties, this adds further 
evidence to eDNA being abundant in the matrices of biofilms on TESVs. The 
microscopy of biofilm matrix eDNA could have been improved by adding DNA to 
biofilms as a positive control, or by attempting to degrade eDNA with DNase enzymes 
as a negative control. Recently, immunogold labelled anti-dsDNA monoclonal 
antibodies and SEM has been used to show eDNA on the surface of Enterococcus 
faecalis cells during initial biofilm formation (Barnes et al., 2012). This technique may 
allow a better detection of eDNA within TESV biofilms.  
The major aim of this study was to determine whether TESV biofilms are susceptible 
to nuclease dispersion with the bacterial nuclease, NucB. NucB has shown clear 
potential against mono-species biofilms (Nijland et al., 2010; Shields et al., 2013) but 
this study also highlights its potential at dispersing mature biofilm-forming micro-
organisms. Interestingly, Candida albicans were dispersed from the surface of TESVs 
treated in this study. This species of fungus can be a colonizer of TESVs on 40% of 
used valves (Bauters et al., 2002), and is therefore an important organism in TESV 
biofouling. Furthermore, DNase I has dispersed C. albicans single-species biofilms by 
up to 40% (Martins et al., 2010). Commensal bacteria, that are often associated with 
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TESV biofouling, including lactobacilli, streptococci, and staphylococci have been 
dispersed by DNase I in previous studies (Qin et al., 2007; Perry et al., 2009; Kaplan et 
al., 2012; Muscariello et al., 2013). From the data presented here, TESV biofilm-
forming micro-organisms are susceptible to DNase treatment when present in natural 
mixed-species biofilms. 
Many attempts have been made to increase the lifespan of TESV devices (reviewed 
by Rodrigues et al., 2007). This is primarily motivated by the cost to healthcare services 
of replacing TESVs, which was estimated to be £44,000 at the Freeman Hospital, 
Newcastle, in 2010 (Shakir et al., 2012). However, the colonisation of TESVs by micro-
organisms also leads to problems for patient such as TESV leakage (Laccourreye et al., 
1997) and poor speech caused by reduced air flow (Elving et al., 2003). Therefore, 
NucB could lead to major improvements in the maintenance of TESVs. However, the 
experimental design examined the dispersal of micro-organisms from the silicone 
surface of TESVs, which is not a true reflection of the removal of biofilms from this 
device. Firstly, the CFUs released were a small number of the total CFUs expected in 
mature biofilm. Also, this method does not give any indication of the number of dead 
cells released during NucB treatment; dead cells were visualised during CLSM. 
Ultimately, after treatment, biofilms were still visible to the naked eye on TESVs. This 
study provides preliminary evidence of the potential of NucB to remove micro-
organisms from TESVs. Extracellular DNA can be more important in the early stages of 
biofilm formation (Whitchurch et al., 2002). Therefore, cleaning of devices with a 
NucB solution from the beginning of use may provide the most potential to prolong the 
life span of TESVs. Another objective would be to tether the NucB protein to the 
silicone surface. The surface of TESVs have been coated with metals, or biosurfactants, 
in the past, to reduce microbial colonisation (Rodrigues et al., 2007). 
To conclude, this preliminary study has shown that eDNA is a measurable 
component of the biofilm matrices of TESVs, and that micro-organisms can be 
dispersed from the surface of these devices by NucB. This suggests that eDNA is acting 
as a biofilm stabiliser in mature, polymicrobial biofilms, and that NucB could have a 
potential role in improving the life span of TESV devices. Further work should 
concentrate on the potential reduction of biofilm formation on TESVs by NucB, and 
determine whether there are any micro-organisms that are more susceptible to NucB 
dispersion than others.  
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Chapter 4: Chronic Rhinosinusitis 
 
4.1 Outline  
 
In the previous chapter results indicated that extracellular DNA (eDNA) contributes to 
TESV biofilm matrix stability. This is important because it shows that clinically 
relevant polymicrobial biofilms, including fungal species, may be treatable with 
nuclease enzymes. Again working in collaboration with the Ear, Nose and Throat 
department of the Freeman Hospital, Newcastle, this study looked in greater detail at the 
contribution of eDNA to biofilm matrix stability, on this occasion against micro-
organisms isolated from chronic rhinosinusitis (CRS). 
 
Although many factors contribute to CRS it has become apparent over the last two 
decades that microbial biofilm infections are associated with many cases of CRS. 
Surface-attached microbial communities present a challenge for the treatment of many 
diseases, including CRS, because micro-organisms living within a biofilm are 
substantially more resistant to antimicrobials than planktonic cells (Gilbert et al., 1997). 
This increased microbial resistance is readily apparent in CRS, because topical and 
systemic antibiotic treatments provide few significant positive outcomes (Fokkens et 
al., 2012). Additionally, antibiotics administered during CRS management can be long-
term (> 12 weeks), which may have a significant impact on increasing bacterial 
resistance, and negative side effects for patients. Ultimately, if the management of CRS 
is to improve, novel treatments are required to eliminate those cases caused by 
microbial biofilms.  
 
The microflora of diseased sinuses is a key issue in developing novel therapeutic 
techniques. Micro-organisms that are most commonly isolated from CRS patients 
include coagulase-negative staphyloccoi, α-haemolytic streptococci, Staphylococcus 
aureus, Corynebacterium spp., Prevotella spp., Peptostreptococcus spp., and 
Propionibacterium spp (Doyle and Woodham, 1991; Brook, 2006; Araujo et al., 2007). 
However, the microbiology of CRS is similar to non-diseased sinuses in healthy 
patients. Specific pathogens may not be responsible for the pathogenesis of CRS but 
rather the uncontrolled immune response to mixed-species biofilms. The majority of 
evidence for biofilm formation in diseased sinuses stems from microscopic analysis of 
sinus mucosa, which may act as a reservoir for pathogenic biofilms in 25-100% of CRS 
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patients (Foreman et al., 2012). Biofilm formation in CRS isolates has been shown by 
culturing sinonasal aspirates in a Calgary Biofilm Detection Assay, with 28.6% of 
patient samples exhibiting biofilm formation (Prince et al., 2008).  
 
In view of the high prevalence of biofilms in CRS patients (see Table 1.3), with a 
diverse microflora, it appears that novel treatments should exploit a common 
characteristic of biofilms. As discussed previously, eDNA, a macromolecule often used 
by microbes to hold biofilms together, is one possible target. DNase I has dispersed or 
inhibited bacteria associated with CRS, including Streptococcus pneumoniae (Hall-
Stoodley et al., 2008), Neisseria spp. (Lappann et al., 2010), Pseudomonas aeruginosa 
(Whitchurch et al., 2002), S. aureus (Kaplan et al., 2012), and Escherichia coli (Tetz 
and Tetz, 2010). Extracellular DNA is also present in the biofilm matrices of 
Staphylococcus epidermidis (Qin et al., 2007) and Haemophilus influenzae (Jurcisek 
and Bakaletz, 2007). Although it is unknown how these species might differ in their use 
of eDNA when isolated from disease, it does suggest that some CRS isolates may be 
dispersed by nuclease enzymes. Nasal irrigation with a solution containing a DNase 
would be the ultimate outcome but at this early stage more evidence is required, 
beginning with single-species biofilm models.   
 
This study hypothesised that extracellular DNA may contribute to the biofilm matrix of 
CRS isolates. Furthermore, an important objective was to determine if NucB could 
disperse these isolates. To begin with, microscopic techniques were used to investigate 
the colonisation of patient sinuses with biofilm cells. This analysis looked at both the 
sinus mucosa, and obstructive mucin as a reservoir for biofilms. The microbiology of 
CRS was investigated by isolating bacteria on a number of media and identifying 
species with 16s rRNA sequencing or by MALDI-TOF mass spectrometry. Twenty-four 
isolates were selected and grown as biofilms using a static 96-well microtiter model. 
Extracellular DNA was extracted and quantified from the biofilm matrices of the 24 
isolates. Lastly, NucB was incubated with mature CRS biofilms and any reduction of 
biofilm extent quantified.  
 
4.2 Microscopic analysis of obstructive mucin and mucosal biopsies from CRS 
patients 
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Microscopic techniques have been used to visualise microbial biofilms associated with 
CRS. This section confirms the association of bacteria with the surface of sinus mucosa, 
as well as visualising the structure of the mucin that obstructs infected sinuses in some 
CRS patients.  
 
4.2.1 Transmission electron microscopy of obstructive mucin 
 
During functional endoscopic sinus surgery (FESS), thick, rubbery secretions were 
aspirated from the sinuses of CRS patients. This material could be coined ‘obstructive 
mucin’, as these secretions become so large that they fill entire sinus cavities. 
Functional endoscopic sinus surgery is the standard surgical treatment for CRS, and this 
procedure aims to remove as much mucin as possible from the paranasal sinuses 
(Bassiouni et al., 2012). During this study, obstructive mucin was removed from the 
paranasal sinuses of CRS patients with or without polyps in the absence of other 
symptoms that would indicate eosinophilic chronic rhinosinusitis (ECRS). To begin 
with, it was thought that this material may be of bacterial origin and as such contain 
eDNA, therefore potentially responding to nuclease treatment. This material is 
extremely tenacious and removing it significantly extends the length of time required in 
the operating theatre, therefore if it were a biofilm eDNA dispersal may improve 
surgical treatment. To investigate the structure of the obstructive mucin, a portion of the 
material from two different CRS patients was cut into small pieces (~1 mm
3
) 
immediately after surgery and fixed in glutaraldehyde. The mucin was embedded and 
sectioned for TEM analysis (see Materials and Methods 2.6.3). The material from the 
two patients appeared similar in structure, and consisted predominantly of an acellular 
matrix either with a striated appearance punctuated by occasional degraded host cells 
and cell debris (Figure 4.1A), or with little structure and many pockets of air space 
(Figure 4.1B). Erythrocytes were sometimes observed in the mucin matrix (not shown). 
However, areas containing large numbers of eosinophils were not observed in any field 
of view. Importantly, bacterial cells and fungi were not seen within the matrix of these 
samples. Therefore, on the basis of these analyses, the obstructive mucin was not a 
microbial biofilm. 
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Figure 4.1 Transmission electron microscopy of obstructive mucin from CRS 
aspirates. In some cases (A), the mucin either formed a layered structure, with 
relatively intact cells towards the outer layers (black arrow) and more degraded cellular 
material further in (white arrow). (B) Alternatively, samples had little clear structure 
and the mucin was punctuated by pockets. The outermost layer of each sample is 
indicated by arrowheads. 
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4.2.2 Surface-associated bacteria on sinus mucosa 
 
As discussed previously, many authors have discovered bacterial biofilms on the 
surface of sinus mucosa. So, whilst microbial cells were not visible in obstructive 
mucin, it couldn’t be discounted that they were still in sinuses but localised to other 
areas. Therefore, mucosal biopsies were also collected from CRS patients, and analysed 
by confocal scanning laser microscopy (CSLM). Initially, propidium iodide and DAPI 
(plus cell membrane counterstaining with Alexa Fluor
®
 647 conjugate of wheat germ 
agglutinin (WGA)) were employed to stain bacteria. However, it was difficult to 
identify micro-organisms with confidence due to the lack of contrast between bacteria 
and host cells (Figure 4.2). Therefore, in subsequent samples bacteria were selectively 
stained by PNA-FISH with the EUB338 probe, and host cells were counterstained with 
DAPI (see Materials and Methods 2.6.1.3). PNA is an artificially synthesised analogue 
of DNA that employs a backbone of repeating N-(2-aminoethyl)-glycine units linked by 
peptide bonds (Nielsen et al., 1991). This backbone contains no phosphate groups and 
therefore has no charge, unlike natural DNA. PNAs are not easily recognized by 
nucleases, are more stable over wider pHs and form stronger bonds to DNA, than DNA, 
as they contain no charge. Prior to the staining of sinus mucosa with the PNA-FISH 
probe, the technique was developed with in vitro cultured bacterial cells. This process 
included optimising the staining protocol and staining various bacteria associated with 
CRS (Figure 4.3). Six bacterial species, both Gram positive, and Gram negative, that are 
of relevance to CRS were tested. Although there was some variation in staining 
intensity all species were visualised with the FISH protocol. Optimisation of staining 
included different lengths of probe hybridization, varied strategies for cell wall 
permeabilization and altered fixation strategies. These techniques were compared via 
brightness of the resulting stain fluorescence during CLSM. Once the technique was 
optimised the probe was employed with CRS biopsy material. This method clearly 
showed microbial DNA on the mucosal surface of some mucosa specimens (Figure 
4.4B). In addition to punctate staining, representing intact bacterial cells, patches of 
more diffuse staining were observed that may represent microbial eDNA. Some 
specimens were free of stainable bacteria (Figure 4.4A), indicating that sinus mucosa is 
not uniformly covered with bacteria. It is possible that bacteria that are difficult to 
permeabilize, like staphylococci (as shown in Figure 4.3), are residing on the sinus 
mucosa but were not stained by the PNA FISH probe. 
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Figure 4.2 Formalin fixed sinus mucosa specimens visualized with fluorescent 
stains. (A) Propidium iodide non-specifically stained mucosal tissue, therefore making 
it hard to differentiate between host and bacterial cells. Bacterial cells may be present 
(white arrow), or this may be an artefact. Nine specimens were stained using this 
method. (B) The dual stain technique of DAPI and WGA yielded clearer images as 
background material was not stained. However, again there is no differentiation 
between host and bacterial cells.  
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Figure 4.3 Determining the efficacy of a PNA-FISH universal bacterial probe at 
staining multiple species of bacteria. Several bacteria are found associated with 
sinuses, and so it was important to assess the staining potential of micro-organisms 
already isolated from diseased sinuses. All species tested were visible, although Gram 
positive bacteria, like S. epidermidis, did not stain as well as Gram negative organisms.  
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Figure 4.4 Confocal laser scanning microscopy of surface associated bacteria on 
mucosa removed from patients diagnosed with CRS. Bacteria (green) were 
visualized using a EUB338 PNA-FISH probe, and epithelial cells (blue) were 
counterstained with DAPI. In some fields, epithelial cells were observed in the absence 
of bacteria (A), and in other fields bacterial biofilm was evident (B). Nine mucosa 
specimens were stained using this technique.  
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4.3 Microbiology of chronic rhinosinusitis 
 
Bacteria often reside in paranasal sinuses, diseased, or healthy, as shown by culture, 
molecular methods, and microscopy. In this section, sinuses were investigated for their 
microbiological content. Micro-organisms were also analysed for extracellular DNase 
activity, which is linked to virulence and may re-structure biofilms. Lastly, the biofilm-
forming ability of selected bacteria was also determined.  
 
4.3.1 Isolation and identification of micro-organisms associated with CRS 
 
Obstructive mucin was collected during FESS by an ENT surgeon, placed in RTF and 
quickly transported to the laboratory. From here, the mucin was pulverized into a 
homogenous paste and used as an inoculum for agars. Specimens were placed onto 
chocolate, blood, fastidious anaerobe and Sabouraud agars, with all media supporting 
growth of micro-organisms, as shown in figure 4.5. These media where chosen from the 
standard operating procedure for the investigation of sinus aspirates, as outlined by the 
health protection agency (HPA, 2009). A diverse range of media and growth conditions 
was employed to aid the capture of as many micro-organisms as possible (see Materials 
and Methods 2.4.1.2). The average number of mucin aspirates collected from patients 
during surgery was 4 (fewest, 1; most, 16). One mucin sample per patient was 
homogenized and used as an inoculum. There was significant variation in aspirate 
texture, colour, size and firmness. Overall, 75 strains of bacteria were isolated from 20 
patients, comprising a total of 16 different genera and 32 separate species (Table 4.1). 
Obstructive mucin contained between 2, to 6, bacterial species per patient. Micro-
organisms were identified by a combination of biochemical and molecular methods (see 
Materials and Methods). The most prevalent organism associated with CRS aspirates 
was Staphylococcus epidermidis, which was isolated from 15 of 20 specimens (75%). 
Staphylococcus aureus and Streptococcus spp. were each isolated from 7 patients (35% 
of samples), Corynebacterium spp. were isolated from 6 patients (30%), and 
Propionibacterium spp. from 5 patients (25%). Other organisms that were less 
frequently isolated included Haemophilus influenzae, Moraxella catarrhalis, Neisseria 
spp., Finegoldia magna, and Enterobacter aerogenes. The majority of isolated bacteria 
were facultative anaerobes. However, both obligate aerobes (for example, Neisseria spp. 
and M. catarrhalis) and obligate anaerobes (F. magna, Propionibacterium spp.) were 
also isolated.  
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Figure 4.5 CRS micro-organisms were isolated on four media types. (A) Blood agar 
from patient 5, (B) chocolate agar from patient 7, (C) fastidious anaerobe agar from 
patient 3, and (D) Sabouraud agar from patient 4. Many colony morphologies are 
visible. Occasionally bacteria grew on Sabouraud agar if they were resistant to the low 
pH (5.6) of the medium.  
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Table 4.1 Bacteria isolated from CRS aspirates. 
Patient Microbial Species Present
a 
Total number 
of isolates 
1 
Enterobacter aerogenes, Staphylococcus epidermidis, Streptococcus sp., Streptococcus pneumoniae, 
Streptococcus salivarius 
5 
2 
Haemophilus influenzae, Microccus luteus, Staphylococcus epidermis,  Staphylococcus hominis,  
Streptococcus pneumoniae 
5 
3 Moraxella catarrhalis,  Staphylococcus aureus,  Streptococcus anginosus 3 
4 
Klebsiella rhizophila, Staphylococcus epidermidis,  Streptococcus constellatus,  Streptococcus intermedius,  
Streptococcus salivarius 
5 
5 Esherichia coli,  Staphylococcus  aureus,  Staphylococcus epidermidis 3 
6 
Corynebacterium pseudodiphtheriticum, Finegoldia magna, Klebsiella pneumoniae, Moraxella catarrhalis, 
Staphylococcus epidermidis, Staphylococcus lugdunensis 
6 
7 Staphylococcus aureus,  Staphylococcus epidermidis,  Staphylococcus warneri,  Streptococcus constellatus 4 
8 Corynebacterium propinquum,  Staphylococcus epidermidis,  Staphylococcus lugdunensis 3 
9 E. aerogenes, Finegoldia magna, Propionibacterium sp.,  Streptococcus pneumoniae 4 
10 Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus epidermidis,  Streptococcus pneumoniae 4 
11 Staphylococcus epidermidis, Staphylococcus warneri 2 
12 Citrobacter koseri,  Staphylococcus epidermidis, Propionibacterium sp., Pseudomonas aeruginosa 4 
13 Corynebacterium  pseudodiphtheriticum, Propionibacterium granulosum, Staphylococcus aureus 3 
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a
Strains highlighted in bold text produced extracellular deoxyribonuclease. 
14 Staphylococcus epidermidis,  Staphylococcus pasteuri,  Staphylococcus warneri 3 
15 
Staphylococcus epidermidis,  Staphylococcus lugdunensis,  Propionibacterium acnes,  Propionibacterium 
granulosum 
4 
16 Corynebacterium propinquum, Neisseria meningitidis,   Staphylococcus  aureus 3 
17 
Neisseria sp.,  Staphylococcus epidermidis,  Streptococcus anginosus,  Streptococcus parasanguinis,  
Streptococcus salivarius 
5 
18 Staphylococcus aureus,  Staphylococcus epidermidis 2 
19 
Corynebacterium pseudodiphtheriticum,  Propionibacterium avidium,  Staphylococcus aureus,  
Staphylococcus epidermidis 
4 
20 Corynebacterium accolens,  Corynebacterium pseudodiphtheriticum, Lactobacillus sp. 3 
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4.3.2 Extracellular DNase activity of CRS isolates 
 
The production of extracellular DNase enzymes by clinical isolates was assessed using 
DNase test agar and staining with toluidine blue (see Materials and Methods 2.4.5). 
Hydrolysis of DNA produces nucleotides and these form a different complex with 
toluidine blue, resulting in pink, rather than blue agar. Extracellular DNase activity is of 
interest because of its role in virulence but also because it may re-structure microbial 
biofilms. All S. aureus isolates produced extracellular DNase, and other producers were 
Streptococcus anginosus group (S. anginosus/S. constellatus/S. intermedius) strains 
(80% of strains), Staphylococcus lugdunensis (33% of strains) and Streptococcus 
salivarius (33% of strains). Extracellular nuclease producers were isolated from 11 out 
of 20 (55%) patients. Examples of DNase activity are shown in Figure 4.6. In only two 
cases, more than one nuclease producing organism was isolated from the same patient 
sample. 
 
4.3.3 Biofilm formation of CRS isolates 
 
Twenty-four bacteria, isolated from obstructive mucin aspirates, were grown in 96-well 
microtiter plates to assay for biofilm formation (see Materials and Methods 2.4.1.5 and 
2.10.2). Biofilm formation is a key aspect of this project because the hypothesis of 
NucB reducing biofilm extent hinges on microbial isolates producing biofilms in vitro. 
Representative strains of all species that produced extracellular DNase were selected for 
these studies, along with a similar number of non-producing organisms. Following 
incubation for 20 h in microtitre wells, all isolates had grown in the planktonic phase to 
OD600>0.1 with the exception of three strains: S. anginosus FH19, S. constellatus FH21 
and S. pneumoniae FH26 (Table 4.2). All 24 strains were also grown in planktonic 
culture (10 mL Falcon tubes) for 8 h, to determine their growth rates (doubling time in 
the logarithmic growth phase). There was significant variation in growth rates from the 
slowest, S. constellatus FH21 (not determined due to very little growth), to the fastest, 
S. salivarius FH27 (37 min). Generally isolates of the same species grew at similar 
rates, although S. salivarius FH28 had a doubling time almost 3 times slower than other 
S. salivarius isolates. Growth rates in planktonic culture did not always correlate with 
the planktonic growth measured in the microtiter assay. For example, S. salivarius 
FH27 had a doubling time of 37 minutes but only grew moderately well in the 
planktonic phase of the microtiter assay (OD600 = 0.20). This is because micro- 
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Figure 4.6 DNase agar test for extracellular DNase activity, using toluidine blue 
stain. This test provides a clear indication of nuclease production by isolates, visible as 
pink areas. Streptococcus intermedius produces a cell-associated nuclease, and therefore 
pink areas of DNA hydrolysis are in close proximity to the colony. In contrast, S. 
aureus extracellular DNase is released, and there is a zone of clearance of 5 mm around 
the colony. Staphylococcus epidermidis and M. catarrhalis do not produce exonucleases 
and as a result have no pink zone of DNA clearance. 
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Table 4.2 Biofilm formation and NucB sensitivity of selected isolates from CRS aspirates. 
Strain
a
 
Planktonic 
Growth OD600 
Mean (S.E.) 
Doubling Time 
Mean (S.E.) 
Biofilm Growth 
OD570 Mean 
(S.E.) 
Nuclease 
Production
b
 
Remaining Biofilm after 
NucB Addition (%) 
p-
value 
Corynebacterium propinquum FH1 0.39 (0.06) 235.38 (11.67) 1.79 (0.78) - 105 0.558 
Corynebacterium pseudodiptheriticum FH2 0.86 (0.24) 129.46 (2.35) 2.61 (0.43) - 92 0.577 
Moraxella catarrhalis FH3 0.39 (0.07) 232.07 (6.46) 0.77 (0.21) - 127 0.349 
Moraxella catarrhalis FH4 0.42 (0.14) 154.69 (5.05) 2.78 (0.21) - 124 0.032 
Staphylococcus aureus FH5 0.40 (0.11) 61.93 (3.20) 1.84 (0.34) + 77 0.003 
Staphylococcus aureus FH6 0.50 (0.08) 74.36 (0.02) 0.71 (0.12) + 59 0.000 
Staphylococcus aureus FH7 0.79 (0.26) 60.55 (3.41) 1.23 (0.22) + 40 0.000 
Staphylococcus epidermidis FH8 0.27 (0.09) 80.83 (5.78) 2.29 (0.41) - 114 0.077 
Staphylococcus epidermidis FH10 0.48 (0.06) 90.49 (1.07) 1.59 (0.22) - 67 0.001 
Staphylococcus epidermidis FH11 0.54 (0.13) 103.64 (4.17) 1.52 (0.24) - 74 0.010 
Staphylococcus lugdunensis FH12 0.74 (0.03) 73.04 (3.64) 1.16 (0.23) - 49 0.001 
Staphylococcus lugdunensis FH13 0.78 (0.05) 69.69 (0.23) 0.57 (0.10) - 66 0.001 
Staphylococcus lugdunensis FH14 0.78 (0.13) 73.31 (15.60) 0.53 (0.05) + 69 0.001 
Staphylococcus warneri FH15 0.59 (0.18) 72.05 (4.07) 0.89 (0.25) - 126 0.005 
Staphylococcus warneri FH17 0.88 (0.16) 64.51 (3.02) 2.40 (0.55) - 90 0.319 
Streptococcus anginosus FH18 0.16 (0.05) 54.00 (2.63) 1.16 (0.07) + 34 0.000 
Streptococcus anginosus FH19
c
 0.07 (0.00) 89.94 (15.01) 0.22 (0.02) + 59 0.015 
Streptococcus constellatus FH20 0.22 (0.04) 103.06 (27.51) 1.90 (0.39) + 44 0.001 
Streptococcus constellatus FH21
c
 0.04 (0.03) n/a 0.31 (0.05) - 39 0.001 
Streptococcus intermedius FH22 0.19 (0.02) 66.79 (1.85) 3.07 (0.80) + 46 0.000 
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Streptococcus pneumoniae FH26 0.07 (0.03) 55.61 (1.06) 1.87 (0.31) - 123 0.585 
Streptococcus salivarius FH27 0.20 (0.06) 37.34 (2.66) 0.99 (0.04) - 92 0.240 
Streptococcus salivarius FH28 0.32 (0.04) 110.71 (28.52) 2.67 (0.96) + 66 0.002 
Streptococcus salivarius FH29 0.23 (0.03) 39.36 (0.71) 1.08 (0.04) - 96 0.692 
a
For details of genera, see Table 4.1. 
bProduction of nuclease was measured on DNase agar, and is indicated by a ‘+’ sign. 
c
Isolates grew poorly in both the planktonic and biofilm phase. 
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organisms can double quickly but reach the stationary phase early due to growth 
limitations in the media used. All strains produced biofilms that were detectable by 
crystal violet staining. Crystal violet adheres to biofilms because it dissociates in 
aqueous solutions to CV+ and chloride (Cl-) ions, the CV+ ions then interact with 
negatively charged molecules in microbial biofilms, staining them purple. Therefore, it 
measures total biofilm extent, and is not a measure of total cell numbers. Generally, 
there was extensive variation in the extent of biofilm formation between different 
species and between different strains of the same species. For example, M. catarrhalis 
FH3 produced a very weak biofilm (A570 = 0.77), whereas M. catarrhalis FH4 formed 
extensive biofilms (A570 = 2.78). Of the strains tested, Streptococcus anginosus FH19 
produced the least abundant biofilms (A570 = 0.22). The mean extent of biofilm 
formation by non-nuclease producers (A570=1.51, S.E. 0.19, n=15) was not significantly 
different from that of nuclease producers (A570=1.48, S.E. 0.32, n=9).  
 
4.4 Analysis of the structural role of eDNA in CRS biofilms 
 
All 24 isolates assayed produced biofilms. These biofilms were treated with NucB to 
determine its efficacy against CRS isolates and therefore how significant eDNA is in 
maintaining structural integrity. Later, certain biofilms were grown on glass coverslips 
and analysed by microscopy after treatment with NucB or with PBS.  
 
4.4.1 Efficacy of NucB against biofilm forming isolates 
 
Pre-formed biofilms were incubated for 1 h in the presence of the microbial DNase 
NucB (Table 4.2) (see Materials and Methods 2.10.3). Biofilms formed by 9 out of 9 
(100%) nuclease producing strains were significantly reduced by NucB (T test 
comparing NucB treatment with buffer control, p<0.05, n=3). By contrast, only 5 out of 
15 (33%) of the biofilms produced by non-nuclease producing bacteria were dispersed 
by NucB. In addition, 2 out of 15 (13%) non-nuclease producers had slightly increased 
levels of biofilm following incubation with NucB than without the enzyme. All S. 
aureus and S. lugdunensis isolates were significantly dispersed by NucB, which is of 
interest because these two species are closely related (Patel et al., 2000). All 
Streptococcus anginosus group (S. anginosus/S. constellatus/S. intermedius) species 
were dispersed by NucB, and as a genus 6 out of 9 Streptococcus spp. were sensitive to 
DNase treatment. The Corynebacterium spp. (isolated in 30% of patients) treated were  
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Figure 4.7 Effects of NucB on the planktonic cells of three CRS isolates. S. aureus 
FH7, S. constellatus FH20 and S. salivarius FH29 were grown in BHY over a period of 
6 hours. (A) At an optical density of 0.2 (black arrows) isolates were challenged with 5 
µg/mL NucB (N) or unchallenged (C) and culture was continued to determine the 
bacteriostatic effect of NucB. (B) Cells were also removed after an hour of incubation 
with NucB (grey bars) or without (white bars) and the total viable cells calculated via 
dilution series onto solid BHY media.   
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not reduced by NucB. Streptococcus anginosus FH18 was the most greatly dispersed 
micro-organism, with biofilm extent decreased by 66%. To assess whether NucB had 
detrimental effects on the cells themselves, three different isolates, S. aureus FH7, S. 
constellatus FH20 and S. salivarius FH29, were cultured to exponential phase in BHY 
broth and challenged with 5 µg ml
-1
 NucB. No effects were observed on the growth rate 
of cells following the challenge (Figure 4.7A). The number of viable cells in each 
culture continued to increase following NucB addition and 1 h after adding NucB there 
was no difference in the number of viable cells in cultures containing NucB compared 
with control cultures without the enzyme (Figure 4.7B). Overall, these data suggest that 
eDNA is an important component of the EPS for over 50% of the CRS isolates, 
including strains that produce extracellular DNase enzymes, and that addition of NucB 
dislodges cells without killing bacteria. 
 
4.4.2 Microscopic analysis of in vitro grown biofilms 
 
To obtain more detailed information about the effects of NucB, biofilms of selected 
organisms were cultured on glass coverslips and analysed by CLSM and SEM (see 
Materials and Methods 2.6.1.1 and 2.6.2). This work focussed on staphylococci and 
streptococci, since these were the genera most commonly isolated from CRS patients. 
The three species tested were Staphylococcus aureus FH7, Streptococcus constellatus 
FH20 and Streptococcus intermedius FH29. In the absence of NucB treatment, biofilms 
formed by S. constellatus FH20 were relatively thin and consisted primarily of a single 
cell layer that covered most of the surface (Figure 4.8). In places, clusters of cells 
projected from the surface to a depth of ~12 µm. Using LIVE/DEAD
®
 BacLight
™
 stain, 
both live cells (green) and dead cells (red) were observed in biofilms; there was 
however  a larger proportion of dead cells than live cells. Biofilms that had been treated 
with NucB were clearly less extensive than the untreated controls, and consisted of 
sparsely distributed single cells or very small aggregates of <10 cells (Figure 4.8B). 
Biofilm formation by S. aureus FH7 on the glass surface was also thin, with clusters of 
cells projecting from the surface (to ~8 µm) (Figure 4.8). Staphylococcus aureus FH7 
survived better than S. constellatus FH20 during biofilm formation and specimen 
processing, as shown by the higher number of live cells (green). Again, slides that were 
incubated with NucB had far fewer cells attached to them than the PBS treated control 
biofilm (Figure 4.8D). To obtain higher resolution images, similar biofilms were 
Chapter 4: Chronic Rhinosinusitis 
114 
 
 
Figure 4.8 Confocal laser scanning microscopy of S. constellatus FH20 and S. 
aureus FH7 biofilms with or without NucB treatment. Biofilms were cultured on 
glass surfaces and visualised with CLSM using LIVE/DEAD
®
 BacLight
™
 stain, which 
stains dead cells red and live cells green. (A and C) Biofilms treated with buffer alone, 
and (B and D) biofilms treated with NucB. Scale bar (white) is 50 µm. 
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Figure 4.9 Scanning electron microscopy of Streptococcus constellatus FH20 
biofilms treated with NucB or buffer control. Biofilms were visualised with SEM 
after treatment for 1 h with buffer (A) or with NucB (B). At higher magnification, 
extracellular material (white arrow) was observed in the absence of NucB treatment (C), 
but was not seen in NucB-treated biofilms (D). Images are representative of 3 replicates 
cultured on separate days. 
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analysed by SEM (Figure 4.9). Again, in the absence of NucB, cell aggregates were 
evident and a relatively large proportion of the surface was covered by micro-organisms 
(Figure 4.9A). By contrast, NucB-treated biofilms almost exclusively contained isolated 
cells or small clusters of cells (Figure 4.9B). In addition, extracellular material was 
apparent in untreated biofilms under high resolution SEM (Figure 4.9C), that was not 
seen in biofilms incubated with NucB (Figure 4.9D). Biofilms formed on glass surfaces 
by S. aureus FH7 or S. intermedius FH22 were also visualised by SEM (data not 
shown). As with S. constellatus FH20, biofilms that were treated with NucB contained 
far less biomass than those incubated in buffer alone. Extracellular polymers were also 
observed in biofilms of these two species.  
 
4.5 Quantification of eDNA in model biofilms 
 
The eDNA content of biofilms formed by CRS micro-organisms was characterised in 
22 out of the 24 isolates selected for further analysis (see Materials and Methods 2.7). 
To quantify levels of eDNA in model biofilms, eDNA and intracellular DNA (iDNA) 
was extracted from biofilm cultures of S. aureus FH7, S. constellatus FH20 and S. 
salivarius FH29. The eDNA was analysed by agarose gel electrophoresis (Figure 
4.10A). Sharp bands migrating at an apparent size of approximately 30 kbp were 
observed in eDNA fractions of S. aureus FH7 and S. constellatus FH20. However, no 
high molecular weight eDNA bands were seen in S. salivarius FH29. Intracellular DNA 
from all three organisms appeared as a smear of high molecular weight fragments, 
probably due to binding of chromosomal DNA to cell wall fragments. The high 
molecular weight eDNA bands were of similar weight to the chromosomal DNA that 
was extracted. In addition to the high molecular weight fragments, small fragments of 
DNA or RNA were seen at the bottom of the gel. Further controls, by treating the 
extracted “eDNA” with RNase and DNase could allow the identification of this LMW 
material. Nucleic acids in each fraction were quantified using the Nanodrop 
spectrophotometer (Figure 4.10B). For each strain, eDNA represented approximately 5-
10 % of the total DNA present in the biofilm. To account for the possibility that samples 
may have contained RNA in addition to DNA, nucleic acids were also quantified using 
PicoGreen dye, which is strongly selective for double stranded DNA. When measured 
using this technique DNA concentrations were up to 15-fold lower, indicating the 
potentially significant proportion of ssDNA and RNA that contributes to the eDNA 
nucleic acid concentration measured by NanoDrop spectrophotometry. The NanoDrop 
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Figure 4.10 The visualization and quantification of eDNA from CRS isolates. (A) 
Intracellular DNA (i) or eDNA (e) was purified from bacterial biofilms of S. aureus 
FH7, S. constellatus FH20 or S. salivarius FH29, and analysed by agarose gel 
electrophoresis. High molecular weight chromosomal DNA is indicated by a black 
bracket; low molecular DNA or RNA is highlighted at the bottom of the gel by a black 
arrow. M; size marker. (B) The concentration of DNA in the intracellular (grey bars) 
and extracellular (white bars) fractions from bacterial biofilms was measured by 
NanoDrop spectrophotometry. Bars represent means of three independent extracts, and 
SEs are indicated. (C) Extracellular DNA concentration in biofilms was also visualised 
for another 19 isolates, with distinct chromosomal DNA bands migrating at an apparent 
size of 30 kbp; the total DNA concentration was measured by NanoDrop 
spectrophotometry, bars represent the average of three replicates and error bars are S.E. 
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spectrophotometer measures all molecules that absorb or scatter light at the wavelength 
of interest (260 nm) and these could include ssDNA, nucleotides, RNA, contaminants 
and molecules that absorb UV light. Staphylococcus aureus FH7 chromosomal DNA 
extractions contained substantial amounts of protein. No significant differences were 
observed between the total amount of eDNA in S. salivarius FH29 biofilms (760 ng/µL) 
and eDNA in biofilms formed by the other two strains (740 ng/µL). Therefore, despite 
the lack of a clear band by agarose gel electrophoresis, it appears that eDNA was 
present in S. salivarius FH29 biofilms.   
To assess whether eDNA was present in biofilms formed by other CRS isolates, 
biofilms of each strain were cultured in 6-well polystyrene microtiter plates and eDNA 
was purified as described in the Materials and Methods chapter. Only two strains were 
omitted from this analysis: S. constellatus FH21 grew very poorly in biofilms and it was 
not possible to extract eDNA, and S. salivarius FH28 was prone to contamination and, 
after several attempts, it was decided not to pursue DNA purification from this strain. 
By agarose gel electrophoresis, sharp bands corresponding to high molecular weight 
eDNA products were observed in all Staphylococcus spp., S. constellatus FH20 and in 
S. intermedius FH22 (Figure 4.10C). By contrast, similar bands were not detected from 
Corynebacterium spp., S. anginosus or S. pneumoniae. Only M. catarrhalis and S. 
salivarius had inter-strain differences in the production of eDNA. Thus, eDNA was not 
visualised in M. catarrhalis FH3 biofilm extracts, whereas eDNA was clearly present in 
M. catarrhalis FH4 (Figure 4.10C). Similarly S. salivarius FH29 did not produce a band 
of eDNA on an agarose gel, whereas a sharp band was seen in S. salivarius FH27. The 
concentrations of eDNA in samples were determined using the Nanodrop 
spectrophotometer. Concentrations of eDNA in the extracts ranged from 206 ng/µL to 
917 ng/µL (Figure 4.10C). Interestingly, there appeared to be little correlation between 
the concentration of eDNA and the presence or absence of a band on the agarose gel. 
For example, M. catarrhalis FH3 produced one of the highest concentrations of eDNA, 
but no band on the gel. Conversely, the eDNA concentration from S. intermedius FH22 
was just 325 ng/µL even though this strain clearly produced a band of eDNA on a gel. 
The production of an extracellular nuclease did not correlate with the presence of a band 
of eDNA on a gel. All strains of S. aureus (nuclease-positive) and S. epidermidis 
(nuclease-negative) produced clear bands of eDNA, for example. With the exception of 
S. anginosus FH18 and S. anginosus FH19, all strains that failed to produce a clear band 
of eDNA on an agarose gel were insensitive to NucB treatment. 
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4.6 Discussion 
 
Despite continued research, the pathophysiology of CRS is relatively poorly 
understood. CRS is one of the most common upper respiratory tract diseases, affecting 
approximately 10% of the adult European population (Hastan et al., 2011). Therefore, it 
impacts significantly on society, with high cost to healthcare services, and reduced 
quality of life in sufferers. There is increasing evidence, although still unclear, that 
micro-organisms are a major factor in the development of CRS (Foreman et al., 2012). 
The major objectives of this study were to characterize the microbial bioburden of 
sinuses in CRS patients with obstructive mucin, to determine whether isolated micro-
organisms produced biofilms and to assess the efficacy of a novel bacterial nuclease, 
NucB, for biofilm control.  
As with many aspects of CRS, the excess mucus production during sinus 
inflammation that can lead to blocking of sinuses, is not well characterised. Mucus 
hypersecreation in the respiratory tract can be related to allergic disorders, as first 
outlined in 1952 (Hinson et al., 1952). With CRS, this has long be associated with 
allergic fungal sinusitis (AFS) and eosinophilic mucin rhinosinusitis (EMRS), the two 
of which may be subcategories of a collective pathological condition eosinophilic 
chronic rhinosinusitis (ECRS) (Ferguson, 2000). At the Freeman Hospital, Newcastle, 
CRS patient sinuses often contain thick mucus that is removed during FESS. This 
material was analysed by TEM and it appeared to contain few degraded eosinophils and 
therefore appears to be different to ECRS mucin (Ponikau et al., 1999). Furthermore, no 
fungi were observed during TEM or culture from mucin. The fungal association with 
CRS is complicated and has long been debated (Ebbens et al., 2009). Culture analysis 
has either yielded very high incidences of fungal carriage (Ponikau et al., 1999), or very 
low fungal isolation (Araujo et al., 2007). Whatever the role of fungi in CRS, in the 
cases presented here none were of a detectable fungal origin. Bacteria were not 
visualised in obstructive mucin, although these can be hard to view using TEM, as 
sections are thin. This result conflicts with the culture analysis of mucin aspirates, 
where 91% were culture positive for bacteria. TEM sections most often contained 
material that had no distinct structure, or cells, either eukaryotic or prokaryotic. The up-
regulation of MUC5AC and MUC5B mucin genes has been identified in CRS patients, 
genes that are expressed in low-levels in healthy sinus epithelium (Kim et al., 2004). 
Overproduction of mucus proteins may be the major pathological process creating the 
mucin observed in this study.  
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Whilst obstructive mucin did not appear to be a reservoir of micro-organisms, 
bacterial biofilms were observed on the surface of sinus mucosa. The detection of 
bacteria employed a PNA-FISH probe, a technique that has increased effectiveness over 
standard FISH (Pereira et al., 2008). Although this approach is highly sensitive, bacteria 
can remain undetected if DNA copy numbers are low (Boase et al., 2013). Nevertheless, 
the biofilms that were visualized were similar to those demonstrated previously 
(Sanderson et al., 2006). Additionally, positive bacteria culture was observed in 20 out 
of 20 patients, suggesting a significant bacterial carriage in the sinuses examined. 
Occasionally micro-organisms were not detectable on mucosal specimens during 
microscopic analysis. 
The microbial population of CRS in this study was dominated by S. aureus, 
coagulase-negative staphylococci and α-haemolytic streptococci. Other studies, using 
culture-dependent techniques have isolated similar bacteria in CRS patients (Brook, 
2006; Araujo et al., 2007). Potentially pathogenic bacteria identified include P. 
aeruginosa, H. influenzae, S. aureus, M. catarrhalis, Neisseria spp., S. pneumoniae, and 
Corynebacteria. It remains unclear if specific pathogens are responsible for the disease 
pathogenesis of CRS. Previously, bacterial micro-organisms were isolated from only 4 
out of 14 healthy maxillary sinuses (Abou-Hamad et al., 2009). A recent study however, 
identified organisms in all 6 healthy control specimens (Boase et al., 2013). There 
appears to be increased abundance of micro-organisms and certain pathogenic species 
including, S. aureus, M. catarrhalis, P. aeruginosa and S. pneumoniae in CRS patient 
sinuses (Boase et al., 2013).  
Interestingly, obligate anaerobes (Propionibacterium spp. or F. magna) were 
cultured during this study. There remains a debate over the role of anaerobic bacteria in 
CRS pathogenesis (Ramadan et al., 2002). Anaerobes have been isolated in as few as 
0% of cases (59 patients) (Doyle and Woodham, 1991), and as many as 88% (Brook, 
1989). A difference even exists between rates isolated from the the maxillary sinus, 
either 6% or 88% (Brook, 1989; Biel et al., 1998). This suggests that it is not sinus 
topography that is creating differences between studies. In this study, bacteria were 
isolated from three paranasal sinuses, maxillary, sphenoid and ethmoid. Anaerobic 
carriage is most likely to be relatively low (Biel et al., 1998; Ramadan et al., 2002; 
Araujo et al., 2007) as the sinuses are air-filled cavities, although O2 concentrations can 
drop to zero during mucin blockage (Carenfelt and Lundberg, 1977), facilitating the 
growth of facultative anaerobes and anaerobes, as found during this study.   
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Culture-independent techniques are becoming more accessible, and have been used 
to study the microflora of CRS (Stressmann et al., 2011; Feazel et al., 2012; Boase et 
al., 2013). Molecular methods may have increased detection sensitivity, as culturing 
relies on micro-organisms adapting to a new environment, without any of the complex 
interactions that occur between species. However, culture-dependent and culture-
independent techniques appear to isolate very similar bacteria in CRS patients (Feazel et 
al., 2012). The bacterial microflora of CRS patient sinuses in this study is in agreement 
with the previous literature.  
Biofilm formation in the paranasal sinuses is likely to be a key factor in the 
pathogenesis of CRS, and therefore determining if strains have the capacity to form 
biofilms is important. The in vitro model employed in this study suggested that all of 
the bacteria tested were capable of biofilm formation. This is unsurprising as it has been 
hypothesised that at least 99% of bacteria can exhibit the biofilm phenotype (Costerton 
et al., 1987). However, in a previous study of the biofilm-forming capacity of P. 
aeruginosa, S. aureus, and coagulase-negative staphylococci isolated from CRS patients 
biofilm formation was apparent in 22 of the 31 isolates studied (Bendouah et al., 2006). 
Again, bacteria were cultured in 96-well plates and stained with CV. The isolates were 
recovered from patients one-year after FESS, whereas in this study bacteria were 
removed during FESS and it is unknown how this will affect biofilm-forming capacity. 
Furthermore, the definition of biofilm formation (absorbance reading) will have an 
effect on how many isolates are considered biofilm formers. Another important study 
used a different model to assess biofilm formation by CRS bacteria, by inoculating a 
modified Calgary biofilm device with sinonasal swabs (Prince et al., 2008). 
Interestingly, cultures were obtained from CRS patients with evidence of mucus 
secretion, and so may have had symptoms similar to patients in this study. Biofilm 
formation was compared against a P. aeruginosa PA01 positive control, and two 
mutants, sad-31 and sad-36, which are non-biofilm forming. Biofilm growth higher 
than the sad-31 mutant was set as the threshold for biofilm formation. However, of the 
157 patient swabs only 45 (28.6%) exhibited any biofilm formation in the Calgary 
model. The higher incidence of biofilm-forming capacity in the bacteria isolated during 
this investigation is likely related to the freshness of isolates, the model system used, 
and the growth conditions employed. Biofilm formation differs between growth media, 
such that nutrient-poor or nutrient-rich media can contribute to higher biofilm extent 
(Dewanti and Wong, 1995; Stepanović et al., 2004). Prince et al., (2008) assayed for 
biofilm formation aerobically, with Luria-Bertani broth, which will underestimate the 
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capacity of anaerobic bacteria to form biofilms from sinonasal swabs. As shown by this 
study, and others, anaerobes make up a significant proportion of the microflora of CRS 
patient sinuses. Our model did not test the capacity of obligate anaerobes to form 
biofilms.  
More than half of the isolates tested were significantly dispersed when treated with 
NucB. Staphylococci are often associated with CRS, and the majority of strains tested 
were dispersed. Staphylococcus aureus has been found to be sensitive to DNase I in 
previous studies (Tetz and Tetz, 2010; Kaplan et al., 2012), indicating a clear role for 
eDNA in creating biofilm stability in this species. However, M. catarrhalis, a species of 
bacteria that in recent study was cultured only from CRS patients, and not healthy 
sinuses (Boase et al., 2013), was not dispersed by nuclease treatment. Moraxella 
catarrhalis FH4 biofilm extent was slightly but significantly increased by the NucB 
enzyme. Although eDNA is known to promote biofilm stability in most bacteria, in 
Caulobacter crescentus biofilms, the addition of 20 µg/mL DNase I during biofilm 
culture increased biofilm formation (Berne et al., 2010). Therefore, as in C. crescentus, 
eDNA may have an inhibitory effect on the M. catarrhalis biofilms studied here. Both 
Corynebacterium spp. remained similar, to control biofilms, in biofilm extent after 
NucB treatment. Species and strain variability in eDNA production and nuclease 
sensitivity is an interesting finding, and could be explored further by genome 
sequencing of the bacteria. This could demonstrate the genetic differences that may be 
responsible for changes in nuclease sensitivity, a point briefly explored in Chapter 5. 
Confocal laser scanning microscopy showed very clear dispersal of both S. aureus 
FH7, and S. constellatus FH20. Although the CLSM images were not subjected to 
quantitative analysis, this technique generally showed clearer dispersal of biofilms than 
the 96-well polystyrene plate model. During CLSM biofilms were cultured on glass, 
rather than polystyrene, which may have led to differences in eDNA dependence. 
Furthermore, the CLSM technique visualises cells, whereas the CV assay stains both 
cells and matrix, which could have led to differences in apparent dispersal efficacy. 
Staphylococcus aureus UAMS-1 48 hour mature biofilms cultured in a flow-cell model 
have been effectively dispersed by treating with 0.5 U/mL DNase I for 24 hours, as 
examined by CLSM (Mann et al., 2009). In this model, results indicated that higher 
inoculum biofilms of S. aureus UAMS-1 were more susceptible to DNase I treatment, 
highlighting the role different conditions have in nuclease effect. Generally, in our 
study, biofilms were cultured starting from a high inoculum, which may partly explain 
the significant disruptive effect of NucB in over half the isolates tested. Scanning 
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electron microscopy of S. constellatus FH20 biofilms again indicated a dispersal effect 
of the NucB enzyme. Additionally, control biofilms contained a stringy, extracellular 
matrix-like material which was missing in treated biofilms. Matrix polymers have been 
visualized in biofilms of Candida albicans GDH 2346, cultured on PVC catheter disks 
with or without shaking (Hawser et al., 1998). Here, cells are clearly linked by strands 
of extracellular matrix, as seen with S. constellatus FH20. It has been hypothesised that 
matrix material contributes to the resistance of microbial biofilms to antimicrobials (Fux 
et al., 2005). The removal of this material by NucB is a positive sign, and may aid the 
efficacy of antibiotics, as noted in other biofilm-forming species, where DNase I had a 
synergistic effect with several antibiotics (Tetz et al., 2009). This remains an untested 
theory, and requires further study.  
An important aspect of the study was to examine the abundance of extracellular 
DNase producers in the microflora of CRS. DNase production is viewed as an important 
virulence marker as it allows organisms such as Streptococcus pyogenes or S. aureus to 
escape neutrophil extracellular trap (NET) killing (Buchanan et al., 2006; Berends et al., 
2010). However, exonucleases may also influence the structure of biofilms, particularly 
in the context of the complex mixed-species biofilms that are likely to form in diseased 
sinuses. Biofilms are thicker in nuclease-deficient mutants of S. aureus and Vibrio 
cholerae than wild-type organisms of the same species (Kiedrowski et al., 2011; Seper 
et al., 2011). However, in a clinically relevant model of catheter biofilms, a clinical S. 
aureus isolate, UAMS-1, that was nuclease-deficient, produced a similar biofilm to the 
wild-type (Beenken et al., 2012). Therefore the total bioburden of biofilms in CRS 
patients may be affected by strain differences in nuclease production. Here, S. 
lugdunensis, S. constellatus and S. salivarius strains were either positive or negative for 
extracellular DNase production. This indicates that extracellular DNase production is 
regulated, that micro-organisms may have different nuclease phenotypes depending on 
environment, or that DNase function is lost by some strains, for instance due to 
environmental influences such as nutrient availability. The production of DNases is 
likely to be tightly regulated, for example, in response to stress or glucose (Kiedrowski 
et al., 2011). The role of DNase production in shaping biofilm structure in clinical 
ecosystems requires more investigation. 
Several of the species isolated produced extracellular DNases. The DNase agar test is 
often used to differentiate species of the same genus, as is often the case with S. aureus 
and coagulase-negative staphylococci. Interestingly, a S. lugdunensis isolate was DNase 
production positive. This species is similar to S. aureus and is often differentiated on the 
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basis of being DNase negative. However, here and in a previous study (Matthews et al., 
2011) this has been found to not always be the case, which may have implications for 
clinical diagnostics. Other differences existed between the reported DNase production 
of propionibacteria, and α-haemolytic streptococci and strains tested here (Hoeffler, 
1977; Palmer et al., 2012). Clearly, DNase activity is a variable trait of clinical isolates.  
Twenty two isolates were analysed for the presence of eDNA in biofilm matrices. All 
isolates contained eDNA that was quantifiable by spectrophotometry. Of these isolates 
large eDNA fragments were visible on agarose gels in 15 of the strains. In some strains, 
such as M. catarrhalis FH3, NanoDrop spectrophotometry revealed high concentrations 
of eDNA that were not visible on agarose gels. Interestingly, this species was not 
nuclease sensitive and therefore low molecular weight DNA may not stabilise the 
biofilm of this isolate. The biofilm matrix could also contain inhibitors that retard 
DNase efficacy, or the LMW eDNA may be resistant to DNase hydrolysis. In 
Pseudomonas fluorescens, eDNA accumulation was altered by RNA release, because it 
diminished DNase activity (Catlin and Cunningham, 1958). It appears that RNA may be 
common in biofilm matrices of CRS isolates, and that this could impact DNase activity. 
This would require further research using RNase and DNase controls to degrade 
extracted biofilm matrix nucleic acids, to ascertain the identity of the LMW 
macromolecules with some confidence. All S. aureus isolates produced eDNA that was 
visible on agarose gels and biofilms that were significantly dispersed by NucB. This 
was also observed in all S. lugdunensis strains. These closely related organisms clearly 
rely heavily on eDNA to add support to the biofilm matrix. Six of the 8 DNase 
producing organisms’ matrices contained DNA fragments that were visible on agarose 
gel. It is unknown if DNase production differs in these micro-organisms when cultured 
on agar, to growth in the static polystyrene model. For instance, periodontal bacteria 
produced extracellular DNase activity differently depending on the nuclease assay used 
(Palmer et al., 2012). This may explain the intact HMW eDNA found in the biofilm 
matrices of some extracellular DNase producers, as DNase may not be produced in the 
microtiter biofilm assay. Both bacteria that were susceptible to nuclease treatment but 
did not produce a defined band of eDNA on agarose gels were S. anginosus strains. 
Either the large fragments of eDNA degraded during the investigation, or the size of 
DNA is not a determining factor in how much strength it adds to a biofilm matrix. Most 
eDNA is likely to be released during cell lysis, and is therefore of high molecular 
weight (of chromosomal origin) (Allesen-Holm et al., 2006). Streptococcus anginosus 
may release smaller fragments of DNA, or its extracellular nuclease activity degrades 
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the chromosomal DNA that is released during cell lysis, without any impact on biofilm 
stability. These results clearly indicate that the majority of fresh clinical CRS isolates 
release eDNA into the biofilm matrix.  
Although the pathogenesis of CRS is unclear there is a link to microbial biofilms 
aiding the inflammatory process behind CRS. Biofilms are resistant to standard 
antimicrobial treatments, as shown by the reduced efficacy of antibiotics in treating 
CRS (Lim et al., 2010). There is a pressing need for novel therapeutic techniques. This 
investigation shows that CRS-associated bacteria produce biofilms, and that these 
biofilms are reduced in extent by the nuclease enzyme, NucB, in vitro. Additionally, to 
add further weight to this finding, CRS isolates produce eDNA that can be quantified, 
or visualized. However, this investigation is at an early stage, as biofilms were modelled 
using a simple approach. NucB has potential in controlling the biofilms formed by CRS 
isolates but further validation will rely on in vivo data. It is important to note that 
Bordetella spp. mono-species biofilms have been dispersed with DNase I in an in vivo 
mouse upper respiratory tract model (Conover et al., 2011). The synergistic effect of 
NucB and antimicrobial agents is of particular interest as a 50% reduction in the 
biomass of biofilms in sinuses could be further increased with the aid of antibiotics. 
Ultimately, as with TESV biofouling, eDNA appears to play a critical role in creating 
biofilm stability in clinically relevant bacteria.  
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Chapter 5: Oral Biofilms 
 
5.1 Outline 
 
The results in Chapters 3 and 4 of this thesis have shown the clear role eDNA has in 
maintaining the stability of biofilms formed by some clinically relevant bacteria. This 
included freshly isolated bacteria from diseased sinuses, and 2-3 month mature biofilms 
on the surface of TESVs. Dental plaque is an oral biofilm that forms on the surface of 
teeth and, if not adequately controlled, leads to the development of dental caries or 
periodontitis. Like other biofilms, dental plaque consists of a robust layer of microbial 
cells embedded in a matrix of polymeric material. The matrix serves a number of 
important functions, for example enhancing adhesion of microbial cells to the tooth 
surface and serving as a barrier against external insults. At present, it is not clear to what 
extent eDNA contributes to the structural integrity of oral biofilms. This chapter aimed 
to determine the importance of eDNA for biofilms of four important oral bacteria, 
Streptococcus gordonii, Actinomyces oris, Streptococcus mutans and Fusobacterium 
nucleatum. Research was also expanded into the direction of mixed-species biofilm 
modelling. 
 
The mechanisms of eDNA release by oral bacteria have been studied in S. gordonii, 
Streptococcus sanguinis and S. mutans. With S. gordonii and S. sanguinis, eDNA 
production through a non-lytic mechanism related to hydrogen peroxide (H2O2) release 
has been demonstrated (Kreth et al., 2009). However, cell death as a result of high 
levels of H2O2 may be responsible for eDNA release in S. gordonii (Itzek et al., 2011). 
Furthermore, a recent study by Liu and Burne (2011) described the important role of the 
AtlA autolysin of S. gordonii DL1, for the release of eDNA that leads to biofilm 
development. Biofilm formation in mutants lacking the AtlA autolysin could be 
partially restored with the addition of 50 ng/µL eDNA. Interestingly, eDNA production 
was 100-fold higher in the presence of oxygen. In S. mutans, competence-stimulating 
peptide (CSP)-induced cell death leads to eDNA release and increased biofilm 
formation (Perry et al., 2009). Extracellular DNA has also been measured in the EPS of 
F. nucleatum and Porphyromonas gingivalis (Ali Mohammed et al., 2013). Clearly, 
eDNA is produced by some oral bacteria, in both planktonic and biofilm culture. 
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Extracellular DNase activity is a common trait of oral bacteria (Palmer et al., 2012). It is 
unknown how these enzymes may re-structure oral biofilm communities, particularly 
those that rely on eDNA for biofilm stability. Palmer et al., (2012) demonstrated that 
oral bacteria DNase activity depends on growth conditions, and it is unknown how this 
impacts biofilm formation on the mouth surface. However, Ali Mohammed et al., 
(2013) found that F. nucleatum and P. gingivalis are not dispersed by bovine DNase I, 
despite eDNA being found in the EPS of these two species. The biofilm-reducing 
effects of DNases on oral biofilms is an under-studied area of oral microbiology.  
 
Each of the four species investigated in this study has a key role in the oral biofilm, and 
oral health. Streptococcus spp., including S. gordonii, are important in the early 
formation of dental plaque and are the dominant species in the early supragingival oral 
biofilm (Jenkinson and Lamont, 1997; Diaz et al., 2006). Along with A. oris, S. 
gordonii are known to promote biofilm formation and facilitate the growth of other oral 
bacteria through attachment to cell surface proteins (Rickard et al., 2003). Whilst S. 
gordonii and A. oris are viewed as oral commensals, F. nucleatum and S. mutans are 
considered deleterious as they contribute to periodontitis and dental caries, respectively 
(Loesche, 1986; Dzink et al., 1988). Therefore, by selecting these organisms this study 
will provide an overview of eDNA dependence in both commensal and pathogenic oral 
bacteria.  
 
Excellent oral hygiene is an effective way of maintaining a healthy mouth and removing 
oral disease causing bacteria (van der Weijden and Hioe, 2005; van der Weijden and 
Slot, 2011). However, improvements can still be made in this sector of healthcare, with 
the NHS spending £1.23 billion per year treating dental diseases (Audit Commission for 
Local Authorities and the National Health Service in England and Wales, 2002). With 
no great change to oral hygiene practice over the last 50 years there is a pressing need 
for novel treatment techniques. As shown previously, NucB has clear potential against 
many biofilm-forming bacteria. Therefore, the addition of NucB to toothpastes or 
mouthwashes could improve the efficacy of these products. Ultimately, before this 
happens it is important to investigate the role of eDNA in maintaining oral biofilm 
stability in simple models and to build on this research.  
 
This study aimed to determine the role of eDNA in assisting the initial attachment of 
oral bacteria to a surface, and in maintaining biofilm stability. The investigation began 
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by extracting eDNA from the EPS of the four bacteria studied. Extracellular DNA was 
stained and viewed by CLSM. Oral biofilms were treated with DNases, both in a single-
species and mixed-species model. Streptococcus mutans strain sensitivity to DNase 
treatment was studied, to further investigate the variability in eDNA dependence 
amongst strains of the same species of bacteria. Lastly, oral biofilms were cultured in a 
flowing, microfluidics model to assess the model’s potential for future testing of DNase 
enzymes versus oral biofilms.  
 
5.2 Extracellular DNA production by selected oral bacteria 
 
To date there has been little research focused on determining the contribution of eDNA 
to the biofilm matrices of oral bacteria. In this study four oral bacteria were cultured as 
biofilms and eDNA was extracted, quantified and then visualised with CLSM.  
 
5.2.1 Extracellular DNA extraction from oral biofilm matrices 
 
To investigate eDNA production by oral bacteria, biofilms were cultured in 6-well 
microtiter dishes and eDNA was extracted (see Materials and Methods 2.7). Four wells 
were used for DNA extraction from biofilms, and the final two wells were stained with 
crystal violet (CV) to assess the growth of the biofilms. Extracellular DNA was only 
extracted from wells where bacteria had reached a biofilm state, set at a threshold of an 
absorbance value >0.1 when dissolved CV was measured at A570. All biofilms grew to 
acceptable levels. The biofilm matrices of S. mutans GS-5, A. oris MG1 and F. 
nucleatum 25586 contained high-molecular weight DNA (Figure 5.1A). In these species 
eDNA resolved to a similar molecular weight as the iDNA extracted from cells. This is 
a similar finding to that in CRS isolates. With F. nucleatum 25586 and S. mutans GS-5 
there were smaller nucleic acids visualized in the eDNA fraction. Enzymatic treatment 
of eDNA extracts from these two species with DNase I resulted in the absence of the 
high-molecular-weight band (Figure 5.1B), confirming that the band was due to DNA. 
However, DNase I did not degrade the lower molecular weight band of F. nucleatum 
25586, indicating that this fraction was not dsDNA and was probably RNA and/or 
ssDNA. No DNA band was observed in eDNA extracts of S. gordonii by agarose gel 
electrophoresis (Figure 5.1A). Intracellular and extracellular DNA fractions were 
measured by NanoDrop spectrophotometry to calculate the proportion of total DNA   
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Figure 5.1 Extracellular DNA extractions from monospecies oral biofilms. Biofilms 
of oral bacteria were grown for 72 h and eDNA was quantified and visualized. (A) 
Agarose gel electrophoresis of extracted extracellular (e) and intracellular (i) DNA. (B) 
500 µg/mL DNase I enzyme treatment (e+D) of eDNA fractions at 37°C for 2 h from F. 
nucleatum 25586 and S. mutans GS-5. (C) Proportion of the total DNA in biofilms that 
was eDNA. Extracellular and intracellular DNA was quantified by spectrophotometry, 
bars represent standard error from three replicates. 
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extracted from biofilms that eDNA contributed for each species (Figure 5.1C). 
Fusobacterium nucleatum 25586 eDNA was 52% of the total biofilm DNA. For this 
species iDNA was lower than other species (888 ng/µL versus 4399 ng/µL). This could 
be due to inefficient cell lysis during DNA extraction, or a genuine result. However, 
eDNA was present in higher amounts from F. nucleatum 25586 biofilm matrices (989 
ng/µL) than for other species (e.g. S. mutans GS-5 654 ng/µL). There was a bright 
LMW (>200 bp) band of material for F. nucleatum, that may be ssDNA, RNA, or some 
other material. NanoDrop spectrophotometry likely overestimates dsDNA concentration 
when these other molecules are present, which may explain the high eDNA readings in 
F. nucleatum. For S. mutans, eDNA also made up a significant proportion (19%) of 
total DNA. Actinomyces oris MG1 and S. gordonii biofilm matrices contained similar 
amounts of eDNA, as measured by NanoDrop, 7% and 6% respectively. This was 
despite the lack of visible eDNA band for S. gordonii DL1 during agarose gel 
electrophoresis (Figure 5.1A).  
 
5.2.2 Extracellular DNA visualised by CLSM in biofilm matrices 
 
Biofilms of the four species were cultured in 6-well microtiter plates for 72 h and 
analysed by CLSM. Biofilms grew on glass coverslips, and were inverted into a staining 
liquid so that biofilm structure and EPS was maintained (see Materials and Methods 
2.6.1.1). All biofilms consisted of thin single-cell layers with occasional aggregations 
that projected ~20 µm from the surface. The biofilms contained live cells (green), dead 
cells (punctate red), and some contained extracellular DNA (diffuse red). Yellow was 
observed in some images, possibly indicating co-localisation of live cells and eDNA. A. 
oris MG1 biofilms contained diffuse areas of red staining, which is consistent with 
eDNA (Figure 5.2B). This was the clearest example of eDNA across the four species 
analysed. Areas of eDNA appeared to be in close proximity to aggregations of dead A. 
oris MG1 cells, indicating a possible source of the DNA, from lysed cells. Extracellular 
DNA was less visible close to live A. oris MG1 cells and aggregations. In biofilms of S. 
mutans GS-5, patches of yellow staining were clearly visible, and some diffuse red 
staining was apparent on expanded images (Figure 5.2D). Yellow staining may be 
explained as the adherence of eDNA to the bacterial cell wall, therefore live cells appear 
both green, and red, thereby merging to give a yellow colour. It is possible that yellow 
staining is an artefact caused by the intercalation of both propidium iodide (PI) and 
SYTO
®
 9 with DNA inside a single cell that has a compromised cell membrane 
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Figure 5.2 Confocal microscopy images of eDNA within oral biofilms. All species 
were cultured for 72 h and then incubated with LIVE/DEAD
®
 BacLight
TM
 biofilm stain 
for 15 minutes, before CLSM image acquisition. (A-D) Maximum projection CLSM 
images of F. nucleatum 25586, A. oris MG1, S. gordonii DL1, and S. mutans GS-5 
respectively. White arrows highlight areas of eDNA. Scale bar is 50 µm.  
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permeable to PI. However, this is unlikely as PI has a higher affinity for DNA and 
displaces SYTO
®
 9 under normal circumstances, thereby allowing the differentiation of 
live and dead cells (Boulos et al., 1999). Increased magnification on areas of S. mutans 
GS-5 cell aggregates showed diffuse red staining between biofilm cells. Here it is 
appears that eDNA may be adhering cells together that are in close proximity. Areas of 
extracellular red staining were also observed by close examination of F. nucleatum 
25586 biofilms (Figure 5.2A). Biofilm cells of this species were organized in a regular 
manner. A number of F. nucleatum 25586 cells were yellow, again indicating the 
presence of eDNA on the cell surface of these bacteria. Very few cells appeared to be 
dead. When magnification was increased, areas of red staining close to F. nucleatum 
25586 cells can be observed. Here, eDNA appeared to have been released from cells. 
This red staining was not cell shaped and therefore may be nucleic acids, or an artefact 
of some kind. Extracellular DNA was less apparent in micrographs of S. gordonii DL1 
biofilms, where there were no diffuse patches of red staining (Figure 5.2C). However, 
some areas of red/green co-localization, giving a yellow appearance, were observed. 
Streptococcus gordonii DL1 biofilms often contained greater than 50% dead cells, this 
was in contrast to the other species where live cells were more apparent. 
 
5.3 Sensitivity of oral biofilms to DNases 
 
The four selected oral bacteria were grown in a static, 96-well microtiter plate model to 
assay DNase I sensitivity. Extracellular DNA was clearly quantifiable and visible in 
these biofilms and therefore it was important to determine its role in aiding biofilm 
adherence and stability. 
 
5.3.1 96-well plate model of DNase I sensitivity 
 
Extracellular DNA is required by some micro-organisms to attach cells to substrata, in 
the earliest phase of biofilm maturation (Whitchurch et al., 2002). To test for the 
inhibitory effect of DNase I on biofilm settlement, 5 µg/mL DNase I was included with 
the inoculum and growth media, for each species, whilst culturing for 20 h in the 
biofilm model. Again, all biofilms grew to an acceptable level of A570 >0.1. 
Streptococcus mutans GS-5, A. oris MG1, and F. nucleatum 25586 biofilms were all 
significantly inhibited by DNase I (Figure 5.3A). Biofilm formation by S. mutans GS-5 
and F. nucleatum 25586 was reduced by >70% when DNase I was present overnight. A. 
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Figure 5.3 Effects of DNase I treatment on biofilms. Using a microtiter plate biofilm 
model, 5 µg/mL DNase I was included during biofilm formation for 20 h (A), or was 
added to preformed biofilms after 20 h (B). Biofilms were stained with crystal violet, 
and the biofilm biomass was quantified by measuring A570. Shaded bars indicate 
controls, and white bars show values with NucB treatment. Bars represent mean data 
from three independent experiments and standard errors are shown. (C) Crystal violet-
stained biofilms, grown in 6-well microtiter dishes (3 mL media, 50 µL inoculum, 37°C 
for 72 h), without or with 5 µg/mL DNase I treatment (C). Statistical significance was 
calculated with the two sample t-test. 
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oris was less sensitive but biofilms were still reduced, on average, by 46%. By contrast, 
DNase I did not significantly impair biofilm formation by S. gordonii DL1 (Figure 
5.3A). 
Mature biofilms (20 h) were treated with 5 µg/mL DNase I to assess the role of 
eDNA in maintaining biofilm integrity in the four oral bacteria. In this assay, S. mutans 
GS-5, A. oris MG1 and F. nucleatum 25586 were remarkably sensitive to DNase I  
(Figure 5.3B). Biofilm extent was significantly reduced by ≥90% for these micro-
organisms, in comparison to PBS treated controls. Additionally, dispersal efficacy was 
higher than the inhibitory effect on biofilm formation in these three species. The DNase 
I enzyme did not disrupt preformed biofilms of S. gordonii DL1 (Figure 5.3B). Mature 
biofilms, grown in 6-well microtiter plates for 72 h, were treated with 5 µg/mL DNase I, 
or PBS, and stained with CV to give a visual representation of the impact of the enzyme 
on biofilm extent (Figure 5.3C). This assay again showed clear biofilm reduction for S. 
mutans GS-5, A. oris MG1 and F. nucleatum 25586 but no effect on S. gordonii DL1 
biofilms.  
Treatment of A. oris MG1 biofilms with heat-inactivated DNase I did not cause a 
reduction in biomass, indicating that enzyme activity was essential for biofilm removal 
(Claire Graham, unpublished work). To assess whether DNase I affected bacterial 
growth or viability, A. oris and S. gordonii biofilms were cultured in the presence or 
absence of 5 µg mL
-1
 DNase I, and the CFU/mL in biofilms and planktonic phases were 
quantified (Nick Jakubovics, unpublished work). In each case, DNase I did not affect 
the total CFU/mL present. However, incubation of A. oris in the presence of DNase I 
resulted in significantly more viable cells in the planktonic phase and significantly 
fewer cells in the biofilm compared with the control. Therefore, DNase I appeared to be 
acting specifically through inhibition of biofilm formation rather than by influencing 
cell viability per se.  
 
5.3.2 Efficacy of NucB and DNase I against S. mutans GS-5 
 
The bacterial enzyme NucB has a number of advantages for biofilm control compared 
with bovine DNase I. However, it is unknown if it has increased efficacy against oral 
biofilms. Therefore, to assess the activity of NucB against S. mutans GS-5 biofilms, 
preformed biofilms were treated with NucB at a range of concentrations (Figure 5.4A). 
DNase I was also used to treat S. mutans GS-5 biofilms at the same concentrations. 
Optimal buffers were used for both DNase I and NucB. For both enzymes a 
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Figure 5.4 Dispersal of S. mutans GS-5 by NucB and DNase I. (A) A range of 
concentrations of NucB and DNase I were incubated with preformed (20 h) S. mutans 
GS-5 biofilms at 37°C for 1 h, and residual biofilms were quantified by crystal violet 
staining. Mean values from three independent assays are shown and error bars represent 
standard error of the mean. (B) Samples of DNase enzymes were visualised in roughly 
equal amounts (5 µg, according to concentrations given) using SDS-PAGE. Lanes: M) 
protein molecular weight marker; 1) NucB (12 kDa) overproduction from Bacillus 
licheniformis N8900 (Nithya Rajarajan, unpublished work); 2) Purified NucB (Alistair 
Hawkins); 3) bpDNase I (29 kDa) (Sigma Aldrich).  
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concentration-dependent reduction in biofilm biomass was observed. The EC50 (half 
maximal effective concentration) values were calculated (using SigmaPlot) to be 1.14 
ng mL
-1
 for NucB and 4.18 ng mL
-1 
for DNase I. Therefore, NucB was effective at an 
approximately 3.7-fold lower concentration than DNase I. However, at a high 
concentration, there was little difference in enzyme activity. This suggests a threshold 
whereby there is sufficient enzyme activity to always disperse >80% S. mutans GS-5 for 
both enzymes.  
Comparison of enzyme activity relies on the use of equal amounts of protein. 
Therefore, NucB and DNase I were visualised using SDS-PAGE with 5 µg of total 
protein (according to manufacturers or colleagues measurements) loaded onto gels 
(Figure 5.4B). Previously, NucB was compared with DNase I but no attempt was made 
to determine the purity of both enzymes (Nijland et al., 2010). For the S. mutans GS-5 
assay NucB of approximately 95 % purity was used (Lane 2, Figure 5.4B). However, 
the bpDNase I obtained from Sigma Aldrich is contaminated by a number of unknown 
proteins, with the purity <50% (Lane 3, Figure 5.4B). The differences in observed 
protein purity makes comparisons between anti-biofilm activity difficult. This is further 
complicated by the unknown enzyme activity (U/mg) of both protein preparations. In 
the Nijland et al., (2010) study, NucB of relatively low purity (Lane 1, Figure 5.4B) was 
compared against DNase I that was likely similar in purity to the preparation used 
during our experiments. These earlier observations which used low purity NucB and 
DNase I may give a better comparison of relative enzyme efficacy against biofilms. In 
this previous study NucB had higher efficacy against biofilms of B. licheniformis 
DSM13, than DNase I, similar to the results obtained in this thesis with S. mutans GS-5. 
 
5.3.3 Dispersal of mixed-species saliva biofilms with NucB 
 
To determine whether eDNA has a role in acting as an adhesin in oral biofilms mixed-
species microcosms grown from human saliva were treated with NucB (see Materials 
and Methods 2.4.1.5, 2.10.2, and 2.10.3). For these experiments, 3 µg/mL NucB (for 
NucB purity see Lane 1, Figure 5.4B) was added to forming and pre-formed biofilms 
grown from six different natural human saliva samples. Firstly, these samples were 
grown in anaerobic conditions, in artificial saliva for 20 h, to culture microcosms that 
modelled the subgingival oral environment (Figure 5.5A/B). When assayed in these 
conditions biofilm formation was significantly inhibited in three out of six biofilms 
when NucB was included during biofilm development. Biofilm formation was reduced 
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Figure 5.5 Effects of NucB against microcosm biofilms. Artificial saliva medium was 
inoculated with untreated saliva from six different volunteers (numbered 1-6) and 
incubated anaerobically to model subgingival dental plaque, or aerobically in the 
presence of 2% sucrose for biofilms modelling supragingival dental plaque. NucB was 
included during biofilm formation to test inhibition, or after biofilm development to 
assess dispersal. Biofilms without NucB (shaded bars) or with NucB (white bars) were 
quantified by staining with crystal violet. Bars represent mean values from three 
independent experiments and standard errors are indicated. Statistical significance was 
calculated with the two sample t-test. 
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by up to 60% by NucB in this model. Furthermore, two of the six mature biofilms were 
significantly reduced by NucB treatment. To mimic supragingival dental plaque, human 
saliva was inoculated in artificial saliva media, with the addition of sucrose, and 
cultured aerobically for 20 h (Figure 5.5C/D). In this model one biofilm was inhibited 
by NucB, and another was significantly increased when treated with NucB in these 
conditions. Also, significant dispersal of preformed biofilms was observed in four of the 
six supragingival biofilms treated. Biofilm formation of the six microcosms was very 
variable in both growth conditions and at times biofilm extent was poor. However, 10 of 
the 24 biofilms tested were significantly reduced by NucB.  
 
5.3.4 Extracellular nuclease activity of single and mixed-species oral bacteria 
 
The extracellular DNase activity of the four oral bacteria and the human saliva samples 
was tested on DNase agar. Micro-organisms were grown for 48 h and then plates were 
flooded with 1 N HCl to precipitate DNA. Dark areas are indicative of extracellular 
nuclease production by isolates. Only S. gordonii DL1 of the four oral bacteria, 
produced DNase activity that was clearly visible on DNase agar (Figure 5.6A). 
Extracellular DNase production was also studied using a FRET assay (see Materials and 
Methods 2.8.7). This method can differentiate between membrane-bound and secreted 
nuclease activity. Furthermore, it analyses nuclease activity in a different culture state 
(planktonic). Oral bacteria have been shown to vary their extracellular DNase 
production depending on culture state (Palmer et al., 2012). When the four micro-
organisms were grown in planktonic cultures and nuclease production was assayed 
using the FRET protocol there was a small amount DNase activity from F. nucleatum 
25586 (Figure 5.6B). It is unknown if this is within the detection limit of the assay. For 
both S. mutans GS-5 and A. oris MG1 extracellular DNase enzyme activity was not 
detected. The FRET assay also suggests that the DNase that S. gordonii DL1 produces 
is membrane bound, as 80% of the total nuclease activity was measured in this fraction 
(Figure 5.6B). It is important to consider that the FRET qPCR probe is ssDNA, and 
therefore any extracellular DNases that are specific for dsDNA hydrolysis would not be 
detected. All six human saliva samples tested exhibited extracellular DNase activity on 
DNase test agar (Figure 5.6C). However, it remains unknown which micro-organisms 
are contributing to this activity as several colony types were visible from each saliva 
culture. There was substantial variation in total DNase activity and type (cell bound or 
released) amongst these cultures. It would have been beneficial to include a negative  
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Figure 5.6 Extracellular DNase activity of S. gordonii DL1, A. oris MG1, S. mutans GS-5, F. nucleatum 25586 and human saliva 
cultures. (A) The four oral bacteria were cultured on DNase test agar and 1 N HCl was used to determine DNA degradation, with a dark 
area indicating DNase activity. (B) DNase activity was assayed for cells and supernatant of planktonic cultures of the four oral bacteria 
using FRET. (C) Six natural human saliva samples were plated on DNase test agar and assayed for extracellular nuclease activity. DNase 
test agar plates were visualised with a digital camera (G:Box, Syngene) and images were altered with Adobe Photoshop CS3 using 
posterization adjustment. Dark zones within agar plates are areas of DNA hydrolysis, whereas white zones are agar that contains intact 
DNA.  
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control, like S. epidermidis, or a positive control, like S. aureus, to make it clearer 
which colonies were producing DNase activity. 
 
5.4 Variable efficacy of DNases versus Streptococcus mutans biofilms 
 
Streptococcus mutans GS-5 is acutely sensitive to nuclease enzymes. However, as 
previously observed in CRS isolates, DNase sensitivity of microbial biofilms can differ 
between strains of the same species. To further investigate this phenomenon four S. 
mutans isolates were treated with NucB, during biofilm formation and after maturation. 
 
5.4.1 NucB activity in a static microplate model 
 
Four strains of S. mutans (GS-5, NG8, UA140 and UA159) were grown in 96-well 
microtiter plates for 20 h and NucB (3 µg/mL) was either included during biofilm 
formation or added for 1 h after biofilm formation. Biofilm extent was monitored using 
the CV assay. As shown previously with both DNase I and NucB, S. mutans GS-5 
biofilm extent was inhibited or dispersed by >80% during nuclease treatment (Figure 
5.7). However, the three other strains differed in their sensitivity to NucB (Figure 5.7). 
For S. mutans NG8 there was 80% less biofilm formation when NucB was included 
overnight, which was similar to S. mutans GS-5. This strain of S. mutans was not 
dispersed by NucB, unlike S. mutans GS-5. Streptococcus mutans UA140 and S. mutans 
UA159 biofilms were neither inhibited nor dispersed by NucB. Furthermore, although 
not significant, biofilm growth was higher in treated biofilms. These results demonstrate 
the variability in DNase sensitivity amongst strains of the same species of bacteria.  
 
5.4.2 Sequencing mutations in S. mutans GS-5 
 
When first isolated S. mutans GS-5 was strongly cariogenic but has since lost this 
cariogenicity. Mutations in gbpC and pac genes have been found in laboratory strains of 
S. mutans GS-5 (Sato et al., 2002). These mutations have been hypothesized to be a 
reason for the lower cariogenicity associated with this strain of S. mutans. However, 
mutations in glucan-binding proteins, like GbpC, and surface adhesins, like PAc, may 
also lead to changes in biofilm formation (Lynch et al., 2007). Sequence analysis of the 
gbpC and pac genes was developed using the primers in Table 2.6 (Materials and 
Methods). The 1752-bp gbpC gene was amplified with primers gbpC5’ and gbpC3’. 
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Figure 5.7 Streptococcus mutans strain sensitivity to NucB treatment. NucB (3 
µg/mL) was added during biofilm formation to test for inhibition (A), or once biofilms 
had grown for 20 h to determine dispersal (B) in S. mutans strains GS-5, NG8, UA140 
and UA159. Biofilms without NucB (shaded bars) or with NucB (white bars) were 
quantified by staining with crystal violet. Bars represent mean values from three 
independent experiments and standard errors are indicated. Statistical significance was 
calculated with the two sample t-test. 
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>gbpCF_gbpC5 -- 13..954 of sequence 
ATTTGTATAAAAAGACATTATTTTTTAATTTATGAGTCTTATTCTTTGAAAAA
ATGTCTTTTTATTGTTATAATTAAAATTGTATTCTTATGAATTAATAATATAA
AGGATGGTTTTTATGAAATCGAAAACTGCTAAAATTACTTTGCTAAGCAGCC
TTGCTTTGGCGGCTTTTGGAGCAACGAATGTTTTTGCAGATGAAGCATCAAC
TCAATTAAATTCTGATACTGTTGCAGCACCTACTGCTGATACACAAGCATCA
GAACCGGCTGCAACAGAAAAAGAACAGTCTCCTGTTGTAACTGTTGTCTAA
AGTCACACACAAGGAAATACAACAACGACAACATCTCAAGTTACTTCTAAA
GAATTGGAAGATGCTAAGGCTAATGCTAATCAGGAAGGTTTAGAAGTCACT
GAAACTGAAACTCAAAAACAGCCTTCGGTAGAAGCTGCAGATGCAGATAAC
AAAGCACAGGCACAAACAATTAATACAGCGGTAGCTGATTATCAAAAGGCA
AAAGCTGAATTTCCTCAAAAACAAGAACAATATAATAAAGATTTTGAAAAG
TATCAGTCTGATGTCAAGGAGTATGAAGCTCAAAAGGCAGCTTACGAGCAA
TATAAAAAAGAAGTTGCACAGGGTTTGGCATCTGGGCGTGTTGAAAAAGCC
CAAGGACTTGTGTTTATTAATGAACCTGAGGCAAAACTTTCTATTGAGGGTG
TTAATCAGTACCTAACAAAAGAAGCACGTCAAAAACATGCAACTGAAGATA
TTCTTCAGCAATATAATACTGATAATTATACAGCTGCTGATTTTACCCAAGC
AAATCCATATGATCCAAAAGAAGATACTTGGTTCAAAATGAAAGTGGGAGA
TCAGATTTCAGTTACCTATGATAATATCGTTAATTCAAAATATAATGATAAA
AAGATTAGTAAGGT 
 
GTAACTGTTGTCTAAAGTCACACACAAGGAAATACAACAACGACAACATCTCAAGTTACT   GS-5          
||| |||||||| ||||||||||||||||||||||||||||||||||||||||||||||| 
GTAGCTGTTGTCGAAAGTCACACACAAGGAAATACAACAACGACAACATCTCAAGTTACT   UA159 
 
Figure 5.8 Sequencing mutations in S. mutans GS-5 gbpC. A substitution at the first 
nucleotide of codon 65 (underlined and boxed) results in a TAA termination codon in 
strain GS-5, while codon 65 is GAA, encoding glutamic acid in other strains. 
Furthermore, a GCT codon is ACT in our strain of S. mutans GS-5.  
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>PACR_PAL3 -- 13..1010 of sequence (reverse complement) 
CCGCCGGTTAAACCAACAGCTCCAACTAAACCAACTTATGAAACAGAAAAG
CCATTAAAACCGGCACCAGTAGCTCCAAATTATGAAAAGGAGCCAACACCG
CCGACAAGGACACCGGATCAAGCAGAGCCAAACAAACCCCACACCGCCGA
CCTATGAAACAGAAAAGCCGTTGGAGCCAGCACCTGTTGAGCCAAGCTATG
AAGCAGAGCCAACACCGCCGACAAGGACACCGGATCAGGCAGAGCCAAAT
AAACCCACACCGCCGACCTATGAAACAGAAAAGCCGTTGGAGCCAGCACCT
GTTGAGCCAAGCTATGAAGCAGAGCCAACGCCACCGACACCAACACCAGAT
CAACCAGAACCAAACAAACCTGTTGAGCCAACTTATGAGGTTATTCCAACA
CCGCCGACTGATCCTGTTTATCAAGATCTTCCAACACCTCCATCTGTACCAA
CTGTTCATTTCCATTACTTTAAACTAGCTGTTCAGCCGCAGGTTAACAAAGA
AATTAGAAACAATAACGATATTAATATTGACAGAACTTTGGTGGCTAAACA
ATCTGTTGTTAAGTTCCAGCTGAAGACAGCAGATCTCCCTGCTGGACGTGAT
GAAACAACTTCCTTTGTCTTGGTAGATCCCCTGCCATCTGGTTATCAATTTA
ATCCTGAAGCTACAAAAGCTGCAAGCCCTGGCTTTGATGTCACTTATGATAA
TGCAACTAATACAGTCACCTTCAAGGCAACTGCAGCAACTTTGGCTACGTTT
AATGCTGATTTGACTAAGTCAGTGGCAACGATTTATCCAACAGTGGTCGGA
CAAGTTCTTAATGATGGCGCAACTTATAAGAATAATTTCACGCTCACAGTCA
ATGATGCTTATGGCATTAAATCCAATGTTGTTCGGGTGACAACTCCTGGTAA
ACCAAATGATCCAGATAATCCAAATAATAATTATATTAAACCAACTAAAGG
TTAATAAAAACGAAAATGCGTGT 
 
TAAACCAACTAAAGGTTAATAAAAACGAAAATG  GS-5 (Our strain) 
|||||||||| |||||||||||||||||||||| 
TAAACCAACT-AAGGTTAATAAAAACGAAAATG  UA159/LJ23/NN2025 
 
Figure 5.9 Sequencing mutations in S. mutans GS-5 pac. In our strain of S. mutans 
GS-5 there is an insertion mutation in the pac gene (an extra adenine base) that causes a 
frameshift, resulting in a TAA (stop) codon (underlined and boxed). This mutation is 
not present in other strains of S. mutans. 
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Once amplified, the gbpC gene was visualised on an agarose gel, purified and sent for 
sequencing using various primers. A full length DNA sequence was generated using 
MEGA5.1 (Tamura et al., 2011). Mutations in the gbpC gene, compared to other S. 
mutans strains, were discovered by searching the sequence. In our laboratory strain of S. 
mutans GS-5 a substitution at the first nucleotide of codon 65 (T for G), results in a 
TAA termination codon (Figure 5.8). For S. mutans UA159 codon 65 is GAA, encoding 
glutamic acid. There is also a missense mutation, changing a GCT codon (alanine) to an 
ACT codon (threonine). However, strains LJ23, 109cS and NN2025 also have the ACT 
codon. It seems likely that the most major mutation would be the change to the stop 
codon TAA. Therefore S. mutans GS-5 likely produces a truncated GbpC protein. 
Analysis of the pac gene identified an insertion mutation (extra A), which causes a 
frameshift and likely results in a truncated version of the PAc protein (Figure 5.9). This 
mutation was not observed in the S. mutans strains, UA159, LJ23 or NN2025 and 
therefore was likely picked up during laboratory culture. Again, this mutation may 
interfere with biofilm formation.  
 
5.5 Microfluidic model of oral biofilms 
 
Modelling natural biofilms such as dental plaque presents a significant challenge for 
oral microbiologists. Currently we are employing a static model system in microtiter 
wells which is useful for studying early biofilm formation. However, continuous-flow 
systems that circulate fresh nutrients allow for the development of mature biofilms in an 
environment that is more akin to the natural habitat of the mouth (e.g. hydrodynamic 
influences). Therefore, these biofilms more closely approximate natural biofilms. 
Recently the BioFlux system (Fluxion Biosciences) has been developed that consists of 
microfluidic channels, in which biofilms are formed under a flow of nutrients. One great 
advantage of the system is that tiny amounts of liquid are required, and it is therefore 
realistic to develop biofilms under flowing human saliva and use enzymes that are not 
easily accessible in high amounts. In addition, the presence of multiple (24) channels in 
a single microfluidic chip enables multiple replicates to be performed in a single run. 
Dr. Alexander Rickard’s laboratory is one of the first in the world to establish the 
BioFlux system for modelling oral biofilms. This laboratory has ample experience with 
both complex biofilm models and confocal laser scanning microscopy. Therefore, after 
obtaining funding from the Society for General Microbiology (President’s Fund for 
Research Visits) I spent 6 weeks in Dr. Rickard’s laboratory learning this novel 
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Figure 5.10 Single-species biofilms cultured in flowing human saliva and visualised 
with CLSM.  BioFlux microfluidic plates were inoculated with S. mutans UA159 (A) 
and S. gordonii DL1 (B) and grown in filter-sterilized saliva for 20 h at 37°C. After 
culture, biofilms were stained with LIVE/DEAD
®
 BacLight
TM
 stain and observed using 
CLSM. Images were obtained using 3D imaging software (Imaris, Bitplane). 
Streptococcus mutans UA159 was grown in the presence of sucrose (2%) and S. 
gordonii DL1 filter-sterilized human saliva was supplemented with 1% THYE. 
  
Chapter 5: Oral biofilms 
148 
 
 
Figure 5.11 Oral mixed-species biofilms grown in flowing human saliva and 
visualised with CLSM. Human saliva was pooled from six individuals and used as the 
inoculum for BioFlux microfluidic experiments. Microfluidic plates were inoculated 
and saliva micro-organisms were fed with filter-sterilized human saliva for 20 h at 
37°C. Biofilms were stained with LIVE/DEAD
®
 BacLight
TM
 stain and examined using 
CLSM and 3D imaging software (Imaris, Bitplane).  
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technique. The major aim was to gain an understanding of the BioFlux microfluidic 
system so that we may consider obtaining a similar system for the laboratory at 
Newcastle University.  
BioFlux microfluidic plates were inoculated with S. mutans UA159, S. gordonii 
DL1, or pooled human saliva and grown in filter-sterilized saliva for 20 h at 37°C (see 
Materials and Methods 2.6.1.4). Streptococcus mutans UA159 was grown in the 
presence of sucrose (2%) and S. gordonii DL1 filter-sterilized human saliva was 
supplemented with 1% THYE. After culture, biofilms were stained with LIVE/DEAD
®
 
BacLight
™
 stain and observed using CLSM (Leica TCS SPE). Images were obtained 
using 3D imaging software (Imaris, Bitplane). Initially, single-species biofilms of S. 
mutans UA159 and S. gordonii DL1 were examined using the BioFlux system (Figure 
5.10). Streptococcus mutans UA159 formed biofilms that consisted of a thin layer of 
micro-organisms and several clumps of larger aggregations of bacteria (Figure 5.10A). 
Interestingly, the aggregations were stained mostly red, giving the appearance of dead 
bacteria. The clumps were circular with a diameter and depth of 30 µm. With S. 
gordonii DL1, streptococci cells and chains were visible, forming larger aggregations 
than seen with S. mutans UA159 (Figure 5.10B). Biofilms projected from the 
microfluidic channel surface by to 40 µm. Dead cells (red) are visible but in a lower 
frequency than seen with S. gordonii biofilms grown in static models (Figure 5.2C). 
Pooled human saliva was also used an inoculum, to model dental plaque biofilms 
(Figure 5.11). The majority of biofilms again consisted of large aggregations of 
bacteria, with areas in-between aggregations that appeared sterile (Figure 5.11A). These 
biofilms projected from the surface by 40 µm, and were up to 120 µm wide. However, 
there was variation as shown in Figure 5.11B. Thin (20 µm) layers of saliva bacteria did 
on occasion cover the entire surface of the microfluidic channel. 
 
5.6 Discussion 
 
Although eDNA has been shown to promote bacterial attachment, and act as a matrix 
support in many biofilm forming species (reviewed by Jakubovics et al., 2013) it has 
been poorly studied in oral bacteria. Streptococcus gordonii DL1, has been shown to 
produce eDNA but it is unknown how this relates to biofilm matrix stability. Therefore, 
this study was initiated to address the key question of whether eDNA is important in 
single and mixed-species oral biofilm formation.   
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High molecular weight eDNA accumulated in the biofilm matrices of A. oris, F. 
nucleatum and S. mutans during biofilm development. Interestingly, F. nucleatum 
produced significant quantities of eDNA in this model (989 ng/µL), whereas it has 
previously been shown to be a minor producer of eDNA (20 ng/µL) (Ali Mohammed et 
al., 2013). Although a HMW band of nucleic acids was not visible on agarose gels for 
S. gordonii, nucleic acids were still measured by NanoDrop spectrometry. However, it 
has been shown that high molecular weight DNA (>11 kb) is needed if it is to act as a 
structural support in S. aureus biofilms (Izano et al., 2008). This may explain the lack of 
efficacy of DNase I against S. gordonii biofilms. Streptococcus gordonii produces an 
extracellular DNase, and this may degrade the DNA that is released during biofilm 
growth. It is also possible that culture conditions reduced the release of HMW nucleic 
acids. Extracellular DNA release in biofilm culture of S. gordonii has been shown to be 
100-fold higher when incubated in aerobic conditions, as opposed to anaerobic (Liu and 
Burne, 2011). It appears that oxygen or the metabolites produced during growth in these 
conditions increases eDNA release. Although DNA damage appears to be the cue for 
eDNA release in S. gordonii (Itzek et al., 2011) in our laboratory growth in the presence 
of oxygen did not increase eDNA content in our strain of S. gordonii (Claire Graham, 
unpublished work). It seems likely that the culture conditions used in this study were 
not optimal for eDNA release but that eDNA release is also tightly regulated. These 
hypotheses require further investigation. 
High molecular weight DNA was extracted from the biofilm matrices of A. oris and 
S. mutans. Furthermore, fluorescent staining of eDNA and CLSM gave clear evidence 
that nucleic acids were present in the biofilms of these species. These data suggest that 
eDNA is produced in these biofilms both on polystyrene and glass surfaces. For A. oris, 
there were clear areas of eDNA within the mono-species biofilm. These areas of 
propidium iodide staining (red), a DNA stain that cannot enter live cells, were close to 
aggregates of dead cells, highlighting a potential source of the eDNA in this species. 
Streptococcus mutans eDNA visualisation was more complex, as there appeared to be a 
DNA matrix attaching cells together but also potentially eDNA close to the cell surface 
of bacteria. When live cells (green) are encased in nucleic acids (red), they appear 
yellow, and this was often the case for S. mutans biofilms. Previously, DNA has been 
shown to increase S. mutans LT11 adherence to hydrophobic and hydrophilic surfaces 
(Das et al., 2010). This suggested that S. mutans cell attachment is aided by eDNA 
during biofilm adherence. Extracellular DNA was visualised in F. nucleatum biofilms 
but it was less clear. Again cells may have had nucleic acids close to the cell surface. 
Chapter 5: Oral biofilms 
151 
 
This could be studied in greater detail using immunogold labelled anti-dsDNA 
monoclonal antibodies and SEM. Using this technique Barnes et al., (2012) provided 
striking images of eDNA close to the cell surface of Enterococcus faecalis cells during 
initial biofilm formation. Very little eDNA was visualised in S. gordonii biofilms, 
which suggests that our staining technique is sensitive to high molecular weight eDNA.  
Interestingly, when the eDNA extracted from the EPS of F. nucleatum and S. mutans 
was treated with DNase I for an hour, the high molecular weight band was digested but 
the low molecular weight fragments remained. This suggests that low molecular weight 
bands were RNA, although 23S/16S/5S rRNA bands were not clearly visible on agarose 
gels. RNase was not used during the extraction process for eDNA. DNase and RNase 
treatment of eDNA from the EPS of Listeria monocytogenes and Bacillus cereus 
biofilms has shown that low molecular weight RNA is present in eDNA extractions 
(Vilain et al., 2009; Harmsen et al., 2010). For Pseudomonas fluorescens, RNA was 
found to be an inhibitor of P. fluorescens DNase activity (Catlin and Cunningham, 
1958), so it is interesting that it is found in oral biofilm matrices.  
DNase I significantly reduced the formation and extent of biofilms in A. oris, S. 
mutans and F. nucleatum. However, S. gordonii biofilms remained intact after DNase I 
treatment, which may suggest that high molecular weight eDNA is most important 
when eDNA acts as a biofilm support. The DNase I sensitive nature of F. nucleatum 
25586 biofilms is in contrast to a previous study, where the same strain was not 
sensitive to DNase I treatment (Ali Mohammed et al., 2013). In this study only LMW 
DNA was visible on agarose gels, whereas our findings suggest HMW DNA is 
produced within F. nucleatum biofilm matrices. The differences in the molecular weight 
of DNA produced by F. nucleatum may explain the increased efficacy of DNase I in our 
study. It is also possible that culture conditions, particularly the length of incubation, 
which was 28 hours longer in the Ali Mohammed et al., (2013) study, gave rise to 
different DNase I sensitivities. Also, our biofilms were treated with 5 µg/mL DNase I, 
which is far lower than the 125-1000 µg/mL concentrations that were used by Ali 
Mohammed et al., (2013). It is unknown how high concentrations of DNase enzymes 
affect the activity against microbial biofilms. The variable nature of eDNA production 
and thus DNase sensitivity is a key point, and needs to be investigated, particularly if 
DNases are to be used in a therapeutic setting.  
DNase I and NucB had a substantial effect on S. mutans GS-5 biofilms. However, 
NucB sensitivity of S. mutans biofilm forming strains was variable. Streptococcus 
mutans NG8 biofilm formation was inhibited by NucB but UA159 and UA140 
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monospecies biofilms were not sensitive to NucB. Although not significant, both 
UA140 and UA159 biofilms were slightly increased in extent when treated with NucB. 
A similar finding was demonstrated by Moraxella catarrhalis FH4, and Staphylococcus 
warneri FH15 biofilms in Chapter 4. Extracellular DNA can have a deleterious effect 
on biofilm formation, for instance in Caulobacter crescentus CB15, where DNase 
treatment increased biofilm attachment (Berne et al., 2010). It is possible that in mature 
biofilms, undergoing nutrient limitation, that DNase treatment facilitates DNA uptake 
as a nutrient source, allowing an increase in bacterial growth. This is an interesting 
hypothesis that would require further study. These findings follow previous data that 
have shown marked differences between DNase sensitivity of biofilms formed by 
different species of bacteria or, sometimes, by different strains of the same organism 
(Lappann et al., 2010; Shields et al., 2013). Whilst the strains, NG8, UA140 and UA159 
were not investigated in detail (eDNA extraction or microscopy) there does seem to be a 
genuine difference in NucB sensitivity.  Certain S. mutans GS-5 laboratory strains carry 
mutations in the cell surface adhesins Antigen I/II (encoded by the pac gene) and 
Glucan-binding protein C (gbpC gene) (Sato et al., 2002). The strain used in this study 
also carried these mutations. GbpC is the principal receptor for glucan, and loss of 
function leads to a decrease in biofilm extent (Lynch et al., 2007). It may be that S. 
mutans GS-5 has replaced the function of GbpC and Antigen I/II with eDNA, although 
this remains an untested hypothesis. However, eDNA has already been shown to be 
important in bacterial adherence for S. mutans LT11 (Das et al., 2010).   
The efficacy of NucB and DNase I against S. mutans GS-5 was compared, however, 
the comparison of these two enzymes is made difficult by differences in enzyme purity. 
DNase I was found to contain multiple proteins, whereas NucB was at least 95 % pure. 
Previous research has shown the increased efficacy of NucB compared with DNase I, 
although both enzymes were relatively impure in these assays (Nijland et al., 2010). 
Further investigations are required to determine if NucB has increased anti-biofilm 
activity over other DNase enzymes. It would be particularly useful to determine the 
amount of enzyme activity per mg of enzyme and this could be performed in the FRET 
assay. NucB had efficacy at dispersing or inhibiting mixed-species microcosms cultured 
from six human saliva samples. Extracellular DNA has been identified in multi-species 
biofilms and DNase enzymes have been used to reduce biofilm extent (Steinberger and 
Holden, 2005; Dominiak et al., 2011; Shakir et al., 2012). Interestingly, there was 
substantial variation in NucB activity amongst the six samples tested. This suggests that 
natural differences in the microbial composition of human saliva and dental plaque 
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leads to a change in biofilm structure and role of eDNA. There was also a change in 
NucB efficacy between biofilm formation and once biofilms had matured in some 
samples. It may be that the role of eDNA changes as biofilms mature. In Pseudomonas 
aeruginosa, eDNA helps the early formation of the biofilm, and then becomes less 
important in mature colonies (Whitchurch et al., 2002).  
Further testing is required to determine the anti-biofilm activity of NucB against 
mixed-species biofilms. Continuous-flow systems that circulate human saliva would 
allow for more realistic experiments of DNase biofilm dispersal. Recently, a 
microfluidic system, the BioFlux, has been shown to allow the culture of mixed-species 
biofilms that are similar in composition to supragingival plaque (Nance et al., 2013). 
Saliva microcosms, single-species S. gordonii DL1, and single-species S. mutans 
UA159 biofilms were cultured using this device. In particular there was a vast 
difference in biofilm structure when comparing static single-species biofilms and those 
cultured in the microfluidics device. Statically cultured biofilms are relatively thin 
continuous layers of cells, whereas culture in the BioFlux leads to thicker biofilms that 
are non-continuous. They resemble the biofilms visualised by SEM on the surface of 
TESVs in Chapter 3. In the future it is hoped that the BioFlux system could be used to 
test DNase enzymes against oral biofilms grown in human saliva. 
Across the four organisms tested, only S. gordonii showed clear extracellular DNase 
production. Many oral bacteria have been shown to produce extracellular nucleases 
(Palmer et al., 2012). Fusobacterium nucleatum produced a small amount of nuclease 
activity when assayed using the FRET protocol. This organism has been shown to be an 
extracellular DNase producer but not when using the DNase test agar assay, which is 
similar to our findings (Palmer et al., 2012). It is possible that during planktonic culture 
cell lysis is releasing an intracellular DNase that accounts for the nuclease activity seen 
in the FRET assay. The nuclease activity of S. gordonii was predominately in the cell 
fraction of planktonically cultured cells, which is suggestive of a cell bound nuclease 
(this nuclease is discussed in greater detail in Chapter 6). An interesting finding was that 
all six saliva cultures were DNase positive when assayed with DNase test agar. It is 
unknown which microbial species contributed to this but it appears that extracellular 
DNase activity is common amongst plaque forming bacteria. This assay would be 
improved with the use of positive and negative DNase-producing bacterial controls. 
The results of this study show clear evidence that oral bacteria produce eDNA that is 
essential for providing structural support. Furthermore, mixed-species oral biofilms also 
rely on eDNA. There is significant variation in the total abundance of eDNA, DNase 
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sensitivity, and temporal changes in DNase sensitivity amongst different oral bacteria 
and strains. Studies on natural dental plaque formed in situ, and ultimately in vivo 
studies in humans, will be required to establish the potential of NucB or other DNases 
for the control of oral biofilms. 
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6.1 Outline 
 
Oral biofilms, single and multi-species, have been shown (Chapter 5) to contain micro-
organisms that rely on eDNA for initial attachment of biofilm cells to a surface and for 
stability of the biofilm once it matures. An interesting finding was that Streptococcus 
gordonii DL1 produces an extracellular nuclease (Figure 5.6). Furthermore, in the 
conditions used, S. gordonii biofilms appeared to contain little eDNA and was not 
susceptible to treatment with exogenous nuclease. Therefore, it is possible that the 
extracellular DNase of S. gordonii is active within biofilms, and that S. gordonii utilises 
an eDNA-independent mechanism for biofilm formation. Streptococcus gordonii is an 
important early colonizer of the tooth surface, and interacts with a number of organisms 
during the accumulation of dental plaque. Therefore, any extracellular enzymes it 
produces could have an important ecological role in the oral cavity. This study aimed to 
identify the exonuclease of S. gordonii and characterise its activity. 
 
Significant amounts of DNA fragments can persist in the environment, for instance in 
soil, where fresh eDNA may remain intact for a number of days (Nielsen et al.). Certain 
micro-organisms have evolved to produce extracellular deoxyribonucleases, to try and 
exploit this resource. The potential role of these enzymes is vast, including degrading 
neutrophil extracellular traps (NETs) (Berends et al., 2010), facilitating biofilm re-
structuring (Kiedrowski et al., 2011; Steichen et al., 2011), reducing transformation 
(Blokesch and Schoolnik, 2008), and utilising DNA as a nutrient source (Liechti and 
Goldberg, 2013). Intuitively, given the lack of nutrients in most of the environments 
micro-organisms reside in, scavenging DNA as a nutrient source would seem the most 
likely role of these enzymes (discussed in Introduction section 1.5). In ocean sediments, 
eDNA contributes to phosphorus cycling, with an estimated 0.45 gigatons of eDNA in 
the top 10 cm of deep sea sediments (Dell'Anno and Danovaro, 2005). This material is 
estimated to account for half of the phosphorus assimilated by bacteria in this 
ecosystem. Phosphorus uptake from eDNA in hyposaline environments is hypothesised 
to be important for the archaean species Haloferax volcanii, although it is unclear what 
role a putative thermonuclease, Hvo_1477, has in this eDNA processing (Chimileski et 
al., 2014). In some cases, such as Shewanella oneidensis MR-1, microbes produce more 
than one extracellular nuclease, and different nucleases can have different functions 
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(Heun et al., 2012). The roles of the nuclease produced by S. gordonii are currently 
unknown. 
 
Many bacteria produce extracellular deoxyribonucleases with notable examples being 
Staphylococcus aureus (Kiedrowski et al., 2011), and Vibrio cholerae (Seper et al., 
2013). Recently, Palmer and others (2012) screened periodontal bacteria and identified 
27 different species that were capable of expressing extracellular DNase activity, 
including S. gordonii. Interestingly, secreted DNase activity was dependant on the 
culture state of the bacteria, and was either cell-adhered or truly extracellular. Many 
streptococci are capable of producing extracellular deoxyribonucleases. These enzymes 
are often linked to virulence (e.g. facilitating escape from NETs) in Streptococcus 
pyogenes (Hasegawa et al., 2010), Streptococcus pneumoniae (Beiter et al., 2006), and 
Streptococcus agalactiae (Derré-Bobillot et al., 2013). Oral streptococci, of which S. 
gordonii is a member (Facklam, 2002), have been shown to produce extracellular 
DNases (Palmer et al., 2012). It is unknown exactly what biological role the 
streptococci nucleases play in mixed-species biofilms. 
 
The focus of many studies on extracellular DNase enzymes has been their roles in 
virulence, and the escape of micro-organisms from NETs. However, given that many 
streptococci, including oral species, exist primarily within mixed-species communities, 
it is possible that extracellular DNases are produced to reduce the colonisation of 
competitors. This seems likely since biofilms of several different oral bacteria including 
the cariogenic species S. mutans are dispersed by nuclease treatment (see Chapter 5). 
This aspect of extracellular DNase production, and microbial antagonism, is a neglected 
area of research. It has been shown previously that S. gordonii (and S. sanguinis) 
produces hydrogen peroxide (H2O2) when grown aerobically, that has a growth limiting 
effect on S. mutans (Kreth et al., 2008). This study highlights the competitive 
interactions that occur between these two species.  
 
The major aim of this project was to characterise the extracellular nuclease of S. 
gordonii, SsnA, with a particular focus on anti-biofilm activity against S. mutans. The 
experimental approach involved expressing and purifying the enzyme. It was observed 
that carbon sources affected enzyme activity and therefore this study also aimed to 
investigate the regulation of SsnA production. Acid production after sugar fermentation, 
and its effect on SsnA enzyme activity was also studied. This project builds upon the 
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previous result chapters which have shown the reliance of eDNA in some biofilm-
forming micro-organisms in a number of systems. With this investigation the research 
had a molecular biological focus, which adds an extra edge to the thesis as a whole.  
 
Results in this chapter, and parts of Chapter 5, are being prepared for submission to 
Molecular Microbiology.  
 
6.2 Identification of a cell surface nuclease (SsnA) of Streptococcus gordonii 
 
The extracellular deoxyribonuclease activity of S. gordonii DL1 was shown in Chapter 
5 (Figure 5.6). The nuclease producing phenotype of S. gordonii is likely to be a regular 
feature of S. gordonii strains as 10 strains have been shown to degrade DNA in a DNase 
test agar assay (Nick Jakubovics, unpublished data). The gene encoding for this protein 
was identified by screening the S. gordonii DL1 genome for DNase 1-like domains 
using NCBI Blast. Three genes were identified as having putative DNase 1-like 
domains. These three targets were then compared with other GenBank genes to find 
sequence homology to previously identified extracellular nucleases. A LPxTG cell wall 
surface protein (accession no. YP_001450928.1) (Figure 6.1A), with a putative DNase 
I-like domain was found to have the most extensive homology to other putative 
extracellular deoxyribonucleases. The 2337-bp gene, encoding a 779 amino acid (aa) 
protein showed greatest homology, 80% identity, to a putative 733-aa endonuclease 
(accession no. WP_003043336.1) of Streptococcus anginosus. This species of 
Streptococcus was found to produce an extracellular nuclease in Chapter 4 (Table 4.1). 
The protein also shared 76% identity over aa 17-709 with a putative endonuclease 
(accession no. WP_002923596.1) of Streptococcus sanguinis. A previously identified 
secreted nuclease of Streptococcus suis (Fontaine et al., 2004) shared 44% identity with 
the putative S. gordonii extracellular DNase (accession no. YP_006081396.1). The gene 
encoding the S. suis nuclease was designated ssnA for S. suis secreted nuclease A. 
Given that S. gordonii and S. suis are both members of the S. sanguinis group of 
streptococci, the putative DNase gene of S. gordonii was also termed ssnA (and will be 
referred to as such from now on). However, in this case ssnA is defined as 
‘streptococcal secreted nuclease A’ as this is a more appropriate term for the gene. 
Other proteins with sequence homology to S. gordonii SsnA included the Gemella 
haemolysans endonuclease (accession no. WP_004263991.1), 66% identity, and the 
Bacillus cereus endonuclease (accession no. WP_000279241.1), 41% identity from aa 
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Figure 6.1 Predicted conserved domains of SsnA and homology with nucleases 
from other species. (A) The 2337-bp open reading frame of the S. gordonii 
extracellular DNase encodes a protein of 779-aa. The SsnA precursor protein is 
predicted to contain a signal peptide (SP, position 1-32) at the N-terminal, and a cell 
wall anchor motif (CA, position 736-774) at the C-terminal end. SsnA also has a 
putative OB-fold domain (position 118-171) at the N-terminal end, and a C-terminal 
end that contains a putative exonuclease/endonuclease/phosphatase domain (position 
356-661) (B) SsnA shares homology with a number of other bacterial produced 
nucleases, and selected examples are shown. Homology (hatched boxes) begins and 
ends within the amino acid residues indicated by the numbers above each box. 
Percentage identities are included after species names in brackets. 
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211-784. The regions that shared sequence homology with S. gordonii SsnA are shown 
in Figure 6.1B. 
The SsnA protein was analysed for conserved domains using the NCBI Conserved 
Domain Database, SignalP-4.1 and CW-PRED (Litou et al., 2008; Petersen et al., 2011; 
Marchler-Bauer et al., 2013). SsnA contains a putative oligonucleotide/oligosaccharide-
binding fold (OB-fold) (similarity to Bacillus subtilis OB-fold) and predicted binding 
sites for Mg
2+
, and phosphate. The C-terminal end of SsnA consists mostly of a putative 
exonuclease/endonuclease/phosphatase domain. These are all features that are expected 
with DNase-like enzymes. The amino acid sequence also contains an LPxTG-motif 
(LPATG) at the C-terminal end, which is a conserved sequence for Gram positive cell 
wall surface proteins. Cleavage of LPxTG between Thr and Gly by sortase A leads to 
covalent anchoring to the cell wall at the new Thr C-terminal end. All predicted 
domains with amino acid positions are shown in Figure 6.1A.  
Prior to this project, the 2337-bp ssnA gene was knocked-out in S. gordonii DL1 to 
further confirm that SsnA was the protein encoding extracellular nuclease activity (Nick 
Jakubovics, unpublished work). Extracellular DNase deficiency was analysed using 
DNase Test agar (Figure 6.2A). By contrast with the wild-type progenitor, 
Streptococcus gordonii ∆ssnA did not produce any extracellular DNase activity. 
Furthermore, using a FRET assay nuclease activity was not detected in S. gordonii 
∆ssnA conditioned media or cells (Figure 6.2B). Streptococcus gordonii DL1 
extracellular deoxyribonuclease activity was compared with Staphylococcus aureus 
FH7 by the FRET assay. DNase activity of S. gordonii DL1 was 5-fold higher in the 
cell fraction (cellular and supernatant fractions were in identical volumes), which gives 
further indication that SsnA is a cell-bound protein. Staphylococcus aureus FH7 
nuclease activity was highest in the conditioned media (3-fold), as was expected since 
the major extracellular DNases of this organism are not cell-bound. This positive 
control gives confidence in the ability of the FRET assay to determine nuclease activity 
in different fractions of a planktonic culture of micro-organisms. 
 
6.3 Biofilm dispersal of S. mutans GS-5 with S. gordonii DL1 
 
To determine how extracellular deoxyribonuclease production by S. gordonii affects S. 
mutans biofilm extent, S. gordonii DL1 cells and conditioned media were added to pre-
formed (20 h) S. mutans GS-5 biofilms. Streptococcus gordonii DL1 cells reduced S. 
mutans GS-5 biofilm extent by 40%, when compared to the control where only PBS 
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Figure 6.2 Targeted disruption of ssnA. An ssnA-deficient mutant was created by 
mutagenesis. This was to confirm that this gene is responsible for the extracellular 
nuclease produced by S. gordonii DL1.  (A) Streptococcus gordonii DL1 and S. 
gordonii ∆ssnA were cultured on DNase Test agar to test for DNase activity. A zone of 
DNA degradation (dark halo) as indicated by the arrow, was apparent for S. gordonii 
DL1 after DNA was precipitated with 1N HCl. There was no zone of DNA removal for 
the ssnA-deficient mutant. This confirms ssnA as the gene responsible for extracellular 
nuclease activity. (B) The nuclease activity of S. gordonii DL1, S. gordonii ∆ssnA and 
S. aureus FH7 was examined by the FRET assay. Again, no significant nuclease activity 
was quantified in the cell (white box) and supernatant (grey box) fractions for the ssnA-
deficient mutant. Most extracellular deoxyribonuclease activity is produced by the cell 
fraction of S. gordonii, which fits with the predicted cell anchor motif within the ssnA 
sequence. Staphylococcus aureus extracellular nuclease activity is highest in the 
supernatant fraction, as expected. Standard error from the mean (3 replicates) is 
indicated by the error bars. 
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was included (Figure 6.3). Intact cells of Streptococcus gordonii ∆ssnA  did not 
significantly disperse pre-formed S. mutans GS-5 biofilms. The nuclease activity of 
cultures was quantified using a FRET assay, confirming the presence of DNase in S. 
gordonii DL1 cell and supernatant fractions. Bovine DNase I (bpDNase I) (5 µg/mL) 
was also included as a control, as it has been previously shown to reduce S. mutans GS-
5 biofilm extent by up to 90% (Chapter 5). This result was again repeated, highlighting 
the dependence of S. mutans GS-5 on eDNA in this system. Interestingly, both S. 
gordonii DL1 and S. gordonii ∆ssnA conditioned media had a dispersal effect. 
Supernatant from wild-type dispersed S. mutans by 40 %. There was a small amount of 
S. mutans dispersal by supernatant from the ssnA-deficient mutant though it was only 20 
%. Conditioned media of S. gordonii DL1 contains nuclease activity but 5-fold less than 
cell fractions (Figure 6.2B). The ssnA-deficient mutant produces minimal nuclease 
activity. Streptococcus gordonii DL1/∆ssnA were grown aerobically, conditions that 
likely lead to H2O2 production, explaining why conditioned media from both strains 
reduced S. mutans biofilm extent (although other factors are possible). As discussed 
earlier, S. gordonii produces H2O2 that has an antagonistic effect against S. mutans 
(Kreth et al., 2008). 
 
6.4 SsnA activity in response to sugar fermentation 
 
6.4.1 Sugar regulation and the role of CcpA and MalR regulators 
 
Carbon catabolite repression (CCR) is a regulatory mechanism in bacteria to ensure the 
selection of optimal carbon sources. Many genes are repressed or activated depending 
on the carbon source present. There is evidence that S. aureus Nuc1 is glucose regulated 
(Kiedrowski et al., 2011; Beenken et al., 2012). Therefore, it was hypothesised that 
expression of ssnA may be either up or down-regulated depending on the carbon source 
present. This would have an immediate impact on the ecology of the oral biofilm, 
particularly with regard to eDNA degradation. The upstream promoter region of the 
ssnA gene was screened for potential binding sites linked to CCR transcription factors 
using RegPrecise (Novichkov et al., 2010). Interestingly, there was a consensus binding 
site in the ssnA promoter region for carbon catabolite protein A (CcpA), a protein 
involved in global transcriptional regulation in response to sugars like glucose (Figure 
6.4). There was also a consensus binding site for MalR, a protein involved in 
maltosaccharide uptake and utilization (Figure 6.4). Therefore, the ccpA and malR genes 
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Figure 6.3 Streptococcus mutans GS-5 biofilm disruption by Streptococcus gordonii. 
Streptococcus mutans GS-5 biofilms were grown anaerobically, at 37°C, for 20 h. Pre-
formed biofilms were then incubated with S. gordonii DL1 (DL1C) or S. gordonii 
∆ssnA (MTC) cells, and S. gordonii DL1 (DL1S) or S. gordonii ∆ssnA (MTS) 
supernatant for 1 hour at 37°C. Biofilm extent was quantified by the crystal violet assay. 
DNase I (5 µg/mL) was included as a positive control, to confirm the eDNA 
dependence of S. mutans GS-5. Control biofilms were treated with PBS only. Standard 
error from the mean (3 replicates) is indicated by the error bars. Statistical significance 
was calculated with the two sample t-test. 
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Figure 6.4 Consensus binding sites in the ssnA promoter region. Contained within 
the promoter region of ssnA are areas that may bind to the CcpA and MalR regulatory 
proteins. Hypothetical binding sites are shown within the promoter sequence (black 
text) by underlining nucleobases. The start of the ssnA ORF is highlighted in colour 
(pink). Promoter sites were predicted using BPROM (SoftBerry). 
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were chosen as targets for gene deletions, to study the regulation of ssnA in response to 
carbon sources. 
The malR and ccpA genes were deleted by an overlap extension PCR mutagenesis 
approach (see Materials and Methods 2.9), and gene deletions were confirmed by 
sequencing. Streptococcus gordonii ∆ccpA and S. gordonii ∆malR were grown on 
DNase test agar containing no sugar, glucose, maltose or galactose. As previously 
discussed, DNase test agar contains DNA and is a method that can confirm extracellular 
deoxyribonuclease activity. Streptococcus gordonii DL1 degraded DNA when no sugar, 
or the non-repressing sugar, galactose was present (Figure 6.5). However, it did not 
produce nuclease activity when glucose or maltose was added to DNase test agar, 
indicating the repression of ssnA by sugars. When S. gordonii ∆ccpA was cultured on 
the two repressing sugars, glucose and maltose, enzyme activity was still visible (Figure 
6.5). This was in contrast to the malR-deficient mutant, which still did not produce 
extracellular deoxyribonuclease activity when grown with repressing sugars present, 
including maltose (Figure 6.5). Streptococcus gordonii ∆malR, along with the wild-
type, also did not produce nuclease activity on DNase Test agar supplemented with a 
maltooligosaccharide mixture (2%) and maltodextrin (2%). These data indicate that 
CcpA down-regulates the extracellular nuclease of S. gordonii when optimal carbon 
sources such as glucose are present. It appears that MalR does not repress SsnA activity. 
The bpDNase I (1 mg/mL) positive control created a zone of DNA degradation on all 
media. Furthermore, the SsnA deficient mutant did not produce extracellular nuclease 
activity on any of the media tested.  
 
6.4.2 Sugar fermentation and acid inhibition 
 
Following the DNase test agar experiments with repressing sugars, nuclease activity 
was assessed quantitatively using the FRET nuclease assay (see Materials and Methods 
2.8.7). This assay allows extracellular deoxyribonuclease activity to be quantified in cell 
or supernatant fractions. Staphylococcus aureus FH7 and S. gordonii DL1 were grown 
in broth culture for 20 h in BHY medium or BHY supplemented with glucose, maltose, 
fructose, galactose or inulin. Thereafter, cells and spent media were separated and 
nuclease activity was measured. Staphylococcus aureus FH7 was used as a positive 
control for extracellular deoxyribonuclease production, as it was shown previously to 
produce a DNase in Chapter 4. Lower extracellular DNase activity was measured in S. 
Chapter 6: Characterising Streptococcus gordonii, SsnA 
167 
 
 
Figure 6.5 Nuclease expression by S. gordonii, and mutants, on DNase Test agars 
containing repressing and a non-repressing sugar. Nuclease activity was screened by 
culturing micro-organisms on DNase Test agar for 48 h, and then flooding the plates 
with 1N HCl to precipitate DNA. Sugars were added to a concentration of 2%, with 
glucose and maltose being repressing sugars, galactose is non-repressing. Black areas 
are zones of DNA degradation, whereas grey is an area where dsDNA is still present. 
The percentage area of DNA digestion was calculated per 5112 pixel (area) box (364.81 
mm
2
) by converting to binary and then measuring the percentage of black and white 
pixels. Image analysis was performed with ImageJ. Streptococcus gordonii ∆ssnA was 
included as a negative control; DNase I (1 mg/mL) was included as a positive control.  
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gordonii DL1 cell and supernatant fractions across all 5 sugars tested in comparison to 
BHY medium containing no sugar (0.2 % glucose) (Figure 6.6). This included the 
repressing sugars glucose, fructose and maltose, and non-repressing sugars, galactose 
and inulin. There was up to a 4-fold decrease in cell-bound nuclease activity, and a 40-
fold decrease in non-cell-bound nuclease activity, although in absolute terms the biggest 
decrease was in cell-bound DNase activity. Similar decreases in extracellular 
deoxyribonuclease activity was shown in S. aureus FH7 (produces a nuclease which is 
not cell-bound) across all sugars except for inulin, where activity was only reduced by 
2-fold (Figure 6.6). The decrease in extracellular nuclease activity in S. gordonii DL1 in 
the presence of either repressing or non-repressing sugars suggested that sugar 
fermentation, and subsequent acid production, may be responsible for the lack of SsnA 
activity. There was a 50 % decrease in S. aureus nuclease activity in response to inulin 
supplementation, which was less than with other carbon sources. It may be that S. 
aureus inefficiently ferments this sugar, producing less acid, although this requires 
further study. No significant nuclease activity was measured for the SsnA deficient 
mutant in any of the media. 
To test the acidification of growth media in response to sugar fermentation the pH of 
each medium was measured after overnight culture (Figure 6.7A). The pH of BHY (no 
sugar) after S. gordonii growth was 5.6. BHY-based media containing sugars all had 
greatly reduced pH (ranging from pH 4 to 4.6) in comparison to standard BHY. To 
further assess the role of low pH in modulating SsnA activity, Streptococcus gordonii 
DL1 was cultured in BHY acidified to pH 5.5 (Figure 6.7B). As expected, extracellular 
DNase activity was greatly inhibited (8-fold reduction) in the presence of acid (Figure 
6.7B). The pH of acidified BHY, after overnight culture, was 4.2, which was similar to 
BHY media that had sugars present.  
The dynamics of SsnA inhibition in response to acidic conditions were further 
analysed by placing S. gordonii DL1 cells, grown in BHY (0.2 % glucose) overnight, in 
low pH buffers. Initial extracellular DNase activity was measured by placing cells in 
PBS (pH 7.1), from here, cells were split and placed into a pH 5.5 and a pH 4.5 buffer. 
Nuclease activity was quantified over the next 4 h. There was a gradual decline in 
extracellular DNase activity in the PBS buffer, after 4 h DNase activity was 76% of the 
starting value (Figure 6.7C). Cell-bound nuclease activity was moderately decreased (to 
56% of the original) when cells were placed in the pH 5.5 buffer for 2 h. Extracellular 
DNase activity was only 2% of the starting activity after 2 h in the pH 4.5 buffer (Figure 
6.7C). Clearly, between pH 5.5 and 4.5 there was a rapid inhibition of SsnA enzyme 
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Figure 6.6 Förster resonance energy transfer assay of S. gordonii DNase activity in the presence of sugars. Bacterial strains were 
cultured overnight in BHY (+ 2% sugar), aerobically, at 37°C. Planktonic cultures were split into cell and supernatant fractions and the 
extracellular nuclease activity of both was quantified. Staphylococcus aureus FH7 nuclease activity was assayed as a positive control, and 
to understand if DNase activity in this species is regulated in a similar manner to S. gordonii. Streptococcus gordonii ∆ssnA was included 
as a negative control. BHYG (glucose), BHYM (maltose), BHYGal (galactose), BHYF (fructose), and BHYI (inulin). Standard error from 
the mean (3 replicates) is indicated by the error bars.  
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Figure 6.7 Inhibition of S. gordonii SsnA in response to acid. (A) The pH of each 
conditioned medium (20 h planktonic growth) was quantified. BHY/HCl is an acidified 
(pH 5.5) medium. (B) Streptococcus gordonii DL1 was cultured overnight in acidified 
BHY and SsnA activity was quantified using the FRET assay. (C) Cell fractions of 
overnight cultured S. gordonii DL1 were suspended in a neutral buffer (PBS) (pH 7.1), 
and two acidic buffers (pH 5.5 or pH 4.5). Cells were incubated for 2 h, and activity was 
measured at intervals. After 2 h the cells in acidic buffers were re-suspended in PBS for 
the remaining 2 h of the assay (double black arrow). Once returned to PBS, the cells 
were split in half and chloramphenicol (chlm) (12.5 µg/mL) was included to inhibit 
protein synthesis in one fraction. Nuclease activity was assayed for a further two h. 
Standard error from the mean (3 replicates) is indicated by the error bars. 
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activity. After 2 h, cells were moved from the pH 4.5 and 5.5 buffers to PBS, to analyse 
the ability of SsnA to regain activity. To account for new protein synthesis cells were 
also placed in PBS plus chloramphenicol. There was a 2-fold increase in SsnA activity, 
compared to cells with inhibited protein synthesis, when cells were moved from pH 5.5 
to pH 7.1 (Figure 6.7C). Furthermore, SsnA activity was increased 3-fold when cells 
were placed in PBS from the pH 4.5 buffer (Figure 6.7C). These results indicate that 
SsnA activity is irreversibly inhibited by the presence of acid but can be restored by de 
novo protein synthesis.  
 
6.5 GST-SsnA protein expression and purification 
 
To further study the role of SsnA in S. mutans antagonism, and confirm the DNase 
activity of this protein, the S. gordonii ssnA gene was fused to a Glutathione S-
transferase (GST) tag in an Escherichia coli protein expression system (Nick 
Jakubovics, unpublished data). Using this system, GST-tagged proteins are expressed in 
E. coli cytoplasm in high amounts. To optimise protein production, Escherichia coli 
was cultured in Luria Bertani broth, Terrific broth or YT-G and growth rates and GST-
SsnA expression were monitored. Ultimately, E. coli grown in YT-G were found to 
produce the highest amounts of GST-SsnA, and therefore this media was used thereafter 
(see Materials and Methods 2.8.4). Figure 6.8A shows how protein expression changed 
over 4 h, compared to an un-induced control. GST-SsnA was subsequently purified 
using affinity chromatography (Figure 6.8A). GST-tagged proteins have a high binding 
affinity for glutathione (GSH coated) resins. Cell lysates were run through a GSH 
matrix after which free reduced GSH was added. Free reduced GSH competitively 
displaces immobilized GST-tagged SsnA, allowing capture of the protein. A diagram of 
this process is included in Appendix E. After this step up to 300 µg of >80% pure 
protein was available for further applications.  
Purified GST-SsnA was exchanged from the elution buffer to TNC buffer  using 
Amicon (Merck Millipore) centrifugal filters. TNC buffer is a reaction solution that 
allows optimal thrombin cleavage of the GST tag from the recombinant protein. 
Thrombin cleavage was optimised using a variety of incubation periods and 
temperatures. Cleavage of the GST tag was found to be optimal when incubated for 72 
h, at room temperature (25°C), using 1 U of thrombin per 50 µg of GST-SsnA. The 
GST tag (26 kDa), SsnA (85 kDa), and GST-SsnA (111 kDa) were visualised on a 12% 
SDS-PAGE gel after thrombin cleavage (Figure 6.8B). 
Chapter 6: Characterising Streptococcus gordonii, SsnA 
172 
 
 
Figure 6.8 Streptococcus gordonii GST-SsnA protein expression and purification. 
(A) 12% SDS-PAGE detection of induced GST-SsnA expression in E. coli. Lanes: M) 
protein molecular weight marker; 1) cell culture without IPTG induction; 2) 1 h IPTG 
induction; 3) 2 h IPTG induction; 4) 3 h IPTG induction; 5) 4 h IPTG induction; 6) 
eluted fraction after glutathione affinity chromatography. GST-SsnA is indicated by the 
black arrow (111 kDa).  (B) Thombin cleavage of the GST-tag from SsnA. Lanes: M) 
protein molecular weight marker; 1) SsnA (thrombin treated) (90 kDa) and GST (26 
kDa) (black arrow); 2) GST-SsnA (111 kDa). (C) Protein concentration determination 
using BSA standards and densitometry after SDS-PAGE. Lanes: M) protein molecular 
weight marker; 1) GST-SsnA; 2) 62.5 µg/mL BSA; 3) 125 µg/mL BSA; 4) 250 µg/mL 
BSA; 5) 500 µg/mL BSA; 6) 1000 µg/mL BSA. (D) Graph of BSA standards after 
densitometry analysis using SynGene GeneTools. Line of best fit through the origin, 
with equation displayed in upper right corner.  
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GST-SsnA was excised from a 12% SDS-PAGE gel, digested by trypsin, and 
analysed by peptide mass fingerprinting (PMF). The mass fingerprinting of the digested 
peptides identified the protein as the putative DNase, SsnA (see Appendix F). Also 
identified by PMF was the GST tag. 
To quantify the amount of GST-SsnA produced by this system the protein was run 
on a 12% SDS-PAGE gel with bovine serum albumin (BSA) standards. This method 
was chosen over the Bradford assay as it is more sensitive, and more appropriate for a 
partially purified protein. GST-SsnA was exchanged from the elution buffer to a DNase 
buffer by Slide-A-Lyzer
®
 dialysis cassettes (Thermo Scientific). This method was 
chosen as the cellulose membrane has low binding characteristics. Initial attempts at 
buffer exchange with the Amicon system led to marked loss of protein, and therefore 
the Slide-A-Lyzer
®
 system was used instead. Once placed in the DNase buffer, 10 µL 
were run alongside BSA standards (2-fold dilution from 1000 to 63 µg/mL) on a 12% 
SDS-PAGE gel (Figure 6.8C). The dilution series was not linear, which was likely due 
to the experimental technique used. Protein concentration was estimated using SynGene 
GeneTools densitometry software (Figure 6.8D). Although yields of GST-SsnA protein 
in cell lysates were circa 300 µg/mL, the exchange between buffers often led to a loss of 
protein. Final concentrations were approximately 100 µg/mL, with a final yield of 500 
µL.  
 
6.6 Zymography of SsnA 
 
After purification of the enzyme, the activity against dsDNA was assessed using in gel 
zymography, an electrophoretic technique that provides a substrate for hydrolytic 
enzymes in a SDS-PAGE gel (see Materials and Methods 2.8.5). In this case salmon 
sperm DNA was included in the SDS-PAGE gel, as a substrate for the DNases. Samples 
of GST-SsnA, SsnA, and bpDNase I, were prepared in a non-reducing buffer without 
boiling, were run through a SDS-PAGE gel and were re-activated post-electrophoresis. 
DNA degradation was then visualised by staining the SDS-PAGE gel with ethidium 
bromide and pictured using ultraviolet light. Areas of DNA digestion appear as dark 
bands against the brightly stained background (ethidium bromide intercalating with 
dsDNA). DNA digestion was shown for both GST-SsnA and SsnA, and was 
comparable with bpDNase I activity when similar amounts were loaded (Figure 6.9A). 
Thrombin cleavage did not fully remove all GST tags from SsnA therefore leaving 
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Figure 6.9 in gel zymography of GST-SsnA DNase activity. (A) GST-SsnA (1) (111 
kDa), SsnA (2) (90 kDa), and DNase I (con) (29 kDa) were ran on a 12% SDS-PAGE 
gel containing dsDNA. Extracellular nucleases were reactivated and gels were stained 
with ethidium bromide. Images were visualised with an UV-light source (Syngene, 
G:Box) and dark zones indicate areas of DNA digestion. (B) SsnA (90 kDa) (black 
arrow) was loaded on a zymogram in amounts ranging from 250 to 10 ng. (C) During 
reactivation of SsnA activity SDS-PAGE gels were incubated at 4°C, room temperature 
(25°C), 30°C, and 37°C. Some residual GST-SsnA activity was present, likely due to 
incomplete thrombin cleavage of all GST-SsnA protein.  
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behind some DNase activity at a higher molecular weight (111 kDa- GST-SsnA) in the 
in gel zymograms. SsnA enzyme was visualised on a zymogram in amounts as low as 
10 ng (Figure 6.9B). Lastly, SsnA was reactivated inbuffer incubated at 4°C, room 
temperature (25°C), 30°C, and 37°C to compare DNA degradation activity across these 
temperatures (Figure 6.9C). DNA degradation was greatest following incubation at 
37°C, and the least at 4°C. As the temperature decreased, less DNase activity was 
present. This result suggests that the optimal temperature for SsnA activity is 37°C, of 
the temperatures tested. However, reactivation of the enzyme depends on the removal of 
SDS from the SDS-PAGE gel, and it is unknown how this changes in response to 
temperature. This may account for some of the decreased activity at lower temperatures.  
 
6.7 Activity of GST-SsnA against S. mutans 
 
It was shown in Section 6.3 that S. mutans GS-5 biofilms are dispersed by S. gordonii 
DL1 cells and not by an ssnA mutant. To test the effects of SsnA on S. mutans GS-5 
biofilms directly, the partially purified GST-SsnA was added to pre-grown biofilms. 
GST-SsnA was applied as it has similar DNase activity to SsnA (Figure 6.9A) and can 
be produced in greater quantities. Streptococcus mutans GS-5 biofilms were grown 
anaerobically (37°C), for 20 h, and treated with 5 µg/mL GST-SsnA for 1 hour at 37°C. 
The biofilm biomass of S. mutans GS-5 was significantly decreased by >90% when 
GST-SsnA was present (Figure 6.10). This was compared to a control where only PBS 
was included with pre-formed biofilms. bpDNase I also removed up to 90% of S. 
mutans GS-5 biofilm, as shown in Chapter 5. The activity of GST-SsnA was also tested 
against pre-formed biofilms of S. gordonii DL1 and S. gordonii ∆ssnA. Neither of these 
strains was significantly dispersed. This corresponds with previous data that showed S. 
gordonii was not susceptible to bpDNase I treatment.  
 
6.8 Discussion 
 
Streptococcus gordonii is a constituent of dental plaque and is an initial colonizer of the 
tooth surface. Dental plaque is formed via a series of aggregations between several 
different species of bacteria, and S. gordonii is involved in many different co-
aggregation interactions. Since S. gordonii co-localises with other bacteria in dental 
plaque, the enzymes produced by S. gordonii could profoundly shape the species 
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Figure 6.10 Anti-biofilm activity of GST-SsnA. Biofilms of S. mutans GS-5, S. 
gordonii DL1, and S. gordonii ∆ssnA were grown in 96-well microtiter plates overnight, 
at 37°C, in aerobic conditions. After 20 h biofilms were incubated in the presence of 
GST-SsnA (5 µg/mL) or PBS only. (A) Biofilm dispersal was calculated as the 
percentage biomass remaining after the addition of GST-SsnA, compared to the PBS 
treated control. Standard error from the mean (3 replicates) is indicated by the error 
bars. (B) Streptococcus mutans GS-5 biofilm dispersal was visualised by staining with 
crystal violet. Statistical significance was calculated with the two sample t-test. 
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composition of dental plaque. We identified an extracellular nuclease, SsnA, produced 
by S. gordonii. The aim of this study was to characterize SsnA in terms of its anti-
biofilm activity against the cariogenic bacterium S. mutans and its regulation in 
response to carbon sources. 
Several Streptococcus spp. produce excreted deoxyribonucleases (Brown, 1950; 
Smith and Bodily, 1967; Palmer et al., 2012). DNases produced by streptococci that 
have been studied in detail include: Streptococcus suis SsnA (Fontaine et al., 2004; de 
Buhr et al., 2013), Streptococcus pyogenes SpnA (Hasegawa et al., 2010), 
Streptococcus pneumoniae EndA (Beiter et al., 2006), and Streptococcus agalactiae 
NucA (Derré-Bobillot et al., 2013). Both S. suis SsnA and S. pyogenes SpnA are 
homologues of the extracellular nuclease of S. gordonii. These proteins, like S. gordonii 
SsnA, contain a Gram positive LPxTG cell wall anchor domain, and are predominantly 
cell-surface located. When analysed with the FRET assay extracellular nuclease activity 
was highest in the cell fraction of S. gordonii cells, suggesting that SsnA is also cell-
bound. There was nuclease activity in the supernatant fraction, which is suggestive of 
some cell-bound SsnA becoming unattached, possibly during cell wall synthesis. This 
was in contrast to the SsnA-deficient mutant that produced no nuclease activity in the 
supernatant fraction, therefore ruling out the presence of intracellular DNase enzymes in 
wild-type supernatant. Staphylococcus aureus, produced higher DNase activity in its 
conditioned media. This bacterium produces at least two extracellular DNases, one cell 
wall located (Nuc2), and the other unbound (Nuc). Interestingly, both SpnA and S. suis 
SsnA contain three OB-fold domains. These small structural motifs may be important 
for nucleic acid binding (Theobald et al., 2003). However, S. gordonii SsnA is predicted 
to have one OB-fold domain. Chang et al., (2011) created truncated versions of SpnA 
that contained all, two or no OB-fold domains. At least two OB-fold domains were 
required for DNase activity as shown by in gel zymography. It is unknown whether S. 
gordonii SsnA requires the OB-fold to bind DNA, or why these three homologues differ 
in this regard.  
The biological role proposed for the extracellular deoxyribonucleases produced by 
streptococci is that they are linked to virulence, although other functions are possible. 
The virulence hypothesis exists because of the finding that neutrophil extracellular traps 
(NETs) can engulf, and kill bacteria, through use of eDNA (Brinkmann et al., 2004). 
Therefore, bacteria produce extracellular nucleases to escape NETs by degrading NET 
eDNA. Group A Streptococcus (Sumby et al., 2005; Buchanan et al., 2006), S. suis (de 
Buhr et al., 2013), S. agalactiae (Derré-Bobillot et al., 2013), and S. pneumoniae 
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(Beiter et al., 2006) produce one or several DNases that have been shown to have anti-
NET activity. Extracellular DNases may also facilitate the spreading of Group A 
Streptococcus through lung mucus that contains high levels of eDNA (Bisno et al., 
2003). However, S. gordonii is not viewed as pathogenic in the oral cavity, so the role 
of the extracellular DNase in this organism is unclear. Extracellular DNase enzymes can 
also regulate DNA uptake in species such as Vibrio cholerae, by degrading DNA and 
therefore reducing uptake of DNA (Blokesch and Schoolnik, 2008). However, there was 
no difference in transformation efficiency between wild-type S. gordonii and the ssnA-
deficient strain (David Taylor, unpublished work). It is also plausible that SsnA 
degrades eDNA that may have a deleterious effect on S. gordonii, for instance inhibiting 
biofilm accumulation (Berne et al., 2010), or causing cell lysis via increased 
concentrations of cations (Mulcahy et al., 2008). However, we propose that S. gordonii 
SsnA has a biofilm reducing effect on oral bacteria such as S. mutans, that require 
eDNA for biofilm stabilisation.  
Gene deletion of ssnA demonstrated that this was the gene responsible for 
extracellular nuclease activity in S. gordonii DL1. Nuclease-deficient cells of S. 
gordonii were incapable of reducing S. mutans biofilm extent, whereas the parental 
strain of S. gordonii reduced colonisation. Although this reduction was less than 
bpDNase I, it demonstrates that S. gordonii SsnA may have a role in influencing biofilm 
species composition. Interestingly, both strains of S. gordonii produced supernatants 
that had an anti-biofilm effect against S. mutans. Streptococcus gordonii, cultured in the 
presence of oxygen, has been shown to have a growth limiting effect on S. mutans 
through the production of H2O2 (Kreth et al., 2008). Although H2O2 wasn’t measured it 
may account for the biofilm reduction caused by both strain supernatants, as they were 
grown aerobically. Cell fractions were washed in PBS and so it is unlikely that there 
were significant levels of residual H2O2. 
Purified, recombinant SsnA has deoxyribonuclease activity and disperses biofilms 
formed by S. mutans. The amount of biofilm dispersion is similar to that seen with 
bpDNase I and NucB (Chapter 5). Wild-type S. gordonii cells and partially purified 
SsnA was shown to disperse S. mutans biofilms. However, the extent of dispersal was 
lower with S. gordonii cells than with GST-SsnA. Naturally SsnA is a cell-membrane-
associated enzyme, which may explain the lower biofilm dispersal. Streptococcus 
gordonii conditioned media also contains nuclease activity, so both may contribute to S. 
mutans dispersal in vivo. Interestingly, SsnA does not have a significant effect against S. 
gordonii biofilms. This suggests that S. gordonii does not produce this enzyme to 
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actively degrade eDNA and disseminate biofilm cells in the experimental conditions 
used. It is possible that a small percentage of S. gordonii cells are susceptible to host-
produced SsnA and that this is missed by the crystal violet assay. Staphylococcus 
aureus produces an extracellular nuclease that has been shown to reduce host biofilm 
extent in vitro (Kiedrowski et al., 2011) as has Neisseria gonorrhoeae Nuc (Steichen et 
al., 2011). However, S. gordonii biofilm matrices do not contain eDNA in great 
quantities in the models used during these studies (Chapter 5). It is unknown if eDNA 
contributes to stability in other growth conditions and models. Therefore this hypothesis 
requires further research. 
Inactivation of the ccpA gene validated its role in regulating ssnA expression in 
response to carbon sources like glucose. CcpA has been shown to be essential for 
carbohydrate catabolite repression in S. gordonii (Dong et al., 2004). Interestingly, loss 
of CcpA function reduces interspecies signalling interactions, via amylase, between S. 
gordonii and Veillonella atypica (Johnson et al., 2009). CcpA has also been linked to 
penicillin tolerance in S. gordonii (Bizzini et al., 2007). Clearly, the global regulator 
CcpA has a wide control on gene expression in low GC Gram positive bacteria. For 
example, up to 300 genes are regulated by CcpA in Bacillus subtilis (Moreno et al., 
2004). The primary function of CcpA is related to sequential utilization of carbon 
sources. The extracellular DNases of Shewanella spp. and Helicobacter pylori utilize 
eDNA as a source of nutrients, such as carbon, phosphorus, or purines (Pinchuk et al., 
2008; Heun et al., 2012; Liechti and Goldberg, 2013). Therefore, the finding that CcpA 
regulates SsnA suggests that this DNase may be required for eDNA digestion, and when 
preferred carbon sources, like glucose, are present, ssnA expression is reduced. 
Recently, the cell bound nuclease of S. suis, SsnA, which shares homology (44%) to S. 
gordonii SsnA, was found to be down- regulated by CcpA during the stationary phase 
(Willenborg et al., 2014). The majority of genes influenced by CcpA in S. suis are 
related to carbon metabolism, however, it is unknown if S. gordonii can survive on 
eDNA as a sole carbon source. This is an important aspect of SsnA production that 
needs further exploration, with the use of defined culture media and the ssnA-deficient 
mutant. If glucose is present in the oral cavity, and ssnA is down-regulated, this may 
have an indirect effect on S. mutans colonisation. Furthermore, acid production during 
sugar fermentation has been shown to reduce SsnA activity, therefore providing another 
reason for S. gordonii to not produce this enzyme when carbon sources are present. It is 
unknown if the ssnA gene is down-regulated in these conditions and this requires further 
study.  
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Although gene regulation in response to preferred carbon sources is an important 
consideration in SsnA anti-biofilm dynamics, it appears that acid-mediated inhibition of 
SsnA might have a larger impact. Lactic acid bacteria, like S. gordonii, are lactic-acid 
producing during carbohydrate fermentation (Platt and Foster, 1958; Axelsson, 2004). 
Planktonic culture in five sugars (glucose, maltose, galactose, fructose and inulin) led to 
media that were 1 pH unit lower than un-supplemented BHY media. Further analysis 
demonstrated that SsnA was rapidly inhibited in low pH environments. Interestingly, S. 
aureus nuclease activity was also lost in response to carbohydrate fermentation. Lower 
extracellular nuclease activity was demonstrated in the presence of glucose previously 
for S. aureus, although this was not linked to acid production (Kiedrowski et al., 2011; 
Beenken et al., 2012). The catalytic properties of SsnA are unknown but DNase 
enzymes work optimally over a wide-range of pH, from 4.2 with Aspergillus nuclease 
S1 (Vogt, 1973), to 9-10 with S. aureus nuclease (Cuatrecasas et al., 1967). SsnA has a 
hypothetical binding site for Mg
2+
 and it may be that lactic acid is acting as a metal 
chelator, thereby reducing DNase activity. Streptococcus pyogenes SpnA, an SsnA 
homologue, requires Mg
2+
 and Ca
2+
 for optimal activity (Chang et al., 2011). Organic 
acids are metal chelators, and can be used in heavy metal detoxification of soils (Wasay 
et al., 2001). However, it should be noted that DNase activity was irreversibly lost in 
acid, and was only restored by protein synthesis. 
Sugar fermentation and acid production is of relevance to the potential interaction 
between S. gordonii SsnA and S. mutans biofilm formation. Streptococcus mutans is 
recognised as the primary microbiological cause of dental caries (tooth decay) (van 
Houte, 1994). Although the shift to a cariogenic (acid-producing/acid-tolerating) oral 
biofilm is complex there is an increase in basal levels of cariogenic micro-organisms 
such as S. mutans and Streptococcus sobrinus in response to dietary sucrose. Therefore, 
carbon sources have a direct impact on the species composition of dental plaque. 
Streptococcus mutans biofilm formation can be dependent on eDNA (Chapter 5; Perry 
et al., 2009). Furthermore, SsnA has a dispersal effect on S. mutans GS-5 biofilms. 
However, the inhibition of SsnA by organic acids produced during sugar metabolism 
may add an extra dimension to the shift to a cariogenic biofilm. Streptococcus mutans is 
strongly acidogenic and therefore may inhibit SsnA activity, resulting in less anti-
biofilm effect against S. mutans. Interestingly, glucose reduces S. gordonii H2O2-
mediated inhibition of S. mutans (Kreth et al., 2008) and sucrose increases S. mutans 
bacteriocin production (Wang and Kuramitsu, 2005). Carbon sources may have a major 
role in the interaction between S. gordonii and S. mutans.  
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It appears that extracellular DNases are a conserved trait of many, but not all, 
streptococci and therefore these enzymes likely have an important role in the biology of 
this genus of micro-organisms. The studies presented here demonstrate that S. gordonii 
SsnA is an active DNase responsible for essentially all the extracellular DNase activity 
under the conditions tested. Further, SsnA is regulated by carbon source availability, 
CcpA, and inhibited by acidic pH. The most significant finding is the SsnA-mediated 
dispersal of S. mutans. Streptococcus gordonii SsnA may have an impact on S. mutans 
colonisation. However, acid production by S. mutans may be a defence response since 
acid inhibits SsnA. Future research should focus on the interaction between these two 
species, although it will be challenging to reproduce this interspecies antagonism in 
vitro.  
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Staphylococcus aureus was found to produce extracellular DNA over 50 years ago 
(Catlin and Cunningham, 1958). However, this early description was not extensively 
followed up until research by Whitchurch et al., (2002) demonstrated the key role 
eDNA plays in facilitating initial biofilm formation in Pseudomonas aeruginosa. The 
last decade of eDNA research has created a paradigm, whereby eDNA is important for 
biofilm formation and holding mature biofilms together. Furthermore, exogenous and 
host-produced deoxyribonucleases have been found to have a key effect on some 
biofilm-forming micro-organisms. Therefore, the start of this PhD thesis, in November 
2010 was placed in a key moment during the expansion of eDNA knowledge. The 
research contained within this thesis provides novel studies into biofilm matrix eDNA 
in three important biofilm systems. Lastly, applying exogenous DNase enzymes to 
biofilms has been investigated as a potential therapeutic approach across the biofilm 
systems studied.  
 
7.1 Summary of chapters 
 
The thesis began with a preliminary investigation into the role of eDNA in maintaining 
biofilm stability in TESV biofilms (Chapter 3). TESV biofouling is an issue that costs 
the Freeman Hospital, Newcastle (NHS) £44,000 a year in new valves (Shakir et al., 
2012). Valves have an average lifespan of as little as 108 days, due in part to biofilm 
colonisation (Kress et al., 2013). Microscopic observations were consistent with 
previous research characterising TESV biofilms as large aggregations of fungal and 
bacterial micro-organisms. By adding a further fluorescent stain, DAPI, to the CLSM 
technique used by Kania et al., (2010), it was possible to visualise eDNA in the biofilm 
matrix of TESV biofilms. These types of microscopic observations do not always 
provide conclusive evidence for eDNA. However, it was also possible to quantify 
eDNA and visualise it by agarose gel electrophoresis. This was the first example of 
eDNA within the biofilm matrix of TESV biofilms, and one of few investigations 
describing eDNA in mixed-species biofilms. Lastly, exogenous NucB was used as an 
anti-biofilm enzyme. This approach showed promise at removing TESV biofilm-
forming micro-organisms from the surface of TESVs (Shakir et al., 2012). Several 
micro-organisms associated with TESV biofouling have been shown to be susceptible to 
DNase treatment, including: Candida albicans (Martins et al., 2010), Lactobacillus 
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plantarum (Muscariello et al., 2013), and Staphylococcus spp. (Qin et al., 2007; Kaplan 
et al., 2012). This investigation showed the clear role of eDNA in maintaining TESV 
biofilm matrix stability. 
Again, working in collaboration with the ENT department of the Freeman Hospital, 
Newcastle, the second results chapter of this thesis (Chapter 4) looked in great detail at 
the role of eDNA in maintaining the biofilm stability of CRS isolates. Chronic 
rhinosinusitis is a complex disease that affects up to 10% of the adult European 
population (Hastan et al., 2011). The pathogenesis of the disease is unclear but there is 
evidence that suggests biofilms are a major factor in the development of the disease 
(Foreman et al., 2012). Therefore, this provided a strong rationale for examining the 
disease further, with the major objective of observing the potential of NucB as an anti-
biofilm enzyme in CRS. There was a large clinical microbiology element to this 
investigation, with 75 bacterial strains being isolated from 22 patients on four different 
agar types. Bacterial strains were similar to those previously observed, using culture-
dependent and culture-independent techniques (Brook, 2006; Araujo et al., 2007; Feazel 
et al., 2012). The microbial population was dominated by S. aureus, coagulase-negative 
staphylococci and α-haemolytic streptococci. Bacteria were isolated from ‘obstructive 
mucin’, a thick mucus-like material that is found in some CRS patient sinuses. This 
mucin was visualised in greater detail using TEM, whilst sinus mucosa was visualised 
with CLSM. These experiments suggested that ‘obstructive mucin’ was not colonised 
by microbial biofilms but that sinus mucosa was. The sinus mucosa biofilms were 
similar to those observed by Sanderson et al., (2006). Twenty-four CRS isolates were 
shown to produce microbial biofilms, with over half (14) being significantly dispersed 
by the NucB enzyme. Furthermore, 15 of the isolates contained eDNA in their biofilm 
matrices that was detectable by agarose gel electrophoresis. It was therefore shown, that 
NucB has potential in controlling biofilms formed by CRS isolates (Shields et al., 
2013). 
Chapter 5 of this thesis examined the biofilm adhesin role of eDNA in the oral 
biofilm, with a clear aim of expanding on the previous two chapters results. Four 
important oral bacteria, Streptococcus gordonii, Actinomyces oris, Streptococcus 
mutans and Fusobacterium nucleatum were examined. Of these four micro-organisms 
only S. gordonii was found to not be susceptible to DNase I treatment. This micro-
organism was also a poor producer of eDNA, although other authors have measured 
eDNA produced in significant quantifies by this bacteria (Kreth et al., 2009; Itzek et al., 
2011; Liu and Burne, 2011). Previously, F. nucleatum had been shown to not be 
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susceptible to DNase I (Ali Mohammed et al., 2013). Interestingly, four S. mutans 
strains all differed in their susceptibility to NucB. This research provided further 
evidence for strain differences in eDNA importance, a feature that was noted in CRS 
isolates. A major part of Chapter 5 was the 6 week research visit to the University of 
Michigan, MI, USA in 2013. Whilst working in Dr. Alexander Rickard’s laboratory a 
microfluidic biofilm modelling technique was learnt. This technique provided 3D 
images of S. gordonii, S. mutans, and mixed-species saliva biofilms. Furthermore, the 
expertise gained during the collaboration may mean a similar system is employed in Dr. 
Jakubovics’s laboratory soon.  
The last results chapter characterised the cell-wall-bound extracellular nuclease of S. 
gordonii. Extracellular DNase activity appears to be a conserved trait of streptococci. 
This research had a molecular biological focus that added many techniques to the 
clinical and applied skills learned earlier in the thesis. Bioinformatic analysis showed 
that S. gordonii SsnA shared most homology with a 733-aa endonuclease produced by 
Streptococcus anginosus. Deletion of the ssnA gene removed the extracellular nuclease 
activity of S. gordonii, both on DNase test agar and in a FRET DNase assay. The SsnA 
enzyme was found to be regulated both by carbon sources and lactic acid production 
during sugar fermentation. Interestingly, S. gordonii SsnA may have an impact on S. 
mutans colonisation in the oral cavity as both S. gordonii cells and purified GST-SsnA 
significantly dispersed S. mutans GS-5 biofilms. However, S. mutans is strongly 
acidogenic and therefore this may disrupt SsnA activity. DNases produced by 
streptococci that have been studied in detail include: Streptococcus suis SsnA (Fontaine 
et al., 2004), Streptococcus pyogenes SpnA (Hasegawa et al., 2010), Streptococcus 
pneumoniae EndA (Beiter et al., 2006), and Streptococcus agalacitae NucA (Derré-
Bobillot et al., 2013). The novel aspect of this investigation was the finding that a 
streptococcal extracellular deoxyribonuclease can disperse biofilms. 
 
7.2 Thesis summary and impact 
 
Each chapter of the thesis contributes to a greater understanding of the role of eDNA in 
maintaining biofilm stability. There have been many previous studies investigating 
eDNA and DNase dispersal but few have looked at chronic diseases and particularly 
mixed-species biofilms. The majority of research has examined eDNA production in 
model micro-organisms like Staphylococcus aureus (Mann et al., 2009) and 
Pseudomonas aeruginosa (Whitchurch et al., 2002). Furthermore, research based on 
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microbial extracellular DNases is often focussed on neutrophil extracellular trap (NET) 
degradation, not biofilm competition, although attention is moving towards this area. 
Therefore, this thesis has included novel investigations grounded on a paradigm that has 
existed for at least a decade. Interesting findings include the strain differences in eDNA 
importance, the overwhelming number of micro-organisms tested that are dispersed or 
inhibited by DNase enzymes and the high concentration of eDNA in most biofilm 
matrices tested. The research adds further weight to the theory that eDNA is an 
important component of microbial biofilm matrices. 
Biofilms from three different areas were studied, the oral biofilm, biofilms in sinuses 
and biofilms that form on TESVs. These microbial systems all form on different 
substratum, from silicone with TESVs, to the hard tissue surface of a tooth 
(supragingival plaque), and lastly mucosal soft tissue in the sinuses. Biofilm-forming 
species were found to require eDNA for attachment in all these systems during 
investigations, implying that bacteria require eDNA during initial attachment across 
many surfaces. Bacterial carriage is also moderately different across these three 
environments, although there are commensal micro-organisms that are found in all. 
Chronic rhinosinusitis is dominated by staphylococci, the early oral biofilm by 
Streptococcus spp., and TESV biofouling is often caused by Candida spp. Again, 
although the microflora differed, micro-organisms from all three systems were 
susceptible to DNase treatment.  
Streptococci can be isolated from sinuses, the oral environment and TESVs. There 
was variability in the efficacy of DNase enzymes versus Streptococcus spp. and strains. 
Other species that showed strain variability of DNase sensitivity included S. aureus and 
S. mutans. Recently, Grande et al., (2014) also linked DNase efficacy to strain 
differences. In this case S. aureus UAMS-1 was not dispersed or inhibited by 
Pulmozyme, although biofilm morphology was altered. This strain of S. aureus 
produces two extracellular nucleases that reduce biofilm formation in vitro (Beenken et 
al., 2012). Deoxyribonuclease activity may be altered due to many factors, including 
growth conditions, production of inhibitors, variance in eDNA structure, altered 
production of eDNA, variable efficacy of DNase enzymes against biofilm eDNA, and 
substratum used to culture biofilms. Clearly further investigations are required but this 
thesis has added further evidence to the variable nature of eDNA production and DNase 
efficacy amongst strains of the same species of micro-organism.  
Importantly, mixed-species biofilms were studied during this thesis. These included 
TESV biofilms, oral saliva microcosms, and microfluidic modelling of oral biofilms. 
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Several biofilms of TESV biofouling and saliva microcosms were susceptible to DNase 
treatment. In particular, it is noteworthy that TESV biofilms that have existed for up to 
2-3 months contain eDNA and are dispersed by NucB treatment. This suggests that 
eDNA is preserved in some biofilm systems for long periods of time, and is still 
exerting an influence on biofilm stability. Although eDNA has been shown to have 
importance in activated sludge biofilms (Dominiak et al., 2011) it is poorly understood 
how eDNA use changes over time during biofilm formation. For the most part it has 
been suggested that eDNA exerts its largest role on biofilm formation during initial 
attachment of cells but our data clearly indicate a role for eDNA in mature biofilms.  
Mixed-species biofilm research can be harder to interpret and have increased 
variability over single-species biofilms but it is important to demonstrate DNase 
potential in biofilms that more closely resemble those found in disease. With that in 
mind, oral biofilms were modelled using flowing human saliva in a microfluidics 
model. Contrasting static biofilms, with the BioFlux device it is clear that by using 
flowing nutrients biofilms can grow thicker, have a higher number of live cells (due to 
the removal of deleterious metabolites), and exhibit different colony morphology. It 
would be interesting to study these biofilms in more detail, in particular by treating with 
DNase enzymes. 
The research contained within this thesis has had an impact on a wider audience 
through public engagement events and media attention (see Appendix C). In particular 
the use of an enzyme from a ‘seaweed bacterium’ has proved an accessible idea to those 
without a strong scientific background. The three biofilms studied all have a great 
impact on many people. Chronic rhinosinusitis affects 10% of the adult European 
population (Hastan et al., 2011), TESV use, although rare, vastly increases the standard 
of living for users, and dental plaque affects anyone with teeth. Therefore this thesis 
contains research that everyone could have an interest in, and hopefully will positively 
impact society as a whole. I have enjoyed discussing it with friends, colleagues and 
complete strangers! 
 
7.3 Research techniques 
 
Many experimental techniques were used and designed during the course of the thesis. 
For example, to determine the anti-biofilm effect against TESV biofouling an 
experiment was designed to adequately measure biofilm dispersal. This has since been 
used by a further two students in Dr. Jakubovics’s laboratory (Edward Mason and 
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Syatirah Abdullah). The in gel zymography technique to visualise deoxyribonuclease 
DNA degradation has been shared with two laboratory groups (Prof. Grant Burgess and 
Dr. Paul Cooper). Microscopic analysis of TESV biofilms using a triple fluorescent 
stain CLSM approach (adapting Kania et al., (2010) technique) has been applied with 
great success by Sufian Al-Sammarraie to study mixed-species biofilm formation on 
denture acrylics. The adaptation of the FRET nuclease activity assay (Kiedrowski et al., 
2011; Beenken et al., 2012) to work in Dr. Jakubovics’s laboratory has also proved a 
success, with students’ now testing nuclease activity in a variety of conditions (Richard 
Holliday and Syatirah Abdullah). Lastly, a microfluidics biofilm culture system (Cellix 
Ltd.), similar to the BioFlux (Fluxion) system used in Dr. Rickard’s laboratory was 
recently tested in Dr. Jakubovics’s laboratory by Jill Robinson using the knowledge 
gained whilst in the United States. It took well over a year to visualise bacteria on the 
surface of sinus mucosa, and the development of a PNA-FISH CLSM technique to do 
so was another challenge during the thesis research. Having started the PhD as a marine 
biologist all microbiological, clinical, and molecular biological research techniques 
were acquired ‘on the job’. 
 
7.4 Future research 
 
The microflora of CRS patient sinuses, and briefly that of TESVs were studied during 
this thesis through the use of culture-dependent methods. It is potentially of value to 
further investigate the microbial populations of these two environments by applying 
culture-independent techniques. During the CRS investigation a sample of obstructive 
mucin from each patient was collected and frozen at -80°C so that it may be possible to 
study the microflora of these samples using a culture-independent technique, such as 
pyrosequencing of the 16S bacterial rRNA gene. However, there was not enough time 
to complete this study in full. Culture-independent analyses have been conducted 
previously in both CRS patients (Stressmann et al., 2011; Feazel et al., 2012; Boase et 
al., 2013) and for TESVs (Buijssen et al., 2012).  
Whilst the research gathered during this thesis has undoubtedly furthered eDNA 
knowledge, it is important to consider future work, and the limitations of the study. In 
keeping with the majority of eDNA biofilm research, this work depended heavily on the 
high-throughput 96-well microtiter assay. However, it is unlikely that these types of 
biofilms closely resemble the biofilms observed in CRS patients or in the oral cavity. 
Therefore, biofilm modelling has to be improved before any in vivo testing can be 
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performed. It would be interesting to ascertain the efficacy of DNase enzymes in a more 
realistic system. For CRS biofilms, it would be important to incorporate host epithelial 
cells or a 3-dimensional tissue model. Oral biofilms may be more realistically modelled 
in a flowing system such as the microfluidic biofilm model (Nance et al., 2013). 
Recently, eDNA has been found to be an important component of Staphylococcus 
epidermidis and Candida albicans biofilms grown in a subcutaneous catheter mouse 
model (Pammi et al., 2013). Furthermore, DNase I has dispersed Bordetella spp. nasal 
biofilms in a mouse model (Conover et al., 2011). These examples show the potential of 
deoxyribonucleases in treating biofilm diseases but investigations of this type should be 
expanded upon. 
A key clinical issue is whether DNase enzymes can increase the efficacy of 
antibiotics against biofilms cells. There is some evidence that this might be the case for 
particular biofilm systems (Tetz et al., 2009; Kaplan et al., 2012). This would be an 
interesting area to expand the CRS research, by including antibiotics during NucB anti-
biofilm assays. Theses assays could be performed using the Calgary Biofilm Device, 
which is designed to test antimicrobial efficacy against microbial biofilms (Ceri et al., 
1999). If deoxyribonuclease enzymes, like NucB, are to be used in a clinical setting it is 
important to prove their efficacy in treatment solutions. For TESV cleaning there are no 
major concerns as treatment solutions usually contain salts at low concentrations. 
However, DNase efficacy in oral hygiene products, that can contain chemicals like 
SDS, fluoride, and EDTA, is unknown. Work in the lab is currently underway to assess 
the compatibility of DNase enzymes with common constituents of oral hygiene 
products. It will be important to find a formulation that permits maximum activity of 
NucB if it is to prove useful at diminishing oral biofilms.  
A potentially interesting topic for further investigation is the question of why 
different strains of the same species exhibit differences in eDNA production and in the 
reliance for eDNA to stabilise biofilms. Analysing the genomes of different strains, and 
comparing them, may allow the identification of important genes in regulating eDNA 
production. Streptococcus mutans would be an obvious target for this approach, since 
significant differences in DNase sensitivity were identified between several different S. 
mutans strains. The accumulation of eDNA also appears to be tightly regulated, and 
depends on factors such as growth phase, and nutrient availability. Further identification 
of the pathways that lead to the release of eDNA will help to understand how this 
molecule enters the biofilm matrix. This could be achieved by screening for eDNA 
defective mutants of a particular species by culturing in a high-throughput 96-well 
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model, and assaying for eDNA content with the PicoGreen stain. Staining eDNA in the 
microplate is a high-throughput technique that has been used by Rikke Meyer’s 
laboratory (unpublished work). Possible eDNA defective mutants would be created 
through transposon mutagenesis. After discovering gene mutations that are responsible 
for lower eDNA content it would then be possible to target gene deletions in wild type 
species and analyse biofilm formation again. Ultimately, it may be possible to establish 
the regulators responsible for producing eDNA, and potential relationships between a 
number of regulators. Species that could be studied in this way could be S. mutans, C. 
albicans or S. aureus, as these micro-organisms all have a major impact on healthcare. 
Working with one species would be the aim, as this greatly simplifies research. This 
work could be expanded by using relevant animal models to analyse biofilm formation 
in vivo. Understanding the basic mechanism of eDNA release will make it easier to 
target this component of biofilm matrices with DNase enzymes or with novel 
compounds that target the DNA release step.  
It is also interesting that S. gordonii produces a deoxyribonuclease that disperses S. 
mutans biofilms. Competition between the two species could change the oral biofilm 
significantly. However, this theory needs further investigation as there are many factors 
that could influence any interaction. This hypothesis could be analysed by culturing the 
two species together in a dual-species biofilm and determining the effect of acid 
production on S. mutans colonisation (inhibitory effect on SsnA activity). Biofilm 
extent by each species in different growth media could be measured both by quantitative 
PCR, and colony forming units on culture media. The dual-species biofilms would be 
cultured in sugar sources (plus minimal sugar), and SsnA activity measured by FRET, 
with the pH of the system also quantified. However, it would be important to consider 
the strain variability of DNase sensitivity in S. mutans. 
Purely from an evolutionary prospective, it seems futile for an organism to devote 
extensive resources to create the molecule of hereditary, DNA, only to expel it into the 
environment. Clearly eDNA is an important aspect of microbial development, or its 
expulsion would not have evolved. It appears that we are only at the start of 
understanding the full dynamics of eDNA and DNase production. 
 
7.5 Final conclusion 
 
To conclude, the research in this thesis has made novel contributions to the 
characterisation of eDNA as a biofilm maintaining compound. Furthermore, 
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extracellular deoxyribonuclease enzymes have been shown to have powerful anti-
biofilm activity across a wide range of micro-organisms in the head and neck. Microbial 
biofilms are an extremely important factor in the pathogenesis of many diseases and a 
greater understanding of them will allow us to eradicate them more easily. Additionally, 
DNase enzymes could potentially be developed for the treatment of many different 
chronic diseases with a biofilm pathogenesis.  
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Appendix A: Relevant Publications 
 
Three papers were published during the thesis and are inserted below.  
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Abstract 
Objective.   The  growth  of  biofilms on  tracheoesophageal 
speech valves shortens  their life span and produces a reser- 
voir of pathogens that may infect the respiratory  tract. The 
authors have discovered a novel nontoxic deoxyribonu- 
clease, NucB, from a marine isolate of Bacillus  licheniformis 
that is effective at dispersing a variety of mono and mixed- 
species bacterial biofilms. The aim of this preliminary study 
was  to  determine  whether  NucB could  also  disrupt  and 
remove  mixed-species biofilms from tracheoesophageal 
speech valves. 
 
Study Design. Laboratory-based  treatment   and  analysis of 
discarded tracheoesophageal speech valves. 
 
Setting. University human  biology laboratory  and  the 
Department of Speech and Language Therapy at a tertiary refer- 
ral hospital. 
 
Subjects and Methods. Seventeen ex vivo tracheoesophageal 
speech valves fouled with natural human biofilms were col- 
lected and divided into 2 equal parts. One half was treated 
with NucB and the other  half with a control buffer solution. 
Biofilm removal was measured by microscopy and by culture 
of dispersed biofilm organisms on agar plates. 
 
Results. Significantly  more  organisms  were  released  from 
biofilms using NucB than  with  buffer solution  alone.  On 
nonselective medium, more  organisms were  cultured in 11 
samples (65%, n = 17, P > .05). Using growth media favoring 
fungi, more organisms were cultured in 14 samples (82%, n = 
17, P >.05). 
 
Conclusion. The nontoxic deoxyribonuclease NucB was 
effective in releasing more microorganisms from biofilms on 
tracheoesophageal  speech valves.  This reflects its potential 
ability to break up and disperse these biofilms. Future stud- 
ies will aim to  develop NucB as a novel agent to  prolong 
the life span of tracheoesophageal speech valves, thus reduc- 
ing health care costs. 
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tracheoesophageal speech valve (TESV) contains a 
1-way valve that diverts the air in the trachea into 
the throat and mouth to enable phonation with the 
tongue and lips, without leakage of the saliva or food from 
the neopharynx into the airway. These valves are placed in 
a  tracheoesophageal  fistula  that  is  surgically  created  to 
allow the passage of air into the upper esophagus and, sub- 
sequently, the oropharynx and oral cavity. In situ, silicone 
TESVs rapidly become colonized with bacteria and fungi, 
some of which are opportunistic pathogens.
1  
Soiling of the 
airway and respiratory tree leads to increased episodes of 
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tracheal aspiration and tracheal irritation, leading to cough- 
ing.
2  
Another symptom that heralds the end of a TESV life 
is increased patient effort required to generate phonation, and 
subsequently speech becomes very disturbed.
3  
Furthermore, 
TESV  failure  impairs  communication  between  the  patient 
and his or her environment.
4
 
The degradation of TESVs also leads to increased health 
care  costs as valves have  to  be  changed more  frequently 
depending on the rate of colonization in a particular individ- 
ual.   In   the   Department   of   Otolaryngology,   Freeman 
Hospital, Newcastle upon Tyne, UK, there were 64 patients 
on our records in 2010 who required TESVs. In the period 
from  January 2010  to  December  2010, 413  TESVs were 
used at a cost of $68,500 (excluding taxes and staff costs). 
Cleaning of TESVs is particularly difficult because the 
micro-organisms   that    colonize    them    form   biofilms.
1
 
Standard current advice given to patients with regard to 
cleaning their TESV is to immerse it in warm water or to 
use  baby  bottle  cleaning  agents  and  gently  mechanically 
clean the valve with a cotton bud or cleaning brush often 
supplied with the TESV. Some TESVs can be removed and 
cleaned  intermittently.  However,  even  frequent  cleaning 
does  not  prolong  the  life  of  the  device  beyond  approxi- 
mately 3 to 5 months.
5  
At present, there are no mechanisms 
to clean permanently indwelling TESVs, and these devices 
are generally replaced every 2 to 3 months. 
We have recently identified a novel biofilm-degrading 
enzyme, NucB, from the marine bacterium Bacillus licheni- 
formis EI-34-6.
6  
In vitro, NucB could disperse biofilms pro- 
duced by a different strain of Bacillus (B licheniformis 
DSM13) and by a range of medically relevant gram-positive 
and gram-negative organisms. NucB is a deoxyribonuclease 
specifically produced by B licheniformis when growing in 
biofilms. NucB targets extracellular DNA (eDNA), an 
important component of the biofilm matrix. 
Treatment of young Pseudomonas aeruginosa biofilms 
with a commercially available nuclease, DNase I, resulted 
in dispersal of cells from the surfaces.
7  
It was also noticed 
that DNase I was more effective at releasing early P aerugi- 
nosa biofilms than at clearing established biofilms from sur- 
faces.
7    
Therefore,  the  assessment  of  dispersed  microbes 
using colony forming units (CFUs) could be an indirect 
method of assessing the effect of nuclease in dispersing at 
least  the  newly  formed  biofilms.  Similarly,  addition  of 
DNase I to planktonic P aeruginosa cultures retarded the de 
novo formation of new biofilm.
7
 
Bacillus  licheniformis NucB  is  smaller  than  DNase  I 
and potentially may migrate through biofilms more effi- 
ciently. Concordantly, our preliminary in vitro studies 
indicate that NucB is more efficient than DNase I at 
removing biofilm.
6
 
The aim of this preliminary study was to investigate the 
potential  of the  NucB enzyme  to  disperse natural mixed- 
species biofilms from TESVs. In the long term, the use of a 
nuclease in cleaning TESVs may make cleaning easier and 
prolong the lifetime of these devices. 
Materials and  Methods 
Study Design 
This study was an anonymized primary research into the effi- 
cacy of NucB nuclease in a laboratory setting, with a case con- 
trolled design. We obtained the approval of the local National 
Health  Service  (NHS)  Trust  Research  and  Development 
(R&D) Department to conduct this research, and it was con- 
firmed that ethical approval was not required. The study was 
anonymous and did not involve any sampling of human tissue. 
No specific patient subgroup among TESV users was selected; 
valves  were  obtained  on  a  ‘‘next-available’’  basis  over  a 
4-month period. 
 
Specimens 
Ex vivo TESVs (Blom-Singer, Forth Medical Ltd, 
Newbury, Berkshire, United Kingdom) that were due to 
be  discarded  were  obtained  from  the  hospital’s  Speech 
and Language Therapy Department (Freeman Hospital, 
Newcastle Upon Tyne) and immediately placed in phos- 
phate buffer solution (PBS) and stored at 4 C for up to 3 
days before analysis. 
 
NucB Treatment  of TESVs 
Valves were divided into 2 equal parts along their longitudinal 
axes using a sterile scalpel (Swann-Morton, Sheffield, UK). 
There were 2 treatment arms. The active treatment used our 
agent, NucB DNase (3 mg/mL), in PBS at pH 7.3. The control 
treatment used PBS alone. Sterile polystyrene 12-well microti- 
ter  plates (Greiner Bio-One, Monroe, North Carolina) were 
used for the treatment of TESV halves. The half valves were 
each washed 3 times with sterile PBS and subsequently placed 
for 1 hour at 20 C either in a treatment well containing 500 
mL NucB solution (3 mg/mL)
6 
and 2.5 mL sterile PBS solu- 
tion or in a control well containing 3.0 mL sterile PBS. 
Triplicate samples of the supernatant were diluted, and 
50-mL aliquots were spread onto nutrient agar (Oxoid, 
Basingstoke,  UK)  or  Sabouraud-dextrose  agar   (Oxoid). 
Plates  were  incubated  for  16  to  20  hours  at  37 C  under 
aerobic conditions. Nutrient agar was chosen as a nonselec- 
tive medium. Sabouraud-dextrose selects for fungi, includ- 
ing  Candida  spp.  Following  incubation  of  plates  for  24 
hours,  colonies    2  mm  were  counted,  and  total  colony- 
forming units (CFUs) released were calculated. Only plates 
with 10 to 400 colonies were counted. Representative colo- 
nies were picked, and strains were isolated by subculturing 
3 times of solidified media. Isolates were analyzed by gram 
staining and microscopy. This method of detecting biofilm 
change was chosen over direct microscopy of valves before 
and after treatment, as the fixative process for scanning 
electron microscopy (SEM) destroys bacteria and alters the 
biofilm appearance by dehydration and the biofilm flora 
within.
8   
In  addition,  SEM  can  only  demonstrate  qualita- 
tively  the  surface  of  the  TESV  or  the  biofilm  upon  it,
9 
making it hard to standardize the data. It is very difficult to 
locate 2 extremely similar biofilms, with reference to their 
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Figure 1. Post 16-hour, 37 C incubation of nutrient agar plates. 
(A) Culture of the tracheoesophageal speech valve (TESV) bath 
containing NucB. (B) Control only. 
 
 
thickness, amount of DNA present, and species composi- 
tion, on the same valve. 
 
Statistical  Analysis 
Statistical analysis was performed on each TESV, compar- 
ing  the  triplicates  from  each  half  of  the  valve.  Means 
derived  from  treatment  and  control  CFU  triplicate  plate 
counts for each TESV half were used for the ratio of treat- 
ment and control values, standard error calculation, and x
2 
comparison testing. From this, P values and statistical sig- 
nificance (P > .05) were derived. 
 
Results 
As this was a laboratory study, no patients were affected. 
Twenty TESVs were obtained. The results of 3 TESVs were 
excluded from our study; 1 TESV culture solution did not 
produce any CFUs, and 2 TESV treatment and control solu- 
tions produced too many colonies to be counted accurately 
and were excluded. The results of the remaining 17 TESV 
culture plates were used for analysis. 
Figure 1 represents the colonies grown from the super- 
natant  from  a  valve.  Half  of  the  valve  was  treated  with 
NucB  nuclease  and  the  other  half  with  PBS  alone.  The 
NucB treatment clearly released more viable micro- 
organisms than  PBS alone. These plates  demonstrate that 
our novel NucB nuclease  liberated  more micro-organisms 
from TESV biofilms compared with the control treatment. 
This suggests that NucB nuclease has the potential to dis- 
rupt TESV biofilms. We hypothesize that the mechanism of 
action is by the degradation of eDNA, which holds the bio- 
film together, in the biofilm matrix on the TESV surface. 
From the CFU data, it was possible to determine which 
treatment generated higher CFU counts per valve. Table 1 
shows which treatment produced significantly higher CFU 
counts  in  all  included  valves.  Higher  CFU  counts  result 
from more micro-organisms being liberated from TESV sur- 
faces.  The  active  treatment  with  NucB  generated  higher 
CFU counts on both nutrient and Sabouraud agar, indicating 
that  more  micro-organisms and  fungi, in  particular,  were 
released by treatment with NucB. Table 2 shows the data 
from the 17 valves included in the study, confirming that 
more organisms were cultured in 11 samples (65%) on non- 
selective nutrient agar plates. The P values for each valve 
are  included.  Table  3  shows  the  use  of  Sabouraud agar 
plates, favoring fungi, from all the included valves. It 
demonstrates that more organisms were cultured in 14 sam- 
ples (82%). Treatment of TESVs with NucB released 5.7- 
fold more CFUs vs control (standard error [SE], 3.7-7.7) on 
selective Sabouraud agar and 5.0-fold more CFUs vs control 
on nonselective nutrient agar (SE, 3.1-6.9), as shown in 
Figure 2. 
Each valve yielded a variety of bacteria and fungi, and 
preliminary analysis using gram staining indicated the pres- 
ence of gram-positive cocci and gram-negative rods. Tests 
identifying  particular  strains  were  not  performed. Colony 
and organism morphology suggested a high prevalence of 
Candida spp. This is consistent with current literature.
10,11
 
 
Discussion 
The aim of this study was to determine the ability of an 
eDNA degrading nuclease NucB to disrupt and remove 
mixed-organism biofilms from TESVs. The application of 
NucB to fouled TESVs resulted in significantly higher num- 
bers of micro-organisms being released from the TESV sur- 
faces compared with the control. NucB was effective at 
releasing organisms from the majority of the 17 TESVs ana- 
lyzed (P > .05 in 11 of 17 nutrient agar plates). The bene- 
fits  of  NucB were similar  when Sabouraud-dextrose agar 
(selective for fungi, P > .05 in 14 of 17 plates) was used, 
illustrating a general applicability of this method on mixed- 
species biofilms. 
It  is  well  known that  micro-organisms in  biofilms  are 
protected against antimicrobials and other external stresses. 
For  example,  the  control  of  Candida   albicans   biofilm 
requires approximately 4 times higher concentrations of flu- 
conazole than are needed to eliminate planktonic (free-floating) 
cells.
12  
Long-term treatment with antifungals is undesirable as it 
encourages selection of resistant strains.
13
 
 
 
Table 1. Summary of Which Treatment Generated  Higher CFU Counts Cultured from Each TESV (n = 17) 
 
Active (NucB)                      Control (Phosphate Buffer Solution)                      Insignificant Difference 
 
Nutrient agar                                                 11a                                                                                         1a                                                                                                     5 
Sabouraud-dextrose agar                               14a                                                                                         2a                                                                                                     1 
 
Significance level was calculated by comparing the 2 halves of each valve. Abbreviations:  CFU, colony-forming unit; TESV, tracheoesophageal speech valve. 
aP >.05. 
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3 2520 600 .0001  
4 21,960 21,840 .941  
5 2910 90 .0001  
6 21,000 12,360 .0001 4.0 
7 1890 300 .0001  
8 1710 1110 .145  
10 27,960 24,300 .0387  
11 10,080 3930 .0001  
12 6420 1470 .0001  
14 9690 8850 .426  
15 5922 582 .0001  
16 28,020 20,760 .0001  
17 3820 2640 .058 0.0 
19 2400 200 .0001  Sabouraud agar 
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19 2360 140 .0001 
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Table 2. Mean of Triplicate Plate CFU Count Using NucB Treatment 
and Control on Nutrient Agar 
 
Valve No.            Treatment CFU           Control CFU           P Value 
8.0 
 
 
 
 
 
 
 
 
 
 
 
 
2.0 
 
 
 
 
 
 
20                               15,400                        15,040                  .79 
 
Note  that valves 9, 13, and 18 were excluded. The bold P values show that 
NucB released more  colony-forming units (CFUs), whereas  the  italic ones 
reflect valve solutions when the control produced more CFUs. 
 
 
 
Table 3. Mean of Triplicate Plate CFU Count Using NucB Treatment 
and Control on Sabouraud Agar 
 
Valve No.            Treatment CFU           Control CFU           P Value 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20                               15,720                           8960                  .0001 
 
Note  that valves 9, 13, and 18 were excluded. The bold P values show that 
NucB released more  colony-forming units (CFUs), whereas the  italic ones 
reflect valve solutions when the control produced more CFUs. 
 
 
 
Biofilms protect  bacteria  and  fungi  from  antimicrobial 
agents by several mechanisms, including reduced penetra- 
tion  of  antimicrobial  agents  into  the  cell  colonies,  slow 
growth of micro-organisms in  biofilms,
14   
the  presence of 
Nutrient agar 
Figure 2. The ratio of micro-organisms released by NucB com- 
pared with control. Standard error  bars are shown. NucB is in gray 
and control in white. CFU, colony-forming unit. 
 
 
highly resistant ‘‘persister’’ cell types in biofilms,15,16  and 
the  upregulation  of  specific  antimicrobial  genes, such  as 
those encoding efflux pumps
17   
in biofilms. A key compo- 
nent of biofilms is the extracellular matrix, which glues 
micro-organisms to  the  surface  and  provides a  barrier  to 
mass transfer of antimicrobial agents. There is now evidence 
that some bacteria in biofilms produce biofilm-degrading 
enzymes to enable the liberation of bacterial cells to new 
sites in a host in vivo. These same enzymes have been 
employed to disperse bacterial biofilms to good effect.
18
 
The antibiofilm properties of the B licheniformis NucB 
enzyme were reported for biofilms formed by a variety of 
aerobic bacteria in model monospecies cultures.
6  
The cur- 
rent work demonstrates that NucB is also effective against 
natural  mixed-species  biofilms  on  TESVs.  Of  particular 
note  is  the  observation  that  Candida  spp.  were  released 
from biofilms by NucB. Candida spp. are common coloni- 
zers of TESV surfaces. In one study, the total Candida spp. 
cultures  constituted  more  than  50%  of  organisms  grown 
from TESVs at both the tracheal and esophageal surfaces of 
valves.
19  
It is noteworthy that Candida spp. have previously 
been shown to employ eDNA to stabilize their biofilms, and 
treatment  with DNase I  promotes biofilm  removal.
20   
The 
eDNA therefore is an important component of mixed micro- 
bial  biofilms  and  is  produced  in  different  ways:  by  cell 
lysis,
21   
autolysis-dependent cell lysis,
22   
or active excretion 
of eDNA from cells, for example, in vesicles.
23  
The eDNA 
is an important factor in the life span of the biofilm, notably 
as a microbial aggregator
24  
or as an important molecule in 
biofilm stability.
25
 
An additional factor influencing the stability of biofilms 
is  the  composition  of  micro-organisms  within  them.  The 
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presence of Candida spp. has been demonstrated to encour- 
age the attachment of Streptococcus gordonii and the devel- 
opment of mixed-species biofilm communities in the oral 
cavity.
26  
This study has shown a link between the behavior 
of Candida  spp. and bacteria, and similar interactions may 
also occur on prosthetic TESV surfaces.
10
 
The  use  of  biosurfactants  to  treat  TESV  biofilms  has 
been investigated; TESV biofilms were treated with a solu- 
tion  extracted  from  cultured  Streptococcus  thermophilus, 
but the active compound was not described.
27  
Another study 
used an active antibiofilm enzyme that was tested by mea- 
suring the altered surface tension of water droplets, although 
not against prosthetic surfaces.
28   
The study presented here 
is the first example of a bacterial nuclease being used to 
remove multispecies biofilms from TESVs. 
This study used the method of micro-organism culture and 
the counting of CFUs to measure degradation of TESV bio- 
films as it was a rapid and sensitive method for detecting bio- 
film  breakdown.  The  results  indicated  that  NucB  is  an 
extremely promising agent for the control of biofilms on 
TESVs. This is an indirect measure of the ability of NucB to 
disrupt the biofilms. However, a great deal of further work is 
required to develop this enzyme as a useful adjunct to current 
cleaning protocols for TESVs. Therefore, further studies will 
aim to develop treatment protocols that can be used by patients 
for maintaining biofilm-free TESVs. The future studies will 
aim at the direct examination of the TESVs to evaluate the 
effectiveness of NucB in preventing and disrupting biofilms. It 
is hoped that such treatments will prolong the life span of 
TESVs and reduce the risks of TESV-related infections. 
Microbial degradation of TESVs has been clearly demon- 
strated by scanning electron microscopy.
9  
Scanning electron 
microscopy has also been employed to study the microbial 
composition of TESV biofilms and has revealed that biofilms 
contain  mixed  populations of yeasts and bacteria.
9,11    
Using 
confocal laser scanning microscopy (CLSM), we detected both 
bacteria and fungi in mixed-species biofilms on TESVs (data 
not shown), which is fully consistent with both the SEM stud- 
ies and the CLSM analyses published by other groups.
10,29
 
Previous studies have documented reproducible spatial varia- 
tions within TESV biofilms—for example, Candida spp. may 
be found deeper and adjacent to the silicone surface.
10
 
In summary, this preliminary study has demonstrated that 
the use of the nuclease enzyme, NucB, from a marine bac- 
terium,  can  release  more  microorganisms  from  biofilms 
found on TESVs in a statistically significant manner. This 
suggests its ability to disrupt biofilms on TESVs. This 
biofilm-degrading enzyme therefore has potential in the 
treatment and maintenance of TESVs, either as a sole treat- 
ment agent or in combination with other substances, to pro- 
long the life span of TESVs. 
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Abstract 
 
Background:  The  persistent   colonization  of  paranasal  sinus  mucosa  by  microbial  biofilms  is  a  major  factor  in  the 
pathogenesis of chronic rhinosinusitis (CRS). Control of microorganisms  within biofilms is hampered by the  presence  of 
viscous extracellular polymers of host or microbial origin, including nucleic acids. The aim of this study was to investigate 
the role of extracellular DNA in biofilm formation by bacteria associated  with CRS. 
 
Methods/Principal Findings:  Obstructive  mucin was collected  from patients  during  functional endoscopic  sinus surgery. 
Examination of the mucous by transmission electron microscopy revealed an acellular matrix punctuated occasionally with 
host cells in varying states of degradation. Bacteria were observed in biofilms on mucosal biopsies, and between two and six 
different species were isolated from each of 20 different patient samples. In total, 16 different bacterial genera were isolated, 
of which the  most  commonly  identified organisms  were coagulase-negative staphylococci, Staphylococcus aureus and a- 
haemolytic streptococci. Twenty-four fresh clinical isolates were selected for investigation of biofilm formation in vitro using 
a microplate  model system. Biofilms formed by 14 strains, including all 9 extracellular nuclease-producing bacteria, were 
significantly disrupted  by treatment with a novel bacterial deoxyribonuclease, NucB, isolated from a marine strain of Bacillus 
licheniformis.  Extracellular biofilm matrix was  observed  in untreated samples  but  not  in those  treated   with  NucB and 
extracellular DNA was purified from in vitro biofilms. 
 
Conclusion/Significance: Our data  demonstrate that  bacteria  associated  with  CRS form robust  biofilms which  can  be 
reduced  by treatment with matrix-degrading  enzymes such as NucB. The dispersal of bacterial biofilms with NucB may offer 
an additional therapeutic target  for CRS sufferers. 
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Introduction 
 
Chronic rhinosinusitis (CRS) is one of the most common upper 
respiratory tract diseases, affecting approximately 10% of the adult 
European population [1]. Rhinosinusitis is an inflammation of the 
paranasal  sinuses that  is  almost  always accompanied  by  in- 
flammation of the nasal airway and is classified as ‘chronic’ if it 
lasts at least 12 consecutive weeks [2]. The  symptoms of CRS 
include blockage or congestion of the nasal passages, nasal 
discharge, facial pain or pressure and/or a reduction or loss of 
sense of smell. The  majority of cases of CRS  are treated  with 
medical therapy consisting of topical steroids and nasal douching 
[3]. Antibiotics such as clarithromycin or amoxicillin may be used 
at the outset of therapy or for acute exacerbations of disease. In 
cases of CRS that are recalcitrant to medical treatment, 
surgicaltechniques may be warranted to improve the drainage 
pathway of the sinuses and  to remove polyps and obstructive 
mucin. Non- invasive surgical interventions, known collectively 
as functional endoscopic sinus surgery (FESS), are now widely 
used, although there  is  limited  evidence  to  support  their  
efficacy [4].  The successful treatment of CRS is hampered by 
the heterogeneity of the disease. Chronic rhinosinusitis is a 
spectrum of diseases with a  variety of causes or  contributing  
factors including smoking, allergies, underlying systemic 
diseases, invasive or  non-invasive fungal infections, viruses and 
bacteria [2,5,6]. Increasingly, it is becoming clear that 
microbial biofilms are associated with many cases of CRS.  The  
growth  of microorganisms within biofilms presents unique 
problems for the management  of CRS.  Within biofilms, micro-
organisms are up to 1,000-fold more resistant to 
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antibiotics than free-living cells of the same species [7]. Increased 
resistance is  due  to  many  factors,  including  the  presence  of 
a  viscous polymeric  matrix  that  restricts  the  penetration   of 
antimicrobials,  slow growth  of  bacteria,  resistant  phenotypes, 
and altered chemical microenvironments [8–11]. In keeping with 
these observations, there is limited evidence that either topical or 
systemic antibiotics  improve  the  outcome  of  CRS  infections 
[12,13] underlining the need for new therapeutic approaches. 
The   role  of  biofilms in  the  initiation  of  CRS  and  their 
recalcitrance to treatment  has received a great deal of attention 
over the last few years. A recent review of the literature identified 
11 studies reporting the analysis of biofilms on sinus mucosa in 
CRS patients [14]. Several different techniques were employed to 
visualise biofilms. Arguably  the  most  convincing  method  was 
fluorescence in situ hybridization,  since  this  provides  contrast 
between  bacterial  DNA  and  host  cells. Biofilms on  mucosal 
surfaces appear as punctate staining (bacterial cells), occasionally 
with some diffuse coloration, suggestive of extracellular nucleic 
acids [9]. All studies detected biofilms in a proportion  of CRS 
patients, with prevalence varying from 25% to 100%. In contrast, 
only three of the eight studies that also analysed non-CRS controls 
identified biofilms on  the  non-CRS  sinus mucosa,  and  these 
involved small numbers of patients. Collectively, these data clearly 
point  to an  association between biofilms on sinus mucosa and 
CRS. In addition, biofilms or biofilm-forming bacteria have been 
associated  with  unfavourable  outcomes  following FESS.  For 
example,  the  presence  of biofilms on  paranasal  sinus mucosa 
was correlated with persistent mucosal inflammation and require- 
ments for lengthy post-surgical follow-up periods [15]. In a large 
cross-sectional study involving 518 CRS patients, the presence of 
sinus biofilms was significantly correlated with prior experience of 
sinus surgery, indicating either that  biofilms contribute to CRS 
recurrence, or that FESS may promote the formation of biofilms 
[16]. Further,  the capacity of paranasal sinus isolates of 
Staphylococcus aureus or Pseudomonas aeruginosa to form biofilms in vitro 
has been associated with the recurrence of CRS symptoms in the 
12 month period following FESS [17]. 
There  is strong evidence that the microflora of the maxillary 
sinus changes during acute sinusitis, towards a predominance of 
Streptococcus pneumoniae,  Haemophilus  influenzae  and,  less frequently, 
Moraxella  catarrhalis  [18,19]. However, the  microbial population 
present  in  CRS  more  closely resembles that  in  non-inflamed 
paranasal sinuses. The most common organisms both in CRS and 
in healthy patients include Staphylococcus aureus,  coagulase-negative 
staphylococci, a-haemolytic streptococci, Corynebacterium spp. and 
strict anaerobes such as Prevotella  spp., Peptostreptococcus  spp. and 
Propionibacterium spp. [19–22]. Therefore, the development of 
biofilms within the  paranasal  sinuses, and  the  subsequent host 
responses to biofilms, may be more important for the pathogenesis 
of CRS than the de novo colonization of the upper respiratory tract 
by specific pathogens. 
In  light of the  resistance of biofilm bacteria  to conventional 
antibiotics, a number  of novel approaches  for treating  biofilms 
have been proposed, including interfering with chemical commu- 
nication between micro-organisms or degrading the biofilm matrix 
with enzymes [23,24]. Biofilms associated with CRS are extremely 
heterogeneous, with many different organisms playing a role, and 
therefore  any  strategy to  clear  biofilms would need  to  target 
a component that is widely utilised by different microorganisms in 
the   biofilm  matrix.   One   possible  target   that   has   received 
significant interest in recent years is extracellular DNA (eDNA). 
The  matrices of a many different bacterial and  fungal biofilms 
contain eDNA, and this molecule has been shown to serve several 
critical functions including stabilising the biofilm structure [25– 
28], enhancing initial adhesion to surfaces [29,30], promoting the 
exchange of genetic information [31], and  acting as a nutrient 
store that can be utilised during nutrient depletion [32]. Recently, 
we have identified an  extracellular bacterial deoxyribonuclease, 
NucB, from a marine isolate of Bacillus  licheniformis strain EI-34-6 
that  can disperse biofilms by degrading eDNA [33]. The 
exogenous addition of NucB to biofilms formed by Escherichia coli, 
Bacillus  subtilis  or  Micrococcus  luteus  resulted in  almost complete 
removal of bacterial cells from surfaces. Hence,  NucB has the 
potential to remove biofilms formed by Gram-positive or Gram- 
negative bacteria. It is anticipated that the development of new 
methods for disrupting viscous biofilm matrices will improve the 
post-surgical outcomes of FESS. In addition, such approaches may 
facilitate the surgery itself if the obstructive mucin is also targeted. 
This study therefore aimed to characterise the potential of NucB to 
disperse biofilms formed by microorganisms associated with CRS. 
 
Materials and Methods 
 
Ethics Statement 
Ethical approval  for the  study was granted  by the  National 
Research  Ethics Service Committee  (North East – Sunderland) 
and each patient gave informed consent before enrolment. 
 
Collection of Specimens 
A total of 20 patients undergoing FESS for the treatment  of 
CRS  at  the  Freeman  Hospital,  Newcastle upon  Tyne,  were 
recruited to this study. All patients met the CRS diagnosis criteria 
published by the Chronic Rhinosinusitis Task Force [2]. Patients 
were recruited to the study only if obstructive mucin was observed 
during the surgical procedure. During FESS, obstructive mucin 
that  was dislodged surgically was collected with mucous traps 
(Sigma Aldrich) and  immediately  placed  into  sterile  reduced 
transport  fluid (RTF) [34].  Specimens were transferred  to  the 
laboratory and stored at 4 C. All samples were processed within 
24 h. 
 
Transmission Electron Microscope Analysis of Obstructive 
Mucin 
Samples of obstructive material removed from patients during 
FESS  were  cut  into  1 mm3    pieces  and   placed  into  2% 
glutaraldehyde  immediately after  surgery. These  samples were 
dehydrated  through  a series of ethanol  washes, embedded  and 
sectioned at Electron Microscopy Research  Services, Newcastle 
University. Sections were  analysed  in  a  transmission electron 
microscope (Philips, CM100). 
 
Visualisation of Bacteria on the Surface of Sinus Mucosa 
Fluorescence in situ hybridisation (FISH) was performed using 
a peptide nucleic acid (PNA) probe  corresponding to the well- 
characterised EUB338 probe [35]. The probe was synthesized as 
a  fluorescein amidite  (FAM) conjugate  by  Panagene.  Mucosal 
biopsy specimens were fixed in 10% formalin directly after 
surgery, and stored at 4 C for up to one month. For PNA-FISH 
analysis, specimens were  transferred  to  50%  ethanol  and  in- 
cubated for 16 h at - 2 0  C.  Biopsy material was transferred to 
1 ml permeabilization buffer (10 mg/ml  lysozyme in PBS) and 
incubated at 37 C  for 30 min. Samples were immersed in 1 ml 
pre-warmed   wash  buffer  (10 mM   Tris-HCl   pH 9.0,   1 mM 
EDTA)  for 30 min  at  55 C.  Pre-warmed  hybridization  buffer 
(25 mM  Tris-HCl  pH 9.0,  100 mM  NaCl,  0.5%  SDS,  30% 
formamide) containing 150 pmol per ml of the PNA probe was 
added to samples and incubated in darkness for 90 min at 55 C. 
Unbound PNA probe was removed by incubating in pre-warmed 
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wash buffer for 30 min at 55 C. Eukaryotic cells were counter- 
stained by immersing the specimens in 1 ml PBS containing 2 mg 
ml21  49,6-diamidino-2-phenylindole  (DAPI) in darkness at 20 C 
for 15 min. Samples were glue-mounted onto a plastic surface and 
immersed  in  2 ml  PBS. Visualisation of  surface bacteria  and 
eukaryotic cells was performed using a Leica TCS SP2 microscope 
with an argon/neon laser for imaging FAM conjugates (excitation 
495 nm,   emission  520 nm),  and   DAPI   (excitation  358 nm, 
emission 461 nm).  Images  were  converted  into  z-stacks using 
Image J software [36]. 
 
Isolation and Culture of Micro-organisms 
A variety of growth media were employed for the isolation and 
routine  culture  of micro-organisms. Blood agar  contained  (per 
litre)  37 g  Brain  Heart   Infusion  (Oxoid),  5 g  Yeast  Extract 
(Merck), and  15 g Bacteriological Agar. After sterilization, 5% 
(v/v)  defibrinated  horse  blood  (TCS  Biosciences) was  added. 
Chocolate agar was prepared using the same recipe except that, 
after the addition of horse blood, the medium was heated to 70uC 
for 10 min. Fastidious Anaerobe Agar (FAA) was purchased from 
The  DNA was suspended in 25 ml  elution buffer (10 mM  Tris 
pH 8.5). 
The  gene encoding 16S  rRNA  was amplified from  2 ml  of 
extracted DNA in a reaction that also contained 5 ml  (25 pmol) 
each  of oligonucleotide primers 0063F and  1387R  [38], 25 ml 
ReddyMix Extensor PCR  Master Mix (Thermo  Scientific) and 
13 ml  dH20.  PCR  reactions were run  using a  GeneAmp  PCR 
System  9700  (Applied Biosystems) with  steps  as  follows: de- 
naturation  at  94 C,  2 min,  followed by 35  cycles of (i)  94 C, 
10 sec, (ii) 55 C, 30 sec, (iii) 68 C, 1 min and a final elongation at 
68 C, 7 min. PCR products were checked on a 1% agarose gel, 
and  fragments of the  expected size were sequenced by MWG 
Eurofins. Forward and reverse sequences were aligned and 
sequence matched using the Ribosomal Database Project website 
(http://rdp.cme.msu.edu/). 
 
Purification of B. licheniformis  NucB 
NucB was produced using a previously described method [33]. 
Bacterial  strain   Bacillus subtilis   NZ8900   containing   plasmid 
pNZ8901  was inoculated into 5 ml sterile Luria  Bertani broth 
21
 
LabM and Sabouraud Dextrose Agar was from Oxoid. (Sigma)  containing  5 mg  l chloramphenicol  and   cultured 
For isolation of micro-organisms, a  portion  of sinus aspirate 
from each patient was homogenized in sterile phosphate buffered 
saline (PBS) and inoculated onto blood agar, chocolate agar, FAA 
and two plates of Sabouraud Dextrose agar. Blood and chocolate 
agar plates were incubated in 5% CO2  at 37uC. Pre-reduced FAA 
plates were incubated  at  37 C anaerobically (Ruskinn, Bugbox 
Plus) in a gas mix consisting of 10% CO2, 10% H2  and 80% N2. 
The Sabouraud Dextrose agar plates were incubated aerobically, 
one at 37 C and the other at 30 C. Plates were examined every 
24–48  hours  for at  least seven days. Individual colonies were 
picked and sub-cultured three times to obtain pure isolates. Strains 
were stored at  -80 C  in BHY medium [Brain Heart  Infusion 
37 g/L (Oxoid) and Yeast Extract 5 g/L (Merck)] diluted to 50% 
aerobically at  37 C  for 18 h.  The  culture  was adjusted to  an 
optical density (OD600)  of 1.0, and  100 mL  were transferred to 
10 ml of sterile LB containing chloramphenicol and  incubated 
aerobically at 37 C for 3 h until OD600 ,1.0 was reached. At this 
point,  5%  v/v  cell free supernatant  of an  overnight B. subtilis 
ATCC6633 culture was added to provide the subtilin required to 
induce NucB production,  and  this was incubated  for a further 
2.5 h. Cells were removed by centrifugation at 6000 g for 20 min 
and the supernatant was sterilized by passing through a 0.2 mm 
syringe filter. The concentration of NucB was estimated by 
comparison  with bovine serum  albumin  standards  on  a  SDS- 
PAGE gel. NucB was stored at 4 C for up to 3 months. NucB was 
purified from the  supernatant  using trichloroacetic acid (TCA) 
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Identification of Isolates 
All  isolates were  initially characterized  by  Gram   staining, 
inspection of colony morphology and  testing for catalase pro- 
duction, haemolysis and ability to grow aerobically or anaerobi- 
cally. A single thick streak of each isolate was plated onto DNase 
agar (Oxoid) to test for extracellular nuclease activity. Plates were 
incubated aerobically or anaerobically at 37 C  for between 24– 
96 h. Once colonies had grown, plates were flooded with 4 ml of 
0.1%  (w/v)  toluidine  blue  (Sigma) to  highlight  nuclease  pro- 
duction. The majority of clinical isolates were further identified to 
species level using a Matrix Assisted Laser Desorption/Ionization 
Time-of-Flight (MALDI-TOF) Mass Spectrometer  (Bruker, Mi- 
croflex) [37]. Isolates were streaked onto blood agar, incubated 
under 5% CO2  or in the absence of oxygen, at 37 C for 24 h and 
transferred to the Pathology Department, Freeman Hospital, 
Newcastle upon Tyne, for identification. 
In cases where MALDI-TOF  analysis yielded ambiguous 
results, for example the  majority of a-haemolytic  streptococci, 
bacterial identification was confirmed by analysis of the 16S rRNA 
gene. Bacteria were cultured in BHY broth,  and  harvested by 
centrifugation  at  4,000 g.  Cells  were  resuspended  in  150 ml 
spheroplasting  buffer  [26%   (w/v)  raffinose,  10 mM   MgCl2, 
20 mM Tris-HCl, pH 6.8] supplemented with 37.5 mg lysozyme 
(Sigma) and 50 U mutanolysin (Sigma), and incubated at 37 C for 
30 min.  Following incubation,  DNA  was  extracted  using  the 
MasterPureTM  Gram  Positive DNA Purification Kit (EpicentreH 
Biotechnologies) in accordance with manufacturer’s instructions. 
the  active  fractions  were  further  concentrated  by  TCA  pre- 
cipitation again and analysed by SDS-PAGE. The concentration 
of protein was estimated by densitometry analysis, in comparison 
with standards of known concentration [33]. 
 
Growth and Biofilm Formation by CRS Isolates 
Planktonic growth kinetics in batch culture were measured in 
BHY broth. Stock cultures of CRS isolates (see above) were diluted 
in BHY to a starting OD600 of ,0.1. Cultures were incubated at 
37uC  and  at hourly intervals, 1 ml samples were removed and 
OD600  was determined. For biofilm assays, 8 ml of  CRS  isolate 
stock cultures (see above) were added to triplicate wells of a sterile 
polystyrene 96-well plate (Corning 3595) containing 200 ml BHY 
broth. The lid was replaced and plates were wrapped in parafilm 
and  incubated  without  shaking aerobically at  37 C  for  18 h. 
Following growth, 150 ml  of  the  non-adherent  planktonic cells 
were removed and transferred to a clean 96-well plate and the 
OD600 was read in a microplate reader (BioTek Synergy HT) to 
quantify growth  in  the  planktonic  phase.  To  quantify biofilm 
extent, 100 ml of 0.5% (w/v) crystal violet were added to each well 
and incubated at 20 C for 15 min. Wells were rinsed 3 times with 
200 ml  PBS. Residual crystal violet was dissolved in 100 ml  7% 
acetic acid and the A570  was read in a microplate reader (BioTek 
Synergy HT).  Each  assay was performed three  times indepen- 
dently. To  assess the  efficacy of NucB for dispersing biofilms, 
biofilms were cultured as above, and washed three times with PBS. 
Purified NucB (3 mg ml21) or PBS alone was added to wells and 
incubated for 1 h at 37 C. Remaining biofilms were quantified by 
staining with crystal violet. 
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Growth and Visualization of Biofilms on Glass Surfaces 
The  effect of NucB on biofilm architecture was visualized by 
confocal  laser  scanning  microscopy  (CSLM)  or  by  scanning 
electron  microscopy  (SEM), using  biofilms cultured  on  glass 
surfaces. Sterile 13 mm diameter glass coverslips were placed in 
wells of a six-well tissue culture plate containing 3 ml BHY. Wells 
were  inoculated  with  50 ml   of   stock  bacterial  cultures  and 
incubated  statically in  air  at  37 C  for  18 h.  Coverslips were 
removed and rinsed three times with PBS, and 1 ml NucB (3 mg 
ml21) or 1 ml PBS (control) was added and incubated for 1 h at 
37 C. For CSLM, coverslips were inverted onto a rubber O-ring 
that had been placed on a microscope slide and filled with Live/ 
DeadH   BacLightTM    stain  (Molecular  Probes).  Biofilms were 
examined using a Leica TCS  SP2 confocal microscope with an 
argon/neon  laser  for  visualisation  of  SYTOH   9  (excitation 
485 nm,  emission 519 nm),  and  propidium  iodide  (excitation 
536 nm, emission 617 nm). For SEM, coverslips were fixed in 2% 
(v/v) glutaraldehyde at 4uC for 16 h. Specimens were rinsed twice 
in PBS and  dehydrated  through  a  series of ethanol  washes as 
follows: 25% ethanol 30 min, 50% ethanol 30 min, 75% ethanol 
30 min, and two washes for 1 h in 100% ethanol. Samples were 
dried in a critical point dryer (Bal-tec), mounted on aluminium 
stubs and sputter coated with gold at Electron Microscopy 
Research Services, Newcastle University. Biofilms were visualised 
using a scanning electron microscope (Cambridge Stereoscan 240). 
 
Extraction and Analysis of eDNA in Biofilms Formed In 
vitro 
Bacterial isolates were cultured in 6-well tissue culture dishes 
(Greiner) containing 3 ml of BHY broth for 72 h aerobically at 
37 C. During this time, broth was carefully removed every 24 h 
and  replaced  with  fresh  medium.  At  the  end  of  the  72 h 
incubation, medium was removed and PBS (1.5 ml) was added. 
Biofilms were gently removed from the surface of the wells using 
a  plastic tissue culture cell scraper. Cells from four wells were 
combined together, and eDNA was purified by a modification of 
the  method  of Kreth  et al. [39].  Briefly, cells were  mixed  by 
vortexing for 20 s, and incubated at 37 C for 1 h in the presence 
of  5 mg   ml21    of  Proteinase  K  (Sigma  Aldrich). Cells  were 
separated from the supernatant, containing eDNA, by centrifuga- 
tion at 16,000 g for 2 min. Extracellular DNA in the supernatant 
was extracted with phenol:chloroform:isoamyl alcohol 
(25:24:1). Samples were centrifuged at 16,000 g  for 5 min to 
separate the phases, and  the  aqueous  phase  was collected. 
DNA  was pre- cipitated by the addition of isopropanol. The DNA 
was pelleted by centrifuging at 16,000 g for 10 min, air dried, and 
re-suspended in 50 ml of 10 mM Tris pH 8.5. For intracellular 
DNA, pelleted cells 
were resuspended in 150 ml spheroplasting buffer, and DNA was 
purified using the method described above. 
The  concentration  and  purity of DNA in each  fraction was 
determined  using a NanoDrop  spectrophotometer.  In  addition, 
double stranded  DNA (dsDNA) was quantified using the Pico- 
Green  dsDNA reagent (Molecular Probes) and  comparing with 
standards of known concentration according to the manufacturer’s 
instructions. Intracellular and extracellular DNA was visualized by 
agarose gel electrophoresis. 
 
Results 
 
Microscopic Analysis of Obstructive Mucin and Mucosal 
Biopsies from CRS Patients 
Obstructive  mucin  is  sometimes observed  in  the  paranasal 
sinuses of CRS patients with or without polyps in the absence of 
other  symptoms that  would indicate  fungal rhinosinusitis. The 
removal   of  this  mucin   from   the   paranasal   sinuses  is  the 
cornerstone of surgical treatment  of CRS [40]. This material is 
extremely tenacious  and  removing  it  significantly extends  the 
length of time required in the operating theatre. To investigate the 
structure of the obstructive mucin, a portion of the material from 
two different CRS patients was cut into small pieces (,1 mm3) 
immediately after surgery and fixed in glutaraldehyde. The mucin 
was embedded and sectioned for TEM analysis (see Materials and 
Methods). The material from the two patients appeared similar in 
structure,  and  consisted predominantly  of an  acellular  matrix 
either with a striated appearance punctuated by occasional 
degraded  host  cells and  cell debris (Figure 1A), or  with  little 
structure and many pockets (Figure 1B). Erythrocytes were 
sometimes observed (not shown). However, areas containing large 
numbers of eosinophils were not observed in any field of view. 
Additionally, bacterial cells and  fungi were not seen within the 
matrix. 
The possibility that microbial cells were present but not directly 
observed could not  be discounted. Therefore,  mucosal biopsies 
were also collected from CRS patients, and analysed by confocal 
scanning laser microscopy (CSLM). Initially, propidium iodide was 
employed to stain bacteria. However, it was difficult to identify 
micro-organisms with  confidence  due  to  the  lack  of  contrast 
between bacteria and host cells. Therefore, in subsequent samples 
bacteria were selectively stained by PNA-FISH with the EUB338 
probe, and host cells were counterstained with DAPI. Using this 
approach,  microbial cells were clearly identified on the mucosal 
surface (Figure 2). In yz and xz projections, it appeared that most 
of the micro-organisms were present in regions above the tissue 
surface or in a layer within the top 10 mm of the tissue. A three- 
dimensional representation of this image is shown in Figure S1. 
The  EUB338 PNA probe targets bacterial 16S ribosomal RNA 
(rRNA) within metabolically active cells [41]. The  detection of 
punctate staining with the EUB338 probe is indicative of microbial 
cells that  were live prior  to  fixation. In  addition  to  the  sharp 
staining of cells, there were also patches of fluorescence from the 
PNA-FISH  probe  that  were more  diffuse (Figure 2B, arrows). 
Since PNA probes can hybridize with complementary DNA in 
addition to RNA [42], it is likely that this fluorescence represents 
extracellular microbial nucleic acids such as RNA or single 
stranded DNA. 
 
Isolation and Identification of Micro-organisms 
Associated with CRS 
Overall, 75 strains of bacteria were isolated from obstructive 
mucin, comprising a total of 16 different genera and 32 separate 
species (Table 1). The  most prevalent organism associated with 
CRS  aspirates was Staphylococcus  epidermidis,  which was isolated 
from 15 of 20 specimens (75%). Staphylococcus aureus and Streptococcus 
spp. were each isolated from 7 patients (35% of samples), 
Corynebacterium  spp.  were  isolated  from  6  patients  (30%), and 
Propionibacterium spp. from 5 patients (25%). Other organisms that 
were less frequently isolated included Haemophilus influenzae, 
Moraxella  catarrhalis,  Neisseria spp., Finegoldia magna,  and Enterobacter 
aerogenes. The majority of isolated bacteria were facultative 
anaerobes. However, both obligate aerobes (for example, Neisseria 
spp. and M. catarrhalis) and obligate anaerobes (F. magna, 
Propionibacterium spp.) were also commonly isolated. No fungi were 
isolated from any of the patient specimens. 
The  production  of extracellular  DNase  enzymes by  clinical 
isolates was assessed using DNase  test agar  and  staining with 
toluidine blue. In  total,  13  of the  75  isolates (17%) produced 
extracellular  DNase  (Table  1). All S. aureus  isolates produced 
extracellular   DNase,   and   other   producers   were   Streptococcus 
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Figure 1. Transmission electron microscopy of obstructive mucin from CRS aspirates. In some cases (A), the mucin either formed a layered 
structure,  with  relatively intact  cells towards  the  outer  layers (black arrow) and  more  degraded cellular material  further  in (white  arrow). (B) 
Alternatively, samples had little clear structure  and the mucin was punctuated by pockets. The outermost layer of each sample is indicated by dark 
arrowheads. 
doi:10.1371/journal.pone.0055339.g001 
 
anginosus group (S. anginosus/S. constellatus/S. intermedius) strains (80% 
of strains), Staphylococcus lugdunensis (33% of strains) and Streptococcus 
salivarius  (33% of strains). Extracellular nuclease producers were 
isolated from 11 out of 20 (55%) patients. In only two cases, more 
than one nuclease producing organism was isolated from the same 
patient sample. 
Efficacy of NucB against Biofilm Forming Isolates 
Twenty-four bacteria,  isolated from patient  specimens, were 
grown in 96-well microtiter plates to assay for biofilm formation. 
Representative strains of all species that  produced  extracellular 
DNase were selected for these studies, along with a similar number 
of non-producing  organisms. Following incubation  for 20 h  in 
microtitre wells, all isolates had grown in the planktonic phase to 
 
 
 
 
Figure 2. Confocal laser scanning microscopy of  surface associated bacteria on  mucosa removed from patients diagnosed with 
CRS. Bacterial DNA (green)  was visualized using  an  EUB338  PNA-FISH probe,  and  epithelial  cell nuclei (blue) were  counterstained with DAPI. 
Maximum projection  images are shown. In some fields, epithelial cells were observed  in the  absence  of bacteria  (A), and in other  fields bacterial 
biofilm was evident (B). B includes z-stacks oriented  from the outside of the mucosal biopsy specimen (labelled ‘top’) to the deeper  layers (indicated 
by a thick white arrow). Small white arrows indicate patches  of diffuse staining, consistent  with the presence  of extracellular nucleic acids. 
doi:10.1371/journal.pone.0055339.g002 
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Table 1. Bacteria isolated from CRS aspirates. 
 
 
Patient   Microbial Species Presenta 
Total number of 
isolates 
 1              Enterobacter aerogenes, Staphylococcus epidermidis, Streptococcus sp., Streptococcus pneumoniae, Streptococcus salivarius                       5 
2              Haemophilus influenzae, Microccus luteus, Staphylococcus epidermis, Staphylococcus hominis, Streptococcus pneumoniae                           5 
3              Moraxella catarrhalis, Staphylococcus aureus, Streptococcus anginosus                                                                                                 3 
4              Klebsiella rhizophila, Staphylococcus epidermidis, Streptococcus constellatus, Streptococcus intermedius, Streptococcus salivarius     5 
5              Esherichia coli, Staphylococcus aureus, Staphylococcus epidermidis                                                                                                                  3 
6              Corynebacterium pseudodiphtheriticum, Finegoldia magna,  Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus epidermidis,       6 
Staphylococcus lugdunensis 
7              Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus warneri, Streptococcus constellatus                                                      4 
8              Corynebacterium propinquum, Staphylococcus epidermidis, Staphylococcus lugdunensis                                                                                   3 
9              E. aerogenes, Finegoldia magna,  Propionibacterium sp., Streptococcus pneumoniae                                                                                          4 
10            Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus epidermidis, Streptococcus pneumoniae                                                          4 
11            Staphylococcus epidermidis, Staphylococcus warneri                                                                                                                                             2 
12            Citrobacter koseri, Staphylococcus epidermidis, Propionibacterium sp., Pseudomonas aeruginosa                                                                     4 
13            Corynebacterium pseudodiphtheriticum, Propionibacterium granulosum, Staphylococcus aureus                                                                3 
14            Staphylococcus epidermidis, Staphylococcus pasteuri, Staphylococcus warneri                                                                                                   3 
15            Staphylococcus epidermidis, Staphylococcus lugdunensis, Propionibacterium acnes, Propionibacterium granulosum                                   4 
16            Corynebacterium propinquum, Neisseria meningitidis, Staphylococcus aureus                                                                                             3 
17            Neisseria sp., Staphylococcus epidermidis, Streptococcus anginosus, Streptococcus parasanguinis, Streptococcus salivarius                       5 
18            Staphylococcus aureus, Staphylococcus epidermidis                                                                                                                                           2 
19            Corynebacterium pseudodiphtheriticum, Propionibacterium avidium, Staphylococcus aureus, Staphylococcus epidermidis                          4 
20            Corynebacterium accolens, Corynebacterium pseudodiphtheriticum, Lactobacillus sp.                                                                                        3 
aStrains highlighted  in bold text produced extracellular deoxyribonuclease. 
doi:10.1371/journal.pone.0055339.t001 
 
OD600.0.1 with the exception of three strains: S. anginosus FH19, 
S. constellatus FH21 and S. pneumoniae FH26 (Table 2). Nevertheless, 
all of these strains produced  biofilms that  were detectable  by 
crystal  violet  staining.  In  fact,  S.  pneumoniae   FH26  produced 
a relatively strong biofilm (A570 = 1.87). Growth rates of each strain 
in BHY medium were determined in planktonic cultures (Table 2). 
No correlation was seen between the maximum growth rate of 
strains and  the capacity to form biofilms. Generally, there  was 
extensive variation in  the  extent  of biofilm formation  between 
different species and between different strains of the same species. 
For example, M. catarrhalis  FH3  produced  a very weak biofilm 
(A570 = 0.77), whereas M. catarrhalis FH4 formed extensive biofilms 
(A570 = 2.78). Of  the  strains  tested,  Streptococcus  anginosus   FH19 
produced  the  least abundant  biofilms (A570 = 0.22). The  mean 
extent    of   biofilm   formation    by    non-nuclease    producers 
(A570 = 1.51, S.E. 0.19, n = 15) was not significantly different from 
that of nuclease producers (A570 = 1.48, S.E. 0.32, n = 9). 
To assess the importance of eDNA in maintaining the structural 
integrity of biofilms, pre-formed biofilms were incubated for 1 h in 
the presence of the microbial DNase NucB (Table 2). Biofilms 
formed by 9 out  of 9 (100%) nuclease producing strains were 
significantly reduced by NucB (T test comparing NucB treatment 
with buffer control, p,0.05, n = 3). By contrast, only 5 out of 15 
(33%) of the biofilms produced  by non-nuclease producing 
bacteria were dispersed by NucB. In addition, 2 out of 15 (13%) 
non-nuclease producers  had  slightly increased levels of biofilm 
following incubation  with NucB than  without the  enzyme. To 
assess whether  NucB had  detrimental  effects on the cells 
themselves, four  different isolates, S. aureus  FH7,  S. constellatus 
FH20, S. salivarius FH29 and M. catarrhalis FH4, were cultured to 
mid-exponential phase in THYE broth and challenged with 5 mg 
ml21  NucB. These isolates were selected as representative Gram- 
positive  and  Gram-negative  organisms  to  assess the  general 
toxicity of  NucB  for  bacterial  cells. Since  the  production  of 
extracellular nucleases by bacteria is widespread, it seemed 
unlikely that  DNase  activity itself would be  toxic to  bacteria. 
Nevertheless, it was important to assess whether the NucB protein 
could inhibit the growth of bacteria. No effects were observed on 
the growth rate of cells following the challenge (data not shown). 
The number of viable cells in each culture continued to increase 
following NucB addition, and 1 h after adding NucB there was no 
difference in  the  number  of viable cells in cultures containing 
NucB  compared   with  control  cultures  without  the  enzyme. 
Overall, these data suggest that eDNA is an important component 
of the EPS for over 50% of the CRS isolates, including strains that 
produce extracellular DNase enzymes, and that addition of NucB 
dislodges cells without killing or inhibiting bacteria. 
 
Microscopic Analysis of in vitro Grown Biofilms 
To obtain more detailed information about the effects of NucB, 
biofilms of selected organisms were cultured on glass coverslips 
and  analysed  by  CLSM  and  SEM.  This  work  focussed on 
staphylococci and streptococci, since these were the genera most 
commonly isolated from CRS patients. In the absence of NucB 
treatment, biofilms formed by S. constellatus FH20 were relatively 
thin and consisted primarily of a single cell layer that covered most 
of the surface (Figure 3). In places, clusters of cells projected from 
the surface to a depth  of ,12 mm. Using BacLight Live/Dead 
stain, both live cells (green) and dead cells (red) were observed in 
biofilms. Biofilms that had been treated with NucB were clearly 
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Table 2. Biofilm formation and NucB sensitivity of selected  isolates from CRS aspirates. 
 
Planktonic Growth                                                                                            Remaining Biofilm 
yield OD600  Mean    Doubling Time     Biofilm  Growth A570     Nuclease        after NucB Addition 
Strain                                                     (S.E.)                             (min)  Mean (S.E.) Mean (S.E.)                    Productiona       (%) 
 
 
P-value 
 Corynebacterium propinquum FH1                  0.39 (0.06)                     235 (11)                   1.79 (0.78)                        2              105                                   0.558 
Corynebacterium pseudodiphtheriticum FH2  0.86 (0.24)                     129 (2)                     2.61 (0.43)                        2              92                                     0.577 
Moraxella catarrhalis FH3                                0.39 (0.07)                     232 (6)                     0.77 (0.21)                        2              127                                   0.349 
Moraxella catarrhalis FH4                                0.42 (0.14)                     155 (5)                     2.78 (0.21)                        2              124                                   0.032 
Staphylococcus aureus FH5                              0.40 (0.11)                     62 (3)                       1.84 (0.34)                        +                         77                                     0.003 
Staphylococcus aureus FH6                              0.50 (0.08)                     74 (0.02)                  0.71 (0.12)                        +                         59                                     0.000 
Staphylococcus aureus FH7                              0.79 (0.26)                     61 (3)                       1.23 (0.22)                        +                         40                                     0.000 
Staphylococcus epidermidis FH8                      0.27 (0.09)                     81 (6)                       2.29 (0.41)                        2              114                                   0.077 
Staphylococcus epidermidis FH10                    0.48 (0.06)                     90 (1)                       1.59 (0.22)                        2              67                                     0.001 
Staphylococcus epidermidis FH11                    0.54 (0.13)                     104 (4)                     1.52 (0.24)                        2              74                                     0.010 
Staphylococcus lugdunensis FH12                   0.74 (0.03)                     73 (4)                       1.16 (0.23)                        2              49                                     0.001 
Staphylococcus lugdunensis FH13                   0.78 (0.05)                     70 (0.2)                    0.57 (0.10)                        2              66                                     0.001 
Staphylococcus lugdunensis FH14                   0.78 (0.13)                     73 (16)                     0.53 (0.05)                        +                         69                                     0.001 
Staphylococcus warneri FH15                          0.59 (0.18)                     72 (4)                       0.89 (0.25)                        2              126                                   0.005 
Staphylococcus warneri FH17                          0.88 (0.16)                     65 (3)                       2.40 (0.55)                        2              90                                     0.319 
Streptococcus anginosus FH18                        0.16 (0.05)                     54 (3)                       1.16 (0.07)                        +                         34                                     0.000 
Streptococcus anginosus FH19b                                     0.07 (0.00)                     90 (15)                     0.22 (0.02)                        +                         59                                     0.015 
Streptococcus constellatus FH20                      0.22 (0.04)                     103 (28)                   1.90 (0.39)                        +                         44                                     0.001 
Streptococcus constellatus FH21b                                 0.04 (0.03)                     NDc                                         0.31 (0.05)                        2              39                                     0.001 
Streptococcus intermedius FH22                      0.19 (0.02)                     67 (2)                       3.07 (0.80)                        +                         46                                     0.000 
Streptococcus pneumoniae FH26                     0.07 (0.03)                     56 (1)                       1.87 (0.31)                        2              123                                   0.585 
Streptococcus salivarius FH27                          0.20 (0.06)                     37 (3)                       0.99 (0.04)                        2              92                                     0.240 
Streptococcus salivarius FH28                          0.32 (0.04)                     111 (29)                   2.67 (0.96)                        +                         66                                     0.002 
Streptococcus salivarius FH29                          0.23 (0.03)                     39 (0.7)                    1.08 (0.04)                        2              96                                     0.692 
aProduction  of nuclease  was measured  on DNase agar, and is indicated by a ‘+’ sign. 
bIsolates grew poorly in both  the planktonic  and biofilm phase. 
cND, not determined. 
doi:10.1371/journal.pone.0055339.t002 
 
less extensive than the untreated controls, and consisted of sparsely 
distributed  single cells or  very  small aggregates  of  ,10  cells 
(Figure 3B). To obtain higher resolution images, similar biofilms 
were analysed by SEM (Figure 4). Again, in the absence of NucB, 
cell aggregates were evident and a relatively large proportion of 
the  surface  was covered  by  micro-organisms (Figure 4A). By 
contrast,  NucB-treated   biofilms  almost  exclusively contained 
isolated cells or small clusters of cells (Figure 4B). In  addition, 
extracellular material was apparent  in untreated  biofilms under 
high resolution SEM (Figure 4C), that was not seen in biofilms 
incubated  with  NucB  (Figure 4D).  Biofilms formed  on  glass 
surfaces by S. aureus FH7 or S. intermedius FH22 were also visualised 
by SEM (not shown). As with S. constellatus  FH20, biofilms that 
were treated  with NucB contained  far less biomass than  those 
incubated in buffer alone. However, extracellular polymers were 
not observed in these organisms. 
 
Quantification of eDNA in Model Biofilms 
To  quantify levels of eDNA  in  model  biofilms, eDNA  and 
intracellular DNA (iDNA) was extracted from biofilm cultures of S. 
aureus FH7, S. constellatus FH20 and S. salivarius FH29. The eDNA 
was analysed by  agarose  gel electrophoresis (Figure 5). Sharp 
bands migrating at an apparent  size of 30 kbp were observed in 
eDNA fractions of S. aureus FH7 and S. constellatus FH20. However, 
no high molecular eDNA bands were seen in S. salivarius FH29. 
Intracellular DNA from all three organisms appeared as a smear of 
high  molecular weight fragments, probably  due  to  binding  of 
chromosomal DNA to cell wall fragments. In addition to the high 
molecular weight fragments, small fragments of DNA or RNA 
were seen at the bottom of the gel. Nucleic acids in each fraction 
were    quantified    using    the    Nanodrop    spectrophotometer 
(Figure 5B). For each strain, eDNA represented  approximately 
5–10% of the total DNA present in the biofilm. To account for the 
possibility that samples may have contained RNA in addition to 
DNA, nucleic acids were also quantified using PicoGreen  dye, 
which is strongly selective for double stranded DNA. No 
significant differences were observed between the  total amount 
of eDNA in S. salivarius  FH29  biofilms and  eDNA in biofilms 
formed by the other  two strains. Therefore, despite the lack of 
a clear band by agarose gel electrophoresis, it appears that eDNA 
was present in S. salivarius FH29 biofilms. 
To  assess whether eDNA was present in biofilms formed by 
other CRS isolates, biofilms of each strain were cultured in 6-well 
plastic dishes and eDNA was purified as described in the Methods 
section. Only  two  strains  were  omitted  from  this  analysis: S. 
constellatus  FH21  grew very poorly in  biofilms and  it  was not 
possible to extract eDNA, and  S. salivarius  FH28  was prone  to 
contamination and, after several attempts, it was decided not to 
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Figure 3. Confocal laser scanning microscopy of Streptococcus constellatus FH20  biofilms with or  without NucB  treatment. Biofilms 
were formed on glass surfaces and were visualised with CLSM using BacLight LIVE/DEAD stain, which stains compromised (dead) cells red and live 
cells green. (A) Biofilms  treated  with buffer alone, and (B) biofilms treated  with NucB. 
doi:10.1371/journal.pone.0055339.g003 
 
pursue DNA purification from this strain. By agarose gel 
electrophoresis, sharp  bands  corresponding  to  high  molecular 
weight eDNA products were observed in all Staphylococcus spp., S. 
constellatus   FH20  and  in  S.  intermedius   FH22  (Figure 5C).  By 
contrast, similar bands were not detected from Corynebacterium spp., 
S. anginosus or S. pneumoniae. Only M. catarrhalis and S. salivarius had 
inter-strain differences in the production of eDNA. Thus, eDNA 
was not visualised in M. catarrhalis FH3 biofilm extracts, whereas 
eDNA  was clearly present  in  M.  catarrhalis  FH4  (Figure 5C). 
Similarly S. salivarius FH29 did not produce a band of eDNA on an 
agarose gel, whereas a sharp band was seen in S. salivarius FH27. 
The concentrations of eDNA in samples were determined using 
the Nanodrop spectrophotometer. Concentrations of eDNA in the 
extracts ranged  from 206 ng ml21   to 917 ng ml21   (Figure 5C). 
Interestingly, there appeared  to be little correlation between the 
concentration of eDNA and the presence or absence of a band on 
the agarose gel. For example, M. catarrhalis FH3 produced one of 
the  highest concentrations of eDNA, but  no  band  on  the  gel. 
Conversely, the eDNA concentration from S. intermedius FH22 was 
just 325 ng ml21  even though this strain clearly produced a band 
of eDNA on a gel. The production of an extracellular nuclease did 
not correlate with the presence of a band of eDNA on a gel. All 
strains of S. aureus (nuclease-positive)  and S. epidermidis  (nuclease- 
negative) produced clear bands of eDNA, for example. With the 
exception of S. anginosus  FH18 and S. anginosus  FH19, all strains 
that failed to produce a clear band of eDNA on an agarose gel 
were insensitive to NucB treatment. 
 
Discussion 
 
There  is mounting  evidence that  microbial biofilms growing 
within paranasal sinuses are a major factor in the pathogenesis of 
CRS [14]. Bacterial biofilms have been most commonly detected 
on the sinus mucosa, whereas fungi tend to be more easily detected 
within the sinonasal mucous. Fungal growth is often accompanied 
by mucous secretions containing large numbers of intact or 
degraded eosinophils, known as ‘eosinophilic mucin’ or ‘allergic 
mucin’ [43–45]. The eosinophils appear to migrate intact from the 
tissues, and  degrade  or  degranulate  upon  reaching  the  mucin, 
possibly in order to target fungi growing within the mucin. Allergic 
mucin  may  be  present  in  the  absence  of  fungi [46].  In  our 
experience, a  number  of patients present with thick, tenacious 
mucin obstructing the paranasal sinsues, but without other 
evidence of fungal rhinosinusitis. We hypothesized that bacterial 
biofilms may  contribute  to  the  pathogenesis of CRS  in  these 
patients. The aim of this study was to characterize the microflora 
in paranasal  sinuses of patients with obstructive mucin, and  to 
assess the  potential  of  a  novel  deoxyribonuclease enzyme  for 
degrading biofilms formed by isolated micro-organisms. 
Initially, the  structure  of obstructive mucin  was investigated 
using TEM. This material contained relatively small numbers of 
degraded  host  cells. Therefore,  this  structure  appears  to  be 
different from eosinophilic mucin [44]. In addition, fungi were not 
observed either by high-resolution TEM of obstructive mucin or 
by culture. The role of fungi in CRS is currently unclear. Culture- 
based studies have reported  very low rates of isolation of fungi 
from CRS samples [20,22], whereas the direct microscopic 
analysis of eosinophilic mucin  in  some cases detects  fungi in 
100% of patient samples [45]. In the patient cohort analysed here, 
CRS appeared to be of a non-fungal aetiology. Bacterial cells were 
also not detected within the obstructive mucin. However, bacteria 
do not generally produce filamentous structures such as hyphae 
and  can  be  difficult to  detect  in  thin  sections. By  carefully 
examining  the  mucosal  surfaces,  bacterial  biofilms could  be 
observed. Bacteria appeared  to be localised on top of the tissue 
or within the outer layer of epithelial cells. It is likely that  the 
dehydration steps involved in sample processing for FISH would 
have compromised the outer barrier of the tissue, leading to an 
irregular  surface and  the  appearance  of bacterial  nucleic acid 
staining  in  regions  slightly below  the  surface  of  the  tissue. 
Alternatively, a proportion of the bacterial cells may have been 
present within the host cytoplasm, as has previously been 
described for S. aureus [47]. Nevertheless, the structure of biofilms 
was consistent with those previously described in CRS patients [9]. 
In addition, more than one species of bacterium was isolated from 
each of the 20 samples tested. 
In  total,  75  strains of bacteria  were isolated from  20  CRS 
patients. On the whole, the organisms identified in this study were 
very similar to those identified in previous culture-based investiga- 
tions into the  microflora of CRS  patients. Thus,  staphylococci 
(both  S.  aureus   and  coagulase-negative staphylococci) and  a- 
haemolytic   streptococci  were   the   most   commonly   isolated 
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Figure 4. Scanning electron microscopy of Streptococcus constellatus FH20 biofilms treated with NucB or buffer control. Biofilms were 
visualised with SEM after treatment for 1 h with buffer (A) or with NucB (B). At higher magnification, extracellular material (white arrow) was observed 
in the absence  of NucB treatment (C), but was not seen in NucB-treated biofilms (D). 
doi:10.1371/journal.pone.0055339.g004 
 
organisms, in agreement with published reports [18,20–22]. 
Corynebacteria  were  isolated  from  seven  CRS  patients,  and 
several potential pathogens were identified, including M. catarrhalis, 
Neissseria  spp. and  H.  influenzae.  All of these species have been 
isolated from CRS cases. However, their contribution to disease 
pathogenesis is unclear [20,22]. Enterobacteriaciae have been 
frequently isolated from CRS  patients [20–22], and  this group 
of organisms was represented here by C. koseri, E. aerogenes, E. coli, 
and K. pneumoniae. There has been some debate about the presence 
of obligate anaerobes in paranasal sinuses of CRS patients. Thus, 
Doyle et al. [22] did not isolate anaerobes from chronic ethmoid 
sinusitis, whereas Brook [21] found that obligate anaerobes formed 
the majority of the bacteria isolated from chronic maxillary 
sinusitis. It is possible that the maxillary sinuses provide a more 
conducive environment for the growth and survival of anaerobes 
than  the  ethmoid  sinuses. Here,  samples were  collected from 
a  mixture  of  maxillary,  sphenoid  and  ethmoid  sinuses, and 
obligate anaerobes (Propionibacterium spp. or F. magna) were isolated 
from  6  of  the  20  patients.  The  micro-organisms isolated and 
identified in this investigation are representative of the culturable 
microflora common in CRS patients. Recently, it has been shown 
that  culture-independent,  pyrosequencing analysis of the  CRS 
microflora identifies a very similar microflora to that  found by 
culture, although  pyrosequencing has greater  sensitivity for 
detecting difficult-to-culture or  low-abundance  micro-organisms 
[48]. 
The capacity of micro-organisms to form biofilms is likely to be 
important for the colonization of paranasal sinuses. Several studies 
have now provided direct evidence that bacteria are commonly 
present  in  biofilms on  sinus  mucosa  in  CRS  patients  [14]. 
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Figure 5. The  visualization and quantification of eDNA from CRS isolates. (A) Intracellular DNA (i) or eDNA (e) was purified from bacterial 
biofilms of S. aureus FH7, S. constellatus FH20 or S. salivarius FH29, and analysed by agarose gel electrophoresis. High molecular weight chromosomal 
DNA is indicated  by a black bracket; low molecular DNA or RNA is highlighted  at the bottom of the gel by a black arrow. M; size marker. (B) The 
concentration of DNA in the  intracellular (grey bars) and  extracellular (white bars) fractions from bacterial biofilms was measured  by NanoDrop 
spectrophotometry. Bars represent  means of three independent extracts, and SEs are indicated. (C) Extracellular DNA concentration in biofilms was 
also visualised for another  19 isolates (see Table 1 for species names). In many cases, distinct bands  were observed  with an apparent migration at 
approximately  30 kbp. The total DNA concentration was measured  by NanoDrop spectrophotometry, bars represent  the average of three replicates 
and error bars are S.E. 
doi:10.1371/journal.pone.0055339.g005 
 
Nevertheless, little is known about whether these organisms are 
particularly well-suited to forming biofilms. The ability of biofilm 
bacteria  on  sinus mucosa to produce  biofilms in vitro  has been 
assessed by directly inoculating mucosal swabs into  a  Calgary 
biofilm device model [49]. P. aeruginosa biofilm-defective mutants 
(sad-31 and sad-36) were separately set up in the model to set the 
threshold value, below which samples were designated as non- 
biofilm formers. Using these criteria, 28.6% of 157 sinus aspirate 
samples  produced   biofilms.  However,   this   is  likely  to   be 
a significant underestimate of the total biofilm-forming capacity 
of mucosal bacteria since the biofilm experiments used only Luria- 
Bertani broth  incubated aerobically, and therefore anaerobic or 
fastidious micro-organisms would not have grown. The capacity of 
clinical isolates of P. aeruginosa,  S. aureus  and  coagulase-negative 
staphylococci, isolated .1  year  post-FESS treatment,  to  form 
biofilms has been assessed as a possible predictor of the long-term 
outcomes of treatment [17]. Over 50% of strains tested produced 
biofilms, and the ability of P. aeruginosa or S. aureus to form biofilms 
appeared to be correlated with a poor clinical evolution of disease. 
To the best of our knowledge, there have been no investigations 
into the biofilm-forming ability of bacteria freshly isolated from 
patients during CRS  treatment.  We aimed to establish whether 
isolated CRS bacteria form biofilms in vitro and, further, whether 
eDNA contributes to the integrity of the biofilm. 
In total, 24 isolated strains were tested for biofilm formation in 
a microplate model system, and all strains produced biofilms to 
some extent. The ability to form biofilms was not closely related to 
the growth rate or yield in planktonic cultures. These data are in 
line with  previous studies on  Listeria   monocytogenes or  Salmonella 
enterica strains, which also found no correlation between the growth 
rate  or yields of individual strains and  their capacities to form 
biofilms in  microplate  model  systems [50,51].  Representative 
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strains of many of the species found in this study have been shown 
to produce DNase I-sensitive biofilms including, for example, S. 
aureus  [52,53],  S. pneumoniae  [54,55],  Neisseria  spp.  [56,57],  P. 
aeruginosa [29] and E. coli [53]. We have recently identified a novel 
DNase enzyme, NucB, from a marine strain of Bacillus licheniformis 
that has potent anti-biofilm activity against a number of bacteria 
including E. coli and M. luteus [33]. This enzyme is smaller in size 
(,12 kDa) than  many other  nucleases, including DNase I, and 
appears to be well adapted to breaking up bacterial biofilms even 
at low concentrations [33]. A key goal of this study was to establish 
whether freshly isolated CRS-associated bacteria produce biofilms 
that  are sensitive to NucB. Overall, .50%  of the strains tested 
produced biofilms that were reduced upon treatment with NucB. 
In fact, the vast majority of staphylococci (8 of 10 strains tested) 
and streptococci (6 of 9 strains) produced NucB-sensitive biofilms. 
In contrast, two Corynebacterium spp. and two M. catarrhalis strains 
made biofilms that were not removed by NucB. In one case the M. 
catarrhalis biofilm  was slightly, but significantly, increased by NucB 
treatment. Whilst eDNA commonly promotes adhesion and 
biofilm formation  by  bacteria,  in  rare  cases eDNA  has  been 
shown to inhibit bacterial settlement [58]. It is possible that eDNA 
may be inhibitory to M. catarrhalis adhesion and that NucB- 
mediated eDNA degradation would therefore promote adhesion 
by this organism. This hypothesis requires further investigation. 
The  production  of extracellular DNase enzymes by bacteria 
may  influence the  structure  of biofilms. For  example, isogenic 
nuclease-deficient mutants of S. aureus,  Neisseria gonorrhoeae or Vibrio 
cholerae form thicker biofilms than their wild-type progenitor strains 
[57,59,60]. However, using in vitro  or in vivo  models of catheter 
biofilms, Beenken et al. [61] found that the total number of viable 
cells in biofilms of the clinical osteomyelitis isolate S. aureus UAMS- 
1  was not  affected by mutation  in  either  of two extracellular 
nuclease-encoding genes. Therefore, it is not clear whether 
microbial nucleases contribute  to the gross biofilm structure  in 
clinically relevant situations. Production  of extracellular DNase 
enzymes has been reported for several of the genera isolated here. 
S. aureus is well-known to produce DNases, and DNase production 
is often used as a phenotypic test to differentiate S. aureus  from 
coagulase-negative staphylococci.  However,  the  test  must  be 
interpreted with caution, since some coagulase-negative staphylo- 
cocci such as S. lugdunensis can produce nucleases [62]. In fact, one 
of the  S. lugdunensis  strains isolated here  was found to produce 
DNase. Corynebacterium diphtheriae and N. gonorrhoeae have also been 
reported to be able to produce extracellular DNase enzymes 
[57,63], but DNases were not detected in any of the Corynebacterium 
spp. or Neisseria spp. identified in this study. Production of DNases 
is variable  in  a-haemolytic  streptococci [64],  and  5  of  the  9 
streptococci isolated here produced DNase activity. Representa- 
tive strains of all species that  produced  nuclease were tested in 
biofilm assays. Interestingly, all 9 nuclease-producing strains made 
biofilms that  were  reduced  by  treatment  with  the  exogenous 
addition  of NucB. These  data  provide clear evidence that  the 
ability of a  strain  to  produce  extracellular nucleases does not 
preclude the formation of biofilms that are stabilised by eDNA. 
The  production  of extracellular DNases is tightly regulated  in 
bacteria.   For  example,  in  S.  aureus,   nuclease  production   is 
regulated  by  the  stress response  sigma factor  B  [59].  Within 
biofilms, nucleases may be produced at low levels or by only a small 
proportion of the cells. 
Here,  direct evidence for the  presence of eDNA in biofilms 
formed  by  22  CRS  isolates was  provided  by  extraction  and 
quantification of eDNA. All strains produced significant amounts 
of eDNA that could easily be measured in the Nanodrop 
spectrophotometer.  A more detailed analysis was conducted on 
three different CRS isolates, including two that produce nucleases 
(S.  aureus  FH7  and  S. constellatus  FH20). In  S. constellatus  FH20 
biofilms, extracellular material was observed by SEM (Figure 4). 
Extracellular DNA purified from S. aureus FH7 and S. constellatus 
FH20  biofilms was visualised as  sharp  high  molecular  weight 
bands on agarose gels with an apparent migration similar to that of 
intracellular chromosomal DNA. However, eDNA from S. 
salivarius FH29 was not detected by this technique. Nevertheless, 
quantitative  measures indicated  that  extracellular nucleic acids 
were  present  in  S.  salivarius   FH29  biofilms. Interestingly,  in 
contrast to S. aureus FH7 and S. constellatus FH20, S. salivarius FH29 
biofilms were not sensitive to NucB. Therefore, it appears that S. 
salivarius  FH29  does not  rely on  large fragments of eDNA  to 
stabilise biofilms. A broader analysis of the CRS isolates identified 
six other  strains that  did not  produce  defined bands of eDNA 
when  analysed  on  agarose  gels. Of  these,  four  strains  were 
insensitive to NucB indicating that, like S. salivarius FH29, these 
strains do not utilise large eDNA fragments for biofilm stabilisa- 
tion. The two strains of S. anginosus did not produce visible bands of 
eDNA on gels, even though both strains were sensitive to NucB. It 
is possible that eDNA from S. anginosus was partially degraded, to 
the point where it did not form a defined band on a gel, but was 
still present in sufficient quantities to be utilised for maintaining 
the biofilm structure. 
Improving the surgical treatment of CRS requires new methods 
for controlling microbial biofilms in the paranasal sinuses. The 
data presented here demonstrate that many CRS-associated 
bacteria produce biofilms that can be reduced by treatment with 
a microbial nuclease NucB in vitro. Given the high prevalence of 
CRS, even a 50% reduction in the colonization of sinus mucosa by 
micro-organisms would be predicted to have significant clinical 
benefits on a population level. Of course, the current  study has 
focussed on in vitro work and it is acknowledged that translating the 
findings to the clinic will require further investigations in animal 
models and ultimately in patients. Before this can be done, the 
safety of  NucB  for  clinical use  must  be  established. We  are 
currently in the process of testing the safety of NucB with a view to 
conducting  clinical trials  in  future.  In  addition,  it  would  be 
interesting to determine whether matrix-degrading enzymes act 
synergistically with antibiotics to control biofilm growth since this 
would present additional therapeutic possibilities. Ultimately, the 
utility of DNase enzymes to aid the treatment of CRS will depend 
upon  in vivo  data.  Nevertheless, we have shown that  NucB has 
clear potential  for the  control  of biofilms formed by clinically 
important strains of bacteria. 
 
Supporting Information 
 
Figure S1    Three-dimensional rotation showing micro-organisms 
associated with the outer layer of a mucosal biopsy. Bacterial DNA 
was hybridized with the EUB338 PNA-FISH probe, and appears 
green in the image. Host cell nuclei were counterstained blue. 
Bacterial cells (punctate green staining) are seen interacting with 
cells on the surface of the biopsy. 
(AVI) 
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Abstract 
 
The  death  and  lysis of  microbial  cells leads  to  the  release of  cytoplasmic 
contents,  many  of which are  rapidly  degraded  by enzymes. However, some 
macromolecules  survive intact  and  find  new  functions  in  the  extracellular 
environment.  There  is  now  strong  evidence that  DNA  released from  cells 
during  lysis, or  sometimes by active secretion, becomes a key component  of 
the macromolecular scaffold in many different biofilms. Enzymatic degradation 
of extracellular DNA can weaken the biofilm structure  and  release microbial 
cells from the surface. Many bacteria produce  extracellular deoxyribonuclease 
(DNase) enzymes that are apparently tightly regulated to avoid excessive 
degradation of the biofilm matrix. Interfering with these control mechanisms, 
or  adding  exogenous DNases, could  prove  a  potent  strategy for  controlling 
biofilm growth. 
 
 
 
Introduction 
 
DNA is the genetic coding material, the very essence of 
life. Yet when a cell dies, the DNA contained within it is 
not  necessarily lost.  In  fact, DNA is  a  relatively stable 
molecule and, in a protected environment, can sometimes 
survive intact  for  thousands  of  years (Hebsgaard  et al. 
2005; Nicholls 2005). This extracellular DNA (eDNA) 
accumulates in the environment, where it can form a sig- 
nificant source of organic nutrients. For example, the top 
10 cm  of deep sea sediments contain  an  estimated 0 45 
gigatons of eDNA, constituting  approx. 50% of the total 
phosphorous  pool for the resident micro-organisms (Del- 
l’Anno and Danovaro 2005). 
Extracellular DNA  is  known  to  cause  problems  for 
health. In cystic fibrosis, eDNA derived from neutrophils 
contributes to the sticky, viscous nature of mucous secre- 
tions (Manzenreiter et al. 2012). It is now also becoming 
clear that eDNA is an important  factor in microbial bio- 
films. The  diverse roles of eDNA include  disseminating 
genes amongst different micro-organisms, acting as a 
nutrient store and strengthening the biofilm matrix. 
Intriguingly, whilst eDNA is a linchpin for biofilm forma- 
tion  by many  micro-organisms,  other  species appear  to 
have  little  or  no  dependence  on  eDNA. In  rare  cases, 
eDNA can  even act  as a  barrier  to  microbial  adhesion 
(Berne et al.  2010). Similarly, major  differences exist in 
the way that different species release DNA into the envi- 
ronment,  and  in the capacities of different organisms to 
uptake free DNA and to incorporate  it into their genetic 
code.  Nevertheless, the  widespread  reliance  of  micro- 
organisms  on  eDNA makes  this  molecule an  attractive 
target  for  new approaches  to  controlling  microbial  bio- 
films. 
 
 
Early descriptions of eDNA 
 
The pioneering experiments of Avery, MacLeod and 
McCarty in  the  1940s demonstrated  unequivocally that 
DNA was the transforming principle for Streptococcus 
pneumoniae and, in doing so, provided the first clear evi- 
dence that  DNA is the  genetic blueprint  for life (Avery 
et al.  1979). At  the  same  time,  this  work  showed that 
DNA remains functional when outside bacterial cells. An 
enzymatic  activity  was  observed  in  dense  cultures  of 
Strep. pneumoniae  that   was  capable  of  degrading  the 
transforming factor. Therefore, even at this early stage, a 
picture began to emerge of a dynamic interplay between 
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bacterial cells and  free DNA in the environment.  In the 
following decade, a number  of descriptions appeared  in 
the  literature  of eDNA as a viscous ‘slime’ surrounding 
bacterial cells and  promoting  the formation  of a pellicle 
in  broth  cultures (Catlin  1956; Catlin and  Cunningham 
1958). Even Staphylococcus aureus, which produces exten- 
sive amounts  of extracellular deoxyribonuclease (DNase), 
accumulated  eDNA in  broth  cultures.  In  this  case, the 
production  of eDNA was enhanced under  DNase inhibi- 
tory conditions, such as high salt, low pH or low calcium 
(Catlin  and  Cunningham   1958).  The  accumulation  of 
eDNA by Pseudomonas fluorescens was dependent  on the 
concomitant  release of RNA, which inhibits extracellular 
DNase activity. Over the following decades, sporadic 
reports  described  physical effects of  eDNA on  cultured 
bacterial cells. For example, the slimy eDNA matrix  was 
shown to promote  cell clumping in Neisseria gonorrhoeae 
(Arko et al. 1979). In 2002, an important  link was made 
between eDNA and the structure of biofilms. During 
investigations of the polysaccharide matrix of Pseudomonas 
aeruginosa biofilms, it was found that eDNA constituted a 
major  component   of  the  matrix  material  (Whitchurch 
et al.  2002). Importantly,  treatment  of  nascent  biofilms 
with DNase I resulted in almost complete removal of cells 
from  the  surface. These data  demonstrated  for  the  first 
time that eDNA plays a key structural role in biofilms, and 
suggested the  possibility that  DNase enzymes might  be 
applicable for biofilm control. 
 
 
Extracellular DNA provides structural support for 
biofilms 
 
The  physical properties  of  the  DNA  molecule  make  it 
ideally suited for providing adhesive support  and protec- 
tion  to  microbial  cells. High  molecular  weight double- 
stranded DNA is viscous (Freund and Bernardi 1963) and, 
when  bound  to  surface of  bacterial cells, can  promote 
adhesion to hydrophobic substrata (Das et al. 2011). There 
is now strong evidence that  eDNA is also an important 
structural component of many different biofilms. For 
example, characterization of biofilm-inhibiting  com- 
pounds from marine bacteria identified a potent anti-bio- 
film molecule produced by an isolate of Bacillus 
licheniformis recovered from the surface of seaweed (Nij- 
land et al. 2010). After fractionation, the active agent was 
shown  to  be the  DNase enzyme NucB. NucB dispersed 
biofilms  formed  by  Micrococcus  luteus, Escherichia coli, 
Bacillus subtilis or B. licheniformis, indicating that eDNA is 
critical for stabilizing biofilms of each of these organisms. 
This  enzyme  also  promoted   the  dispersal  of  biofilms 
formed  by over 50% of bacterial strains freshly isolated 
from the paranasal sinuses of patients with chronic rhinos- 
inusitis (Fig. 1) (Shields et al. 2013). A number of studies 
have now demonstrated that different DNase enzymes can 
inhibit  the  formation  of  biofilms, or  can  disperse pre- 
formed biofilms, of many bacteria and fungi (Table 1). On 
the other hand, there are also several examples of biofilms 
that  contain  significant quantities  of eDNA but  are not 
dispersed by DNase enzymes (Lappann et al. 2010; Grande 
et al. 2011; Shields et al. 2013). Even in cases where DNase 
treatments do not remove biofilms, it is possible that they 
may weaken the biofilm structure. Thus, DNase treatment 
of biofilms has been shown to increase sensitivity to anti- 
microbials (Tetz et al. 2009; Tetz and Tetz 2010; Kaplan 
et al. 2012; Martins  et al. 2012), sodium  dodecyl sulfate 
(Allesen-Holm et al. 2006) or mechanical removal by soni- 
cation (Hu et al. 2012). Conversely, the addition of exoge- 
nous   DNA  to   Ps. aeruginosa  biofilms  increases  their 
tolerance to antimicrobial peptides and to aminoglycoside 
antibiotics such as tobramycin  and  gentimicin (Mulcahy 
et al. 2008; Chiang et al. 2013; Lewenza 2013). 
 
 
Origins of eDNA in biofilms 
 
Cell lysis provides a simple mechanism for releasing DNA 
into  the environment.  In some cases, active mechanisms 
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Figure 1  Extracellular DNA stabilizes biofilms of a clinical isolate of Staphylococcus  aureus.  Biofilms of Staph.  aureus  FH7 were  cultured  statically 
on glass coverslips and  treated  for 1 h at 37°C with PBS (a) or with PBS containing  3 lg ml
 1  
Bacillus licheniformis NucB (b). Cells were  stained 
with BacLight LIVE/DEAD dye and  living cells appear  green,  whereas  dead  cells stain red. (c) Extracellular DNA (e) extracted  from the  biofilm con- 
tains high molecular weight  DNA (>10 kbp), as does intracellular chromosomal  DNA (i), and indicated  by a square  bracket.  A marker (M) is shown 
for comparison.  Image was reproduced in part from Shields et al. (2013). 
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Micro-organism 
 
DNase enzyme 
Inhibition (I) or 
Dispersal (D)* 
 
Reference 
Bacteria 
Acinetobacter  baumanii,  Escherichia coli, Haemophilus  influenza, 
Klebsiella pneumoniae, Pseudomonas aeruginosa, 
Staphylococcus aureus,  Streptococcus  pyogenes 
Bordetella bronchiseptica, Bordetella pertussis 
 
DNase I 
 
 
DNase I 
 
D 
 
 
D, I 
 
Tetz et al. (2009) 
 
 
Conover et al. (2011) 
E. coli, Bacillus licheniformis, Bacillus subtilis, Micrococcus luteus 
E. coli, Staph.  aureus 
Enterococcus faecalis 
Listeria monocytogenes 
Neisseria gonorrhoeae 
Ps. aeruginosa 
Ps. aeruginosa 
Staph.  aureus 
Staph.  aureus,  Staphylococcus epidermidis 
Staph.  aureus,  Staph.  epidermidis, Staphylococcus  lugdunensis, 
Streptococcus  anginosus,  Streptococcus  constellatus, 
Streptococcus  intermedius,  Strepcococcus  salivarius 
Streptococcus  pneumoniae (clinical isolates) 
NucB (B. licheniformis) 
DNase I 
DNase I 
DNase I 
Nuc (N. gonorrhoeae) 
DNase I 
Varidase 
Varidase 
hrDNase I 
NucB (B. licheniformis) 
 
 
hrDNase I 
D 
I 
I 
D, I 
D 
D, I 
D 
D 
D, I 
D 
 
 
D 
Nijland et al. (2010) Tetz 
and Tetz (2010) Thomas 
et al. (2008) Harmsen et 
al. (2010) Steichen et al. 
(2011) Whitchurch et al. 
(2002) Nemoto  et al. 
(2003) Nemoto  et al. 
(2000) Kaplan et al. 
(2012) Shields et al. 
(2013) 
 
 
Hall-Stoodley et al. (2008) 
 
Candida albicans 
Aspergillus fumigatus 
 
DNase I 
DNase I 
 
D 
D 
 
Martins et al. (2010) 
Rajendran et al. (2013) 
 
 
 
Table  1  Examples of inhibition or dispersal of biofilms by exogenous  nucleases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fungi 
 
 
 
DNase I, bovine  DNase I;  hrDNase I, human  recombinant DNase I;  Varidase, a combination  of streptokinase and  streptodornase (streptococcal 
DNase). 
*Inhibition of biofilm formation  by inclusion of DNase during biofilm development or dispersal of preformed  biofilms. 
 
 
for initiating the lysis of a proportion  of a cell population 
contribute  to  eDNA release. The  existence of  autolysis 
mechanisms  has been known  for  many  years, but  their 
importance  for  releasing DNA  and  modulating  biofilm 
formation  is only beginning to be appreciated. In Entero- 
coccus faecalis, for example, autolysis is mediated by fratri- 
cide.   Microbial   fratricide   is   a   process   by   which   a 
proportion  of the  cells in a population  of micro-organ- 
isms, upon  induction,  release a factor that kills their 
siblings. In  the  case of Ent. faecalis, fratricide occurs in 
response to a quorum-sensing  signal at high cell densities 
(Thomas et al. 2009). Fratricide is mediated by the prote- 
ase GelE, which triggers a pathway that results in activa- 
tion of the primary autolysin AtlA. Immunity  to GelE is 
conferred  by the  AtlA-modifying protein  SprE. A small 
proportion   of  cells within  a  population  of  Ent. faecalis 
lack  SprE  and  undergo  autolysis in  response  to  GelE, 
releasing eDNA that stabilizes the biofilm (Thomas et al. 
2009). However, the links between autolysis and  biofilm 
formation  in Ent. faecalis are still far from clear. Disrup- 
tion  of the alternative sigma factor r54  leads to reduced 
autolysis and  DNA release from  cells, but  results in the 
development  of relatively thick biofilms (Iyer and  Han- 
cock  2012).  It  is  possible  that   compensatory  systems 
enable biofilm formation in the r
54  
mutant.  Nevertheless, 
there   is  accumulating   evidence  that   autolytic  and/or 
fratricidal  mechanisms  contribute  to  eDNA release and 
enhanced  biofilm production  in a wide range of micro- 
organisms including Gram-positive and Gram-negative 
bacteria,  and  fungi  (Allesen-Holm  et al.  2006; Yamada 
et al. 2009; Lappann et al. 2010; Hsu et al. 2011; Liu and 
Burne  2011; Bose et al.  2012; Christner  et al.  2012; Ju 
et al. 2012; Rajendran et al. 2013). A variety of environ- 
mental signals and cues trigger DNA release. For example, 
in  Ps. aeruginosa, the  release of  DNA  is  modulated  in 
response  to   the   pqs  quorum-sensing   system  and   to 
changes in the external iron concentration (Allesen-Holm 
et al. 2006; Yang et al. 2007). 
The active release of DNA fragments via lysis-indepen- 
dent mechanisms has been described in bacteria. For 
example, many Gram-negative organisms produce  mem- 
brane vesicles that  contain  DNA either in the lumen  or 
on the outer  surface (Dorward and Garon 1990; School- 
ing et al. 2009). Membrane vesicles originating from bac- 
terial  cell surfaces have been  observed in  Ps. aeruginosa 
monospecies biofilms and  in  natural  mixed-species bio- 
films  such  as  early  dental  plaque  (Frank  and  Houver 
1970; Schooling and Beveridge 2006). The production  of 
membrane vesicles by Pseudomonas spp. promotes biofilm 
formation    (Baumgarten   et al.   2012).   It   is   possible, 
although  by no  means  confirmed,  that  vesicle-mediated 
delivery of  DNA  to  the  biofilm  matrix  contributes  to 
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enhanced   biofilm   production.    Cell   lysis–independent 
DNA release has recently been described in an undomesti- 
cated strain  of the  Gram-positive  species B. subtilis and 
appears  to  be  linked  to  the  early competence  pathway 
(Zafra et al. 2012). In N. gonorrhoeae, an unusual type IV 
secretion  system (T4SS) provides  an  alternative mecha- 
nism  for  the  extrusion  of  DNA  into  the  extracellular 
milieu  (Hamilton  et al.  2005). Unlike  most  T4SSs, the 
N. gonorrhoeae system does not  require  cell–cell contact 
to  function.  N. gonorrhoeae biofilms are stabilized by an 
extensive matrix of eDNA (Steichen et al. 2011). At pres- 
ent,  the  relative contributions  of cell lysis, outer  mem- 
brane  vesicle production   and  the  T4SS to  the  overall 
matrix composition are unknown. 
 
 
Structural composition of eDNA in biofilms 
 
The primary sequence of eDNA is no different from that 
of  intracellular  DNA  (Zafra  et al.  2012),  but  there  is 
mounting    evidence   that   there   are   other   differences 
between eDNA and  intracellular  DNA, at  least in  some 
cases.  DNA  secreted  by  the  N. gonorrhoeae T4SS, for 
example,   requires   an   origin   of   transfer   (oriT)   and 
sequences of base pairs adjacent to oriT will therefore be 
enriched in eDNA compared with sites at distal portions 
of chromosome. The secreted DNA is single stranded and 
protected  from  5′–3′  exonuclease digestion,  possibly by 
interaction  with a protein  at the  5′ end  (Salgado-Pabon 
et al. 2007). The binding  of eDNA by proteins  has also 
been observed in several other  systems. In  Staph. aureus 
biofilms,  eDNA  catalyses the  covalent  cross-linking  of 
extracellular beta toxin, resulting in a stable nucleoprotein 
matrix (Huseby et al. 2010). The Strep. pneumoniae extra- 
cellular cell wall hydrolase LytC binds DNA in a nonse- 
quence-specific  manner   and   forms  nucleoprotein 
complexes in  biofilms (Domenech  et al. 2013). Neisseria 
meningitidis also forms extracellular nucleoprotein 
structures through interactions of the heparin-binding 
antigen NhbA and the alpha-peptide of IgA protease with 
eDNA (Arenas  et al.  2013).  In  the  Gram-negative  soil 
bacterium  Myxococcus  xanthus,  eDNA forms  complexes 
with  exopolysaccharides resulting in  biofilms with 
increased mechanical strength and adhesion capacity (Hu 
et al.  2012). Binding of  exogenous DNA to  membrane 
vesicles in  the  Ps. aeruginosa biofilm  matrix  has  been 
observed, although it is not yet clear what role this plays 
in  the  structure  or  function  of  the  biofilm  (Schooling 
et al. 2009). 
Extracellular DNA in biofilms can be visualized using 
fluorescent dyes, even in complex fungal/bacterial biofilms 
such as those present on fouled tracheoesophageal speech 
valves (Fig. 2). Imaging of eDNA can be enhanced using 
labelled anti-DNA immunoglobulins (Barnes et al. 2012). 
When extracted and purified from biofilms, eDNA often 
appears to be similar in structure  to chromosomal DNA. 
In many cases, eDNA forms a sharp band on agarose gels 
with an apparent migration of >10 kbp (Fig. 1c) (Shields 
et al. 2013). Analysis of eDNA by multilocus PCR or by 
random amplification of polymorphic DNA (RAPD) PCR 
has shown that eDNA is very similar in sequence compo- 
sition to chromosomal DNA in some organisms (Allesen- 
Holm et al. 2006; Qin et al. 2007; Rajendran et al. 2013), 
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Figure 2  Observation  of extracellular DNA (eDNA) in biofilms on fouled  tracheoesophageal speech  valves. (a) Voice prostheses  become  blocked 
during usage  with a thick microbial biofilm which is visible to the  naked  eye (brown  discolouration  in the  centre  of the  valve). (b) High-resolution 
imaging  by scanning  electron  microscopy demonstrates that  biofilms contain  different  types of cells including cocci and  rod shaped  bacteria,  and 
fungal  hyphae.  (c) Biofilms were  stained  with  propidium  iodide (red) and  4′,6-diamidino-2-phenylindole (DAPI; blue) to  highlight  dead  cells and 
eDNA, respectively, and  Alex Fluor-conjugated  concanavalin  A (green),  which  labels fungal  cell walls. eDNA is abundant within the  biofilm (thin 
arrow).  In some  regions,  propidium  iodide co-localized with DAPI (thick arrow),  probably  indicating  a localized region  with a high concentration 
of eDNA. 
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but markedly different in others (Steinberger and Holden 
2005; Bo€ckelmann et al. 2006; Grande et al. 2011). In the 
latter  case,  differences  may  arise  from  selective DNA 
secretion,  as  exemplified  by  the   N. gonorrhoeae T4SS 
described above, or  from  modification  of eDNA within 
the  biofilm  matrix.  However, it  is not  clear at  present 
which sequences are enriched in  eDNA, or  whether the 
enrichment  of sequences impacts on  the rate of transfer 
of  specific genes between  cells. It  is  also  possible that 
eDNA differs chemically from DNA inside cells, for exam- 
ple, by having different patterns  of methylation.  Clearly, 
there are many unanswered questions about the structure 
of eDNA within  biofilms. Further  investigations in  this 
area will be important  not only for the understanding  of 
the function of eDNA in biofilms, but also for the accu- 
rate interpretation  of data from studies that employ DNA 
amplification methodologies to analyse microbial biofilm 
communities. 
 
 
Extracellular DNA turnover 
 
Many   bacteria   produce   extracellular  DNase  enzymes, 
which are anchored  to the cell wall or secreted into  the 
extracellular milieu. The ability of different strains to pro- 
duce DNases does not  appear  to  correlate with reduced 
dependence  on   eDNA  for  biofilm  formation   (Shields 
et al. 2013). However, studies with isogenic mutants  have 
provided  evidence that  extracellular  nucleases keep  the 
growth of biofilms in check. In Shewanella oneidensis, the 
disruption  of genes encoding two extracellular nucleases, 
ExeS and ExeM, resulted in altered biofilm formation and 
the accumulation of eDNA (Godeke et al. 2011). Disrup- 
tion  of a third  nuclease-encoding gene, endA, had  little 
effect on  biofilm structure  (Heun  et al. 2012). Increased 
eDNA and  biofilm formation  has also been observed in 
DNase-defective mutants  of Vibrio cholerae or  N. gonor- 
rhoeae  (Seper   et al.   2011;  Steichen  et al.   2011).   In 
Staph. aureus,  the   disruption   of  nuc1  or   nuc2  genes 
encoding two extracellular nucleases resulted in increased 
biofilm formation  in vitro (Kiedrowski et al. 2011; Been- 
ken et al.  2012). However, the  introduction  of nuclease 
mutants into a murine catheter biofilm model resulted in 
reduced biofilm, determined as an increase in daptomycin 
sensitivity compared with the isogenic wild type (Beenken 
et al.  2012). It  is likely that  these nucleases have addi- 
tional roles in vivo that are not required in simple in vitro 
models. One key in vivo function  of microbial nucleases 
is the degradation of neutrophil  extracellular traps, which 
enables bacteria to escape from host immune systems 
(Beiter et al.  2006; Buchanan  et al.  2006; Berends et al. 
2010). It remains to be determined whether the degrada- 
tion  of host  DNA is important  for  the  development  of 
Staph. aureus biofilms on artificial surfaces in vivo. 
Extracellular microbial nucleases play a number  of key 
roles in bacteria, and their functions are likely facilitated 
by the proximity between bacterial cells and eDNA in the 
biofilm matrix. For example, the degradation of eDNA by 
DNases mobilizes nucleotides  that  can  be scavenged by 
micro-organisms as a source of carbon, nitrogen and 
phosphorous  (Pinchuk  et al. 2008; Mulcahy et al. 2010). 
Extracellular DNA  chelates  metal  ions  (Mulcahy  et al. 
2008), and it is possible that  extracellular nucleases pro- 
mote  the scavenging of trace metals by biofilm bacteria. 
Extracellular DNases also contribute  to  genetic transfor- 
mation.  Thus, the DNase activity observed by Avery and 
colleagues (Avery et al. 1979), and later identified as the 
cell wall-bound  enzyme EndA, nicks eDNA to  provide 
single-stranded substrate for the DNA uptake machinery 
and  is  essential  for  transformation   (Berge  et al.  2002; 
Moscoso  and  Claverys 2004).  It  is  not  clear  whether 
extracellular nucleases also have roles in the turnover  of 
DNA within cells, or whether they remain  inactive until 
they are outside the cell. 
 
 
Potential of exogenous nucleases for  biofilm 
control 
 
The  identification  of  eDNA  as  a  critical  molecule  for 
diverse  biofilms  immediately  suggests a  potential 
approach  for  biofilm  control  by  degrading  the  eDNA 
either  with chemical agents or  with enzymes. The latter 
approach  is  more  likely to  be  viable because enzymes, 
unlike chemical agents, are highly selective for the eDNA 
component   of  the  biofilm.  Enzymatic  degradation   of 
eDNA could potentially be achieved either by up-regulat- 
ing endogenous DNases within the biofilm or by adding 
nucleases exogenously. To induce the expression of 
endogenous DNases, the regulation of these systems must 
be understood.  Many bacterial nucleases are controlled at 
the level of transcription.  For example, in Staph. aureus, 
expression of Nuc is repressed by sigma factor B or glu- 
cose  (Kiedrowski  et al.  2011;  Schulthess  et al.  2011). 
Streptococcus pyogenes extracellular nucleases are regulated 
by the peroxide response regulator PerR and the nutrient 
stress-responsive  transcriptional   regulator   CodY  (Wen 
et al. 2011; McDowell et al. 2012). Nuclease production 
by V. cholerae is linked to  quorum  sensing and  compe- 
tence through  the HapR regulator (Blokesch and School- 
nik 2008). HapR becomes active at high cell densities and 
represses nuclease expression, allowing the  accumulation 
of eDNA for genetic transformation. In Clostridium 
perfringens, expression of the extracellular nuclease CadA 
is controlled by the virulence-related VirR/VirS two-com- 
ponent  system  (Okumura   et al.  2005).  Clearly, micro- 
organisms possess many  different systems for  regulating 
the expression of extracellular nucleases, and  approaches 
N.S. Jakubovics et al. Extracellular DNA in biofilms  
 
 
 
to control biofilm formation  based on stimulating intrin- 
sic nuclease expression are still some way off. 
The exogenous addition of nucleases may be a simpler 
approach  for  biofilm control.  Bacterial and  mammalian 
DNases have been shown to disperse monospecies biofilms 
in  vitro (Table 1).  Bovine DNase I  dramatically reduces 
the  thickness of dual-species Ps. aeruginosa/Staph. aureus 
biofilms, and B. licheniformis NucB promotes the dispersal 
of mixed-species biofilms from tracheoesophageal speech 
valves (Yang et al.  2011; Shakir et al.  2012), indicating 
that DNases may be broadly applicable for control of nat- 
ural mixed-species biofilms. Varidase and human  recom- 
binant DNase I (hrDNase I; marketed as Pulmozyme
      
or 
Dornase Alfa) have been employed in patients.  Varidase 
contains a DNase (streptodornase)  and a plasminogen 
activator (streptokinase). This has previously been used to 
promote wound healing (Smith et al. 2011), but has been 
withdrawn in most countries. Human recombinant DNase 
is employed clinically as a mucolytic for the treatment  of 
cystic fibrosis. There is some evidence that hrDNase I can 
disperse biofilms in vitro (Hall-Stoodley et al. 2008; Kap- 
lan et al. 2012), although it is not clear whether this activ- 
ity  occurs  in  vivo. A drawback  of  mammalian  DNases 
such as hrDNase I is that  they require  glycosylation for 
activity and cannot therefore be produced in bacterial 
expression systems (Fujihara et al. 2008), which dramati- 
cally increases the  costs of  production  and  limits  their 
potential applications. The purification of bacterial DNases 
can also be problematic, because they are often poorly tol- 
erated in E. coli. For example, expression of Strep. pneu- 
moniae  EndA  in  E. coli  is  difficult  unless  active  site 
residues are mutated (Midon et al. 2012). Further medical 
and biotechnological application of nucleases will require 
systems for their improved production,  such as the opti- 
mized  B. licheniformis NucB expression system that  has 
recently been described (Rajarajan et al. 2012). 
 
 
Conclusions 
 
Over the last decade or so, it has become clear that eDNA 
is a major structural component of many different micro- 
bial biofilms. Numerous  reports  have described the  dis- 
ruption  of  biofilms in  vitro by digestion  of  the  matrix 
with DNase enzymes. The next challenge is to move these 
studies into  more  natural  biofilm systems, where condi- 
tions  tend  to  be  less than  optimal  for  DNase  enzyme 
activity. Ultimately, the ability to employ DNases as bio- 
film control enzymes may depend on the development of 
enzymes that are robust, safe and active over a wide range 
of temperatures and pH values. It is unlikely that a single 
enzyme will be a ‘magic bullet’, capable of destroying all 
problematic  biofilms. However, even small successes in 
this field could provide major benefits for biofilm control. 
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Appendix B: Conference and Meeting Attendance 
 
31/10/2013: SfAM PECS Research Conference 2013, London (Poster Presentation) 
 
 
 
Title: An acid-sensitive deoxyribonuclease from the oral commensal Streptococcus 
gordonii  
 
The biofilm extracellular matrix can contain significant amounts of extracellular DNA 
which has a range of functions, including acting as a biofilm adhesin and increasing 
matrix stability. We have identified a surface-associated nuclease, SsnA, in the common 
oral commensal Streptococcus gordonii. The aim of this work was to assess the role of 
SsnA in disrupting biofilms produced by the cariogenic species Streptococcus mutans 
and the impact of acid on SsnA activity. The S. gordonii ssnA gene was fused to a 
Glutathione S-transferase (GST) tag in an Escherichia coli protein expression system 
and purified by affinity chromatography. The deoxyribonuclease activity of SsnA 
against double stranded DNA was confirmed using zymography. SsnA inhibited the 
attachment of S. mutans or dispersed S. mutans biofilms, grown in 96-well microtiter 
plates, by up to 90% compared with controls. Using fluorescence resonance energy 
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transfer assays, SsnA activity was rapidly inhibited by the presence of acid (pH 4.5). S. 
mutans is strongly acidogenic and potentially could protect itself from SsnA matrix 
degradation through the production of acid from carbohydrates. Future studies will aim 
to assess whether S. gordonii SsnA is inhibited by acid produced by S. mutans cultured 
with sucrose in order to characterise the ecological role of SsnA in dental plaque 
biofilms.  
 
 
10/09/2013: Eurobiofilms 2013, Ghent University, Belgium (Oral Presentation) 
 
Title: Removal of Oral Biofilms by a Marine Microbial Deoxyribonuclease 
 
Objectives: The biofilm matrix can contain significant amounts of extracellular DNA 
(eDNA), which has a number of key functions including acting as an adhesin and a 
scaffold during biofilm formation. The aims of this study were to determine if eDNA is 
present in oral biofilms and to investigate whether biofilms are sensitive to removal by a 
novel marine bacterial nuclease, NucB. 
 
Methods: Extracellular DNA in the biofilm matrices of Streptococcus gordonii DL1, 
Actinomyces oris MG1, Streptococcus mutans GS-5 and Fusobacterium nucleatum 
25586 was extracted and quantified. Extracellular DNA was visualised in intact 
biofilms using confocal laser scanning microscopy (CLSM). Species were grown in 96-
well plates and treated with bovine DNase I to assess its efficacy at removing forming, 
and pre-formed biofilms. A similar model was employed to evaluate anti-biofilm 
activity of NucB against mixed-species biofilms cultured from human saliva. 
 
Results: S. mutans, F. nucleatum and A. oris produced eDNA that migrated as a sharp 
band during agarose gel electrophoresis. Microscopy showed eDNA in A. oris biofilms 
and less clearly in S. mutans and F. nucleatum biofilms.  Biofilm biomass was reduced 
by up to 90% following treatment with DNase I. S. gordonii biofilms contained little 
eDNA and were not susceptible to DNase I. NucB caused a significant reduction in 10 
of the 24 saliva biofilms tested. 
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Conclusions: The data provide clear evidence that biofilms formed by oral bacteria rely 
on eDNA for structural support. Further studies will determine whether NucB can be 
used clinically for oral biofilm control. 
 
08/05/2013: COHR Research Afternoon, Newcastle (Oral Presentation) – 1st Place  
 
Title: Oral Biofilms Contain Extracellular DNA and are Dispersed by DNase I 
 
Objectives: Extracellular DNA (eDNA) is released by some oral bacteria but it is 
unknown if this contributes to oral biofilm matrix stability. The aims of this study were 
to determine if eDNA is present in oral biofilms and investigate if deoxyribonuclease I 
(DNase I) can disperse these biofilms. 
 
Methods: The abundance of eDNA in the established biofilm matrices of 4 oral bacteria, 
Streptococcus gordonii DL1, Actinomyces oris MG1, Streptococcus mutans GS-5 and 
Fusobacterium nucleatum 25586 was quantified via DNA extraction. Extracellular 
DNA was visualised with confocal laser scanning microscopy using LIVE/DEAD® 
BacLight™ to stain DNA surrounding the bacterial cells. Each species was grown in a 
96-well plate biofilm model and treated with bovine DNase I to assess its efficacy at 
removing forming, and pre-formed biofilms. 
 
Results: Streptococcus mutans, Fusobacterium nucleatum and Actinomyces oris 
produced enough eDNA to visualise it as a sharp band during agarose gel 
electrophoresis. For S. mutans and F. nucleatum, eDNA accounted for between 20-50% 
of the total DNA present. Microscopy revealed eDNA in A. oris biofilms. For S. mutans 
and F. nucleatum eDNA was less visible although it appears to be cell bound.  The 
addition of DNase I to A. oris, S. mutans and F. nucleatum biofilms caused dispersal 
and inhibition of up to 90%. By contrast, Streptococcus gordonii biofilms contained 
little eDNA and were not susceptible to DNase I.  
 
Conclusions: The data provide clear evidence that some oral biofilms depend on eDNA 
for structural support. Further studies are needed on in vivo grown dental plaque to 
elucidate any therapeutic potential. 
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25/03/2013: ICaMB’s Postgraduate Research Symposium, Dental Lecture Theatre 
D, Newcastle (Oral Presentation) 
 
Title: From Seaweed to Sinuses – Extracellular DNA in Biofilms 
 
A biofilm is a microbial community that is attached to a surface and encased in a 
hydrated polymeric matrix. In a biofilm, microbes exhibit greater resistance both to 
antimicrobial agents and the host immune system. Resistance is due, in part, to the 
robust polymeric matrix. Research has shown that the matrix contains significant 
amounts of extracellular DNA (eDNA) and that eDNA plays a number of key functions 
including acting as an adhesin and a scaffold for biofilm attachment. These observations 
pave the way for the development of novel anti-biofilm strategies employing DNA 
degrading enzymes (DNases). The aims of this project were to quantify the amount of 
eDNA and the potential of nucleases to disperse biofilms of relevance to the head and 
neck, including those associated with voice prostheses, chronic rhinosinusitis, and 
dental caries/periodontitis. Notably, this project began in marine science where a 
seaweed dwelling bacteria, Bacillus licheniformis, was found to produce an anti-biofilm 
compound that was later identified as a nuclease, NucB. Later, working in collaboration 
with the Ear, Nose and Throat department of the Freeman Hospital, Newcastle this 
enzyme was applied to testing its efficacy against biofilms that foul voice prostheses 
and those that cause chronic rhinosinusitis. Voice prostheses are given to patients 
who’ve received a total laryngectomy following cancer, as a way of rehabilitating 
speech. However, these silicon devices become damaged by the microbial biofilms that 
grow on the surface. With Chronic Rhinosinusitis, it is thought that bacterial biofilms 
contribute to the inflammation of the sinuses and/or block the sinuses. In both cases 
NucB was shown to be effective against these biofilms in the models employed. With 
chronic rhinosinusitis, a disease that affects 10% of the European population, the 
sinuses were found to contain many species of bacteria, of which several also produced 
eDNA, giving a reason for their susceptibility to NucB. 
 
For dental plaque, a complex mixed-species biofilm, research began by quantifying the 
eDNA found in the biofilm matrices of Actinomyces oris, Streptococcus mutans, 
Fusobacterium nucleatum and Streptococcus gordonii – four important oral bacteria. 
These biofilms contained eDNA, and three of the species, A. oris, S. mutans, F. 
nucleatum, were dispersed by bovine DNase I. NucB was used to treat mixed-species 
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biofilms grown from human saliva inoculae and had a variable effect, leading to a 
reduction in 10 of the 24 biofilms tested. Streptococcus gordonii, an important early 
colonizer of dental plaque produces an extracellular nuclease, SsnA. To further 
understand the role of this enzyme in S. gordonii the ssnA gene was cloned into an 
Escherichia coli protein expression system and the protein was purified using affinity 
chromatography. The activity of the enzyme against dsDNA was verified using 
zymography. SsnA also dispersed the biofilm of S. mutans GS-5. Notably, this enzyme 
was down-regulated in response to the low pH environments created by sugar 
fermentation. This could have implications in the oral environment, which is 
characterized as having periods of acidity, thus stopping the use of this enzyme by S. 
gordonii at particular time points. 
 
Taken together, the data indicate that eDNA is an important component in many 
clinically relevant biofilm forming bacteria. What has emerged is that total eDNA and 
the efficacy of nucleases against microbial biofilms is highly variable. This variation 
and the application of more complex mixed-species biofilm models is the next vital 
avenue of research. Fundamentally, why do bacteria expend energy creating the 
molecule of heredity, DNA, only to discard it into the matrix around them? 
 
26/10/2012: North East Postgraduate Conference, The Hancock Museum, 
Newcastle (Poster Presentation) 
 
Presented the same poster as that at the SGM Autumn Conference. 
 
03/09/2012: SGM Autumn Conference 2012, Warwick University (Poster 
Presentation) 
 
Title: Characterization of a Surface-associated Nuclease of Streptococcus gordonii 
 
The biofilm extracellular matrix contains significant amounts of extracellular DNA 
(eDNA) which has a range of functions, including acting as a biofilm adhesin and a 
structural support. However, the eDNA may also be a target for matrix turnover and 
degradation. Thus, we have identified a surface-associated nuclease, SsnA, in the 
common oral commensal Streptococcus gordonii. The aim of this work was to assess 
the role of SsnA in disrupting biofilms produced by different oral bacteria. The 
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Streptococcus gordonii ssnA gene was cloned into a Glutathione S-transferase (GST) 
Escherichia coli protein expression system and purified by affinity chromatography. 
The activity of SsnA was confirmed using zymography, showing that the purified 
protein degraded double stranded DNA. SsnA was able to disperse or inhibit the 
attachment of oral bacteria, grown in 96-well microtiter plates. This included strains of 
the cariogenic bacteria Streptococcus mutans, which were dispersed by up to 90% by 
the enzyme. Future studies will aim to assess whether S. gordonii can disperse or inhibit 
bacteria in a mixed species model. It may be that this enzyme plays an important role in 
the plaque biofilm by reducing the abundance of oral bacteria that rely on extracellular 
DNA in their biofilm matrices. 
 
Poster: 
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26/04/2012: Oral Microbiology and Immunology Group Postgraduate Meeting, 
Newcastle (Oral Presentation) 
 
Title: Extracellular DNA in Biofilms Associated with Chronic Rhinosinusitis 
 
Chronic Rhinosinusitis (CRS) affects approximately 10% of the adult European 
population. It is an inflammatory disease that is often triggered by bacterial biofilms in 
the paranasal sinuses. Healthy sinuses are non-sterile but there is an important 
microbiological flora change in CRS, with species such as Streptococcus pneumoniae 
and Staphylococcus aureus being more frequently isolated in disease. Oral bacteria, 
including Fusobacterium spp. and Prevotella spp. can also be found in the sinuses of 
CRS sufferers, indicating that there is a connection between the oral cavity and the 
paranasal sinuses. Increasingly, it appears that biofilm forming bacteria utilise 
extracellular DNA (eDNA) for initial adhesion to surfaces and for biofilm matrix 
stability. In addition, some bacteria produce extracellular DNases to remodel biofilm 
matrices. This project aimed to investigate the role of eDNA and microbial DNases in 
biofilms formed by CRS-associated bacteria. 
 
Twenty patients diagnosed with CRS were recruited to the study. Microbiological 
analysis of aspirates removed during functional endoscopic sinus surgery revealed an 
average of 3.75 bacterial isolates per patient (75 isolates in total). Bacteria associated 
with CRS included coagulase-negative staphylococci, corynebacteria, streptococci, and 
S. aureus. Thirteen (17%) strains produced an extracellular DNase. All S. aureus 
isolates produced an extracellular DNase, and other producers were Streptococcus 
milleri group strains, Staphylococcus lugdunensis and Streptococcus salivarius. 
Selected isolates were cultured in 96-well microtiter plates to determine their ability to 
form biofilms. All tested isolates were capable of forming biofilms, although the extent 
of formation was species and strain specific. The role of eDNA was investigated by 
treating biofilms with a bacterial DNase. This enzyme removed between 0-60% of 
biofilm in different monoculture systems. Taken together, these results demonstrate that 
CRS-associated bacteria utilise eDNA in biofilms, and that some CRS bacteria have the 
potential to remodel this component of the matrix.  
 
18/04/2012: Society for Applied Microbiology Spring Meeting, Stratford-upon-
Avon (Attended Meeting) 
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17/11/2011: ICaMB Postgraduate Conference, Baddiley-Clark, Newcastle (Oral 
Presentation) 
 
12/09/2011: British Society for Oral and Dental Research Annual Meeting, 
Sheffield (Oral Presentation) 
 
Title: Reducing Dental Plaque Formation with a Novel Bacterial Nuclease 
 
Objectives: Although extracellular DNA (eDNA) is known to be a significant 
component of many environmental and health-associated biofilm matrices, its role in 
oral biofilms is unclear. We have identified a novel extracellular nuclease (NucB) from 
Bacillus licheniformis, which can disperse biofilms by degrading constituent eDNA.  
The aim of this investigation was therefore to determine whether model dental plaque 
biofilms can be disrupted using this enzyme. 
 
Methods: Biofilms were developed on the surface of polystyrene microtitre plates from 
strains of oral bacteria or from natural microbial populations in human saliva. Salivary 
inoculae from 6 volunteers were used for establishing mixed-species biofilm 
populations. Mixed species biofilms were incubated for up to 20 hours at 37
o
C either 
aerobically in the presence of 2% sucrose or anaerobically. Single strains were 
incubated anaerobically. NucB (1 µg ml
-1
) was applied to cultures either before or after 
biofilm development. Residual biofilm was quantified by staining with crystal violet. 
 
Results: NucB inhibited and/or dispersed a variety of single strain and mixed-species 
oral biofilms. In mixed-species cultures, reductions in biofilm biomass of up to 66% 
were observed when NucB was added prior to biofilm formation compared with 
untreated controls. Addition of NucB to preformed biofilms resulted in up to 42% 
reduction of the attached biofilm. Certain individual bacterial strains were extremely 
sensitive to NucB; biofilm extent was reduced by up to 90% in the presence of the 
enzyme. Nuclease sensitivity of biofilms from natural salivary inoculae was dependent 
on incubation conditions (anaerobic versus aerobic with sucrose) and the time span of 
biofilm development.  
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Conclusions: We have shown that the addition of nuclease inhibits and disperses 
biofilms grown in vitro, suggesting that eDNA may play a role in oral biofilm formation 
in vivo. Therefore, microbial nucleases such as NucB may be highly effective at 
controlling the accumulation of dental plaque. 
 
 
23/05/2011: Marine Science and Technology Postgraduate Symposium, Newcastle 
(Oral Presentation) – 1st Place 
 
13/05/2011: British Rhinological Society Annual Meeting, Edinburgh (Poster 
Presentation) – 3rd Place 
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08/04/2011: Scottish and Northern Periodontal Research Group Conference 2011, 
Old Library Building (Attended Meeting) 
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Appendix C: Public Engagement 
 
Newcastle Science City Showcase 
 
Held at the Centre for Life in Newcastle city centre, this event was aimed at showcasing 
the rich diversity of scientific discovery in Newcastle. Our event allowed children and 
adults to explore the oral biofilm with active demonstrations of plaque bacteria with a 
microscope, plaque disclosing tablets and competitions for fluffy microbes!  
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Chronic Rhinosinusitis Press Release 2013 
 
Coinciding with the publication of a paper in PLoS ONE there was a press release that 
featured on TV, radio and internationally in newspapers.  
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British Science Festival 2013 – What’s hiding in Your Mouth? 
 
I helped organise an event at the British Science Festival, held in Newcastle in 2013. 
This free event aimed to promote knowledge about oral hygiene and the microbiology 
of the mouth. 
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Appendix D: Vector Maps 
 
pUC 19 
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pGEX-KT 
 
 
Appendices 
237 
 
Appendix E: GST-tag purification diagram
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Appendix F: GST-SsnA Peptide Mass Fingerprinting Results 
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